
<html lang="en"     class="pb-page"  data-request-id="6dfce550-6a71-424d-bdc3-dc33982adb6b"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;article:article:10.1021/jm100505n;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;wgroup:string:ACHS website Group;issue:issue:10.1021/jmcmar.2010.53.issue-16;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Discovery of (3S,3aR)-2-(3-Chloro-4-cyanophenyl)-3-cyclopentyl-3,3a,4,5-tetrahydro-2H-benzo[g]indazole-7-carboxylic Acid (PF-3882845), an Orally Efficacious Mineralocorticoid Receptor (MR) Antagonist for Hypertension and Nephropathy" /></meta><meta name="dc.Creator" content="Marvin J.  Meyers" /></meta><meta name="dc.Creator" content="Graciela B.  Arhancet" /></meta><meta name="dc.Creator" content="Susan L.  Hockerman" /></meta><meta name="dc.Creator" content="Xiangyang  Chen" /></meta><meta name="dc.Creator" content="Scott A.  Long" /></meta><meta name="dc.Creator" content="Matthew W.  Mahoney" /></meta><meta name="dc.Creator" content="Joseph R.  Rico" /></meta><meta name="dc.Creator" content="Danny J.  Garland" /></meta><meta name="dc.Creator" content="James. R.  Blinn" /></meta><meta name="dc.Creator" content="Joe T.  Collins" /></meta><meta name="dc.Creator" content="Shengtian  Yang" /></meta><meta name="dc.Creator" content="Horng-Chih  Huang" /></meta><meta name="dc.Creator" content="Kevin F.  McGee" /></meta><meta name="dc.Creator" content="Jay M.  Wendling" /></meta><meta name="dc.Creator" content="Jessica D.  Dietz" /></meta><meta name="dc.Creator" content="Maria A.  Payne" /></meta><meta name="dc.Creator" content="Bruce L.  Homer" /></meta><meta name="dc.Creator" content="Marcia I.  Heron" /></meta><meta name="dc.Creator" content="David B.  Reitz" /></meta><meta name="dc.Creator" content="Xiao  Hu" /></meta><meta name="dc.Description" content="We have discovered a novel class of nonsteroidal pyrazoline antagonists of the mineralocorticoid receptor (MR) that show excellent potency and selectivity against other nuclear receptors. Early ana..." /></meta><meta name="Description" content="We have discovered a novel class of nonsteroidal pyrazoline antagonists of the mineralocorticoid receptor (MR) that show excellent potency and selectivity against other nuclear receptors. Early ana..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="July 30, 2010" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/jm100505n" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2010 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Fjm100505n" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Fjm100505n" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Fjm100505n" /></link>
        
    
    

<title>Discovery of (3S,3aR)-2-(3-Chloro-4-cyanophenyl)-3-cyclopentyl-3,3a,4,5-tetrahydro-2H-benzo[g]indazole-7-carboxylic Acid (PF-3882845), an Orally Efficacious Mineralocorticoid Receptor (MR) Antagonist for Hypertension and Nephropathy | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/jm100505n" /></meta><meta property="og:title" content="Discovery of (3S,3aR)-2-(3-Chloro-4-cyanophenyl)-3-cyclopentyl-3,3a,4,5-tetrahydro-2H-benzo[g]indazole-7-carboxylic Acid (PF-3882845), an Orally Efficacious Mineralocorticoid Receptor (MR) Antagonist for Hypertension and Nephropathy" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-16/jm100505n/production/images/large/jm-2010-00505n_0012.jpeg" /></meta><meta property="og:description" content="We have discovered a novel class of nonsteroidal pyrazoline antagonists of the mineralocorticoid receptor (MR) that show excellent potency and selectivity against other nuclear receptors. Early analogues were poorly soluble and had a propensity to inhibit the hERG channel. Remarkably, both of these challenges were overcome by incorporation of a single carboxylate moiety. Structural modification of carboxylate-containing lead R-4g with a wide range of substituents at each position of the pyrazoline ring resulted in R-12o, which shows excellent activity against MR and reasonable pharmacokinetic profile. Introduction of conformational restriction led to a novel series characterized by exquisite potency and favorable steroid receptor selectivity and pharmacokinetic profile. Oral dosing of 3S,3aR-27d (PF-3882845) in the Dahl salt sensitive preclinical model of salt-induced hypertension and nephropathy showed blood pressure attenuation significantly greater than that with eplerenone, reduction in urinary albumin, and renal protection. As a result of these findings, 3S,3aR-27d was advanced to clinical studies." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/jm100505n"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/jm100505n">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Fjm100505n&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Fjm100505n&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/jm100505n&amp;href=/doi/10.1021/jm100505n" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2010</span><span class="cit-fg-volume">, 53</span><span class="cit-fg-issue">, 16</span><span class="cit-fg-pageRange">, 5979-6002</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/53/16" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/jm100506y" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/jm9013696" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Discovery of (3<i>S</i>,3a<i>R</i>)-2-(3-Chloro-4-cyanophenyl)-3-cyclopentyl-3,3a,4,5-tetrahydro-2<i>H</i>-benzo[<i>g</i>]indazole-7-carboxylic Acid (PF-3882845), an Orally Efficacious Mineralocorticoid Receptor (MR) Antagonist for Hypertension and Nephropathy</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Marvin+J.++Meyers">Marvin J. Meyers</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Graciela+B.++Arhancet">Graciela B. Arhancet</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Susan+L.++Hockerman">Susan L. Hockerman</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Xiangyang++Chen">Xiangyang Chen</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Scott+A.++Long">Scott A. Long</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Matthew+W.++Mahoney">Matthew W. Mahoney</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Joseph+R.++Rico">Joseph R. Rico</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Danny+J.++Garland">Danny J. Garland</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=James.+R.++Blinn">James. R. Blinn</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Joe+T.++Collins">Joe T. Collins</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Shengtian++Yang">Shengtian Yang</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Horng-Chih++Huang">Horng-Chih Huang</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Kevin+F.++McGee">Kevin F. McGee</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jay+M.++Wendling">Jay M. Wendling</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jessica+D.++Dietz">Jessica D. Dietz</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Maria+A.++Payne">Maria A. Payne</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Bruce+L.++Homer">Bruce L. Homer</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Marcia+I.++Heron">Marcia I. Heron</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=David+B.++Reitz">David B. Reitz</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Xiao++Hu">Xiao Hu</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff1"><span class="aff-symbol">†</span> <span class="aff-text">St. Louis Laboratories, Pfizer Global Research and Development, Pfizer, Inc., 700 Chesterfield Parkway West, Chesterfield, Missouri 63017</span></div><div class="aff-info" id="aff2"><span class="aff-symbol">‡</span> <span class="aff-text">Albany Molecular Research, Inc., 26 Corporate Circle, Albany, New York 12203</span></div><div class="corresp-info"><strong>*</strong>To whom correspondence should be addressed. For M.J.M.: phone, 314-977-5197; fax, 314-977-5220; e-mail, <a href="/cdn-cgi/l/email-protection#ef82828a968a9d9cd7af9c839ac18a8b9a"><span class="__cf_email__" data-cfemail="abc6c6ced2ced9d893ebd8c7de85cecfde">[email protected]</span></a>. For G.B.A.: phone, 636-926-7471; fax, 636-926-7449; e-mail, <a href="/cdn-cgi/l/email-protection#aec9dccfcdc7cbc2cf80cfdcc6cfc0cdcbdaeec0c1d8dbddc7c0da80cdc1c3"><span class="__cf_email__" data-cfemail="85e2f7e4e6ece0e9e4abe4f7ede4ebe6e0f1c5ebeaf3f0f6ecebf1abe6eae8">[email protected]</span></a></div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Fjm100505n&amp;href=/doi/10.1021%2Fjm100505n" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2010</span></span><span class="cit-volume">, 53</span><span class="cit-issue">, 16</span><span class="cit-pageRange">, 5979–6002</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">July 30, 2010</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>26 April 2010</li><li><span class="item_label"><b>Published</b> online</span>30 July 2010</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 26 August 2010</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/jm100505n" title="DOI URL">https://doi.org/10.1021/jm100505n</a></div><div class="article_header-article-copyright"><strong>Copyright © 2010 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D5979%26pageCount%3D24%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DMarvin%2BJ.%2BMeyers%252C%2BGraciela%2BB.%2BArhancet%252C%2BSusan%2BL.%2BHockerman%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D53%26issueNum%3D16%26contentID%3Djm100505n%26title%3DDiscovery%2Bof%2B%25283S%252C3aR%2529-2-%25283-Chloro-4-cyanophenyl%2529-3-cyclopentyl-3%252C3a%252C4%252C5-tetrahydro-2H-benzo%255Bg%255Dindazole-7-carboxylic%2BAcid%2B%2528PF-3882845%2529%252C%2Ban%2BOrally%2BEfficacious%2BMineralocorticoid%2BReceptor%2B%2528MR%2529%2BAntagonist%2Bfor%2BHypertension%2Band%2BNephropathy%26numPages%3D24%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D6002%26publicationDate%3DAugust%2B2010">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/jm100505n"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">4262</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">79</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/jm100505n" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Discovery of (3S,3aR)-2-(3-Chloro-4-cyanophenyl)-3-cyclopentyl-3,3a,4,5-tetrahydro-2H-benzo[g]indazole-7-carboxylic Acid (PF-3882845), an Orally Efficacious Mineralocorticoid Receptor (MR) Antagonist for Hypertension and Nephropathy&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Marvin&quot;,&quot;last_name&quot;:&quot;J. Meyers&quot;},{&quot;first_name&quot;:&quot;Graciela&quot;,&quot;last_name&quot;:&quot;B. Arhancet&quot;},{&quot;first_name&quot;:&quot;Susan&quot;,&quot;last_name&quot;:&quot;L. Hockerman&quot;},{&quot;first_name&quot;:&quot;Xiangyang&quot;,&quot;last_name&quot;:&quot;Chen&quot;},{&quot;first_name&quot;:&quot;Scott&quot;,&quot;last_name&quot;:&quot;A. Long&quot;},{&quot;first_name&quot;:&quot;Matthew&quot;,&quot;last_name&quot;:&quot;W. Mahoney&quot;},{&quot;first_name&quot;:&quot;Joseph&quot;,&quot;last_name&quot;:&quot;R. Rico&quot;},{&quot;first_name&quot;:&quot;Danny&quot;,&quot;last_name&quot;:&quot;J. Garland&quot;},{&quot;first_name&quot;:&quot;James.&quot;,&quot;last_name&quot;:&quot;R. Blinn&quot;},{&quot;first_name&quot;:&quot;Joe&quot;,&quot;last_name&quot;:&quot;T. Collins&quot;},{&quot;first_name&quot;:&quot;Shengtian&quot;,&quot;last_name&quot;:&quot;Yang&quot;},{&quot;first_name&quot;:&quot;Horng-Chih&quot;,&quot;last_name&quot;:&quot;Huang&quot;},{&quot;first_name&quot;:&quot;Kevin&quot;,&quot;last_name&quot;:&quot;F. McGee&quot;},{&quot;first_name&quot;:&quot;Jay&quot;,&quot;last_name&quot;:&quot;M. Wendling&quot;},{&quot;first_name&quot;:&quot;Jessica&quot;,&quot;last_name&quot;:&quot;D. Dietz&quot;},{&quot;first_name&quot;:&quot;Maria&quot;,&quot;last_name&quot;:&quot;A. Payne&quot;},{&quot;first_name&quot;:&quot;Bruce&quot;,&quot;last_name&quot;:&quot;L. Homer&quot;},{&quot;first_name&quot;:&quot;Marcia&quot;,&quot;last_name&quot;:&quot;I. Heron&quot;},{&quot;first_name&quot;:&quot;David&quot;,&quot;last_name&quot;:&quot;B. Reitz&quot;},{&quot;first_name&quot;:&quot;Xiao&quot;,&quot;last_name&quot;:&quot;Hu&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2010&quot;,&quot;month&quot;:&quot;07&quot;,&quot;day&quot;:&quot;30&quot;,&quot;issue&quot;:&quot;16&quot;,&quot;volume&quot;:&quot;53&quot;,&quot;pages&quot;:&quot;5979-6002&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/jm100505n&quot;},&quot;abstract&quot;:&quot;We have discovered a novel class of nonsteroidal pyrazoline antagonists of the mineralocorticoid receptor (MR) that show excellent potency and selectivity against other nuclear receptors. Early analogues were poorly soluble and had a propensity to inhibit the hERG channel. Remarkably, both of these challenges were overcome by incorporation of a single carboxylate moiety. Structural modification of carboxylate-containing lead R-4g with a wide range of substituents at each position of the pyrazoline ring resulted in R-12o, which shows excellent activity against MR and reasonable pharmacokinetic profile. Introduction of conformational restriction led to a novel series characterized by exquisite potency and favorable steroid receptor selectivity and pharmacokinetic profile. Oral dosing of 3S,3aR-27d (PF-3882845) in the Dahl salt sensitive preclinical model of salt-induced hypertension and nephropathy showed blood pressure attenuation significantly greater than that with eplerenone, reduction in urinary albumin, a&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Fjm100505n&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm100505n" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm100505n&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=jm100505n" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm100505n&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=jm100505n" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Fjm100505n&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm100505n&amp;href=/doi/10.1021/jm100505n" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/jm100505n" /></input><a href="/doi/pdf/10.1021/jm100505n" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (3 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/jm100505n&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Fjm100505n%26sid%3Dliteratum%253Aachs%26pmid%3D20672822%26genre%3Darticle%26aulast%3DMeyers%26date%3D2010%26atitle%3DDiscovery%2Bof%2B%25283S%252C3aR%2529-2-%25283-Chloro-4-cyanophenyl%2529-3-cyclopentyl-3%252C3a%252C4%252C5-tetrahydro-2H-benzo%255Bg%255Dindazole-7-carboxylic%2BAcid%2B%2528PF-3882845%2529%252C%2Ban%2BOrally%2BEfficacious%2BMineralocorticoid%2BReceptor%2B%2528MR%2529%2BAntagonist%2Bfor%2BHypertension%2Band%2BNephropathy%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D53%26issue%3D16%26spage%3D5979%26epage%3D6002%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (1)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=291171" title="Antagonists">Antagonists</a>,</li><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a>,</li><li><a href="/action/doSearch?ConceptID=292349" title="Alkyls">Alkyls</a>,</li><li><a href="/action/doSearch?ConceptID=291711" title="Selectivity">Selectivity</a>,</li><li><a href="/action/doSearch?ConceptID=292186" title="Receptors">Receptors</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/53/16" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-16/jmcmar.2010.53.issue-16/production/jmcmar.2010.53.issue-16.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_tgr1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-16/jm100505n/production/images/medium/jm-2010-00505n_0012.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-16/jm100505n/production/images/large/jm-2010-00505n_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm100505n&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">We have discovered a novel class of nonsteroidal pyrazoline antagonists of the mineralocorticoid receptor (MR) that show excellent potency and selectivity against other nuclear receptors. Early analogues were poorly soluble and had a propensity to inhibit the hERG channel. Remarkably, both of these challenges were overcome by incorporation of a single carboxylate moiety. Structural modification of carboxylate-containing lead <i><b>R</b></i><b>-4g</b> with a wide range of substituents at each position of the pyrazoline ring resulted in <i><b>R</b></i><b>-12o</b>, which shows excellent activity against MR and reasonable pharmacokinetic profile. Introduction of conformational restriction led to a novel series characterized by exquisite potency and favorable steroid receptor selectivity and pharmacokinetic profile. Oral dosing of <b>3</b><i><b>S</b></i><b>,3a</b><i><b>R</b></i><b>-27d</b> (PF-3882845) in the Dahl salt sensitive preclinical model of salt-induced hypertension and nephropathy showed blood pressure attenuation significantly greater than that with eplerenone, reduction in urinary albumin, and renal protection. As a result of these findings, <b>3</b><i><b>S</b></i><b>,3a</b><i><b>R</b></i><b>-27d</b> was advanced to clinical studies.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i1">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_41658" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_41658" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Almost one in three adults in the U.S. has high blood pressure (BP<a class="ref internalNav" href="#fnabbrev" aria-label="a">a</a>), <div class="NLM_fn" id="fnabbrev">a<p class="last">Abbreviations: MR, mineralocorticoid receptor; BP, blood pressure; CCB, calcium channel blocker; RAAS, renin−angiotensin−aldosterone system; ACE, angiotensin converting enzyme; ARB, angiotensin receptor blocker; NR, nuclear receptor; CHF, congestive heart failure; HTS, high-throughput screening; SFC, supercritical fluid chromatography; DMF, <i>N</i>,<i>N</i>-dimethylformamide; NBS, <i>N</i>-bromosuccinimide; THF, tetrahydrofuran; TEA, triethylamine; DME, dimethoxyethane; LDA, lithium diisopropylamide; THP, tetrahydropyran; NOE, nuclear Overhauser effect; LiHMDS, lithium hexamethyldisilazide; SAR, structure−activity relationship; PR, progesterone receptor; AR, androgen receptor; GR, glucocorticoid receptor; ER, estrogen receptor; PK, pharmacokinetic; iv, intravenous; po, oral dosing; CL, clearance; <i>V</i><sub>dss</sub>, volume of distribution at steady state; <i>F</i>, oral bioavailability; SS, salt sensitive; SBP, systolic blood pressure; b.i.d., twice a day; UACR, urinary albumin to creatinine ratio.</p></div> putting them at a markedly increased risk of major cardiovascular and renal diseases and shortened life expectancy.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> Several classes of antihypertensive drugs have been developed. These include diuretics, calcium channel blockers (CCB), and drugs that target the renin−angiotensin−aldosterone system (RAAS), known as renin inhibitors, angiotensin converting enzyme inhibitors (ACE), and angiotensin receptor blockers (ARBs).<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a></div><div class="NLM_p">Aldosterone is a steroid hormone that mediates sodium reabsorption by binding to the mineralocorticoid receptor (MR), a member of the nuclear receptor (NR) superfamily of ligand-dependent transcription factors. Abnormal activation of the MR by elevated levels of aldosterone in the presence of salt imbalance causes hypertension and other detrimental effects to the cardiovascular system such as glomerular and tubular sclerosis.<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> Although upstream inhibitors of RAAS have demonstrated clinically successful drug therapy in treating congestive heart failure (CHF), the utility of ACE inhibitors is limited because of “aldosterone breakthrough”, a phenomenon where aldosterone levels elevate overtime. Direct blockade of aldosterone activation of the MR may provide an improved or add-on therapy to existing standard of care.</div><div class="NLM_p">There are two approaches to treat this abnormal level of aldosterone activation of the MR. One approach involves lowering elevated aldosterone levels using aldosterone synthase inhibitors.<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a> Alternatively, MR antagonists, such as spironolactone and more recently eplerenone, selectively block MR activation by aldosterone, resulting in a lowering of blood pressure in hypertensive patients and improved cardiac function, reduced hospitalizations, and reduced mortality in heart failure patients.<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a> Furthermore, human clinical trials have demonstrated that administration of MR antagonists spironolactone and eplerenone resulted in a greater reduction in albuminuria compared to ACE inhibitors with similar hypotensive effects in hypertensive patients, demonstrating the therapeutic potential of MR antagonists for diabetic nephropathy.<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a></div><div class="NLM_p">In general, steroidal MR antagonists present issues of complex chemical synthesis, undesirable physical properties, and poor selectivity versus other steroid hormone receptors. For example, spironolactone therapy has been limited because of poor selectivity versus other NRs and undesirable side effects (gynecomastia, hyperkalemia, menstrual irregularities).<a onclick="showRef(event, 'cit5c ref7'); return false;" href="javascript:void(0);" class="ref cit5c ref7">(5c, 7)</a> Thus, there has been an effort to discover novel classes of selective, potent, nonsteroidal MR antagonists in recent years (e.g., <b>1</b>, <b>2</b>, Chart <a class="ref internalNav" href="#cht1" aria-label="1">1</a>).<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> As part of our research program directed toward the discovery of new nonsteroidal MR antagonists, we and others have recently reported that dihydropyridines (e.g, <b>3</b>) also possess excellent MR antagonist activity.<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a></div><figure id="cht1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Chart 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-16/jm100505n/production/images/medium/jm-2010-00505n_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-16/jm100505n/production/images/large/jm-2010-00505n_0013.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Chart 1. Steroidal and Nonsteroidal MR Antagonists</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-16/jm100505n/production/images/large/jm-2010-00505n_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm100505n&amp;id=cht1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">In an effort to discover a nonsteroidal MR antagonist with superior druglike properties and improved nuclear hormone receptor selectivity profile, we identified pyrazoline compound <b>4a</b>, a racemate, during a high-throughput screening (HTS) campaign. Pyrazoline derivatives and related nonsteroidal scaffolds have also been described by others as ligands for the estrogen, progesterone, and androgen receptors.<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> Described herein is the modification of this novel class of nonsteroidal MR antagonists, which has led to the identification of potent and selective conformationally restricted pyrazoline MR antagonists. On the basis of its favorable potency, selectivity, pharmacokinetic profile, and in vivo efficacy in the Dahl salt-sensitive model of hypertension,<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> pyrazoline <b>3</b><i><b>S</b></i><b>,3a</b><i><b>R</b></i><b>-27d</b> (PF-3882845) was selected as a clinical candidate.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i3">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_22073" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_22073" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Pyrazoline <b>4a</b> (Chart <a class="ref internalNav" href="#cht2" aria-label="2">2</a>) was identified as having MR antagonist activity on aldosterone-induced activation of a luciferase reporter driven by MR ligand binding domain in HUH7 cells (IC<sub>50</sub> = 460 nM).<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> Although having an acceptable activity as a starting point, <b>4a</b> had many undesirable features that needed to be amended in order to develop a bona fide lead, namely, the presence of a nitro and a phenol group and a triaryl scaffold that rendered it very insoluble and lipophilic. We modified each position in the pyrazoline ring (termed as N1, C3, and C5) and then incorporated the preferred groups in a final array of analogues.</div><figure id="cht2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Chart 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-16/jm100505n/production/images/medium/jm-2010-00505n_0014.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-16/jm100505n/production/images/large/jm-2010-00505n_0014.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Chart 2. Pyrazoline HTS Hit</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-16/jm100505n/production/images/large/jm-2010-00505n_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm100505n&amp;id=cht2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i5" class="anchor-spacer"></div><h3 class="article-section__title" id="_i5"> Chemistry</h3><div class="NLM_p">The synthesis of pyrazolines <b>4a</b>−<b>k</b> is shown in Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a>.<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> The first step is the formation of chalcone intermediate <b>6</b> by base- or acid-catalyzed Claisen−Schmidt condensation of an aryl or alkyl aldehyde with an aryl methyl ketone. Treatment of <b>6</b> with commercially available phenylhydrazines <b>7</b> under acidic conditions afforded the racemic pyrazoline in reasonable overall yields. Ester containing pyrazolines were hydrolyzed under basic conditions to give the corresponding carboxylic acids (e.g., <b>4f</b>,<b>i</b>). Select examples were then resolved by chiral supercritical fluid chromatography (SFC) to yield the individual enantiomers.</div><figure id="sch1" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-16/jm100505n/production/images/medium/jm-2010-00505n_0015.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-16/jm100505n/production/images/large/jm-2010-00505n_0015.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of Trisubstituted Pyrazolines <b>4a</b>−<b>k</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-16/jm100505n/production/images/large/jm-2010-00505n_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm100505n&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) NaOH, EtOH; (b) <b>7</b>·HCl, EtOH, 80 °C; (c) <b>7</b>, H<sub>2</sub>SO<sub>4</sub> or HCl, EtOH, reflux; (d) (i) <b>7</b>, HCl, <i>n</i>-BuOH, reflux; (ii) KOH or NaOH; (e) HCl, EtOH, reflux; (f) <b>7</b>, AcOH, 80 °C; (g) Si(OEt)<sub>4</sub>, KF, DMF, 50 °C; (h) chiral SFC.</p></p></figure><div class="NLM_p">Carboxylic acid containing pyrazolines <b>12a</b>−<b>p</b> were synthesized as shown in Scheme <a class="ref internalNav" href="#sch2" aria-label="2">2</a>. Condensation of chalcones <b>10</b> with the appropriate arylhydrazine <b>9</b> gave carboxylates <b>12a</b>−<b>p</b> directly or via subsequent basic hydrolysis of the corresponding esters <b>11</b>. Those arylhydrazines (<b>9</b>) that were not commercially available were prepared by fluoride displacement of the corresponding cyanofluorobenzene <b>8</b> with hydrazine in ethanol. Select examples were resolved by chiral SFC to give the <i>R</i>-enantiomers (vide infra).</div><figure id="sch2" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-16/jm100505n/production/images/medium/jm-2010-00505n_0016.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-16/jm100505n/production/images/large/jm-2010-00505n_0016.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of Benzoic Acid Substituted Pyrazolines <b>12a</b>−<b>p</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-16/jm100505n/production/images/large/jm-2010-00505n_0016.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm100505n&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) (i) hydrazine monohydrate, EtOH; (ii) HCl; (b) EtOH, 80 °C; (c) NaOH, EtOH, 80 °C; (d) NaOH; (e) chiral SFC.</p></p></figure><div class="NLM_p">Pyrazolines <b>15a</b>−<b>g</b> were prepared via a cycloaddition route<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> (Scheme <a class="ref internalNav" href="#sch3" aria-label="3">3</a>). Condensation of arylhydrazines <b>9</b> with methyl 4-formylbenzoate under basic conditions gave arylhydrazones <b>13</b> in good yield. Arylhydrazones <b>13</b> were treated with <i>N</i>-bromosuccinimide (NBS) to generate bromoimidates <b>14</b>, which in turn were treated with triethylamine to effect the 1,3-dipolar cycloaddition with alkyl and aryl olefins. After hydrolysis of the methyl ester, pyrazolines <b>15a</b>−<b>g</b> were obtained as racemates in good yield.</div><figure id="sch3" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-16/jm100505n/production/images/medium/jm-2010-00505n_0017.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-16/jm100505n/production/images/large/jm-2010-00505n_0017.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Synthesis of Benzoic Acid Substituted Pyrazolines <b>15a</b>−<b>g</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-16/jm100505n/production/images/large/jm-2010-00505n_0017.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm100505n&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) <b>9</b>·HCl, Et<sub>3</sub>N, DMF; (b) NBS, Me<sub>2</sub>S, ClCH<sub>2</sub>CH<sub>2</sub>Cl, 0 °C to room temp; (c) Et<sub>3</sub>N, THF; (d) NaOH.</p></p></figure><div class="NLM_p">To enable the efficient synthesis of optically pure pyrazoline analogues with preferred N1 and C5 groups and various C3 carboxylate substitution paterns, advanced intermediate <i><b>R</b></i><b>-17</b> was synthesized via 1,3-dipolar cycloaddition of an in situ generated bromonitrilimine and an alkene<a onclick="showRef(event, 'cit14a ref15'); return false;" href="javascript:void(0);" class="ref cit14a ref15">(14a, 15)</a> (Scheme <a class="ref internalNav" href="#sch4" aria-label="4">4</a>). Hydrazone <b>16</b> was prepared from 4-cyanophenylhydrazine by reaction with glyoxylic acid in acqueous hydrochloric acid. Treatment of <b>16</b> with a solution of NBS in DMF at 0 °C followed by addition of the alkene compound in the presence of triethylamine (TEA) at room temperature gave intermediate <b>17</b> in racemic form and acceptable yields. Preparative chiral SFC afforded chiral intermediate <i><b>R</b></i><b>-17</b>.</div><figure id="sch4" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-16/jm100505n/production/images/medium/jm-2010-00505n_0018.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-16/jm100505n/production/images/large/jm-2010-00505n_0018.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Synthesis of Pyrazoline Intermediate <i><b>R</b></i><b>-17</b> and Pyrazoline Lead <i><b>R</b></i><b>-4g</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-16/jm100505n/production/images/large/jm-2010-00505n_0018.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm100505n&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) glyoxylic acid, aq HCl (74%); (b) (i) NBS, DMF, 0 °C to room temp; (ii) 4-fluorostyrene, Et<sub>3</sub>N (20%); (c) chiral SFC; (d) 4-carboxyphenylboronic acid, Pd(PPh<sub>3</sub>)<sub>4</sub>, aq Cs<sub>2</sub>CO<sub>3</sub>, DMF.</p></p></figure><div class="NLM_p">To positively establish the configuration at C5 for the MR active pyrazoline, each enantiomer of <b>17</b> was reacted with <i>p</i>-benzoic boronic acid, and both resulting pyrazoline <b>4g</b> enantiomers were tested for MR activity. The X-ray crystal structure of <i><b>R</b></i><b>-17</b> enantiomer yielding MR active enantiomer <i><b>R</b></i><b>-4g</b> was obtained, and the configuration at C5 was determined to be <i>R</i> (Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>).</div><figure id="fig1" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-16/jm100505n/production/images/medium/jm-2010-00505n_0019.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-16/jm100505n/production/images/large/jm-2010-00505n_0019.jpeg" id="gr12" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. X-ray crystal structure of advanced intermediate <i><b>R</b></i><b>-17</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-16/jm100505n/production/images/large/jm-2010-00505n_0019.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm100505n&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The desired C5 cyclopentyl intermediate <i><b>R</b></i><b>-20</b> was also prepared via the 1,3-dipolar cycloaddition route shown in Scheme <a class="ref internalNav" href="#sch4" aria-label="4">4</a>. However, this route suffered from poor yields, scalability, and reproducibility (data not shown). An alternative approach<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> is detailed in Scheme <a class="ref internalNav" href="#sch5" aria-label="5">5</a>. Cyclopentanecarboxaldehyde was condensed with ethyl 2-(diethoxyphosphoryl)acetate to give unsaturated ester <b>18</b> in good yield. Condensation of <b>18</b> with arylhydrazine <b>9a</b> under basic conditions gave pyrazolinone <b>19</b> in good yield. Racemic chloropyrazoline <b>20</b> was obtained upon treatment of <b>19</b> with phosphorus oxychloride in 60% yield over three synthetic steps. Chiral resolution of <b>(±)-20</b> by SFC gave <i><b>R</b></i><b>-20</b>. Desired C5-cyclopentyl pyrazolines <i><b>R</b></i><b>-21a</b>−<b>e</b> were prepared by efficient Suzuki coupling of intermediates <i><b>R</b></i><b>-20</b> with substituted methyl benzoateboronic acids or pinacol esters followed by basic hydrolysis.</div><figure id="sch5" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Scheme 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-16/jm100505n/production/images/medium/jm-2010-00505n_0020.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-16/jm100505n/production/images/large/jm-2010-00505n_0020.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 5. Synthesis of Pyrazoline Intermediate <i><b>R</b></i><b>-20</b> and Pyrazolines <i><b>R</b></i><b>-15g</b> and <i><b>R</b></i><b>-21a</b>−<b>d</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-16/jm100505n/production/images/large/jm-2010-00505n_0020.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm100505n&amp;id=sch5"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions. (a) (EtO)<sub>2</sub>POCH<sub>2</sub>CO<sub>2</sub>Et, NaOEt (87%); (b) <b>9a</b>, NaOEt (79%); (c) POCl<sub>3</sub>, CH<sub>3</sub>CN, 80 °C (88%); (d) chiral SFC; (e) (i) Pd(PPh<sub>3</sub>)<sub>4</sub> or Pd(dppf)<sub>2</sub>Cl<sub>2</sub>, aq Na<sub>2</sub>CO<sub>3</sub> or Cs<sub>2</sub>CO<sub>3</sub>, DME or DMF; if necessary, (ii) NaOH.</p></p></figure><div class="NLM_p">Pyrazoline <i><b>R</b></i><b>-12o</b> was further derivitized as shown in Scheme <a class="ref internalNav" href="#sch6" aria-label="6">6</a>. Deprotection of the methyl ether with boron tribromide followed by alkylation with 2-(3-bromopropoxyl)tetrahydro-2<i>H</i>-pyran, ester hydrolysis, and tetrahydropyran deprotection with acid resulted in propyloxy ether analogue <i><b>R</b></i><b>-22</b>. Additionally, <i><b>R</b></i><b>-12o</b> was deprotonated at the C4 position with lithium diisopropylamide (LDA) and then alkylated with iodomethane. Hydrolysis of the methyl ester gave a single stereoisomer <b>4</b><i><b>S</b></i><b>,5</b><i><b>S</b></i><b>-23</b>.</div><figure id="sch6" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Scheme 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-16/jm100505n/production/images/medium/jm-2010-00505n_0021.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-16/jm100505n/production/images/large/jm-2010-00505n_0021.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 6. Synthesis of Pyrazolines <b>22</b> and <b>23</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-16/jm100505n/production/images/large/jm-2010-00505n_0021.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm100505n&amp;id=sch6"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) BBr<sub>3</sub>, CH<sub>2</sub>Cl<sub>2</sub>; (b) (i) Br(CH<sub>2</sub>)<sub>3</sub>OTHP, Cs<sub>2</sub>CO<sub>3</sub>, DMF, 80 °C; (ii) NaOH; (c) HCl, THF (74% over steps a−c); (d) (i) LDA, THF; (ii) iodomethane; (e) NaOH (60% over steps d and e).</p></p></figure><div class="NLM_p">In an effort to enhance potency, we prepared a series of conformationally restricted pyrazolines (Scheme <a class="ref internalNav" href="#sch7" aria-label="7">7</a>). These pyrazolines were prepared in a manner similar to the nonconformationally restricted analogues; cyclic ketones <b>24</b> were condensed with an alkyl or aryl aldehyde to give the requisite chalcone derivatives <b>25</b>. Condensation with arylhydrazines <b>9</b> gave the desired pyrazolines <b>26</b> as predominantly the cis-diastereomer (structure confirmed by nuclear Overhauser effect (NOE) and 2D NMR studies; data not shown). Hydrolysis of the ethyl esters gave the final pyrazoline products <b>(±)-27a</b>−<b>q</b>. Select examples were then resolved by chiral SFC. X-ray crystallography of pyrazoline <b>3</b><i><b>R</b></i><b>,3a</b><i><b>R</b></i><b>-27c</b> confirmed both the relative and absolute stereochemistry of the active enantiomer (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>).</div><figure id="sch7" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Scheme 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-16/jm100505n/production/images/medium/jm-2010-00505n_0022.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-16/jm100505n/production/images/large/jm-2010-00505n_0022.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 7. Synthesis of Conformationally Restricted Pyrazolines <b>27a</b>−<b>q</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-16/jm100505n/production/images/large/jm-2010-00505n_0022.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm100505n&amp;id=sch7"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) R<sup>3</sup>CHO, H<sub>2</sub>SO<sub>4</sub> or HCl, EtOH, 80 °C; (b) R<sup>3</sup>CHO, pyrrolidine, MeOH; (c) (i) LiHMDS, THF, 0 °C; (ii) R<sup>3</sup>CHO; (d) <b>9a</b>−<b>g</b>·HCl, EtOH, 80 °C; (e) aq NaOH, MeOH, THF; (f) chiral SFC.</p></p></figure><figure id="fig2" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-16/jm100505n/production/images/medium/jm-2010-00505n_0023.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-16/jm100505n/production/images/large/jm-2010-00505n_0023.jpeg" id="gr13" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. X-ray crystal structure of <b>3</b><i><b>R</b></i><b>,3a</b><i><b>R</b></i><b>-27c</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-16/jm100505n/production/images/large/jm-2010-00505n_0023.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm100505n&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The stereocenter at C4 could be epimerized under basic conditions (Scheme <a class="ref internalNav" href="#sch8" aria-label="8">8</a>). For example, <b>(±)-</b><i><b>cis</b></i><b>-27p</b> was epimerized with sodium methoxide in methanol at 60 °C to give a mixture of cis and trans diastereomers which were separable by HPLC. Confirmation of stereochemistry for <b>(±)-</b><i><b>cis</b></i><b>-27p</b> and <b>(±)-</b><i><b>trans</b></i><b>-27p</b> was obtained by 2D NMR and NOE studies (see Scheme <a class="ref internalNav" href="#sch8" aria-label="8">8</a>), consistent with that observed for <b>27c</b>. Furthermore, 1D <sup>1</sup>H NMR was found to be diagnostic for the cis isomer by a δ shift of approximately 0.5−1.0 ppm downfield for the C5 proton relative to that for the trans isomer.</div><figure id="sch8" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Scheme 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-16/jm100505n/production/images/medium/jm-2010-00505n_0024.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-16/jm100505n/production/images/large/jm-2010-00505n_0024.jpeg" id="gr10" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 8. Epimerization of <b><i>cis</i>-27p</b> to <b><i>trans</i>-27p</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-16/jm100505n/production/images/large/jm-2010-00505n_0024.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm100505n&amp;id=sch8"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) NaOMe, MeOH, THF, 50 °C, 24 h (20%).</p></p></figure><div class="NLM_p">In an effort to take advantage of the acidity of the C4-hydrogen atom, <b>3</b><i><b>S</b></i><b>,3a</b><i><b>R</b></i><b>-27d</b> was protected as the methyl ester <b>28</b> with trimethylsilyldiazomethane, treated with LDA at −78 °C, and trapped with iodomethane to give the methylated derivative (Scheme <a class="ref internalNav" href="#sch9" aria-label="9">9</a>). Subsequent hydroysis of the methyl ester gave the final product <b>3</b><i><b>S</b></i><b>,3a</b><i><b>R</b></i><b>-29</b>. The assigned stereochemistry of <b>3</b><i><b>S</b></i><b>,3a</b><i><b>R</b></i><b>-29</b> was confirmed by NOE and 2D NMR experiments (data not shown).</div><figure id="sch9" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Scheme 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-16/jm100505n/production/images/medium/jm-2010-00505n_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-16/jm100505n/production/images/large/jm-2010-00505n_0001.jpeg" id="gr11" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 9. Synthesis of Methylated Conformationally Restricted Pyrazoline <b>3</b><i><b>S</b></i><b>,3a</b><i><b>R</b></i><b>-29</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-16/jm100505n/production/images/large/jm-2010-00505n_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm100505n&amp;id=sch9"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) trimethylsilyldiazomethane, THF, MeOH (quant); (b) (i) LiHMDS, THF, −78 °C; (ii) iodomethane, −78 °C; (c) NaOH (31% over steps b and c).</p></p></figure></div><div id="sec3" class="NLM_sec NLM_sec_level_2"><div id="ac_i15" class="anchor-spacer"></div><h3 class="article-section__title" id="_i15"> Biological Results</h3><div id="sec3_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i16" class="anchor-spacer"></div><h4 class="article-section__title" id="_i16"> In Vitro Structure−Activity Relationships (SARs)</h4><div class="NLM_p">The potency and SAR of pyrazolines as antagonists of MR were evaluated using a functional Gal4-based cellular transcription assay.<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> After considerable effort, the cyano group was identified as the most suitable replacement for the nitro group on the N1 phenyl group (Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>). The N1 SAR proved to be very narrow as more than 113 non-cyano analogues were made with only 23 having MR IC<sub>50</sub> < 1 μM (e.g., only <i>p</i>-F, <i>p</i>-Cl, <i>p</i>-Br, and <i>p</i>-CO2Et were tolerated but were deemed less desirable than cyano from a druggability standpoint; data not shown). With N1 set as a <i>p</i>-benzonitrile, subsequent rounds of exploration around the C3 and C5 groups led to the discovery of compound <b>4b</b> wherein the C3 cyclic carbamate group was found to be superior to the phenol, resulting in a 10-fold improvement in potency (MR IC<sub>50</sub> = 58 nM). Furthermore, MR antagonist potency was found to reside primarily in the <i>R</i>-enantiomer based on X-ray crystal structures of <i><b>R</b></i><b>-4c</b> (data not shown) and the <i><b>R</b></i><b>-17</b> synthetic precursor to pyrazoline <i><b>R</b></i><b>-4g</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>).</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Preliminary Hit to Lead SAR for Select Analogues</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-16/jm100505n/production/images/medium/jm-2010-00505n_0002.gif" alt="" id="fx1" /></img><div class="scrollable-table-wrap"><table class="table single-image frame_bottom"><colgroup><col align="center" /></col></colgroup><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="center"><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-16/jm100505n/production/images/medium/jm-2010-00505n_0003.gif" alt="" id="fx2" /></img></td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup>a</sup><p class="last">Reference <a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">12</a>. <i>n</i> ≥ 3.</p></div><div class="footnote" id="t1fn2"><sup>b</sup><p class="last">Reference <a onclick="showRef(event, 'cit17d'); return false;" href="javascript:void(0);" class="ref cit17d">17d</a>.</p></div><div class="footnote" id="t1fn3"><sup>c</sup><p class="last">n.d. = not determined.</p></div></div></div><div class="NLM_p">Despite significant advances in potency, it became apparent that early analogues in this compound class suffered from potency on the hERG channel<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> and poor aqueous solubility. An analysis of hERG potential, aqueous solubility, and MR potency is shown in Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>. The majority of pyrazolines evaluated had a propensity to inhibit the hERG channel (defined as >30% inhibition at 10 μM in the dofetilide-Cy3B competitive binding assay<a onclick="showRef(event, 'cit17c'); return false;" href="javascript:void(0);" class="ref cit17c">(17c)</a>). Of the compounds that passed our hERG criteria (<30% inhibition of dofetilide at 10 μM), only carboxylic acids were found to also have superior aqueous solubility. In fact, all carboxylic acid containing pyrazolines evaluated were inactive in this dofetilide competitive binding assay, regardless of the location of the carboxylate (vide infra). Since most steroidal NRs cannot tolerate a polar carboxylate because of the lipophilic character of their binding sites, we were delighted to find that C3 carboxylate containing pyrazolines were potent MR antagonists. To verify this finding, a series of compounds (e.g., <i><b>R</b></i><b>-4b</b>, <b>4d</b>−<b>g</b>) were selected to determine the SAR for each of the three aryl groups for MR potency versus the hERG channel in the patch clamp assay (Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>). Compounds <b>4e</b>−<b>g</b> demonstrate that the incorporation of a carboxylate group onto any of the three aryl groups dramatically reduces the hERG potency for these pyrazoline compounds and maintains solubility (aqueous solubility of >30 μM). In addition to maintaining selectivity versus the hERG channel, carboxylic acid <b>4g</b> maintains reasonable potency for MR with an IC<sub>50</sub> of 246 nM. Because of its MR potency (IC<sub>50</sub> = 101 nM), aqueous solubility, and hERG selectivity, enantiomer <i><b>R</b></i><b>-4g</b> was selected as a lead with suitable properties for further modification.</div><figure id="fig3" data-index="14" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-16/jm100505n/production/images/medium/jm-2010-00505n_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-16/jm100505n/production/images/large/jm-2010-00505n_0004.jpeg" id="gr14" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. SAR analysis of physical properties, hERG potential, and MR potency in non-conformationally restricted pyrazolines: identification of compound <i><b>R-</b></i><b>4g</b>. Individual pyrazolines shaped by compound class are amides (◼), esters (▲), carboxylic acids (☼), and miscellaneous (e.g., heterocycles, phenols, etc.) (●) and are colored by aqueous solubility: ≤3 μM (red), 3−30 μM (yellow), >30 μM (green), not determined (gray). Dofetilide = dofetilide-Cy3B competitive binding assay, with % inhibition at 10 μM compound (see ref <a onclick="showRef(event, 'cit17c'); return false;" href="javascript:void(0);" class="ref cit17c">17c</a>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-16/jm100505n/production/images/large/jm-2010-00505n_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm100505n&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Each of the three pyrazoline ring substituents (N1, C3, and C5) was modified simultaneously while keeping the carboxylate fixed (Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>). As we had observed earlier, the nitrile at R<sup>1</sup> was found to be preferred for MR potency (<b>4h</b>−<b>k</b>). Deletion of the nitrile group resulted in a 97-fold loss of potency (<b>4h</b>). Ethyl ester <b>4i</b> was also tolerated in this position, being nearly equipotent to the nitrile, but the corresponding carboxylate <b>4j</b> was not, although this could be due to poor cellular permeability. An effort to improve the potency of nitrile-containing N1 resulted in a 2- to 5-fold enhancement in potency when small nonpolar substituents such as cholo, methyl, or trifluoromethyl groups are incorporated in the position ortho to the nitrile (<b>12c</b>−<b>f</b>). Fluorine substitution (<b>12a</b>) or other halogen subtsitution in the position meta to the nitrile (<b>12b</b>,<b>d</b>) provided negligible or slightly reduced potency for MR. Incorporation of a second nitrile significantly reduced MR potency (<b>12g</b>).</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. N1 and C5 Position SAR of Pyrazoline Carboxylic Acids</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-16/jm100505n/production/images/medium/jm-2010-00505n_0005.gif" alt="" id="fx3" /></img><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">R<sup>1</sup></th><th class="colsep0 rowsep0" align="center">R<sup>2</sup></th><th class="colsep0 rowsep0" align="center">R<sup>3</sup></th><th class="colsep0 rowsep0" align="center">R<sup>4</sup></th><th class="colsep0 rowsep0" align="center" char=".">MR IC<sub>50</sub> (nM)<a class="ref internalNav" href="#t2fn1" aria-label="a">a</a></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i><b>R</b></i><b>-4g</b></td><td class="colsep0 rowsep0" align="left">CN</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">4-F-Ph</td><td class="colsep0 rowsep0" align="char" char=".">101</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>4h</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">4-F-Ph</td><td class="colsep0 rowsep0" align="char" char=".">9730</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>4i</b></td><td class="colsep0 rowsep0" align="left">CO<sub>2</sub>Et</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">4-F-Ph</td><td class="colsep0 rowsep0" align="char" char=".">180</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>4j</b></td><td class="colsep0 rowsep0" align="left">COOH</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">4-F-Ph</td><td class="colsep0 rowsep0" align="char" char=".">>10000</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>4k</b></td><td class="colsep0 rowsep0" align="left">OCH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">4-F-Ph</td><td class="colsep0 rowsep0" align="char" char=".">1440</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>12a</b></td><td class="colsep0 rowsep0" align="left">CN</td><td class="colsep0 rowsep0" align="left">F</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">4-F-Ph</td><td class="colsep0 rowsep0" align="char" char=".">243</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>12b</b></td><td class="colsep0 rowsep0" align="left">CN</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">F</td><td class="colsep0 rowsep0" align="left">4-F-Ph</td><td class="colsep0 rowsep0" align="char" char=".">535</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>12c</b></td><td class="colsep0 rowsep0" align="left">CN</td><td class="colsep0 rowsep0" align="left">Cl</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">4-F-Ph</td><td class="colsep0 rowsep0" align="char" char=".">56</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>12d</b></td><td class="colsep0 rowsep0" align="left">CN</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">Cl</td><td class="colsep0 rowsep0" align="left">4-F-Ph</td><td class="colsep0 rowsep0" align="char" char=".">284</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>12e</b></td><td class="colsep0 rowsep0" align="left">CN</td><td class="colsep0 rowsep0" align="left">CH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">4-F-Ph</td><td class="colsep0 rowsep0" align="char" char=".">56</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>12f</b></td><td class="colsep0 rowsep0" align="left">CN</td><td class="colsep0 rowsep0" align="left">CF<sub>3</sub></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">4-F-Ph</td><td class="colsep0 rowsep0" align="char" char=".">127</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>12g</b></td><td class="colsep0 rowsep0" align="left">CN</td><td class="colsep0 rowsep0" align="left">CN</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">4-F-Ph</td><td class="colsep0 rowsep0" align="char" char=".">>1000</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>12i</b></td><td class="colsep0 rowsep0" align="left">CN</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">4-Pyr</td><td class="colsep0 rowsep0" align="char" char=".">>10000</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>12j</b></td><td class="colsep0 rowsep0" align="left">CN</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">3-Pyr</td><td class="colsep0 rowsep0" align="char" char=".">>10000</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>12k</b></td><td class="colsep0 rowsep0" align="left">CN</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">2-Pyr</td><td class="colsep0 rowsep0" align="char" char=".">>10000</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>12l</b></td><td class="colsep0 rowsep0" align="left">CN</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">2-furyl</td><td class="colsep0 rowsep0" align="char" char=".">410</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>12m</b></td><td class="colsep0 rowsep0" align="left">CN</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">2-thienyl</td><td class="colsep0 rowsep0" align="char" char=".">763</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>15a</b></td><td class="colsep0 rowsep0" align="left">CN</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">Bn</td><td class="colsep0 rowsep0" align="char" char=".">3650</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>15b</b></td><td class="colsep0 rowsep0" align="left">CN</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">3-F-Ph</td><td class="colsep0 rowsep0" align="char" char=".">441</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>15c</b></td><td class="colsep0 rowsep0" align="left">CN</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">3-MeO-Ph</td><td class="colsep0 rowsep0" align="char" char=".">1590</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>15d</b></td><td class="colsep0 rowsep0" align="left">CN</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left"><i>c</i>-Hex</td><td class="colsep0 rowsep0" align="char" char=".">1290</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>15e</b></td><td class="colsep0 rowsep0" align="left">CN</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left"><i>c</i>-Pent</td><td class="colsep0 rowsep0" align="char" char=".">151</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>12h</b></td><td class="colsep0 rowsep0" align="left">CN</td><td class="colsep0 rowsep0" align="left">Cl</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left"><i>i</i>-Pr</td><td class="colsep0 rowsep0" align="char" char=".">383</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>15f</b></td><td class="colsep0 rowsep0" align="left">CN</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left"><i>t</i>-Bu</td><td class="colsep0 rowsep0" align="char" char=".">2530</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>15g</b></td><td class="colsep0 rowsep0" align="left">CN</td><td class="colsep0 rowsep0" align="left">Cl</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left"><i>c</i>-Pent</td><td class="colsep0 rowsep0" align="char" char=".">54</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup>a</sup><p class="last">Reference <a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">12</a>. <i>n</i> ≥ 3.</p></div></div></div><div class="NLM_p">Evaluation of C5 (R<sup>4</sup>) revealed an extremely tight SAR and a strong preference for 4-fluorophenyl as the preferred aromatic substituent (<b>12i</b>−<b>m</b>, <b>15b</b>,<b>c</b>). For example, the 3-fluorophenyl and 3-methoxyphenyl derivatives lost 2-fold and 6-fold potency for MR. Some heterocycles such as furan and thiophene (<b>12l</b>−<b>m</b>) are tolerated in this position, while incorporation of more basic pyridines significantly reduced MR potency (<b>12i</b>−<b>k</b>). Replacement of the 4-fluorophenyl group with a benzyl or cyclohexyl group resulted in a 14- and a 5-fold loss in potency, respectivly (<b>15a</b>,<b>d</b>). Given the sensitivity of the C5 position, it is remarkable to find that incorporation of cyclopentyl in the C5 position (<b>15e</b>) gave a slight improvement in potency over 4-fluorophenyl with an IC<sub>50</sub> of 151 nM. Substitution with an isopropyl group was tolerated (<b>12h</b>) but <i>tert</i>-butyl resulted in a 10-fold reduction in potency (<b>15f</b>). The potency of cyclopentyl analogues was further enhanced by substitution on N1 with a chloro group (<b>15g</b>) to 54 nM. Generally speaking, we found the C5 cyclopentyl group to impart a desirable combination of improved MR potency, solubility, and selectivity.</div><div class="NLM_p">Having identified cyclopentyl and 3-substituted 4-cyanophenyl as the preferred C5 and N1 substituents, a series of C3 substituents were evaluated on the <i>R</i>-cyclopentyl scaffold, resulting in further potency enhancements as shown in Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>. The <i>R</i>-enantiomer of <b>15g</b> was found to be quite potent for MR with an IC<sub>50</sub> of 16 nM. The addition of small halogens ortho to the C3 carboxylate (<i><b>R</b></i><b>-21a</b>, <i><b>R</b></i><b>-12n</b>) was tolerated. Substitution with methoxy groups in either ortho or meta positions results in further increased potency with IC<sub>50</sub> values of 2−14 nM (<i><b>R</b></i><b>-12o</b>, <i><b>R</b></i><b>-12p</b>). The ortho alkoxy group could be further enlarged to ethoxy (<i><b>R</b></i><b>-21b</b>) or even hydroxypropyloxy (<i><b>R</b></i><b>-22</b>) without significantly reducing the MR potency. Interestingly, trifluoromethoxy was less well tolerated, resulting in a 6-fold loss of MR potency (<i><b>R</b></i><b>-21c</b>). Extension of the carboxylate itself resulted in nearly a 10-fold loss of MR potency (<i><b>R</b></i><b>-21d</b>). Notably, addition of a methyl group to the pyrazoline core was tolerated but with a 5-fold reduction in potency (<b>4</b><i><b>S</b></i><b>,5</b><i><b>S</b></i><b>-23</b>).</div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. SAR of C3 Substituents with Preferred N1 and C5 Groups</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-16/jm100505n/production/images/medium/jm-2010-00505n_0006.gif" alt="" id="fx4" /></img><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">R<sup>2</sup></th><th class="colsep0 rowsep0" align="center">R<sup>5</sup></th><th class="colsep0 rowsep0" align="center">R<sup>6</sup></th><th class="colsep0 rowsep0" align="center">R<sup>7</sup></th><th class="colsep0 rowsep0" align="center">R<sup>8</sup></th><th class="colsep0 rowsep0" align="center">R<sup>9</sup></th><th class="colsep0 rowsep0" align="center" char=".">MR IC<sub>50</sub> (nM)<a class="ref internalNav" href="#t3fn1" aria-label="a">a</a></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i><b>R</b></i><b>-15g</b></td><td class="colsep0 rowsep0" align="left">Cl</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">COOH</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="char" char=".">16</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i><b>R</b></i><b>- 21a</b></td><td class="colsep0 rowsep0" align="left">Cl</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">F</td><td class="colsep0 rowsep0" align="left">COOH</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="char" char=".">52</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i><b>R</b></i><b>-12n</b></td><td class="colsep0 rowsep0" align="left">Cl</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">Cl</td><td class="colsep0 rowsep0" align="left">COOH</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="char" char=".">26</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i><b>R</b></i><b>-12o</b></td><td class="colsep0 rowsep0" align="left">Cl</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">OMe</td><td class="colsep0 rowsep0" align="left">COOH</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="char" char=".">14</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i><b>R</b></i><b>-12p</b></td><td class="colsep0 rowsep0" align="left">Cl</td><td class="colsep0 rowsep0" align="left">MeO</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">COOH</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="char" char=".">2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i><b>R</b></i><b>-21b</b></td><td class="colsep0 rowsep0" align="left">Cl</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">OEt</td><td class="colsep0 rowsep0" align="left">COOH</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="char" char=".">6</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i><b>R</b></i><b>-22</b></td><td class="colsep0 rowsep0" align="left">Cl</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">O(CH<sub>2</sub>)<sub>3</sub>OH</td><td class="colsep0 rowsep0" align="left">COOH</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="char" char=".">13</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i><b>R</b></i><b>-21c</b></td><td class="colsep0 rowsep0" align="left">Cl</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">OCF<sub>3</sub></td><td class="colsep0 rowsep0" align="left">COOH</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="char" char=".">80</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i><b>R</b></i><b>-21d</b></td><td class="colsep0 rowsep0" align="left">Cl</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">CH<sub>2</sub>COOH</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="char" char=".">135</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>4</b><i><b>S</b></i><b>,5</b><i><b>S</b></i><b>-23</b></td><td class="colsep0 rowsep0" align="left">Cl</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">OMe</td><td class="colsep0 rowsep0" align="left">COOH</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="char" char=".">69</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t3fn1"><div class="footnote" id="t3fn1"><sup>a</sup><p class="last">Reference <a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">12</a>. <i>n</i> ≥ 3.</p></div></div></div><div class="NLM_p">Potency data for conformationally restricted pyrazolines <b>27a</b>−<b>q</b> and <b>29</b> are shown in Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a>. Conformational restriction of the benzoic acid with a five-membered ring (<i><b>cis</b></i><b>-27a</b>) resulted in a 18-fold loss of MR potency relative to lead <b>4g</b>. In contrast, the six-membered ring restriction (<i><b>cis</b></i><b>-27b</b>) resulted in only a 2-fold loss of MR potency. Incorporation of a chlorine on N1 (<i><b>cis</b></i><b>-27c</b>) further restored potency to 223 nM. As is the case with the nonconformationally restricted pyrazolines, the MR potency lies primarily in one of the two cis-enantiomers. For example, single enantiomer <b>3</b><i><b>R</b></i><b>,3a</b><i><b>R</b></i><b>-27c</b> has an IC<sub>50</sub> of 41 nM versus 3500 nM for its enantiomer <b>3</b><i><b>S</b></i><b>,3a</b><i><b>S</b></i><b>-27c</b>. X-ray crystallographic data for <b>3</b><i><b>R</b></i><b>,3a</b><i><b>R</b></i><b>-27c</b> confirmed that this is the same preferred orientation of the C5 group observed in the nonconformationally restricted pyrazolines.</div><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. Conformationally Restricted SAR</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-16/jm100505n/production/images/medium/jm-2010-00505n_0007.gif" alt="" id="fx5" /></img><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">R<sup>1</sup></th><th class="colsep0 rowsep0" align="center">R<sup>2</sup></th><th class="colsep0 rowsep0" align="center">R<sup>3</sup></th><th class="colsep0 rowsep0" align="center">X</th><th class="colsep0 rowsep0" align="center" char=".">MR IC<sub>50</sub> (nM)<a class="ref internalNav" href="#t4fn1" aria-label="a">a</a></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i><b>cis</b></i><b>-27a</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">4-F-Ph</td><td class="colsep0 rowsep0" align="left">bond</td><td class="colsep0 rowsep0" align="char" char=".">4340</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i><b>cis</b></i><b>-27b</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">4-F-Ph</td><td class="colsep0 rowsep0" align="left">CH<sub>2</sub></td><td class="colsep0 rowsep0" align="char" char=".">553</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i><b>cis</b></i><b>-27c</b></td><td class="colsep0 rowsep0" align="left">Cl</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">4-F-Ph</td><td class="colsep0 rowsep0" align="left">CH<sub>2</sub></td><td class="colsep0 rowsep0" align="char" char=".">223</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>3</b><i><b>R</b></i><b>,3a</b><i><b>R</b></i><b>-27c</b></td><td class="colsep0 rowsep0" align="left">Cl</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">4-F-Ph</td><td class="colsep0 rowsep0" align="left">CH<sub>2</sub></td><td class="colsep0 rowsep0" align="char" char=".">41</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>3</b><i><b>S</b></i><b>,3a</b><i><b>S</b></i><b>-27c</b></td><td class="colsep0 rowsep0" align="left">Cl</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">4-F-Ph</td><td class="colsep0 rowsep0" align="left">CH<sub>2</sub></td><td class="colsep0 rowsep0" align="char" char=".">3500</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i><b>cis</b></i><b>-27d</b></td><td class="colsep0 rowsep0" align="left">Cl</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">c-Pent</td><td class="colsep0 rowsep0" align="left">CH<sub>2</sub></td><td class="colsep0 rowsep0" align="char" char=".">21</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i><b>cis</b></i><b>-27e</b></td><td class="colsep0 rowsep0" align="left">Cl</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">c-Bu</td><td class="colsep0 rowsep0" align="left">CH<sub>2</sub></td><td class="colsep0 rowsep0" align="char" char=".">21</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i><b>cis</b></i><b>-27f</b></td><td class="colsep0 rowsep0" align="left">Cl</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">cyclopentene</td><td class="colsep0 rowsep0" align="left">CH<sub>2</sub></td><td class="colsep0 rowsep0" align="char" char=".">15</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i><b>cis</b></i><b>-27g</b></td><td class="colsep0 rowsep0" align="left">Cl</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">THF</td><td class="colsep0 rowsep0" align="left">CH<sub>2</sub></td><td class="colsep0 rowsep0" align="char" char=".">720</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i><b>cis</b></i><b>-27 h</b></td><td class="colsep0 rowsep0" align="left">Cl</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">pyran</td><td class="colsep0 rowsep0" align="left">CH<sub>2</sub></td><td class="colsep0 rowsep0" align="char" char=".">127</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i><b>cis</b></i><b>-27i</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left"><i>c</i>-Pent</td><td class="colsep0 rowsep0" align="left">CH<sub>2</sub></td><td class="colsep0 rowsep0" align="char" char=".">89</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i><b>cis</b></i><b>-27j</b></td><td class="colsep0 rowsep0" align="left">CH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left"><i>c</i>-Pent</td><td class="colsep0 rowsep0" align="left">CH<sub>2</sub></td><td class="colsep0 rowsep0" align="char" char=".">4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i><b>cis</b></i><b>-27k</b></td><td class="colsep0 rowsep0" align="left">OCH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left"><i>c</i>-Pent</td><td class="colsep0 rowsep0" align="left">CH<sub>2</sub></td><td class="colsep0 rowsep0" align="char" char=".">7</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i><b>cis</b></i><b>-27l</b></td><td class="colsep0 rowsep0" align="left">CH<sub>2</sub>OCH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left"><i>c</i>-Pent</td><td class="colsep0 rowsep0" align="left">CH<sub>2</sub></td><td class="colsep0 rowsep0" align="char" char=".">150</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i><b>cis</b></i><b>-27 m</b></td><td class="colsep0 rowsep0" align="left">OBn</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left"><i>c</i>-Pent</td><td class="colsep0 rowsep0" align="left">CH<sub>2</sub></td><td class="colsep0 rowsep0" align="char" char=".">488</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i><b>cis</b></i><b>-27n</b></td><td class="colsep0 rowsep0" align="left">OH</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left"><i>c</i>-Pent</td><td class="colsep0 rowsep0" align="left">CH<sub>2</sub></td><td class="colsep0 rowsep0" align="char" char=".">>500</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i><b>cis</b></i><b>-27o</b></td><td class="colsep0 rowsep0" align="left">Cl</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">4-F-Ph</td><td class="colsep0 rowsep0" align="left">O</td><td class="colsep0 rowsep0" align="char" char=".">849</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i><b>cis</b></i><b>-27p</b></td><td class="colsep0 rowsep0" align="left">Cl</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left"><i>c</i>-Pent</td><td class="colsep0 rowsep0" align="left">O</td><td class="colsep0 rowsep0" align="char" char=".">65</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i><b>trans</b></i><b>-27p</b></td><td class="colsep0 rowsep0" align="left">Cl</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left"><i>c</i>-Pent</td><td class="colsep0 rowsep0" align="left">O</td><td class="colsep0 rowsep0" align="char" char=".">146</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i><b>cis</b></i><b>-27q</b></td><td class="colsep0 rowsep0" align="left">CH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left"><i>c</i>-Pent</td><td class="colsep0 rowsep0" align="left">O</td><td class="colsep0 rowsep0" align="char" char=".">39</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>3</b><i><b>S</b></i><b>,3a</b><i><b>R</b></i><b>-29</b></td><td class="colsep0 rowsep0" align="left">Cl</td><td class="colsep0 rowsep0" align="left">CH<sub>3</sub></td><td class="colsep0 rowsep0" align="left"><i>c</i>-Pent</td><td class="colsep0 rowsep0" align="left">CH<sub>2</sub></td><td class="colsep0 rowsep0" align="char" char=".">25</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t4fn1"><div class="footnote" id="t4fn1"><sup>a</sup><p class="last">Reference <a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">12</a>. <i>n</i> ≥ 3.</p></div></div></div><div class="NLM_p">Replacement of the 4-fluorophenyl ring in C5 with the preferred cyclopentyl ring resulted in a more dramatic 10-fold potency enhancement (<i><b>cis</b></i><b>-27d</b> versus <i><b>cis</b></i><b>-27c</b>; IC<sub>50</sub> = 21 nM and 223 nM, respectively) relative to the nonconformationally restricted series (<b>15g</b> versus <b>12c</b>; IC<sub>50</sub> = 54 and 56 nM, respectively). Cyclobutyl (<i><b>cis</b></i><b>-27e</b>) and cyclopentene (<i><b>cis</b></i><b>-27f</b>) groups are equipotent to the cyclopentyl group. In contrast, oxygenated varients tetrahydrofuryl and pyranyl resulted in significant losses of potency (<i><b>cis</b></i><b>-27g</b> and <i><b>cis</b></i><b>-27 h</b>).</div><div class="NLM_p">Similar to the nonconformationally series, N1 substitution (R<sup>1</sup>) with chloro was preferred over hydrogen (<i><b>cis</b></i><b>-27d</b> versus <i><b>cis</b></i><b>-27i</b>). Methyl and methoxy substitution resulted in an even greater potency enhancement as observed with <i><b>cis</b></i><b>-27j</b> and <i><b>cis</b></i><b>-27k</b> with IC<sub>50</sub> of 4 and 7 nM, respectively. However, incorporation of larger substituents such as CH<sub>2</sub>OCH<sub>3</sub> (<i><b>cis</b></i><b>-27l</b>) and benzyloxy (<i><b>cis</b></i><b>-27 m</b>) and polar groups such as hydroxy (<i><b>cis</b></i><b>-27n</b>) resulted in substantial losses of potency.</div><div class="NLM_p last">Chromene derivatives where X = O are also potent MR antagonists (<i><b>cis</b></i><b>-27o-q</b>), albeit 3- to 10-fold less potent than the corresponding hydrocarbon (X = CH<sub>2</sub>; <i><b>cis</b></i><b>-27c</b>,<b>d</b>,<b>j</b>). As observed for X = CH<sub>2</sub>, incorporation of a cyclopentyl group in place of the 4-fluorophenyl group resulted in a dramatic potency enhancement (<i><b>cis</b></i><b>-27o</b>,<b>27p</b>). Interestingly, the trans isomer <i><b>trans</b></i><b>-27p</b> is only 2- to 3-fold less potent than the cis isomer <i><b>cis</b></i><b>-27p</b>, suggesting that the stereochemistry of the 3a-position is of only marginal importance relative to the 3-position where a dramatic loss of potency was observed for enantiomers in the nonconformationally restricted series (<i><b>R</b></i><b>-4g</b> versus <i><b>S</b></i><b>-4g</b>). As might be anticipated given the relatively forgiving stereochemistry at this position, a 3a-methyl group is tolerated (<b>3</b><i><b>S</b></i><b>,3a</b><i><b>R</b></i><b>-29</b>) resulting in only a 3-fold loss relative to 3a-H analogue <b>3</b><i><b>S</b></i><b>,3a</b><i><b>R</b></i><b>-27d</b> (see Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a>).</div></div><div id="sec3_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i21" class="anchor-spacer"></div><h4 class="article-section__title" id="_i21"> Molecular Modeling Studies</h4><div class="NLM_p">To understand the potential binding mode for these pyrazolines, an induced-fit model of <b>3</b><i><b>S</b></i><b>,3a</b><i><b>R</b></i><b>-27d</b> was prepared using the 1.95 Å MR/corticosterone X-ray crystal structure <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2A3I">2A3I</a> (Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>a).<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> In this model, the N1 cyanophenyl group resides in the A-ring pocket, hydrogen-bonding to Q776 and R817, mimicking the A-ring 3-carbonyl group of corticosterone (see Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>b). This is consistent with the cyanoaryl binding mode observed in crystal structures for ligands of other nuclear hormone receptors such as the androgen and progesterone receptors.<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> The pendent cyclopentyl group forces the L960 side chain into a higher-energy conformation and displaces the N770 side chain from its normal position, disrupting the hydrogen bonding network stabilized by the 11β-hydroxy group of corticosterone. This feature may be an important component contributing to the antagonism of MR by these pyrazolines, as previous structural studies have suggested that steroidal activation of MR requires (in addition to the C-3 ketone) that the ligand form hydrogen bonds to N770 in helix 3 and to T945 in helix 10.<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> Additionally, the ligand carboxylate displaces the side chains of L848 and particularly F941, opening a channel to solvent under helix 11. This feature is consistent with the activity of extended analogues such as <b>4d</b>.</div><figure id="fig4" data-index="15" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-16/jm100505n/production/images/medium/jm-2010-00505n_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-16/jm100505n/production/images/large/jm-2010-00505n_0008.jpeg" id="gr15" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Induced-fit model of <b>3</b><i><b>S</b></i><b>,3a</b><i><b>R</b></i><b>-27d</b> in MR: (a) compound <b>3</b><i><b>S</b></i><b>,3a</b><i><b>R</b></i><b>-27d</b>, ball and stick, showing residues L960 (helix 12), F941 (helix 11), N770 (helix 3), Q776 and R817 (ketosteroid recognition), and F829, tube; (b) overlay of native crystal MR/corticosterone crystal structure 2A3I (red) with the <b>3</b><i><b>S</b></i><b>,3a</b><i><b>R</b></i><b>-27d</b>/MR induced-fit model. The congruence of the cyanophenyl ring with the steroid A/B ring system is apparent, as is the disruption of the N770 and L960 side chains by the cyclopentyl, and the movement of F941 caused by the carboxylate.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-16/jm100505n/production/images/large/jm-2010-00505n_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm100505n&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec3_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i22" class="anchor-spacer"></div><h4 class="article-section__title" id="_i22"> Selectivity and Binding Assays</h4><div class="NLM_p">The antagonist potencies in these functional cell-based assays correlate reasonably well to competitive radioligand binding assays. For example, the binding affinity of <b>3</b><i><b>S</b></i><b>,3a</b><i><b>R</b></i><b>-27d</b> for MR is within 4-fold of the functional potency (MR binding IC<sub>50</sub> = 2.7 nM). Likewise, the binding affinity of <b>3</b><i><b>S</b></i><b>,3a</b><i><b>R</b></i><b>-27d</b> for the progesterone receptor (PR) is within 2-fold of the functional PR potency (PR binding IC<sub>50</sub> = 310 nM). In terms of binding affinity, <b>3</b><i><b>S</b></i><b>,3a</b><i><b>R</b></i><b>-27d</b> has a selectivity factor of 115-fold for MR over PR, comparable to spironolactone (MR binding IC<sub>50</sub> = 8.1 nM vs PR binding IC<sub>50</sub> = 2440 nM; 301-fold) and eplerenone (MR binding IC<sub>50</sub> = 138 nM vs PR binding IC<sub>50</sub> > 10 000 nM; >72-fold).</div><div class="NLM_p">MR antagonist selectivity for a select group of enantiomerically pure analogues versus other steroidal nuclear hormone receptors was determined in a similar functional Gal4 cellular assay format (Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a>).<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> These pyrazoline compounds are remarkably selective as a class versus the androgen receptor (AR), glucocorticoid receptor (GR), PR, and estrogen receptor (ER), generally exhibiting selectivities of >200-fold, with some exceptions for more modest PR selectivities of approximately >40-fold.</div><div class="NLM_p">Undesirable side effects of spironolactone-based therapy, such as gynecomastia and menstrual irregularities, have been linked to its progestational and antiandrogenic effects.<a onclick="showRef(event, 'cit5c ref7'); return false;" href="javascript:void(0);" class="ref cit5c ref7">(5c, 7)</a> For example, spironolactone is a PR agonist (in vitro EC<sub>50</sub> = 2.6 μM)<a onclick="showRef(event, 'cit5c'); return false;" href="javascript:void(0);" class="ref cit5c">(5c)</a> and an AR antagonist while eplerenone is devoid of PR agonist activity (EC<sub>50</sub> > 100 μM)<a onclick="showRef(event, 'cit5c'); return false;" href="javascript:void(0);" class="ref cit5c">(5c)</a> and is selective versus the AR (see Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a>). Importantly, these pyrazolines, including <b>3</b><i><b>S</b></i><b>,3a</b><i><b>R</b></i><b>-27d</b>, were also tested for PR agonist activity and were found to be inactive up to concentrations of 100 μM (EC<sub>50</sub>, data not shown), similar to eplerenone.</div><div class="NLM_table-wrap" id="tbl5"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 5. NHR Selectivity<a class="ref internalNav" href="#t5fn1" aria-label="a">a</a> for a Select Group of Pyrazoline Carboxylic Acids</div></div></div><div class="scrollable-table-wrap"><table class="table single-image frame_bottom"><colgroup><col align="center" /></col></colgroup><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="center"><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-16/jm100505n/production/images/medium/jm-2010-00505n_0009.gif" alt="" id="fx6" /></img></td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t5fn1"><div class="footnote" id="t5fn1"><sup>a</sup><p class="last">Reference <a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">12</a>. <i>n</i> ≥ 3.</p></div></div></div></div><div id="sec3_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i24" class="anchor-spacer"></div><h4 class="article-section__title" id="_i24"> Pharmacokinetic Data</h4><div class="NLM_p">Rat pharmacokinetic (PK) data for a select group of enantiomerically pure analogues are shown in Table <a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">6</a>. As a class, both nonconformationally restricted and conformationally restricted pyrazoline carboxylic acids have reasonably low clearance values, modest half-lives, and good bioavailabilities. Replacement of the 4-fluorophenyl C5 group with a cyclopentyl group does result in higher clearance values (e.g., <i><b>R</b></i><b>-12c</b> CL = 6.9 (mL/min)/kg vs <i><b>R</b></i><b>-15g</b> CL = 34 (mL/min)/kg). However, conformational restriction of <i><b>R</b></i><b>-15g</b> results in analogue <b>3</b><i><b>S</b></i><b>,3a</b><i><b>R</b></i><b>-27d</b> (CL = 9.8 (mL/min)/kg), a more metabolically stable compound, suggesting that there is some inherent improvement in clearance induced by conformational restriction. Further improvements could be made in reducing clearance by introduction of an oxygen atom to the conformationally restricted series (<b>3</b><i><b>S</b></i><b>,3a</b><i><b>R</b></i><b>-27d</b> vs <b>3</b><i><b>S</b></i><b>,3a</b><i><b>R</b></i><b>-27q</b> CL = 4.6 (mL/min)/kg) or by replacement of the methoxy of <i><b>R</b></i><b>-12o</b> with the ethoxy group of <i><b>R</b></i><b>-21b</b>.</div><div class="NLM_table-wrap" id="tbl6"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 6. Rat Pharmacokinetic Data<a class="ref internalNav" href="#t6fn1" aria-label="a">a</a> for a Select Group of Pyrazoline Carboxylic Acids</div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="char" char="." /></col><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center" char=".">dose, mg/kg</th><th class="colsep0 rowsep0" align="center">route</th><th class="colsep0 rowsep0" align="center" char=".">CL, (mL/min)/kg</th><th class="colsep0 rowsep0" align="center" char="."><i>V</i><sub>dss</sub>, mL/kg</th><th class="colsep0 rowsep0" align="center" char="."><i>t</i><sub>1/2</sub>, h</th><th class="colsep0 rowsep0" align="center" char="."><i>F</i>, %</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i><b>R</b></i><b>-12c</b></td><td class="colsep0 rowsep0" align="char" char=".">2</td><td class="colsep0 rowsep0" align="left">iv</td><td class="colsep0 rowsep0" align="char" char=".">6.9</td><td class="colsep0 rowsep0" align="char" char=".">1.5</td><td class="colsep0 rowsep0" align="char" char=".">2.6</td><td class="colsep0 rowsep0" align="char" char="."> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="char" char=".">2</td><td class="colsep0 rowsep0" align="left">po</td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char=".">46</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i><b>R</b></i><b>-15g</b></td><td class="colsep0 rowsep0" align="char" char=".">2</td><td class="colsep0 rowsep0" align="left">iv<a class="ref internalNav" href="#t6fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="char" char=".">34</td><td class="colsep0 rowsep0" align="char" char=".">3.6</td><td class="colsep0 rowsep0" align="char" char=".">1.2</td><td class="colsep0 rowsep0" align="char" char="."> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="char" char=".">2</td><td class="colsep0 rowsep0" align="left">po<a class="ref internalNav" href="#t6fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char=".">100</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i><b>R</b></i><b>-12o</b></td><td class="colsep0 rowsep0" align="char" char=".">2</td><td class="colsep0 rowsep0" align="left">iv</td><td class="colsep0 rowsep0" align="char" char=".">24</td><td class="colsep0 rowsep0" align="char" char=".">3.9</td><td class="colsep0 rowsep0" align="char" char=".">1.9</td><td class="colsep0 rowsep0" align="char" char="."> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="char" char=".">2</td><td class="colsep0 rowsep0" align="left">po</td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char=".">57</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i><b>R</b></i><b>-21b</b></td><td class="colsep0 rowsep0" align="char" char=".">1</td><td class="colsep0 rowsep0" align="left">iv</td><td class="colsep0 rowsep0" align="char" char=".">9.2</td><td class="colsep0 rowsep0" align="char" char=".">2.3</td><td class="colsep0 rowsep0" align="char" char=".">2.5</td><td class="colsep0 rowsep0" align="char" char="."> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="char" char=".">1</td><td class="colsep0 rowsep0" align="left">po</td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char=".">50</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>3</b><i><b>S</b></i><b>,3a</b><i><b>R</b></i><b>-27i</b></td><td class="colsep0 rowsep0" align="char" char=".">2</td><td class="colsep0 rowsep0" align="left">iv</td><td class="colsep0 rowsep0" align="char" char=".">5.5</td><td class="colsep0 rowsep0" align="char" char=".">0.6</td><td class="colsep0 rowsep0" align="char" char=".">1.3</td><td class="colsep0 rowsep0" align="char" char="."> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="char" char=".">2</td><td class="colsep0 rowsep0" align="left">po</td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char=".">83</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>3</b><i><b>S</b></i><b>,3a</b><i><b>R</b></i><b>-27d</b></td><td class="colsep0 rowsep0" align="char" char=".">2</td><td class="colsep0 rowsep0" align="left">iv</td><td class="colsep0 rowsep0" align="char" char=".">9.8</td><td class="colsep0 rowsep0" align="char" char=".">1.4</td><td class="colsep0 rowsep0" align="char" char=".">1.7</td><td class="colsep0 rowsep0" align="char" char="."> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="char" char=".">2</td><td class="colsep0 rowsep0" align="left">po</td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char=".">86</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>3</b><i><b>S</b></i><b>,3a</b><i><b>R</b></i><b>-27q</b></td><td class="colsep0 rowsep0" align="char" char=".">2</td><td class="colsep0 rowsep0" align="left">iv</td><td class="colsep0 rowsep0" align="char" char=".">4.6</td><td class="colsep0 rowsep0" align="char" char=".">0.6</td><td class="colsep0 rowsep0" align="char" char=".">1.6</td><td class="colsep0 rowsep0" align="char" char="."> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="char" char=".">2</td><td class="colsep0 rowsep0" align="left">po</td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char=".">57</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t6fn1"><div class="footnote" id="t6fn1"><sup>a</sup><p class="last">For PK studies, male rats (Sprague−Dawley), <i>n</i> = 2, were dosed intravenously (iv) and orally (po) at 1 or 2 mg/kg. Compounds were formulated for solution dosing in 10% ethanol/70% PEG400/20% phosphate buffered saline, pH 7.4. Plasma samples were analyzed by LC/MS/MS.</p></div><div class="footnote" id="t6fn2"><sup>b</sup><p class="last">Formulated for solution dosing in 10% ethanol/50% PEG400/40% phosphate buffered saline, pH 7.4.</p></div></div></div></div><div id="sec3_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i26" class="anchor-spacer"></div><h4 class="article-section__title" id="_i26"> Dahl Salt Sensitive Efficacy Model for Hypertension and Nephropathy</h4><div class="NLM_p">On the basis of its potency for MR, selectivity versus other nuclear receptors, broad target selectivity in the CEREP panel (>100×), and pharmacokinetic properties, the effect of <b>3</b><i><b>S</b></i><b>,3a</b><i><b>R</b></i><b>-27d</b> on blood pressure (BP) and kidney injury was tested in male Dahl salt sensitive (SS) rats fed with 4% NaCl. Rats were dosed orally via gavage with wet-milled <b>3</b><i><b>S</b></i><b>,3a</b><i><b>R</b></i><b>-27d</b> in vehicle (0.5% methylcellulose/0.1% Tween 80) at 10, 40, and 100 mpk/d, twice a day. For comparison, eplerenone was dosed at 100 mpk/d (dosed in chow because of its very short half-life in rats). Treatment was initiated at the beginning of salt feeding (day 0), and BP was monitored using telemetry units. The results are shown in Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a>. After 21 days of salt feeding, animals treated with vehicle showed a dramatic increase (40−50 mmHg) in systolic blood pressure (mean 24 h SBP), typical of Dahl SS rats. As has been demonstrated previously, BP increase was much lower in the eplerenone fed group, which represented a significant BP reduction compared to the vehicle group. Similar statistically significant BP reduction was also observed with 10 mpk <b>3</b><i><b>S</b></i><b>,3a</b><i><b>R</b></i><b>-27d</b>. Most noticeably, rats dosed with <b>3</b><i><b>S</b></i><b>,3a</b><i><b>R</b></i><b>-27d</b> at 40 and 100 mpk had negligible increase in BP over 21 days in the presence of high salt (<5 mmHg), a striking reduction of BP compared with the vehicle group and a statistically significantly better BP reduction relative to the eplerenone 100 mpk chow group.</div><figure id="fig5" data-index="16" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-16/jm100505n/production/images/medium/jm-2010-00505n_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-16/jm100505n/production/images/large/jm-2010-00505n_0010.jpeg" id="gr16" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Blood pressure lowering effect of <b>3</b><i><b>S</b></i><b>,3a</b><i><b>R</b></i><b>-7d</b> in Dahl SS rats: vehicle (◆); eplerenone, 100 mpk/d, chow (●); <b>3</b><i><b>S</b></i><b>,3a</b><i><b>R</b></i><b>-27d</b>, 10 mpk/d, b.i.d. (△); <b>3</b><i><b>S</b></i><b>,3a</b><i><b>R</b></i><b>-27d</b>, 40 mpk/d, b.i.d. (▲); <b>3</b><i><b>S</b></i><b>,3a</b><i><b>R</b></i><b>-27d</b>, 100 mpk/d, b.i.d. (◻). Radiotelemetrized arterial systolic blood pressure (SBP) was measured with the DATAQUEST A.R.T., version 3.0, Gold software. The values represent the average of all data points collected from each animal every 15 min for a 10 s interval over a 24 h period. SBP data were collected continuously over the course of the entire study (days 1−21). <i>n</i> = 6 for the <b>3</b><i><b>S</b></i><b>,3a</b><i><b>R</b></i><b>-27d</b> 100 mpk group, and <i>n</i> = 9 for all other groups: <i>P</i> < 0.05 versus vehicle (∗); <i>P</i> < 0.05 versus eplerenone (∗∗).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-16/jm100505n/production/images/large/jm-2010-00505n_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm100505n&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Salt fed Dahl SS rats develop kidney injury and, as a result, increased urinary albumin excretion. Urinary albumin to creatinine ratio (UACR) is a validated clinical biomarker for kidney damage. Since the creatinine levels remain constant and is not affected by salt or compound treatment, 24 h urinary albumin excretion was used as a biomarker to evaluate the effect of <b>3</b><i><b>S</b></i><b>,3a</b><i><b>R</b></i><b>-27d</b> on kidney injury at the end of the same study described above. <b>3</b><i><b>S</b></i><b>,3a</b><i><b>R</b></i><b>-27d</b> dosed at 10 mpk produced a similar decrease (18−19%) of urinary albumin as compared with eplerenone (Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a>a). <b>3</b><i><b>S</b></i><b>,3a</b><i><b>R</b></i><b>-27d</b> dosed at 40 and 100 mpk achieved 50−60% urinary albumin reduction, which is considered maximum in this model because they matched the levels from rats fed with low salt, as determined previously.</div><figure id="fig6" data-index="17" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-16/jm100505n/production/images/medium/jm-2010-00505n_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-16/jm100505n/production/images/large/jm-2010-00505n_0011.jpeg" id="gr17" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Renal protective effects of <b>3</b><i><b>S</b></i><b>,3a</b><i><b>R</b></i><b>-27d</b> in Dahl SS rats. (a) The 24 h urines were collected using metabolic cage. Urinary albumin was analyzed with the Hitachi 912 automated diagnostic clinical chemistry analyzer according to standard procedures: <i>P</i> < 0.05 versus vehicle (∗). (b) Glomerulosclerosis was evaluated by assessing 100 glomeruli and scoring severity of individual glomeruli from 0 to 4. The total glomerular score for each animal was calculated as follows: 1<i>X</i> (number of glomeruli with severity score 1) + 2<i>X</i> (number of glomeruli with severity score 2) + 3<i>X</i> (number of glomeruli with severity score 3) + 4<i>X</i> (number of glomeruli with severity score 4): <i>P</i> < 0.05 versus vehicle (∗); <i>P</i> < 0.05 versus eplerenone (∗∗). (c) Effect of <b>3</b><i><b>S</b></i><b>,3a</b><i><b>R</b></i><b>-27d</b> on serum potassium (K<sup>+</sup>): <i>P</i> < 0.05 versus vehicle (∗); <i>P</i> < 0.05 versus eplerenone (∗∗); <i>P</i> = 0.058 versus eplerenone (∗∗∗).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-16/jm100505n/production/images/large/jm-2010-00505n_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm100505n&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The protection on the kidney was further confirmed by assessing structure changes in the kidney after hematoxylin and eosin, periodic acid Schiff, or trichrome staining. The severity of the glomerular damage was scored from 0 to 4, and 100 glomeruli were assessed for each animal. A total glomerulosclerosis score for each animal was calculated on the basis of severity and the number of glomeruli with each severity score. Eplerenone treatment resulted in a significantly lower mean glomerulosclerosis score compared with the vehicle group, indicative of renal protection by eplerenone (Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a>b). A further decrease of glomerulosclerosis score was achieved in both 10 and 40 mpk <b>3</b><i><b>S</b></i><b>,3a</b><i><b>R</b></i><b>-27d</b> treatment groups, suggesting that <b>3</b><i><b>S</b></i><b>,3a</b><i><b>R</b></i><b>-27d</b> afforded significantly better protective effect on the kidney than eplerenone at the doses tested. In addition, <b>3</b><i><b>S</b></i><b>,3a</b><i><b>R</b></i><b>-27d</b> appeared to be more potent on glomerulosclerosis than on urinary albumin since 10 mpk <b>3</b><i><b>S</b></i><b>,3a</b><i><b>R</b></i><b>-27d</b> treatment reached maximal effect on glomerulosclerosis while 40 mpk was needed to get maximal effect on urinary albumin. Nonetheless, these data together demonstrate that <b>3</b><i><b>S</b></i><b>,3a</b><i><b>R</b></i><b>-27d</b> may be a useful renal protective agent.</div><div class="NLM_p last">Serum potassium levels were measured from blood samples taken at the end of the study. As expected, eplerenone treatment resulted in an increase of serum potassium relative to vehicle treatment (Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a>c). <b>3</b><i><b>S</b></i><b>,3a</b><i><b>R</b></i><b>-27d</b> appeared to have a more attenuated effect on serum potassium than eplerenone. The 10 mpk <b>3</b><i><b>S</b></i><b>,3a</b><i><b>R</b></i><b>-27d</b> group had significantly lower serum potassium but similar BP reduction compared with the eplerenone group. Moreover, 40 mpk <b>3</b><i><b>S</b></i><b>,3a</b><i><b>R</b></i><b>-27d</b> treatment had maximal effect on BP and kidney damage but resulted in a lower, though not statistically significant (<i>P</i> = 0.058), serum potassium level relative to eplerenone. These results indicate that <b>3</b><i><b>S</b></i><b>,3a</b><i><b>R</b></i><b>-27d</b> may have reduced risk in inducing hyperkalemia in the target patient population.</div></div></div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i27">Conclusion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_56416" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_56416" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">We have discovered a novel class of nonsteroidal pyrazoline antagonists of MR with excellent potency and good selectivity in cellular transcription assays. Careful modification of the N1, C3, and C5 substituents resulted in leads <i><b>R</b></i><b>-4g</b> and <i><b>R</b></i><b>-12o</b>, identifying (1) the meta-substituted para-benzonitrile as the preferred N1 substituent and A-ring mimic, (2) the para-benzoic acid as the preferred C3 group because of its solubility and superior selectivity profile vs the hERG channel, and (3) the cyclopentyl group as the preferred C5 group. Introduction of conformational restriction of the C3 benzoic acid led to the discovery of pyrazoline <b>3</b><i><b>S</b></i><b>,3a</b><i><b>R</b></i><b>-27d</b>, a remarkably high affinity selective MR antagonist in vitro. <b>3</b><i><b>S</b></i><b>,3a</b><i><b>R</b></i><b>-27d</b> reduces blood pressure, decreases urinary albumin, and protects kidney in Dahl SS rat, a preclinical model of salt induced hypertension and nephropathy, and may have reduced the side effect on serum potassium levels. As a result of its in vitro potency and selectivity, in vivo efficacy, pharmacokinetic properties, and preclinical safety profile, pyrazoline <b>3</b><i><b>S</b></i><b>,3a</b><i><b>R</b></i><b>-27d</b> was selected as a clinical candidate for diabetic nephrophathy and is currently in clinical studies.</div></div><div id="sec5" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i28">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_15778" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_15778" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">All materials were obtained from commercial sources and used as purchased. Chromatography solvents were HPLC grade and were used without further purification. Thin layer chromatography (TLC) analysis was performed using Merck silica gel 60 F-254 thin layer plates. LC−MS analyses were performed on Mariner TOF from Perseptive Biosystems. The scan range was <i>m</i>/<i>z</i> 100−1000. The sample was introduced by flow inject from an Agilent 1100 with 100 μL/min MeOH (10 mM ammonium acetate) into the electrospray source. Preparative reverse phase HPLC was performed on a Gilson 215 liquid handler equipped with a Dynamax Microsorb C18 (300 Å) column (41.4 mm × 25 cm, 8 μm) and Gilson 156 variable length UV detector (acetonitrile/water/0.05% TFA). Chiral resolution was performed by supercritical fluid chromatography (SFC) on a Berger SFC MultiGram II system equipped with a Chiralpak AS-H, Chiralpak AD-H, or Chiralcel OJ-H column (Chiral Technologies, 30 mm × 250 mm) and eluted with 20−50% alcohol/CO<sub>2</sub>, 50−70 mL/min. Where noted, analytical chiral chromatography was performed on the equivalent Chiralpak AS-H, Chiralpak AD-H, or Chiralcel OJ-H column (Chiral Technologies, 4.6 mm × 100 mm, 3 mL/min). The purity of tested compounds was ≥95% as determined by combustion analysis or by HPLC conducted on an Agilent 1100 system using a reverse phase C8 column with diode array detector unless stated otherwise. NMR spectra were recorded on a Bruker or Varian 400 MHz spectrometer. The signal of the deuterated solvent was used as internal reference. Chemical shifts (δ) are given in ppm and are referenced to residual not fully deuterated solvent signal. Coupling constants (<i>J</i>) are given in Hz.</div><div id="sec5_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i29" class="anchor-spacer"></div><h3 class="article-section__title" id="_i29"> Preparation of Arylhydrazines: Method A. 2-Chloro-4-hydrazinylbenzonitrile Hydrochloride (<b>9a</b>)</h3><div class="NLM_p last">A mixture of 2-chloro-4-fluorobenzonitrile (20.0 g, 129 mmol), hydrazine monohydrate (9.4 mL, 193 mmol), and ethanol (80 mL) was refluxed for 4 h. The mixture was diluted with water (200 mL). The precipitate was filtered, washed with water, and dried to give an off-white solid (16.8 g). The solid was suspended in diethyl ether (400 mL) and treated with 2 N hydrogen chloride/diethyl ether (50 mL, 100 mmol). The precipitate was filtered, washed with diethyl ether, and dried to give the title compound as a white solid (16.3 g, 79.9 mmol, 62% yield). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 9.63 (br s, 3 H), 9.17 (br s, 1 H), 7.74 (d, <i>J</i> = 8.9 Hz, 1 H), 7.13 (d, <i>J</i> = 2.1 Hz, 1 H), 6.92 (dd, <i>J</i> = 8.6, 2.1 Hz, 1 H). ES-MS <i>m</i>/<i>z</i> 168 (M + H).</div></div><div id="sec5_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i30" class="anchor-spacer"></div><h3 class="article-section__title" id="_i30"> 3-Chloro-4-hydrazinylbenzonitrile Hydrochloride (<b>9b</b>)</h3><div class="NLM_p last">The title compound was prepared according to method A from 3-chloro-4-fluorobenzonitrile (1.56 g, 10 mmol) at 80 °C to give a pale-pink solid (1.53 g, 7.54 mmol, 75% yield). ES-MS <i>m</i>/<i>z</i> 168 (M + H).</div></div><div id="sec5_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i31" class="anchor-spacer"></div><h3 class="article-section__title" id="_i31"> 4-Hydrazinyl-2-methylbenzonitrile Hydrochloride (<b>9c</b>)</h3><div class="NLM_p last">A mixture of 4-fluoro-2-methylbenzonitrile (20.4 g, 151 mmol), hydrazine monohydrate (14.6 mL, 302 mmol), and ethanol (80 mL) was refluxed for 48 h. The mixture was diluted with water (200 mL). The precipitate was filtered, washed with water, and dried to give an off-white solid (16.1 g). The solid was suspended in diethyl ether (400 mL) and treated with 2 N hydrogen chloride/diethyl ether (55 mL, 110 mmol). The precipitate was filtered, washed with diethyl ether, and dried to give <b>9c</b> as a white solid (15.6 g, 85.0 mmol, 56% yield). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 8.42 (br s, 1 H), 8.33 (br s, 3 H), 7.51 (d, <i>J</i> = 8.6 Hz, 1 H), 6.81 (d, <i>J</i> = 1.9 Hz, 1 H), 6.74 (dd, <i>J</i> = 8.6, 2.4 Hz, 1 H), 2.35 (s, 3 H). ES-MS <i>m</i>/<i>z</i> 148 (M + H).</div></div><div id="sec5_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i32" class="anchor-spacer"></div><h3 class="article-section__title" id="_i32"> 4-Hydrazinyl-2-(trifluoromethyl)benzonitrile Hydrochloride (<b>9d</b>)</h3><div class="NLM_p last">The title compound was prepared according to method A from 4-fluoro-2-(trifluoromethyl)benzonitrile (1.89 g, 10 mmol) at 80 °C to give an off-white solid (1.89 g, 8.0 mmol, 80% yield). ES-MS <i>m</i>/<i>z</i> 202 (M + H).</div></div><div id="sec5_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i33" class="anchor-spacer"></div><h3 class="article-section__title" id="_i33"> 4-Hydrazinylphthalonitrile Hydrochloride (<b>9e</b>)</h3><div class="NLM_p last">The title compound was prepared according to method A from 4-fluorophthalonitrile (1.0 g, 6.8 mmol) at 80 °C to give a pale-yellow solid (949 mg, 4.89 mmol, 72% yield). ES-MS <i>m</i>/<i>z</i> 159 (M + H).</div></div><div id="sec5_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i34" class="anchor-spacer"></div><h3 class="article-section__title" id="_i34"> 4-Hydrazinyl-2-methoxybenzonitrile Hydrochloride (<b>9f</b>)</h3><div class="NLM_p last">The title compound was prepared according to method A from 4-fluoro-2-methoxybenzonitrile (4.97 g, 32.9 mmol) refluxing overnight to give the title compound (3.54 g, 17.8 mmol, 54% yield). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 3.82 (s, 3 H), 6.44 (dd, <i>J</i> = 8.46, 2.01 Hz, 1 H), 6.64 (d, <i>J</i> = 2.15 Hz, 1 H), 7.41 (d, <i>J</i> = 8.32 Hz, 1 H), 7.99 (s, 2 H), 8.40 (s, 1 H). ES-MS <i>m</i>/<i>z</i> 164 (M + H).</div></div><div id="sec5_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i35" class="anchor-spacer"></div><h3 class="article-section__title" id="_i35"> 4-Hydrazinyl-2-(methoxymethyl)benzonitrile Hydrochloride (<b>9g</b>)</h3><div class="NLM_p">A solution of 2-methyl-4-fluorobenzonitrile (3.5 g, 25.9 mmol) in 40 mL of carbon tetrachloride was treated with <i>N</i>-bromosuccinimide (4.6 g, 25.9 mmol) and benzoylperoxide (157 mg, 0.65 mmol). The mixture was heated to reflux for 3 h, cooled to room temperature, and allowed to stir overnight. The solids were filtered off and washed with carbon tetrachloride. The filtrate was condensed and purified by flash column chromatography (5−50% ethyl acetate/hexanes). The second eluting peak was concentrated in vacuo to yield 2-(bromomethyl)-4-fluorobenzonitrile (1.35 g, 0.63 mmol, 25% yield) as a white solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 4.79 (s, 2 H), 7.44 (dt, <i>J</i> = 8.59, 2.69 Hz, 1 H), 7.68 (dd, <i>J</i> = 9.53, 2.55 Hz, 1 H), 8.01 (dd, <i>J</i> = 8.59, 5.64 Hz, 1 H).</div><div class="NLM_p">A solution of 2-(bromomethyl)-4-fluorobenzonitrile (501 mg, 2.3 mmol) in methanol (5 mL) was treated with sodium methoxide (5.6 mL of 0.5 M solution in methanol, 2.81 mmol) and stirred for 1 h at room temperature and then heated to 55 °C for 2 h. The mixture was cooled to room temperature, condensed to dryness, and purified by flash chromatography (5−60% ethyl acetate/hexanes). Pure fractions were pooled and concentrated in vacuo to yield 4-fluoro-2-(methoxymethyl)benzonitrile (110 mg, 0.66 mmol, 28% yield) as an oil. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 7.97 (dd, <i>J</i> = 8.46, 5.50 Hz, 1 H), 7.46 (dd, <i>J</i> = 9.53, 2.55 Hz, 1 H), 7.39 (td, <i>J</i> = 8.59, 2.69 Hz, 1 H), 4.58 (s, 2 H), 3.37 (s, 3 H).</div><div class="NLM_p last">A mixture of 4-fluoro-2-(methoxymethyl)benzonitrile (110 mg, 0.67 mmol), hydrazine monohydrate (133 mg, 0.13 mL, 2.6 mmol), and ethanol (5 mL) was heated to reflux overnight. The mixture was cooled to room temperature and condensed. The residue was dissolved in methanol and treated with 2.0 N hydrogen chloride in diethyl ether. The solvent was removed and the solid was dried to give <b>9g</b> as an off-white solid.</div></div><div id="sec5_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i36" class="anchor-spacer"></div><h3 class="article-section__title" id="_i36"> 2-(Benzyloxy)-4-hydrazinylbenzonitrile (<b>9h</b>)</h3><div class="NLM_p">Benzyl alcohol (3.25 g, 30 mmol) was slowly added to a stirred suspension of sodium hydride (1.15 g, 28.7 mmol) in toluene (50 mL) at room temperature. The mixture was stirred for 30 min. Then 2,4-difluorobenzonitrile was added all at once and stirring continued overnight. The mixture was quenched with water, extracted three times with ethyl acetate, washed with brine, dried over magnesium sulfate, filtered, and condensed. The crude product was dissolved in hot ethyl acetate and triturated with hexanes to give 2-(benzyloxy)-4-fluorobenzonitrile (5.4 g, 23.8 mmol, 88% yield) as a white solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 5.30 (s, 2 H), 6.99 (td, <i>J</i> = 8.46, 2.42 Hz, 1 H), 7.29−7.51 (m, 6 H), 7.86 (dd, <i>J</i> = 8.59, 6.44 Hz, 1 H).</div><div class="NLM_p last">A solution of 2-(benzyloxy)-4-fluorobenzonitrile (4.8 g, 21 mmol) in ethanol (80 mL) was treated with hydrazine monohydrate (2.6 g, 2.5 mL, 53 mmol) and heated to reflux for 3 days. The mixture was cooled to room temperature and concentrated. Water was added and the residue was extracted three times with ethyl acetate, dried over magnesium sulfate, filtered, and condensed to give <b>9h</b> (3.8 g, 15.8 mmol, 75% yield) as an off-white solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 4.27 (s, 2 H), 5.16 (s, 2 H), 6.36 (dd, <i>J</i> = 8.73, 1.75 Hz, 1 H), 6.61 (d, <i>J</i> = 1.61 Hz, 1 H), 7.30 (d, <i>J</i> = 8.59 Hz, 1 H), 7.32−7.51 (m, 5 H), 7.78 (s, 1 H). ES-MS <i>m</i>/<i>z</i> 240 (M + H).</div></div><div id="sec5_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i37" class="anchor-spacer"></div><h3 class="article-section__title" id="_i37"> Preparation of α,β-Unsaturated Ketones: Method B1</h3><div class="NLM_p last">The methyl ketone (2 mmol) was dissolved in EtOH (3 mL) and treated with the aldehyde (1.1 equiv) followed by 2.5 N NaOH (15−20 mL). The mixture was stirred at room temperature overnight and neutralized with 1 N HCl. A precipitate formed and was collected by filtration. The crude product was dried in a vacuum oven and used in the next step.</div></div><div id="sec5_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i38" class="anchor-spacer"></div><h3 class="article-section__title" id="_i38"> Preparation of α,β-Unsaturated Ketones: Method B2</h3><div class="NLM_p last">The methyl ketone (1.0 mmol) was dissolved in <i>N</i>,<i>N</i>-dimethylformamide (1 mL) and treated with the aldehyde (1.0 mmol) followed by tetraethyl orthosilicate (0.5 mmol) and potassium fluoride (1.0 mmol). The solution was heated to 50 °C for 3 h, diluted with water, and extracted with ethyl acetate. The organic layer was washed with water, brine and dried over sodium sulfate. The slurry was filtered and concentrated. Addition of water to residue provided the crude product as a solid which was collected by vacuum filtration.</div></div><div id="sec5_11" class="NLM_sec NLM_sec_level_2"><div id="ac_i39" class="anchor-spacer"></div><h3 class="article-section__title" id="_i39"> Preparation of α,β-Unsaturated Ketones: Method B3</h3><div class="NLM_p last">A mixture of cyclic aryl ketone <b>24</b> (10 mmol) and aldehyde (20 mmol) in methanol (20 mL) was treated with pyrrolidine (1.0 mL, 12 mmol) at room temperature. After 1−6 h, the mixture was cooled to 0 °C, and the precipitate was filtered and washed with cold methanol to give the desired α,β-unsaturated ketone.</div></div><div id="sec5_12" class="NLM_sec NLM_sec_level_2"><div id="ac_i40" class="anchor-spacer"></div><h3 class="article-section__title" id="_i40"> Preparation of α,β-Unsaturated Ketones: Method B4</h3><div class="NLM_p last">A solution of aldehyde (1.2 equiv) and cyclic aryl ketone <b>24</b> (1.0 equiv) in concentrated hydrochloric acid (or 4 N hydrogen chloride in dioxane) and ethanol was refluxed overnight. The mixture was diluted with water, filtered, and dried to give the desired α,β-unsaturated ketone.</div></div><div id="sec5_13" class="NLM_sec NLM_sec_level_2"><div id="ac_i41" class="anchor-spacer"></div><h3 class="article-section__title" id="_i41"> Preparation of α,β-Unsaturated Ketones: Method B5</h3><div class="NLM_p last">A solution of cyclic aryl ketone <b>24</b> (1.9 mmol) in tetrahydrofuran (5 mL) was added dropwise under nitrogen to a 1 M solution of lithium hexamethyldisilazide in tetrahydrofuran (2 mL) cooled with an ice bath. After addition was complete the reaction mixture was stirred for 30 min and treated with a solution of aldehyde (2.0 mmol) in tetrahydrofuran (5 mL). The mixture was allowed to warm to room temperature under stirring. After 2 h, the mixture was quenched with saturated ammonium chloride and extracted with ethyl acetate. The organic layers were dried over sodium sulfate, concentrated, and the crude product was purified by silica gel flash chromatrography (ethyl acetate/heptanes) or reverse-phase HPLC (acetonitrile/water/0.1% trifluoroacetic acid) to give the desired α,β-unsaturated ketone.</div></div><div id="sec5_14" class="NLM_sec NLM_sec_level_2"><div id="ac_i42" class="anchor-spacer"></div><h3 class="article-section__title" id="_i42"> 4-(3-(4-Fluorophenyl)acryloyl)benzoic Acid (<b>6a</b>)</h3><div class="NLM_p last">To suspension of 4-fluorobenzaldehyde (13.7 mL, 128 mmol) and 4-acetylbenzoic acid (20 g, 122 mmol) in EtOH (200 mL) was added 2.5 N NaOH (200 mL). The mixture was stirred at room temperature for 1.5 h. The mixture was diluted with acetonitrile (400 mL) and filtered. The resulting precipitate was suspended in water (300 mL) and 1 N HCl (200 mL), and the mixture was stirred for 20 min, filtered, and dried to give 4-(3-(4-fluorophenyl)acryloyl)benzoic acid (25.3 g, 93.6 mmol, 77%). ES-MS <i>m</i>/<i>z</i> 271 (M + H).</div></div><div id="sec5_15" class="NLM_sec NLM_sec_level_2"><div id="ac_i43" class="anchor-spacer"></div><h3 class="article-section__title" id="_i43"> Ethyl 4-(3-(4-Fluorophenyl)acryloyl)benzoate (<b>10a</b>)</h3><div class="NLM_p last">To <b>6a</b> (15 g, 55.5 mmol) in ethanol (250 mL) was added sulfuric acid (5 mL), and the mixture was refluxed overnight. A precipitate formed upon cooling which was collected by vacuum filtration and washed with ethanol to give the title compound as a solid (12.7 g, 42.6 mmol, 77%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 1.43 (t, <i>J</i> = 7.1 Hz, 3 H), 4.43 (q, <i>J</i> = 7.1 Hz, 2 H), 7.13 (t, <i>J</i> = 8.6 Hz, 2 H), 7.44 (d, <i>J</i> = 15.3 Hz, 1 H), 7.66 (dd, <i>J</i> = 8.6, 5.4 Hz, 2 H), 7.79 (d, <i>J</i> = 15.8 Hz, 1 H), 8.05 (d, <i>J</i> = 8.6 Hz, 2 H), 8.12−8.24 (m, 2 H). ES-MS <i>m</i>/<i>z</i> 299 (M + H).</div></div><div id="sec5_16" class="NLM_sec NLM_sec_level_2"><div id="ac_i44" class="anchor-spacer"></div><h3 class="article-section__title" id="_i44"> Preparation of Pyrazolines: Method C1</h3><div class="NLM_p last">The α,β-unsaturated ketone (1 mmol) was dissolved in EtOH (15 mL). The arylhydrazine hydrochloride (1 mmol) was added, and the mixture was heated at 80 °C until the reaction was complete (generally overnight). The solvent was evaporated under vacuum and crude solid was purified by reverse phase HPLC to give the pyrazoline.</div></div><div id="sec5_17" class="NLM_sec NLM_sec_level_2"><div id="ac_i45" class="anchor-spacer"></div><h3 class="article-section__title" id="_i45"> Preparation of Pyrazolines Followed by Ester Hydrolysis: Method C2</h3><div class="NLM_p last">A solution of the arylhydrazine hydrochloride <b>9</b> (1.5 mmol) and α,β-unsaturated ketone <b>10a</b> (1.0 mmol) in ethanol (8 mL/mmol) was stirred at 80 °C under nitrogen atmosphere for 2−24 h. The reaction was monitored by LC−MS. Upon completion of the condensation reaction, the mixture was cooled to room temperature, treated with THF (4 mL/mmol) and 2.5 N sodium hydroxide (2 mL/mmol), and stirred overnight. The mixture was concentrated to half the volume under a stream of nitrogen, diluted with water (10−15 mL/mmol), and neutralized with 3 N HCl (1.5 mL/mmol). The resulting precipitate was collected, washed with water, and dried to provide the pyrazoline product.</div></div><div id="sec5_18" class="NLM_sec NLM_sec_level_2"><div id="ac_i46" class="anchor-spacer"></div><h3 class="article-section__title" id="_i46"> Preparation of Conformationally Restricted Pyrazolines: Method C3</h3><div class="NLM_p last">A mixture of cyclic α,β-unsaturated ketone <b>25</b> (1 mmol), arylhydrazine hydrochloride <b>9</b> (1.2−1.5 mmol), and absolute ethanol (8 mL) was sparged with argon and stirred at 80 °C for 4−24 h. The reaction mixture was cooled to room temperature and filtered. The resulting solids were washed with ethanol to give the cis isomer of the pyrazoline ester as the major or only diastereomer.</div></div><div id="sec5_19" class="NLM_sec NLM_sec_level_2"><div id="ac_i47" class="anchor-spacer"></div><h3 class="article-section__title" id="_i47"> Ester Hydrolysis: Method D</h3><div class="NLM_p last">A solution of pyrazoline ester <b>11</b> or <b>26</b> (1 mmol) in tetrahydrofuran (6 mL) and methanol (2 mL) was treated with 2.5 N sodium hydroxide (2 mL). The mixture was stirred at room temperature until the reaction was complete as determined by reverse-phase HPLC (1−24 h). The resulting mixture was concentrated to approximately half the original volume under a stream of nitrogen and acidified to a pH < 4 with aqueous hydrochloric acid. The mixture was diluted with water and filtered to give the pyrazoline carboxylic acid.</div></div><div id="sec5_20" class="NLM_sec NLM_sec_level_2"><div id="ac_i48" class="anchor-spacer"></div><h3 class="article-section__title" id="_i48"> (±)-4-[5-(4-Fluorophenyl)-1-(4-nitrophenyl)-4,5-dihydro-1<i>H</i>-pyrazol-3-yl]phenol (<b>4a</b>)</h3><div class="NLM_p last">1-(4-Hydroxyphenyl)ethanone and 4-fluorobenzaldehyde were reacted according to method B1 to give the chalcone which was reacted with 4-nitrophenylhydrazine according to method C1 to give <b>4a</b> (89%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 3.17 (dd, <i>J</i> = 17.78, 4.49 Hz, 1 H), 3.93 (dd, <i>J</i> = 17.98, 11.72 Hz, 1 H), 5.69 (dd, <i>J</i> = 11.72, 4.30 Hz, 1 H), 6.73−6.92 (m, 2 H), 7.01 (d, <i>J</i> = 8.99 Hz, 2 H), 7.11−7.21 (m, 2 H), 7.21−7.40 (m, 2 H), 7.64 (d, <i>J</i> = 8.99 Hz, 2 H), 8.02 (d, <i>J</i> = 9.38 Hz, 2 H). HRMS (C<sub>21</sub>H<sub>16</sub>FN<sub>3</sub>O<sub>3</sub>) calcd 378.1248, obsd 378.1254.</div></div><div id="sec5_21" class="NLM_sec NLM_sec_level_2"><div id="ac_i49" class="anchor-spacer"></div><h3 class="article-section__title" id="_i49"> (±)-4-[5-(4-Fluorophenyl)-3-(2-oxo-2,3-dihydro-1,3-benzoxazol-6-yl)-4,5-dihydro-1<i>H</i>-pyrazol-1-yl]benzonitrile (<b>4b</b>)</h3><div class="NLM_p last">6-Acetylbenzo[<i>d</i>]oxazol-2(3<i>H</i>)-one (0.164 g, 1.0 mmol) and 4-fluorobenzaldehyde were reacted according to method B1 to give chalcone <b>6b</b> (0.630 g, 89%) as a pale-yellow solid: mp 300 °C dec. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.29 (s, 1H), 7.96−7.89 (m, 4H), 7.81 (br s, 1H), 7.67 (d, <i>J</i> = 15.6 Hz, 1H), 7.26 (t, <i>J</i> = 8.8 Hz, 2H), 7.00 (d, <i>J</i> = 8.2 Hz, 1H);. ES-MS <i>m</i>/<i>z</i> 284 (M + H). The chalcone (0.58 mmol) was reacted with 4-cyanophenylhydrazine hydrochloride according to method C1 to give <b>4b</b> (0.228 g, 81%) as a light-yellow solid: mp 179−180 °C. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 11.85 (s, 1H), 7.73 (d, <i>J</i> = 1.4 Hz, 1H), 7.58 (dd, <i>J</i> = 8.1, 1.5 Hz, 1H), 7.56 (d, <i>J</i> = 9.1 Hz, 2H), 7.31−7.27 (m, 2H), 7.17 (app t, <i>J</i> = 8.8 Hz, 2H), 7.14 (d, <i>J</i> = 8.1 Hz, 1H), 7.07 (d, <i>J</i> = 8.8 Hz, 2H), 5.68 (dd, <i>J</i> = 12.0, 5.0 Hz, 1H), 3.96 (dd, <i>J</i> = 17.3, 12.0 Hz, 1H), 3.17 (dd, <i>J</i> = 17.3, 5.0 Hz, 1H). ES-MS <i>m</i>/<i>z</i> 399 (M + H). Anal. (C<sub>23</sub>H<sub>15</sub>FN<sub>4</sub>O<sub>2</sub>·0.35H<sub>2</sub>O) C, H, N.</div></div><div id="sec5_22" class="NLM_sec NLM_sec_level_2"><div id="ac_i50" class="anchor-spacer"></div><h3 class="article-section__title" id="_i50"> 4-[(5<i>R</i>)-5-(4-Fluorophenyl)-3-(2-oxo-2,3-dihydro-1,3-benzoxazol-6-yl)-4,5-dihydro-1<i>H</i>-pyrazol-1-yl]benzonitrile (<b><i>R</i>-4b</b>) and 4-[(5<i>S</i>)-5-(4-Fluorophenyl)-3-(2-oxo-2,3-dihydro-1,3-benzoxazol-6-yl)-4,5-dihydro-1<i>H</i>-pyrazol-1-yl]benzonitrile (<b><i>S</i>-4b</b>)</h3><div class="NLM_p last">The compounds were obtained by chiral separation of <b>(±)-4b</b> on a Chiralpak AS-H column (30 mm × 250 mm) eluted with 50% MeOH/CO<sub>2</sub>, 70 mL/min flow rate. <i><b>R</b></i><b>-4b</b>: ES-MS <i>m</i>/<i>z</i> 399 (M + H), earlier eluting peak, <i>t</i><sub>R</sub> = 5.5 min, >99.5% ee by chiral HPLC. <i><b>S</b></i><b>-4b</b>: ES-MS <i>m</i>/<i>z</i> 399 (M + H), later eluting peak, <i>t</i><sub>R</sub> = 7.25 min, >99.5% ee by chiral HPLC.</div></div><div id="sec5_23" class="NLM_sec NLM_sec_level_2"><div id="ac_i51" class="anchor-spacer"></div><h3 class="article-section__title" id="_i51"> 4-[(5<i>R</i>)-3-(2,4-Dimethyl-1,3-thiazol-5-yl)-5-(4-fluorophenyl)-4,5-dihydro-1<i>H</i>-pyrazol-1-yl]benzonitrile (<b><i>R</i>-4c</b>)</h3><div class="NLM_p last">1-(2,4-Dimethylthiazol-5-yl)ethanone (1.0 mmmol) and 4-fluorobenzaldehyde (1.0 mmmol) were reacted according to method B1 to give the chalcone. The chalcone (1 mmol) was reacted with 4-cyanophenylhydrazine hydrochloride (1.0 mmol) according to method C1 to give crude pyrazoline which was purified by silica gel chromatography (5−50% EtOAc/hexane) to yield <b>(±)-4c</b> (53%): <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 2.52 (s, 3 H), 2.62 (s, 3 H), 3.17 (dd, <i>J</i> = 17.6, 4.9 Hz, 1 H), 4.07 (dd, <i>J</i> = 17.6, 12.1 Hz, 1 H), 5.66 (dd, <i>J</i> = 11.9, 5.1 Hz, 1 H), 6.97 (d, <i>J</i> = 8.5 Hz, 2 H), 7.14−7.24 (m, 2 H), 7.30 (dd, <i>J</i> = 8.2, 5.5 Hz, 2 H), 7.57 (d, <i>J</i> = 7.9 Hz, 2 H). ES-MS <i>m</i>/<i>z</i> 377 (M + H). Chiral separation of <b>(±)-4c</b> on a Chiralpak AS-H column (30 mm × 250 mm) eluted with 50%MeOH/CO<sub>2</sub>, 70 mL/min flow afforded <i><b>R</b></i><b>-4c</b>: later eluting peak, <i>t</i><sub>R</sub> = 8.81 min, >95% ee by chiral HPLC. ES-MS <i>m</i>/<i>z</i> 377 (M + H).</div></div><div id="sec5_24" class="NLM_sec NLM_sec_level_2"><div id="ac_i52" class="anchor-spacer"></div><h3 class="article-section__title" id="_i52"> (±)-4-[1-(4-Cyanophenyl)-5-(4-fluorophenyl)-4,5-dihydro-1<i>H</i>-pyrazol-3-yl]-<i>N-</i>[2-(dimethylamino)ethyl]-<i>N-</i>methylbenzamide Trifluoroacetate (<b>4d</b>)</h3><div class="NLM_p last">To a solution of acid <b>(±)-4 g</b> (1 mmol) in 5 mL of anhydrous DMF under nitrogen at room temperature was added HBTU (1.1 mmol), followed by <i>N</i>,<i>N</i>-diisopropylethylamine (1.5 mmol). After the mixture was stirred for 5 min, triethyl-1,2-diamine (1.5 mmol) was added and stirring was continued for another hour. The mixture was then filtered and purified by reverse phase HPLC, eluting with a gradient of acetonitrile in water containing 1% TFA. The fractions containing pure product were combined and lyophilized to give the desired product <b>4d</b> (110 mg, 23%). ES-MS <i>m</i>/<i>z</i> 470 (M + H).</div></div><div id="sec5_25" class="NLM_sec NLM_sec_level_2"><div id="ac_i53" class="anchor-spacer"></div><h3 class="article-section__title" id="_i53"> (±)-4-[1-(4-Cyanophenyl)-3-(2-oxo-2,3-dihydro-1,3-benzoxazol-6-yl)-4,5-dihydro-1<i>H</i>-pyrazol-5-yl]benzoic Acid (<b>4e</b>)</h3><div class="NLM_p last">6-Acetylbenzo[<i>d</i>]oxazol-2(3<i>H</i>)-one (0.164 g, 1.0 mmol) and methyl 4-formylbenzoate were reacted according to method B1 to give the chalcone (30%). The chalcone was reacted with 4-cyanophenylhydrazine hydrochloride according method C1 to give <b>4e</b> (40 mg, 31%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 3.22 (dd, <i>J</i> = 17.99, 5.10 Hz, 1 H), 3.97 (dd, <i>J</i> = 17.72, 12.35 Hz, 1 H), 5.71 (dd, <i>J</i> = 12.08, 5.10 Hz, 1 H), 7.03 (d, <i>J</i> = 8.86 Hz, 2 H), 7.11 (d, <i>J</i> = 8.06 Hz, 1 H), 7.33−7.37 (m, 2 H), 7.51−7.58 (m, 3 H), 7.70 (d, <i>J</i> = 1.34 Hz, 1 H), 7.87−7.92 (m, 2 H), 11.84 (s, 1 H), 12.92 (s, 1 H). HRMS M + H calcd for C<sub>24</sub>H<sub>16</sub>N<sub>4</sub>O<sub>4</sub>, 425.1244, obsd 425.1289. Anal. (C<sub>24</sub>H<sub>16</sub>N<sub>4</sub>O<sub>4</sub>) Calcd: C, 67.92; H, 3.80; N, 13.20. Found: C, 67.45; H, 3.45; N, 12.87.</div></div><div id="sec5_26" class="NLM_sec NLM_sec_level_2"><div id="ac_i54" class="anchor-spacer"></div><h3 class="article-section__title" id="_i54"> (±)-4-[5-(4-Fluorophenyl)-3-(2-oxo-2,3-dihydro-1,3-benzoxazol-6-yl)-4,5-dihydro-1<i>H</i>-pyrazol-1-yl]benzoic Acid (<b>4f</b>)</h3><div class="NLM_p">A stirred suspension of chalcone <b>6b</b> (0.68 mmol) and 4-hydrazinylbenzoic acid hydrochloride (0.715 mmol) in 3% hydrochloric acid/1-butanol (6.0 mL) was heated at reflux overnight. After this time the precipitate was collected by filtration and triturated with ethanol. The solid was purified by flash column chromatography to provide ethyl 4-[5-(4-fluorophenyl)-3-(2-oxo-2,3-dihydrobenzoxazol-6-yl)-4,5-dihydropyrazol-1-yl]benzoate hydrate (0.231 g, 58%) as a light-yellow solid: mp 237−239 °C. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 11.86 (s, 1H), 7.73 (d, <i>J</i> = 9.0 Hz, 2H), 7.71 (d, <i>J</i> = 1.4 Hz, 1H), 7.58 (dd, <i>J</i> = 8.1, 1.5 Hz, 1H), 7.31−7.28 (m, 2H), 7.19−7.13 (m, 3H), 7.04 (d, <i>J</i> = 8.9 Hz, 2H), 5.67 (dd, <i>J</i> = 12.0, 5.0 Hz, 1H), 4.22 (q, <i>J</i> = 7.2 Hz, 2H), 3.95 (dd, <i>J</i> = 17.8, 12.0 Hz, 1H), 3.20 (dd, <i>J</i> = 17.8, 5.0 Hz, 1H), 1.26 (t, <i>J</i> = 7.2 Hz, 3H). ES-MS <i>m</i>/<i>z</i> 446 (M + H). Anal. (C<sub>25</sub>H<sub>20</sub>FN<sub>3</sub>O<sub>4</sub>·0.25H<sub>2</sub>O) C, H, N.</div><div class="NLM_p last">To a stirred suspension of ethyl 4-[5-(4-fluorophenyl)-3-(2-oxo-2,3-dihydrobenzoxazol-6-yl)-4,5-dihydropyrazol-1-yl]benzoate (0.164 g, 0.368 mmol) in methanol/THF (1:1, 8.0 mL) was added potassium hydroxide (5.5 mL of 1.0 M solution in water, 5.50 mmol). After the mixture was stirred for 4 d, 2 M hydrochloric acid was added to adjust the reaction mixture to pH 6 and the precipitate was collected by filtration. The solid was purified by flash column chromatography (95:5 methylene chloride/methanol) to provide <b>4f</b> (0.10 g, 65%) as a yellow solid: mp 179−181 °C. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 12.08 (br s, 1H), 7.73 (d, <i>J</i> = 9.0 Hz, 2H), 7.70 (d, <i>J</i> = 1.4 Hz, 1H), 7.57 (dd, <i>J</i> = 8.1, 1.6 Hz, 1H), 7.31−7.39 (m, 2H), 7.20−7.13 (m, 3H), 7.03 (d, <i>J</i> = 8.9 Hz, 2H), 5.65 (dd, <i>J</i> = 12.0, 5.0 Hz, 1H), 3.95 (dd, <i>J</i> = 17.6, 12.0 Hz, 1H), 3.19 (dd, <i>J</i> = 17.6, 5.0 Hz, 1H). ES-MS <i>m</i>/<i>z</i> 416 (M − H). Anal. (C<sub>23</sub>H<sub>16</sub>FN<sub>3</sub>O<sub>4</sub>) C, H, N.</div></div><div id="sec5_27" class="NLM_sec NLM_sec_level_2"><div id="ac_i55" class="anchor-spacer"></div><h3 class="article-section__title" id="_i55"> (±)-4-[1-(4-Cyanophenyl)-5-(4-fluorophenyl)-4,5-dihydro-1<i>H</i>-pyrazol-3-yl]benzoic Acid (<b>4g</b>)</h3><div class="NLM_p last">4-Acetylbenzoic acid (5 mmol) and 4-fluorobenzaldehyde were reacted according to method B1 to give <b>6a</b>. Chalcone <b>6a</b> was reacted with 4-cyanophenylhydrazine hydrochloride according to method C1 to give <b>4g</b> (72%): <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 3.22 (dd, <i>J</i> = 17.99, 5.10 Hz, 1 H), 3.98 (td, <i>J</i> = 12.35, 5.10 Hz, 1H), 5.71 (dd, <i>J</i> = 12.08, 4.30 Hz, 1 H), 7.08 (d, <i>J</i> = 8.86 Hz, 2 H), 7.15 (tt, <i>J</i> = 8.86, 1.88 Hz, 2 H), 7.28 (td, <i>J</i> = 5.37, 2.15 Hz, 2 H), 7.57 (d, <i>J</i> = 8.86 Hz, 2 H), 7.87 (dd, <i>J</i> = 8.59, 1.88 Hz, 2 H), 7.97 (dd, <i>J</i> = 8.59, 1.88 Hz, 2 H), 13.05 (s, 1 H). ES-MS <i>m</i>/<i>z</i> 386 (M + H). Anal. (C<sub>23</sub>H<sub>16</sub>FN<sub>3</sub>O<sub>2</sub>) C, H, N.</div></div><div id="sec5_28" class="NLM_sec NLM_sec_level_2"><div id="ac_i56" class="anchor-spacer"></div><h3 class="article-section__title" id="_i56"> 2-(2(4-Cyanophenyl)hydrazone)acetic Acid (<b>16</b>)</h3><div class="NLM_p last">4-Cyanophenylhydrazine hydrochloride (3.40 g, 20 mmol) was suspended in aqueous hydrochloric acid (20%, 20 mL), and a solution of glyoxylic acid in water (4 mL) was added. Reaction was stirred at room temperature overnight. The solid was filtered off, washed with water, and dried. Recrystallization from acetonitrile gave pure hydrazone (2.805 g, 74%).</div></div><div id="sec5_29" class="NLM_sec NLM_sec_level_2"><div id="ac_i57" class="anchor-spacer"></div><h3 class="article-section__title" id="_i57"> (<i>R</i>)-4-(3-Bromo-5-(4-fluorophenyll)-4,5-dihydro-1<i>H</i>-pyrazol-1-yl)benzonitrile (<b><i>R</i>-17</b>)</h3><div class="NLM_p last">Hydrazone <b>16</b> (0.935 g, 5 mmol) was dissolved in DMF (12 mL), and a solution of NBS (1.77 g, 10 mmol) in DMF (12 mL) was added dropwise at 0 °C under nitrogen (<i>Caution</i>: exothermic reaction). After addition was complete, the reaction mixture was stirred at room temperature for 1 h. 4-Fluorostyrene (2.5 mL, 20 mmol) was added and then dropwise TEA (0.700 mL, 5 mmol). The mixture was left stirring overnight, then poured into cold water (100 mL) and extracted three times with ether. The combined organic extracts were washed with brine, dried over sodium sulfate, and concentrated under vacuum to give the crude product. Purification by flash chromatography (15% EtOAc/hexane) gave <b>(±)-17</b> (690 mg, 20% yield): <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 3.06 (dd, <i>J</i> = 18.26, 5.91 Hz, 1 H), 3.96 (dd, <i>J</i> = 18.13, 11.95 Hz, 1 H), 5.57 (dd, <i>J</i> = 12.09, 6.18 Hz, 1 H), 6.90 (m, 2 H), 7.20 (m, 2 H), 7.30 (m, 2 H), 7.55 (m, 2 H). ES-MS <i>m</i>/<i>z</i> 345 (M + H). <b>(±)-17</b> was resolved by chiral chromatography on a Chiralpak AS-H column (30 mm × 250 mm) eluted with 50% methanol/CO<sub>2</sub>, 70 mL/min, to give <i><b>R</b></i><b>-17</b>: ES-MS <i>m</i>/<i>z</i> 409 (M + H), later eluting peak, <i>t</i><sub>R</sub> = 8.26 min, >99% ee by chiral HPLC. <i><b>S</b></i><b>-17</b>: ES-MS <i>m</i>/<i>z</i> 409 (M + H), earlier eluting peak, <i>t</i><sub>R</sub> = 7.23 min, >99% ee by chiral HPLC.</div></div><div id="sec5_30" class="NLM_sec NLM_sec_level_2"><div id="ac_i58" class="anchor-spacer"></div><h3 class="article-section__title" id="_i58"> 4-[(5<i>R</i>)-1-(4-Cyanophenyl)-5-(4-fluorophenyl)-4,5-dihydro-1<i>H</i>-pyrazol-3-yl]benzoic acid (<b><i>R</i>-4g</b>)</h3><div class="NLM_p last">Bromopyrazoline <i><b>R</b></i><b>-17</b> (0.23 mmol) and 4-carboxyphenylboronic acid (0.25 mmol) were loaded in a vial, and the vial was purged with nitrogen for 15 min. Palladium(0) tetrakis(triphenylphosphine (∼10 mg) was added under nitrogen. DMF (3 mL) was added followed by Cs<sub>2</sub>CO<sub>3</sub> (2 M aqueous solution, purged, 0.50 mmol). The mixture was heated at 85 °C for 6 h. The solid was filtered off and the remaining filtrate was loaded onto reverse phase HPLC for purification to give <i><b>R</b></i><b>-4g</b> (116 mg). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 3.25 (dd, <i>J</i> = 17.8, 5.1 Hz, 1 H), 4.01 (dd, <i>J</i> = 17.9, 12.1 Hz, 1 H), 5.75 (dd, <i>J</i> = 12.1, 4.9 Hz, 1 H), 7.11 (d, <i>J</i> = 8.5 Hz, 2 H), 7.15−7.22 (m, 2 H), 7.31 (dd, <i>J</i> = 8.2, 5.5 Hz, 2 H), 7.60 (d, <i>J</i> = 8.2 Hz, 2 H), 7.87−7.93 (m, 2 H), 7.99 (d, <i>J</i> = 8.2 Hz, 2 H), 13.11 (br s, 1 H). ES-MS <i>m</i>/<i>z</i> 386 (M + H) . Anal. (C<sub>23</sub>H<sub>16</sub>FN<sub>3</sub>O<sub>2</sub>·0.25H<sub>2</sub>O) C, H, N.</div></div><div id="sec5_31" class="NLM_sec NLM_sec_level_2"><div id="ac_i59" class="anchor-spacer"></div><h3 class="article-section__title" id="_i59"> 4-[(5<i>S</i>)-1-(4-Cyanophenyl)-5-(4-fluorophenyl)-4,5-dihydro-1<i>H</i>-pyrazol-3-yl]benzoic Acid (<i><b>S</b></i><b>-4g</b>)</h3><div class="NLM_p last">Bromopyrazoline <i><b>S</b></i><b>-17</b> (0.23 mmol) and 4-carboxyphenylboronic acid (0.25 mmol) were reacted as described for <i><b>R</b></i><b>-4g</b> to give <i><b>S</b></i><b>-4g</b>. ES-MS <i>m</i>/<i>z</i> 386 (M + H).</div></div><div id="sec5_32" class="NLM_sec NLM_sec_level_2"><div id="ac_i60" class="anchor-spacer"></div><h3 class="article-section__title" id="_i60"> (±)-4-[5-(4-Fluorophenyl)-1-phenyl-4,5-dihydro-1<i>H</i>-pyrazol-3-yl]benzoic Acid (<b>4h</b>)</h3><div class="NLM_p last">A solution of <b>6a</b> (200 mg, 0.74 mmol) and phenylhydrazine (2.22 mmol) in ethanol (6 mL and sulfuric acid (60 μL) was degassed and purged with argon. The mixture was heated to reflux for 1 h and then cooled to room temperature. Diethyl ether was added and the insoluble material filtered off. The filtrate was then concentrated and purified by flash chromatography (0−25% methanol/dichloromethane). The desired fractions were pooled and concentrated to give a yellow solid (90 mg, 0.25 mmol, 33%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 3.14 (dd, <i>J</i> = 17.45, 6.18 Hz, 1 H), 3.92 (dd, <i>J</i> = 17.45, 12.35 Hz, 1 H), 5.59 (dd, <i>J</i> = 12.49, 6.04 Hz, 1 H), 6.75 (t, <i>J</i> = 7.38 Hz, 1 H), 7.03 (d, <i>J</i> = 7.52 Hz, 2 H), 7.16 (m, 4 H), 7.32 (dd, <i>J</i> = 8.73, 5.50 Hz, 2 H), 7.83 (d, <i>J</i> = 8.59 Hz, 2 H), 7.96 (d, <i>J</i> = 8.86 Hz, 2 H), 12.99 (s, 1 H). ES-MS <i>m</i>/<i>z</i> 361.2 (M + H). HRMS calcd for C<sub>22</sub>H<sub>17</sub>FN<sub>2</sub>O<sub>2</sub>: 361.1347, found 361.1375. Anal. (C<sub>22</sub>H<sub>17</sub>FN<sub>2</sub>O<sub>2</sub>) Calcd: C, 73.32; H, 4.76; N, 7.77. Found: C, 73.18; H, 4.31; N, 7.74.</div></div><div id="sec5_33" class="NLM_sec NLM_sec_level_2"><div id="ac_i61" class="anchor-spacer"></div><h3 class="article-section__title" id="_i61"> (±)-4-{1-[4-(Ethoxycarbonyl)phenyl]-5-(4-fluorophenyl)-4,5-dihydro-1<i>H</i>-pyrazol-3-yl}benzoic Acid (<b>4i</b>)</h3><div class="NLM_p last">4-Benzoic acid hydrazine (1 mmol) was dissolved in EtOH (5 mL), and molecular sieves were added followed by a catalytic amount of concentrated HCl. The reaction mixture was refluxed overnight, filtered, and concentrated to give crude ethyl 4-hydrazinylbenzoate. Chalcone <b>6a</b> (1 mmol) was reacted with ethyl 4-hydrazinylbenzoate according to method C1 using glacial acetic acid in place of HCl to give crude product purified by HPLC to yield <b>4i</b> (46%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 13.06 (br s, 1 H), 7.99 (d, <i>J</i> = 8.20 Hz, 2 H), 7.89 (d, <i>J</i> = 8.20 Hz, 2 H), 7.77 (d, <i>J</i> = 8.98 Hz, 2 H), 7.28−7.34 (m, 2 H), 7.14−7.21 (m, 2 H), 7.09 (d, <i>J</i> = 8.98 Hz, 2 H), 5.74 (dd, <i>J</i> = 12.11, 5.08 Hz, 15 H), 4.19−4.22 (q, <i>J</i> = 7.03 Hz, 2 H), 4.00 (dd, <i>J</i> = 17.58, 12.11 Hz, 1 H), 3.23 (dd, <i>J</i> = 17.77, 4.88 Hz, 1 H), 1.26 (t, <i>J</i> = 7.03 Hz, 3 H). ES-MS <i>m</i>/<i>z</i> 433 (M + H).</div></div><div id="sec5_34" class="NLM_sec NLM_sec_level_2"><div id="ac_i62" class="anchor-spacer"></div><h3 class="article-section__title" id="_i62"> (±)-4,4′-[5-(4-Fluorophenyl)-4,5-dihydro-1<i>H</i>-pyrazole-1,3-diyl]dibenzoic Acid (<b>4j</b>)</h3><div class="NLM_p last">Chalcone <b>6a</b> (1 mmol) was reacted with ethyl 4-hydrazinylbenzoate according to method C1. The crude pyrazoline in THF (4 mL) was treated with aqueous NaOH (3 mL) and stirred overnight at room temperature. The mixture was concentrated and then treated with 8 mL of 1 N HCl. The resulting precipitate was filtered and purified by reverse phase HPLC to give <b>4j</b> (220 mg, 0.54 mmol, 54%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 3.22 (dd, <i>J</i> = 17.7, 5.1 Hz, 1 H), 3.99 (dd, <i>J</i> = 17.9, 12.2 Hz, 1 H), 5.73 (dd, <i>J</i> = 12.2, 5.0 Hz, 1 H), 7.08 (d, <i>J</i> = 8.9 Hz, 2 H), 7.14−7.21 (m, 2 H), 7.27−7.35 (m, 2 H), 7.76 (d, <i>J</i> = 8.9 Hz, 2 H), 7.89 (d, <i>J</i> = 8.6 Hz, 2 H), 7.96−8.02 (m, 2 H), 12.70 (br s, 2 H). Anal. (C<sub>23</sub>H<sub>17</sub>FN<sub>2</sub>O<sub>4</sub>·0.25H<sub>2</sub>O) C, H, N.</div></div><div id="sec5_35" class="NLM_sec NLM_sec_level_2"><div id="ac_i63" class="anchor-spacer"></div><h3 class="article-section__title" id="_i63"> (±)-4-[5-(4-Fluorophenyl)-1-(4-methoxyphenyl)-4,5-dihydro-1<i>H</i>-pyrazol-3-yl]benzoic Acid (<b>4k</b>)</h3><div class="NLM_p last">To the chalcone <b>6a</b> (300 mg 1.0 mmol) in ethanol (6 mL) was added 4-methoxyphenylhydrazine (1.5 mmol) followed by 2 drops of concentrated HCl. The mixture was heated to 80 °C overnight and then was cooled to room temperature and concentrated to dryness. The residue was purified flash chromatography (0−10% methanol/methylene chloride). The desired fractions were combined and concentrated to give a yellow/orange solid (115 mg, 0.29 mmol, 29%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 3.10 (dd, <i>J</i> = 17.32, 7.12 Hz, 1 H), 3.64 (s, 3 H), 3.88 (dd, <i>J</i> = 17.32, 12.49 Hz, 1 H), 5.50 (dd, <i>J</i> = 12.35, 6.98 Hz, 1 H), 6.78 (d, <i>J</i> = 9.13 Hz, 2 H), 6.96 (d, <i>J</i> = 9.13 Hz, 2 H), 7.15 (t, <i>J</i> = 8.86 Hz, 2 H), 7.32 (dd, <i>J</i> = 8.73, 5.50 Hz, 2 H), 7.79 (d, <i>J</i> = 8.32 Hz, 2 H), 7.95 (d, <i>J</i> = 8.59 Hz, 2 H), 12.96 (s, 1 H). ES-MS <i>m</i>/<i>z</i> 391 (M + H). Anal. (C<sub>23</sub>H<sub>19</sub>FN<sub>2</sub>O<sub>3</sub>) C, H, N.</div></div><div id="sec5_36" class="NLM_sec NLM_sec_level_2"><div id="ac_i64" class="anchor-spacer"></div><h3 class="article-section__title" id="_i64"> (±)-4-[1-(4-Cyano-3-fluorophenyl)-5-(4-fluorophenyl)-4,5-dihydro-1<i>H</i>-pyrazol-3-yl]benzoic Acid (<b>12a</b>)</h3><div class="NLM_p last">Chalcone <b>6a</b> was reacted with 4-cyano-3-fluorophenylhydrazine hydrochloride according to method C1 to give <b>12a</b> as a solid (113 mg, 0.28 mmol, 28%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 3.24−3.31 (m, 1 H), 3.97−4.09 (m, 1 H), 5.77 (dd, <i>J</i> = 12.1, 4.7 Hz, 1 H), 6.85 (d, <i>J</i> = 9.0 Hz, 1 H), 7.04 (d, <i>J</i> = 12.5 Hz, 1 H), 7.18 (t, <i>J</i> = 8.8 Hz, 2 H), 7.28−7.34 (m, 2 H), 7.62 (dd, <i>J</i> = 8.6, 7.8 Hz, 1 H), 7.90−8.01 (m, 4 H), 13.10 (br s, 1 H). ES-MS <i>m</i>/<i>z</i> 404 (M + H). Anal. (C<sub>23</sub>H<sub>15</sub>F<sub>2</sub>N<sub>3</sub>O<sub>2</sub>) Calcd: C, 68.48; H, 3.75; N, 10.42. Found: C, 68.12; H, 3.37; N, 9.92.</div></div><div id="sec5_37" class="NLM_sec NLM_sec_level_2"><div id="ac_i65" class="anchor-spacer"></div><h3 class="article-section__title" id="_i65"> (±)-4-[1-(4-Cyano-2-fluorophenyl)-5-(4-fluorophenyl)-4,5-dihydro-1<i>H</i>-pyrazol-3-yl]benzoic Acid (<b>12b</b>)</h3><div class="NLM_p last">Chalcone <b>6a</b> was reacted with 4-cyano-2-fluorophenylhydrazine hydrochloride according to method C1 to give <b>12b</b> as a solid (69.1 mg, 0.171 mmol, 32%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 3.32 (dd, <i>J</i> = 17.8, 4.1 Hz, 1 H), 3.97 (dd, <i>J</i> = 17.6, 11.7 Hz, 1 H), 5.89 (dt, <i>J</i> = 11.6, 3.8 Hz, 1 H), 7.10 (t, <i>J</i> = 9.0 Hz, 2 H), 7.16−7.23 (m, 2 H), 7.54 (dd, <i>J</i> = 8.6, 1.6 Hz, 1 H), 7.62 (dd, <i>J</i> = 13.3, 2.0 Hz, 1 H), 7.72 (t, <i>J</i> = 8.6 Hz, 1 H), 7.91 (d, <i>J</i> = 8.6 Hz, 2 H), 7.99 (d, <i>J</i> = 8.6 Hz, 2 H), 13.06 (br s, 1 H). Anal. (C<sub>23</sub>H<sub>15</sub>F<sub>2</sub>N<sub>3</sub>O<sub>2</sub>) C, H, N.</div></div><div id="sec5_38" class="NLM_sec NLM_sec_level_2"><div id="ac_i66" class="anchor-spacer"></div><h3 class="article-section__title" id="_i66"> (±)-4-[1-(3-Chloro-4-cyanophenyl)-5-(4-fluorophenyl)-4,5-dihydro-1<i>H</i>-pyrazol-3-yl]benzoic Acid (<b>12c</b>)</h3><div class="NLM_p last">The title compound was prepared according to method C2. The crude product was recrystallized from DMF/methanol as yellow needles (302 mg, 0.72 mmol, 72%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 3.24−3.31 (m, 1 H), 4.02 (dd, <i>J</i> = 17.9, 11.9 Hz, 1 H), 5.79 (dd, <i>J</i> = 12.1, 3.8 Hz, 1 H), 6.94 (d, <i>J</i> = 8.6 Hz, 1 H), 7.18 (t, <i>J</i> = 7.9 Hz, 2 H), 7.27−7.35 (m, 3 H), 7.67 (dd, <i>J</i> = 8.6, 1.6 Hz, 1 H), 7.90−8.02 (m, 4 H), 13.10 (s, 1 H). ES-MS <i>m</i>/<i>z</i> 420 (M + H).</div></div><div id="sec5_39" class="NLM_sec NLM_sec_level_2"><div id="ac_i67" class="anchor-spacer"></div><h3 class="article-section__title" id="_i67"> 4-[(5<i>R</i>)-1-(3-Chloro-4-cyanophenyl)-5-(4-fluorophenyl)-4,5-dihydro-1H-pyrazol-3-yl]benzoic Acid (<i><b>R</b></i><b>-12c</b>)</h3><div class="NLM_p last">Chiral separation of <b>(±)-12c</b> on a Chiralpak AD-H column (30 mm × 250 mm) eluted with 50% MeOH/CO<sub>2</sub>, 50 mL/min flow, afforded <i><b>R</b></i><b>-12c</b>: first eluting peak, <i>t</i><sub>R</sub> = 3.52 min, >95% ee by chiral HPLC. ES-MS <i>m</i>/<i>z</i> 420 (M + H).</div></div><div id="sec5_40" class="NLM_sec NLM_sec_level_2"><div id="ac_i68" class="anchor-spacer"></div><h3 class="article-section__title" id="_i68"> (±)-4-[1-(2-Chloro-4-cyanophenyl)-5-(4-fluorophenyl)-4,5-dihydro-1<i>H</i>-pyrazol-3-yl]benzoic Acid (<b>12d</b>)</h3><div class="NLM_p last">The title compound was prepared according to method C2. The crude product was dissolved in DMF/methanol and purified by reverse-phase HPLC (40−95% acetonitrile/water/0.05% TFA) to give the title compound as a pale-yellow solid (204 mg, 0.487 mmol, 49%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 3.39 (dd, <i>J</i> = 17.7, 4.8 Hz, 1 H), 3.98 (dd, <i>J</i> = 17.6, 11.7 Hz, 1 H), 6.14 (dd, <i>J</i> = 11.4, 4.7 Hz, 1 H), 7.06 (t, <i>J</i> = 9.0 Hz, 2 H), 7.21 (dd, <i>J</i> = 8.9, 5.4 Hz, 2 H), 7.64 (d, <i>J</i> = 1.1 Hz, 2 H), 7.83 (t, <i>J</i> = 1.1 Hz, 1 H), 7.91 (d, <i>J</i> = 8.6 Hz, 2 H), 8.00 (d, <i>J</i> = 8.6 Hz, 2 H), 13.05 (br s, 1 H). Anal. (C<sub>23</sub>H<sub>15</sub>ClFN<sub>3</sub>O<sub>2</sub>) C, H, N.</div></div><div id="sec5_41" class="NLM_sec NLM_sec_level_2"><div id="ac_i69" class="anchor-spacer"></div><h3 class="article-section__title" id="_i69"> (±)-4-[1-(4-Cyano-3-methylphenyl)-5-(4-fluorophenyl)-4,5-dihydro-1<i>H</i>-pyrazol-3-yl]benzoic Acid (<b>12e</b>)</h3><div class="NLM_p last">The title compound was prepared according to method C2 as an orange solid (407 mg, 1.02 mmol, quant). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 2.36 (s, 3 H), 3.23 (dd, <i>J</i> = 18.0, 5.1 Hz, 1 H), 3.99 (dd, <i>J</i> = 17.8, 12.3 Hz, 1 H), 5.73 (dd, <i>J</i> = 12.3, 5.3 Hz, 1 H), 6.81 (dd, <i>J</i> = 8.6, 2.0 Hz, 1 H), 7.13−7.20 (m, 3 H), 7.29 (dd, <i>J</i> = 8.6, 5.5 Hz, 2 H), 7.50 (d, <i>J</i> = 9.0 Hz, 1 H), 7.89 (d, <i>J</i> = 8.6 Hz, 2 H), 7.98 (d, <i>J</i> = 8.2 Hz, 2 H), 13.07 (s, 1 H). Anal. (C<sub>24</sub>H<sub>18</sub>FN<sub>3</sub>O<sub>2</sub>·0.1H<sub>2</sub>O) C, H, N.</div></div><div id="sec5_42" class="NLM_sec NLM_sec_level_2"><div id="ac_i70" class="anchor-spacer"></div><h3 class="article-section__title" id="_i70"> (±)-4-{1-[4-Cyano-3-(trifluoromethyl)phenyl]-5-(4-fluorophenyl)-4,5-dihydro-1<i>H</i>-pyrazol-3-yl}benzoic Acid (<b>12f</b>)</h3><div class="NLM_p last">The title compound was prepared according to method C2. The crude product was recrystallized from DMF/methanol as yellow needles (411 mg, 0.907 mmol, 91%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 3.33 (dd, <i>J</i> = 18.0, 4.8 Hz, 1 H), 4.06 (dd, <i>J</i> = 18.0, 12.1 Hz, 1 H), 5.85 (dd, <i>J</i> = 11.9, 5.0 Hz, 1 H), 7.15−7.22 (m, 3 H), 7.31−7.36 (m, 2 H), 7.53 (br s, 1 H), 7.85 (d, <i>J</i> = 8.6 Hz, 1 H), 7.92−8.02 (m, 4 H), 13.05 (br s, 1 H). ES-MS <i>m</i>/<i>z</i> 454 (M + H).</div></div><div id="sec5_43" class="NLM_sec NLM_sec_level_2"><div id="ac_i71" class="anchor-spacer"></div><h3 class="article-section__title" id="_i71"> (±)-4-[1-(3,4-Dicyanophenyl)-5-(4-fluorophenyl)-4,5-dihydro-1<i>H</i>-pyrazol-3-yl]benzoic Acid (<b>12g</b>)</h3><div class="NLM_p last">The title compound was prepared according to method C2 using AcOH in place of ethanol. The crude ester was filtered, dried, and hydrolyzed with sodium hydroxide as described in method C2. The crude product was recrystallized from DMF/methanol as an orange solid (89.1 mg, 0.217 mmol, 43%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 3.26−3.37 (m, 1 H), 4.05 (dd, <i>J</i> = 18.0, 12.1 Hz, 1 H), 5.81 (dd, <i>J</i> = 12.1, 4.7 Hz, 1 H), 7.13−7.25 (m, 3 H), 7.26−7.35 (m, 2 H), 7.70 (br s, 1 H), 7.82 (d, <i>J</i> = 8.6 Hz, 1 H), 7.90−8.03 (m, 4 H), 13.04 (br s, 1 H). ES-MS <i>m</i>/<i>z</i> 411 (M + H).</div></div><div id="sec5_44" class="NLM_sec NLM_sec_level_2"><div id="ac_i72" class="anchor-spacer"></div><h3 class="article-section__title" id="_i72"> (±)-4-[1-(3-Chloro-4-cyanophenyl)-5-isopropyl-4,5-dihydro-1<i>H</i>-pyrazol-3-yl]benzoic Acid (<b>12h</b>)</h3><div class="NLM_p last"><b>12h</b> was prepared as example <b>12i</b> using isobutyraldehyde and 3-chloro-4-cyanophenylhydrazine hydrochloride to give the product as a yellow solid (60 mg, 0.19 mmol, 17%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 0.55 (d, <i>J</i> = 6.71 Hz, 3 H), 0.94 (d, <i>J</i> = 6.71 Hz, 3 H), 2.22−2.33 (m, 1 H), 3.25−3.40 (m, 2 H), 4.70 (td, 1 H), 7.17 (dd, <i>J</i> = 8.86, 2.15 Hz, 1 H), 7.39 (d, <i>J</i> = 2.15 Hz, 1 H), 7.71 (d, <i>J</i> = 8.59 Hz, 1 H), 7.90 (d, 2 H), 7.97 (d, 2 H). ES-MS <i>m</i>/<i>z</i> 368 (M + H). HRMS (C<sub>20</sub>H<sub>18</sub>N<sub>3</sub>O<sub>2</sub>) calcd, 368.1160; found, 368.1189.</div></div><div id="sec5_45" class="NLM_sec NLM_sec_level_2"><div id="ac_i73" class="anchor-spacer"></div><h3 class="article-section__title" id="_i73"> (±)-4-[1-(4-Cyanophenyl)-5-pyridin-4-yl-4,5-dihydro-1<i>H</i>-pyrazol-3-yl]benzoic Acid (<b>12i</b>)</h3><div class="NLM_p last">Methyl 4-acetylbenzoate and 4-pyridine carboxaldehyde were reacted according to method B2 to give the chalcone (220 mg, 82%). The chalcone (220 mg, 0.82 mmol) was suspended in ethanol (5 mL), and 4-cyanophenylhydrazine HCl was added followed by one pellet of NaOH. The solution was heated to 80 °C for 3 h. The solution was concentrated to half volume, and the residue was acidified to pH 4 with 1 N HCl and concentrated. The crude material was purified by reverse-phase HPLC (acetonitrile/water/TFA) to provide the title compound as a solid (140 mg, 0.29 mmol, 35%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 3.30 (dd, <i>J</i> = 17.86, 4.97 Hz, 1 H), 4.05 (dd, <i>J</i> = 17.86, 12.49 Hz, 1 H), 5.82 (dd, <i>J</i> = 12.76, 5.50 Hz, 1 H), 7.08 (d, <i>J</i> = 9.13 Hz, 2 H), 7.40 (d, <i>J</i> = 5.91 Hz, 2 H), 7.60 (d, <i>J</i> = 9.13 Hz, 2 H), 7.87 (d, <i>J</i> = 8.59 Hz, 2 H), 7.97 (d, <i>J</i> = 8.59 Hz, 2 H), 8.60 (d, <i>J</i> = 6.18 Hz, 2 H). ES-MS <i>m</i>/<i>z</i> 369 (M + H). HRMS (C<sub>22</sub>H<sub>16</sub>N<sub>4</sub>O<sub>2</sub>) calcd, 396.1346; found, 369.1302. Anal. (C<sub>22</sub>H<sub>16</sub>FN<sub>4</sub>O<sub>2</sub>·C<sub>2</sub>HF<sub>3</sub>O<sub>2</sub>) C, H, N.</div></div><div id="sec5_46" class="NLM_sec NLM_sec_level_2"><div id="ac_i74" class="anchor-spacer"></div><h3 class="article-section__title" id="_i74"> (±)-4-[1-(4-Cyanophenyl)-5-pyridin-3-yl-4,5-dihydro-1<i>H</i>-pyrazol-3-yl]benzoic Acid (<b>12j</b>)</h3><div class="NLM_p last"><b>12j</b> was prepared as example <b>12i</b> using 3-pyridinecarboxaldehyde to give the product as a solid (320 mg, 0.79 mmol, 82%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 3.34 (d, <i>J</i> = 5.10 Hz, 1 H), 4.02 (dd, <i>J</i> = 17.86, 12.22 Hz, 1 H), 5.80 (dd, <i>J</i> = 12.22, 4.70 Hz, 1 H), 7.11 (d, <i>J</i> = 8.86 Hz, 2 H), 7.33 (dd, <i>J</i> = 8.32, 5.10 Hz, 1 H), 7.54−7.56 (m, 1 H), 7.58 (d, <i>J</i> = 9.13 Hz, 2 H), 7.88 (d, 2 H), 7.97 (d, <i>J</i> = 8.59 Hz, 2 H), 8.47 (dd, <i>J</i> = 4.70, 1.48 Hz, 1 H), 8.55 (d, <i>J</i> = 2.42 Hz, 1 H), 13.06 (br s, 1 H). ES-MS <i>m</i>/<i>z</i> 369 (M + H). HRMS (M + H) calcd for C<sub>22</sub>H<sub>16</sub>N<sub>4</sub>O<sub>2</sub>, 396.1346; found, 369.1342.</div></div><div id="sec5_47" class="NLM_sec NLM_sec_level_2"><div id="ac_i75" class="anchor-spacer"></div><h3 class="article-section__title" id="_i75"> (±)-4-[1-(4-Cyanophenyl)-5-pyridin-2-yl-4,5-dihydro-1<i>H</i>-pyrazol-3-yl]benzoic Acid (<b>12k</b>)</h3><div class="NLM_p last"><b>12k</b> was prepared as example <b>12i</b> using 2-pyridinecarboxaldehyde to give <b>12k</b> as a solid (83 mg, 0.21 mmol, 45%): <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 3.36 (dd, <i>J</i> = 17.86, 5.24 Hz, 1 H), 4.01 (dd, <i>J</i> = 17.99, 12.35 Hz, 1 H), 5.73 (dd, <i>J</i> = 12.49, 5.50 Hz, 1 H), 7.09 (d, <i>J</i> = 8.86 Hz, 2 H), 7.31 (ddd, <i>J</i> = 7.52, 4.83, 1.07 Hz, 1 H), 7.37 (d, <i>J</i> = 7.79 Hz, 1 H), 7.56 (d, <i>J</i> = 9.13 Hz, 2 H), 7.79 (td, <i>J</i> = 7.65, 1.88 Hz, 1 H), 7.88 (d, <i>J</i> = 8.86 Hz, 2 H), 7.97 (d, <i>J</i> = 8.86 Hz, 2 H), 8.53 (ddd, <i>J</i> = 4.83, 1.75, 0.94 Hz, 1 H). ES-MS <i>m</i>/<i>z</i> 369 (M + H). HRMS (M + H) calcd for C<sub>22</sub>H<sub>16</sub>N<sub>4</sub>O<sub>2</sub>, 396.1346; found, 369.1334.</div></div><div id="sec5_48" class="NLM_sec NLM_sec_level_2"><div id="ac_i76" class="anchor-spacer"></div><h3 class="article-section__title" id="_i76"> (±)-4-[1-(4-Cyanophenyl)-5-(2-furyl)-4,5-dihydro-1<i>H</i>-pyrazol-3-yl]benzoic Acid (<b>12l</b>)</h3><div class="NLM_p last">4-Acetylbenzoic acid and 2-furylaldehyde were reacted according to method B1. The chalcone was reacted with 4-cyanophenylhydrazine according to method C1 to give <b>12l</b> (4% yield): <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 3.45 (dd, <i>J</i> = 17.59, 4.97 Hz, 1 H), 3.85 (t, <i>J</i> = 12.35 Hz, 1 H), 5.83 (dd, <i>J</i> = 12.22, 4.70 Hz, 1 H), 6.37 (dd, <i>J</i> = 3.22, 1.88 Hz, 1 H), 6.51 (dd, <i>J</i> = 3.22, 0.81 Hz, 1 H), 7.24 (ddd, <i>J</i> = 9.13, 2.42, 2.15 Hz, 2 H), 7.54 (dd, <i>J</i> = 1.88, 0.81 Hz, 1 H), 7.60 (ddd, <i>J</i> = 9.33, 2.28, 2.08 Hz, 2 H), 7.87−7.92 (m, 2 H), 7.96−8.00 (m, 2 H), 13.03 (s, 1 H). HRMS (C<sub>21</sub>H<sub>15</sub>N<sub>3</sub>O<sub>3</sub>) calcd, 358.1186; found, 358.1155. Anal. (C<sub>21</sub>H<sub>15</sub>N<sub>3</sub>O<sub>3</sub>·0.5H<sub>2</sub>O) Calcd: C, 68.84; H, 4.41; N, 11.47. Found C, 68.51; H, 3.92; N, 11.37.</div></div><div id="sec5_49" class="NLM_sec NLM_sec_level_2"><div id="ac_i77" class="anchor-spacer"></div><h3 class="article-section__title" id="_i77"> (±)-4-[1-(4-Cyanophenyl)-5-(2-thienyl)-4,5-dihydro-1<i>H</i>-pyrazol-3-yl]benzoic Acid (<b>12m</b>)</h3><div class="NLM_p last">4-Acetylbenzoic acid and 2-thiophenecarbaldehyde were reacted according to method B1 to give the chalcone. The chalcone was reacted with 4-cyanophenylhydrazine according to method C1 to give <b>12m</b> (30%): <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 3.36 (dd, <i>J</i> = 17.72, 4.57 Hz, 1 H), 3.96 (dd, <i>J</i> = 17.72, 11.82 Hz, 1 H), 6.07 (dd, <i>J</i> = 11.68, 4.43 Hz, 1 H), 6.93 (dd, <i>J</i> = 4.83, 3.49 Hz, 1 H), 7.14 (dd, <i>J</i> = 3.49, 1.34 Hz, 1 H), 7.20 (ddd, <i>J</i> = 9.13, 2.42, 2.15 Hz, 2 H), 7.38 (dd, <i>J</i> = 4.97, 1.21 Hz, 1 H), 7.59 (ddd, <i>J</i> = 8.86, 2.42, 1.61 Hz, 2 H), 7.89 (m, <i>J</i> = 8.59, 1.61, 1.61 Hz, 2 H), 7.96−8.00 (m, 2 H), 13.02 (s, 1 H). ES-MS <i>m</i>/<i>z</i> 374 (M + H).</div></div><div id="sec5_50" class="NLM_sec NLM_sec_level_2"><div id="ac_i78" class="anchor-spacer"></div><h3 class="article-section__title" id="_i78"> 2-Chloro-4-[(5<i>R</i>)-1-(3-chloro-4-cyanophenyl)-5-cyclopentyl-4,5-dihydro-1<i>H</i>-pyrazol-3-yl]benzoic Acid (<i><b>R</b></i><b>-12n</b>)</h3><div class="NLM_p last">4-Acetyl-2-chlorobenzoic acid and cyclopentylaldehyde were reacted according to method B1. The chalcone was reacted with <b>9a</b> according to method C1 to give <b>(±)-12n</b> (94 mg). Chiral separation of <b>(±)-12n</b> on a Chiralpak AS-H column (30 mm × 250 mm) eluted with 50%MeOH/CO<sub>2</sub>, 70 mL/min flow, yielded <i><b>R</b></i><b>-12n</b> as the earlier eluting peak. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 13.45 (1 H, s), 7.89 (1 H, s), 7.79−7.86 (2 H, m), 7.70 (1 H, d, <i>J</i> = 8.9 Hz), 7.20 (1 H, dd, <i>J</i> = 8.9, 2.1 Hz), 4.90 (1 H, td, <i>J</i> = 7.6, 3.9 Hz), 3.36−3.51 (1 H, m), 3.23 (1 H, m), 2.43 (1 H, m), 1.66−1.81 (1 H, m), 1.18−1.64 (6 H, m), 0.92−1.06 (1 H, m). ES-MS <i>m</i>/<i>z</i> 428 (M + H). Anal. (C<sub>22</sub>H<sub>19</sub>Cl<sub>2</sub>N<sub>3</sub>O<sub>2</sub>) C, H, N. >99.5% ee by chiral HPLC.</div></div><div id="sec5_51" class="NLM_sec NLM_sec_level_2"><div id="ac_i79" class="anchor-spacer"></div><h3 class="article-section__title" id="_i79"> 4-[(5<i>R</i>)-1-(3-Chloro-4-cyanophenyl)-5-cyclopentyl-4,5-dihydro-1<i>H</i>-pyrazol-3-yl]-2-methoxybenzoic Acid (<i><b>R</b></i><b>-12o</b>)</h3><div class="NLM_p last">4-Acetyl-2-methoxybenzoic acid and cyclopentylaldehyde were reacted according to method B1. The chalcone was reacted with <b>9a</b> according to method C1 to give <b>(±)-12o</b> (92%). Chiral separation of <b>(±)-12o</b> on a Chiralpak AS-H column (30 mm × 250 mm) eluted with 50%MeOH/CO<sub>2</sub>, 70 mL/min flow, yielded <i><b>R</b></i><b>-12o</b> as the later eluting peak, <i>t</i><sub>R</sub> = 3.67 min. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 0.97−1.08 (m, 1 H), 1.22−1.44 (m, 3 H), 1.47−1.65 (m, 3 H), 1.73−1.82 (m, 1 H), 2.42−2.48 (m, 1 H), 3.27 (dd, <i>J</i> = 17.86, 3.63 Hz, 1 H), 3.48 (dd, <i>J</i> = 18.26, 11.55 Hz, 1 H), 3.92 (s, 3 H), 4.91 (ddd, <i>J</i> = 11.41, 3.89, 3.76 Hz, 1 H), 7.22 (dd, <i>J</i> = 8.86, 2.15 Hz, 1 H), 7.41−7.46 (m, 3 H), 7.71 (t, <i>J</i> = 8.86 Hz, 2 H), 12.71 (br s 1 H). ES-MS <i>m</i>/<i>z</i> 424 (M + H).</div></div><div id="sec5_52" class="NLM_sec NLM_sec_level_2"><div id="ac_i80" class="anchor-spacer"></div><h3 class="article-section__title" id="_i80"> 4-[(5<i>R</i>)-1-(3-Chloro-4-cyanophenyl)-5-cyclopentyl-4,5-dihydro-1<i>H</i>-pyrazol-3-yl]-3-methoxybenzoic Acid (<i><b>R</b></i><b>-12p</b>)</h3><div class="NLM_p last">4-Acetyl-3-methoxybenzoic acid and cyclopentylaldehyde were reacted according to method B1. The chalcone was reacted with <b>9a</b> according to method C1 to give <b>(±)-12p</b> (80%). Chiral separation of <b>(±)-12p</b> on a Chiralpak AS-H column (30 mm × 250 mm) eluted with 50% MeOH/CO<sub>2</sub>, 70 mL/min flow, yielded <i><b>R</b></i><b>-12p</b> as the later eluting peak. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 1.02−1.13 (m, 1 H), 1.18−1.29 (m, 1 H), 1.31−1.62 (m, 5 H), 1.70−1.79 (m, 1 H), 2.38−2.48 (m, 1 H), 3.55 (dd, <i>J</i> = 18.66, 10.98 Hz, 1 H), 3.92 (s, 3 H), 4.80−4.86 (m, 1 H), 7.16 (dd, <i>J</i> = 8.78, 1.46 Hz, 1 H), 7.35 (s, 1 H), 7.56−7.61 (m, 2 H), 7.69 (d, <i>J</i> = 8.78 Hz, 1 H), 7.89 (d, <i>J</i> = 8.05 Hz, 1 H). ES-MS <i>m</i>/<i>z</i> 424 (M + H).</div></div><div id="sec5_53" class="NLM_sec NLM_sec_level_2"><div id="ac_i81" class="anchor-spacer"></div><h3 class="article-section__title" id="_i81"> Methyl 4-((2-(4-Cyanophenyl)hydrazono)methyl)benzoate (<b>13a</b>)</h3><div class="NLM_p last">To a solution of 4-cyanophenylhydrazine hydrochloride (24.4 mmol) in DMF (60 mL) and triethylamine (29.3 mmol) was added methyl 4-formylbenzoate (4.0 g, 24.4 mmol). The mixture was stirred at room temperature for 18 h. Water (100 mL) was added and the resulting yellow solid was collected by vacuum filtration and dried in a vacuum oven to provide <b>13a</b> (23.6 mmol, 97%).</div></div><div id="sec5_54" class="NLM_sec NLM_sec_level_2"><div id="ac_i82" class="anchor-spacer"></div><h3 class="article-section__title" id="_i82"> Methyl 4-((2-(3-Chloro-4-cyanophenyl)hydrazono)methyl)benzoate (<b>13b</b>)</h3><div class="NLM_p last">To a solution of 3-chloro-4-cyanophenylhydrazine hydrochloride (24.5 mmol) in DMF (50 mL) and triethylamine (29.4 mmol) was added methyl 4-formylbenzoate (4.0 g, 24.4 mmol). The mixture was stirred at room temperature for 18 h. Water (100 mL) was added and the resulting yellow solid was collected by vacuum filtration and dried in a vacuum oven to provide <b>13b</b> (23.6 mmol, 86%).</div></div><div id="sec5_55" class="NLM_sec NLM_sec_level_2"><div id="ac_i83" class="anchor-spacer"></div><h3 class="article-section__title" id="_i83"> Methyl 4-(Bromo(2-(4-cyanophenyl)hydrazono)methyl)benzoate (<b>14a</b>)</h3><div class="NLM_p last">To a suspension of <i>N</i>-bromosuccinimide (28.9 mmol) in dichloroethane (30 mL), cooled to 0 °C, was added dimethyl sulfide (57.9 mmol). The mixture was stirred for 15 min, and hydrazone <b>13a</b> (19.3 mmol) was added followed by additional dichloroethane (30 mL). The mixture was stirred at room temperature overnight, water (100 mL) was added, and the resulting red solid was collected to provide <b>14a</b> (65%).</div></div><div id="sec5_56" class="NLM_sec NLM_sec_level_2"><div id="ac_i84" class="anchor-spacer"></div><h3 class="article-section__title" id="_i84"> Methyl 4-(Bromo(2-(3-chloro-4-cyanophenyl)hydrazono)methyl)benzoate (<b>14b</b>)</h3><div class="NLM_p last">To a suspension of <i>N</i>-bromosuccinimide (14.4 mmol) in dichloroethane (15 mL), cooled to 0 °C, was added dimethyl sulfide (28.8 mmol). The mixture was stirred for 15 min, and then hydrazone <b>13b</b> (9.6 mmol) was added followed by additional dichloroethane (15 mL). The mixture was stirred at room temperature overnight, water (100 mL) was added, and the resulting red solid was collected to provide <b>14b</b> (97%).</div></div><div id="sec5_57" class="NLM_sec NLM_sec_level_2"><div id="ac_i85" class="anchor-spacer"></div><h3 class="article-section__title" id="_i85"> (±)-4-[5-Benzyl-1-(4-cyanophenyl)-4,5-dihydro-1<i>H</i>-pyrazol-3-yl]benzoic Acid (<b>15a</b>)</h3><div class="NLM_p"><b>Step 1.</b> To a solution of <b>14a</b> (204 mg, 0.57 mmol) in tetrahydrofuran (2 mL) were added allylbenzene (67 mg, 0.57 mmol) and triethylamine (0.12 mL, 0.85 mmol). The mixture was stirred for 4 h at room temperature. After concentration of solvent, the crude material was purified using normal phase chromatography (ethyl actate/hexane) to provide the intermediate pyrazoline ester (61 mg, 27%).</div><div class="NLM_p last"><b>Step 2.</b> To a solution of the pyrazoline prepared in step 1 (61 mg, 0.15 mmol) in tetrahydrofuran (2 mL) was added 1 N NaOH (1 mL). The mixture was stirred for 18 h at room temperature, concentrated to half volume, and acidified with 1 N HCl to pH 2. The resulting solid was collected by vacuum filtration to provide <b>15a</b> as a yellow solid (41 mg, 0.11 mmol, 71%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 2.70 (dd, <i>J</i> = 13.56, 9.26 Hz, 1 H), 3.01−3.17 (m, 1 H), 3.40 (dd, <i>J</i> = 17.45, 11.01 Hz, 1 H), 4.89−4.97 (m, 2 H), 7.14−7.30 (m, <i>J</i> = 7.25 Hz, 5 H), 7.33 (d, <i>J</i> = 9.13 Hz, 2 H), 7.68 (d, <i>J</i> = 9.13 Hz, 2 H), 7.73 (d, <i>J</i> = 8.32 Hz, 2 H), 7.91 (d, <i>J</i> = 8.59 Hz, 2 H). ES-MS <i>m</i>/<i>z</i> 382 (M + H). HPLC purity 95%. HRMS (M + H) calcd for C<sub>24</sub>H<sub>19</sub>N<sub>3</sub>O<sub>2</sub>, 382.1550; found, 382.1575.</div></div><div id="sec5_58" class="NLM_sec NLM_sec_level_2"><div id="ac_i86" class="anchor-spacer"></div><h3 class="article-section__title" id="_i86"> (±)-4-[1-(4-Cyanophenyl)-5-(3-fluorophenyl)-4,5-dihydro-1<i>H</i>-pyrazol-3-yl]benzoic Acid (<b>15b</b>)</h3><div class="NLM_p last">Following the procedure of example <b>15a</b>, using 1-fluoro-3-vinylbenzene (83 mg, 0.68 mmol), gave <b>15b</b> as a solid (45 mg, 0.11 mmol, 20%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 3.24 (d, <i>J</i> = 5.10 Hz, 1 H), 4.00 (dd, <i>J</i> = 17.86, 12.22 Hz, 1 H), 5.72 (dd, <i>J</i> = 12.49, 5.24 Hz, 1 H), 7.02−7.13 (m, 5 H), 7.33−7.42 (m, 1 H), 7.58 (d, <i>J</i> = 9.13 Hz, 2 H), 7.87 (d, <i>J</i> = 8.59 Hz, 2 H), 7.93−7.99 (m, 2 H,) 13.06 (s, 1 H). ES-MS <i>m</i>/<i>z</i> 386 (M + H). HRMS (M + H) calcd for C<sub>23</sub>H<sub>16</sub>FN<sub>3</sub>O<sub>2</sub>, 386.1299; found, 386.1310. Anal. (C<sub>23</sub>H<sub>16</sub>FN<sub>3</sub>O<sub>2</sub>·0.25H<sub>2</sub>O) Calcd: C, 70.85; H, 4.27; N, 10.78. Found: C, 70.64; H, 3.77; N, 10.70.</div></div><div id="sec5_59" class="NLM_sec NLM_sec_level_2"><div id="ac_i87" class="anchor-spacer"></div><h3 class="article-section__title" id="_i87"> (±)-4-[1-(4-Cyanophenyl)-5-(3-methoxyphenyl)-4,5-dihydro-1<i>H</i>-pyrazol-3-yl]benzoic Acid (<b>15c</b>)</h3><div class="NLM_p last">Following the procedure of example <b>15a</b>, using 1-methoxy-3-vinylbenzene (91 mg, 0.68 mmol), gave <b>15c</b> as a solid (97 mg, 0.24 mmol, 43%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 3.22 (dd, <i>J</i> = 17.86, 5.50 Hz, 1 H), 3.68 (s, 3 H), 3.98 (dd, <i>J</i> = 17.72, 12.08 Hz, 1 H), 5.64 (dd, <i>J</i> = 12.35, 5.37 Hz, 1 H), 6.75 (d, <i>J</i> = 8.06 Hz, 1 H), 6.80−6.85 (m, 2 H), 7.09 (d, <i>J</i> = 8.86 Hz, 2 H), 7.24 (dd, <i>J</i> = 8.86, 7.52 Hz, 1 H), 7.57 (d, <i>J</i> = 9.13 Hz, 2 H), 7.87 (d, <i>J</i> = 8.59 Hz, 2 H), 7.96 (d, <i>J</i> = 8.59 Hz, 2 H). ES-MS <i>m</i>/<i>z</i> 398 (M + H). HRMS (M + H) calcd for C<sub>24</sub>H<sub>19</sub>N<sub>3</sub>O<sub>3</sub>, 398.1499; found, 398.1484.</div></div><div id="sec5_60" class="NLM_sec NLM_sec_level_2"><div id="ac_i88" class="anchor-spacer"></div><h3 class="article-section__title" id="_i88"> (±)-4-[1-(4-Cyanophenyl)-5-cyclohexyl-4,5-dihydro-1<i>H</i>-pyrazol-3-yl]benzoic Acid (<b>15d</b></h3><div class="NLM_p last">Following the procedure of example <b>15a</b>, using vinyl cyclohexane (0.15 mL, 1.1 mmol), gave <b>15d</b> as a solid (100 mg, 0.27 mmol, 34%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 0.75−1.24 (m, 6 H), 1.54 (d, <i>J</i> = 9.13 Hz, 1 H), 1.59−1.75 (m, 2 H), 1.84−1.96 (m, 1 H), 3.30−3.36 (m, 2 H), 4.63 (td, <i>J</i> = 9.47, 6.24, 3.09 Hz, 1 H), 7.24 (d, <i>J</i> = 8.86 Hz, 2 H), 7.62 (d, <i>J</i> = 9.13 Hz, 2 H), 7.85 (d, <i>J</i> = 8.59 Hz, 2 H), 7.96 (d, <i>J</i> = 8.59 Hz, 2 H). ES-MS <i>m</i>/<i>z</i> 374 (M + H). HRMS (M + H) calcd for C<sub>23</sub>H<sub>23</sub>N<sub>3</sub>O<sub>2</sub>, 374.1863; found, 374.1869.</div></div><div id="sec5_61" class="NLM_sec NLM_sec_level_2"><div id="ac_i89" class="anchor-spacer"></div><h3 class="article-section__title" id="_i89"> (±)-4-[1-(4-Cyanophenyl)-5-cyclopentyl-4,5-dihydro-1<i>H</i>-pyrazol-3-yl]benzoic Acid (<b>15e</b>)</h3><div class="NLM_p last">Following the procedure of example <b>15a</b>, using vinyl cyclopentane (0.76 mL, 5.6 mmol), gave <b>15e</b> as a solid (127 mg, 0.35 mmol, 66%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 0.97−1.07 (m, 2 H), 1.19−1.39 (m, 2 H), 1.42−1.63 (m, 3 H), 1.66−1.79 (m, 2 H), 3.18 (dd, <i>J</i> = 18.13, 3.89 Hz, 1 H), 3.43 (dd, <i>J</i> = 17.72, 11.28 Hz, 1 H), 4.82 (td, <i>J</i> = 7.79, 3.49 Hz, 1 H), 7.24 (d, <i>J</i> = 8.86 Hz, 2 H), 7.60 (d, <i>J</i> = 9.13 Hz, 2 H), 7.78 (d, <i>J</i> = 8.32 Hz, 2 H), 7.92 (d, <i>J</i> = 8.32 Hz, 2 H). ES-MS <i>m</i>/<i>z</i> 360 (M + H). HRMS (M + H) calcd for C<sub>22</sub>H<sub>21</sub>N<sub>3</sub>O<sub>2</sub>, 360.1707; found, 360.1748</div></div><div id="sec5_62" class="NLM_sec NLM_sec_level_2"><div id="ac_i90" class="anchor-spacer"></div><h3 class="article-section__title" id="_i90"> (±)-4-[5-<i>tert</i>-Butyl-1-(4-cyanophenyl)-4,5-dihydro-1<i>H</i>-pyrazol-3-yl]benzoic Acid (<b>15f</b>)</h3><div class="NLM_p last">Following the procedure of example <b>15a</b>, using 3,3-dimethyl-1-butene (0.18 mL, 1.4 mmol), gave <b>15f</b> as a solid (26 mg, 0.07 mmol, 64%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 0.84 (s, 9 H), 3.30−3.36 (m, 2 H), 4.52 (dd, <i>J</i> = 9.53, 3.89 Hz, 1 H), 7.34 (d, <i>J</i> = 9.13 Hz, 2 H), 7.59 (d, <i>J</i> = 9.13 Hz, 2 H), 7.90 (d, 2 H), 7.97 (d, 2 H), 13.04 (br s, 1 H). ES-MS <i>m</i>/<i>z</i> 348 (M + H). HRMS (M + H) calcd for C<sub>21</sub>H<sub>21</sub>N<sub>3</sub>O<sub>2</sub>, 348.1707; found, 348.1682.</div></div><div id="sec5_63" class="NLM_sec NLM_sec_level_2"><div id="ac_i91" class="anchor-spacer"></div><h3 class="article-section__title" id="_i91"> (±)-4-[1-(3-Chloro-4-cyanophenyl)-5-cyclopentyl-4,5-dihydro-1<i>H</i>-pyrazol-3-yl]benzoic Acid (<b>15g</b>)</h3><div class="NLM_p"><b>Step 1.</b> To a solution of <b>13b</b> (1.0 g, 2.55 mmol) in tetrahydrofuran (5 mL) were added vinylcyclopentane (0.35 mL, 2.55 mmol) and triethylamine (0.46 mL, 3.31 mmol). The mixture was stirred for 4 h at ambient temperature. After concentration of solvent, the crude material was purified using normal phase chromatography (ethyl actate/hexane) to provide the pyrazoline (61 mg, 27%).</div><div class="NLM_p last"><b>Step 2.</b> To a solution of the pyrazoline prepared in step 1 (61 mg, 0.15 mmol) in tetrahydrofuran (2 mL) was added 1 N NaOH (1 mL), and the mixture was stirred for 18 h at ambient temperature. The solution was concentrated to half volume and acidified with 1 M HCl to pH 2. The resulting solid was collected by vacuum filtration to provide the title compound as a solid (190 mg, 0.48 mmol, 40%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 0.90−1.06 (m, 1 H), 1.16−1.64 (m, 6 H), 1.74 (dd, <i>J</i> = 13.02, 9.80 Hz, 1 H), 2.36−2.46 (m, 1 H), 3.23 (dd, <i>J</i> = 18.13, 3.63 Hz, 1 H), 3.46 (dd, <i>J</i> = 17.86, 11.41 Hz, 1 H), 4.83−4.96 (m, 1 H), 7.18 (dd, <i>J</i> = 9.00, 2.28 Hz, 1 H), 7.39 (d, <i>J</i> = 2.15 Hz, 1 H), 7.70 (d, <i>J</i> = 8.86 Hz, 1 H), 7.86−7.93 (m, 2 H), 7.94−8.01 (m, 2 H), 13.06 (br s, 1 H). ES-MS <i>m</i>/<i>z</i> 394 (M + H). HRMS (C<sub>22</sub>H<sub>20</sub>ClN<sub>3</sub>O<sub>2</sub>) calcd, 394.1317; found, 394.1275.</div></div><div id="sec5_64" class="NLM_sec NLM_sec_level_2"><div id="ac_i92" class="anchor-spacer"></div><h3 class="article-section__title" id="_i92"> Ethyl 3-Cyclopentylacrylate (<b>18</b>)</h3><div class="NLM_p last">To a solution of diethyl [(ethoxycarbonyl)methyl]phosphonate (11.7 g, 52.0 mmol) in THF (100 mL) was added 21% sodium ethoxide (20.4 mL, 54.6 mmol) at 0 °C, and the solution was stirred for 20 min. To this solution was added cyclopentanecarbaldehyde (5.00 g, 50.9 mmol), and the mixture was allowed to warm to room temperature overnight. The solution was diluted to 500 mL with hexanes and was washed with water (200 mL). The aqueous layer was extracted with hexane (200 mL) and then hexane (100 mL). The combined organic layer was washed with brine (200 mL), dried over magnesium sulfate, filtered, and evaporated to give a yellow oil. The oil was purified by silica gel chromatography with 10% EA/Hex to give a light-yellow oil (7.52 g, 44.7 mmol, 87.7% yield) containing ∼10% of regioisomeric ethyl 3-cyclopentylidenepropanoate. ES-MS <i>m</i>/<i>z</i> 169 (M + H). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 1.20 (t, <i>J</i> = 7.12 Hz, 3 H), 1.29−1.42 (m, 2 H), 1.50−1.70 (m, 4 H), 1.73−1.83 (m, 2 H), 2.55−2.68 (m, 1 H), 4.10 (q, <i>J</i> = 6.98 Hz, 2 H), 5.82 (dd, <i>J</i> = 15.57, 1.34 Hz, 1 H), 6.86 (dd, <i>J</i> = 15.57, 8.06 Hz, 1 H).</div></div><div id="sec5_65" class="NLM_sec NLM_sec_level_2"><div id="ac_i93" class="anchor-spacer"></div><h3 class="article-section__title" id="_i93"> 2-Chloro-4-(5-cyclopentyl-3-oxopyrazolidin-1-yl)benzonitrile (<b>19</b>)</h3><div class="NLM_p last">A mixture of <b>18</b> (12.41 g, 73.8 mmol) and 2-chloro-4-hydrazinobenzonitrile (20.1 g, 98.5 mmol) in EtOH (260 mL) was treated with 21% sodium ethoxide (83 mL, 220 mmol) under argon. The mixture was heated to 80 °C overnight and was heated another 3 h at reflux. The mixture was cooled to about 40 °C and quenched with 6 M HCl (50 mL). The resulting orange mixture was cooled to room temperature on an ice bath and then poured (slowly) into a stirring solution of water (1200 mL). The cloudy mixture was stirred for 20 min, and a precipitate formed which was collected by vacuum filtration. The solid was dried on the high vacuum overnight over phosphorus pentoxide to give the title compound as an orange solid (17.06 g, 58.9 mmol, 79.8%). ES-MS <i>m</i>/<i>z</i> 290 (M + H). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 1.14−1.29 (m, 1 H), 1.30−1.44 (m, 1 H), 1.46−1.83 (m, 6 H), 2.01−2.18 (m, 2 H), 2.92 (dd, <i>J</i> = 16.65, 8.59 Hz, 1 H), 4.24 (t, <i>J</i> = 7.92 Hz, 1 H), 6.97 (dd, <i>J</i> = 8.86, 2.42 Hz, 1 H), 7.09 (d, <i>J</i> = 2.42 Hz, 1 H), 7.77 (d, <i>J</i> = 8.86 Hz, 1 H), 10.45 (s, 1 H).</div></div><div id="sec5_66" class="NLM_sec NLM_sec_level_2"><div id="ac_i94" class="anchor-spacer"></div><h3 class="article-section__title" id="_i94"> 2-Chloro-4-[(5<i>R</i>)-3-chloro-5-cyclopentyl-4,5-dihydro-1<i>H</i>-pyrazol-1-yl]benzonitrile (<i><b>R</b></i><b>-20</b>)</h3><div class="NLM_p last">A mixture of <b>19</b> (15.3 g, 52.9 mmol) in acetonitrile (85 mL) was evacuated/purged with argon. Next, phosphorus oxychloride (5.33 mL, 58.2 mmol) was added and the mixture was heated at 80 °C for 2.5 h. The mixture was diluted with dichloromethane (300 mL) and quenched with water (300 mL) and brine (200 mL) (emulsion). The layers were separated and the organic layer was washed with water (300 mL) to give an emulsion which was filtered. The combined aqueous layers were back-extracted with ethyl acetate (300 mL). The combined organic layers were dried over magnesium sulfate, filtered, and evaporated to give an oil. The oil was dissolved in 30% EA/Hex and purified by silica gel chromatography with 35−50% EtOAc/hexane to give <b>(±)-20</b> as a light-yellow oil (14.5 g, 47.0 mmol, 88.9% yield). ES-MS <i>m</i>/<i>z</i> 308 (M + H). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 1.12−1.24 (m, 2 H), 1.49−1.74 (m, 5 H), 1.74−1.86 (m, 1 H), 2.43−2.57 (m, 1 H), 2.89 (dd, <i>J</i> = 17.99, 4.30 Hz, 1 H), 3.34 (dd, <i>J</i> = 18.13, 11.41 Hz, 1 H), 4.53−4.65 (m, 1 H), 6.87 (dd, <i>J</i> = 8.73, 2.28 Hz, 1 H), 7.09 (d, <i>J</i> = 2.42 Hz, 1 H), 7.46 (d, <i>J</i> = 8.86 Hz, 1 H). <b>(±)-20</b> (14.5 g, 47.0 mmol) was resolved by SFC chiral chromatography on a Chiralpak AD-H column (30 mm × 250 mm) eluted with 20% methanol/CO<sub>2</sub>, 70 mL/min, to give <i><b>R</b></i><b>-20</b> (6.2 g, 43% yield): later eluting peak, <i>t</i><sub>R</sub> = 3.88 min (Chiralpak AD-H;, 20% MeOH/CO<sub>2</sub>), >99% ee by chiral HPLC. ES-MS <i>m</i>/<i>z</i> 308 (M + H). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 1.03−1.23 (m, 2 H), 1.33−1.78 (m, 6 H), 2.33−2.45 (m, 1 H), 2.99 (dd, <i>J</i> = 18.26, 4.03 Hz, 1 H), 3.51 (dd, <i>J</i> = 18.26, 11.28 Hz, 1 H), 4.80−4.92 (m, 1 H), 7.03 (dd, <i>J</i> = 8.86, 2.42 Hz, 1 H), 7.19 (d, <i>J</i> = 2.15 Hz, 1 H), 7.70 (d, <i>J</i> = 8.86 Hz, 1 H). <i><b>S</b></i><b>-20</b> (5.9 g, 41% yield): ES-MS <i>m</i>/<i>z</i> 308 (M + H); earlier eluting peak, <i>t</i><sub>R</sub> = 3.00 min, >99% ee by chiral HPLC.</div></div><div id="sec5_67" class="NLM_sec NLM_sec_level_2"><div id="ac_i95" class="anchor-spacer"></div><h3 class="article-section__title" id="_i95"> 4-[(5<i>R</i>)-1-(3-Chloro-4-cyanophenyl)-5-cyclopentyl-4,5-dihydro-1<i>H</i>-pyrazol-3-yl]benzoic Acid (<i><b>R</b></i><b>-15g</b>)</h3><div class="NLM_p last">A mixture of <i><b>R</b></i><b>-20</b> (104 mg, 0.338 mmol), (4-carboxyphenyl)boronic acid (76 mg, 0.46 mmol), tetrakis(triphenylphosphine)palladium(0) (21 mg, 0.018 mmol), 2 M aqueous sodium carbonate (0.53 mL, 1.06 mmol), and DME (2 mL) was stirred at 80 °C in a vial under Ar for 5 h. The mixture was diluted with ethyl acetate and water. The organic layer was discarded, and the aqueous was acidified with 1 N HCl and extracted twice with ethyl acetate. The combined organic layer was evaporated and the resulting residue was dissolved in DMF and then purified by reverse phase chromatography with 40−95% acetonitrile/water to give the title compound as a yellow solid (86 mg, 0.218 mmol, 64% yield). ES-MS <i>m</i>/<i>z</i> 394 (M + H). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 1.04 (d, <i>J</i> = 8.8 Hz, 1 H), 1.20−1.68 (m, 6 H), 1.78 (d, <i>J</i> = 12.4 Hz, 1 H), 2.47 (br s, 1 H), 3.50 (dd, <i>J</i> = 17.9, 10.6 Hz, 1 H), 4.86−4.95 (m, 1 H), 7.21 (d, <i>J</i> = 8.8 Hz, 1 H), 7.42 (s, 1 H), 7.72 (d, <i>J</i> = 8.8 Hz, 1 H), 7.93 (d, <i>J</i> = 8.8 Hz, 2 H), 7.97−8.04 (m, 2 H). HRMS <i>m</i>/<i>z</i> found, 394.1234 (M + H); calcd, 394.1322.</div></div><div id="sec5_68" class="NLM_sec NLM_sec_level_2"><div id="ac_i96" class="anchor-spacer"></div><h3 class="article-section__title" id="_i96"> 4-[(5<i>R</i>)-1-(3-Chloro-4-cyanophenyl)-5-cyclopentyl-4,5-dihydro-1<i>H</i>-pyrazol-3-yl]-2-fluorobenzoic Acid (<i><b>R</b></i><b>-21a</b>)</h3><div class="NLM_p last">Chloropyrazoline <i><b>R</b></i><b>-20</b> (1 mmol), 4-borono-2-fluorobenzoic acid (1.1 mmol), and palladium(0) tetrakis(triphenylphosphine) (0.05 mmol) were loaded in a vial. DMF (2 mL) was added, and the vial was purged with nitrogen. A degassed 2 M solution of cesium carbonate (2 equiv) was added under nitrogen, and the reaction mixture was heated at 85 °C for 8 h. The mixture was diluted with additional DMF, filtered, and purified by reverse-phase HPLC to give pure <i><b>R</b></i><b>-21a</b> (350 mg, 85%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 7.82−8.00 (m, 1 H), 7.70 (1 H, s), 7.58−7.78 (m, 2 H), 7.43 (s,1 H), 7.20 (d, <i>J</i> = 8.78 Hz, 1 H), 4.80−5.04 (m, 1 H), 3.44 (dd, <i>J</i> = 17.93, 11.35 Hz, 1 H), 3.40 (m, 1 H), 2.40−2.45 (m, 1H), 1.68−1.84 (m, 2 H), 1.43−1.68 (m, 2 H), 1.19−1.43 (m, 2 H), 0.87−1.09 (m, 2 H). Anal. (C<sub>22</sub>H<sub>19</sub>ClFN<sub>3</sub>O<sub>2</sub>·0.25H<sub>2</sub>O) Calcd: C, 63.46; H, 4.73; N, 10.09. Found: C, 63.10; H, 4.24; N, 10.05.</div></div><div id="sec5_69" class="NLM_sec NLM_sec_level_2"><div id="ac_i97" class="anchor-spacer"></div><h3 class="article-section__title" id="_i97"> 4-[(5<i>R</i>)-1-(3-Chloro-4-cyanophenyl)-5-cyclopentyl-4,5-dihydro-1<i>H</i>-pyrazol-3-yl]-2-ethoxybenzoic Acid (<i><b>R</b></i><b>-21b</b>)</h3><div class="NLM_p">To 4-bromo-2-hydroxybenzoic acid (5.0 g, 23 mmol) and potassium carbonate (12.7 g, 92.2 mmol) in DMF (85 mL) was added ethyl iodide (5.53 mL, 69.1 mmol), and the mixture was heated at 100 °C for 4 h. Another portion of ethyl iodide (5 mL, 62.5 mmol) and potassium carbonate (12 g, 86.8 mmol) was added, and the mixture was heated at 100 °C for another 4 h. The mixture was poured into water (400 mL) and extracted three times with diethyl ether (200 mL). The combined organic layers were washed with brine (200 mL), dried over magnesium sulfate, filtered, and evaporated to give an oil. The oil was purified by silica gel chromatography with 0−30% EA/Hex to give ethyl 4-bromo-2-ethoxybenzoate as a white solid (5.19 g, 19 mmol, 83%). <sup>1</sup>H NMR (400 MHz, chloroform-<i>d</i>) δ ppm 1.38 (t, <i>J</i> = 7.12 Hz, 3 H), 1.47 (t, <i>J</i> = 6.98 Hz, 3 H), 4.10 (q, <i>J</i> = 6.98 Hz, 2 H), 4.35 (q, <i>J</i> = 7.25 Hz, 2 H), 7.09−7.13 (m, 2 H), 7.66 (d, <i>J</i> = 8.59 Hz, 1 H). ES-MS <i>m</i>/<i>z</i> 273 (M + H).</div><div class="NLM_p">To a mixture of ethyl 4-bromo-2-ethoxybenzoate (2.5 g, 9.2 mmol), bis(pinacolato)diboron (2.57 g, 10.1 mmol), and potassium acetate (2.71 g, 27.6 mmol), Pd(dppf)<sub>2</sub>Cl<sub>2</sub>·CH<sub>2</sub>Cl<sub>2</sub> complex (225 mg, 0.276 mmol) was added DMF (35 mL). The reaction vial was purged and filled with argon. The mixture was heated at 80 °C overnight. The reaction mixture was diluted with diethyl ether (250 mL), filtered through a pad of Celite, and evaporated to give an oil. The oil was purified by silica gel chromatography with 0−30% EA/Hex to give ethyl 2-ethoxy-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzoate as an oil (2.59 g, 8.09 mmol, 88%). ES-MS <i>m</i>/<i>z</i> 321 (M + H).</div><div class="NLM_p last">A mixture <i><b>R</b></i><b>-20</b> (45 mg, 0.15 mmol), ethyl 2-ethoxy-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzoate (56 mg, 0.17 mmol), tetrakis(triphenylphosphine)palladium(0) (9.2 mg, 0.008 mmol), 2 M aqueous sodium carbonate (0.22 mL, 0.44 mmol), and DME (1 mL) was stirred at 80 °C in a vial under Ar for 2 h. The mixture was diluted with ethyl acetate, washed with water, and the layers were separated. The organic layer was treated with 3-mercaptopropyl functionalized silica gel to scavenge the palladium catalyst, stirred for 10 min, filtered, and evaporated. The residue was dissolved in 1.5 mL of THF, 1 mL of methanol and treated with 0.5 mL of 1.25 M NaOH, and the solution was stirred overnight. The solution was diluted with ethyl acetate and quenched with 1 N HCl. The organic layer was evaporated to give an oil. The oil was dissolved in DMSO and purified by reverse phase HPLC to give <i><b>R</b></i><b>-21b</b> as a solid (64 mg, 0.78 mmol, 53%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 0.91−1.09 (m, 1 H), 1.32 (t, <i>J</i> = 7.0 Hz, 5 H), 1.42−1.64 (m, 3 H), 1.66−1.80 (m, 1 H), 2.34−2.49 (m, 2 H), 3.19−3.33 (m, 1 H), 3.27 (br s, 1 H), 3.43 (dd, <i>J</i> = 17.6, 11.7 Hz, 1 H), 4.08−4.24 (m, 2 H), 4.82−4.92 (m, 1 H), 7.17 (d, <i>J</i> = 7.3 Hz, 1 H), 7.31−7.45 (m, 2 H), 7.65 (dd, <i>J</i> = 15.7, 8.4 Hz, 2 H). HRMS (C<sub>24</sub>H<sub>24</sub>ClN<sub>3</sub>O<sub>3</sub>) calcd, 438.1506; found, 438.1569.</div></div><div id="sec5_70" class="NLM_sec NLM_sec_level_2"><div id="ac_i98" class="anchor-spacer"></div><h3 class="article-section__title" id="_i98"> 4-[(5<i>R</i>)-1-(3-Chloro-4-cyanophenyl)-5-cyclopentyl-4,5-dihydro-1<i>H</i>-pyrazol-3-yl]-2-(trifluoromethoxy)benzoic Acid (<i><b>R</b></i><b>-21c</b>)</h3><div class="NLM_p">A solution of 4-bromo-2-(trifluoromethoxy)iodobenzene in 25 mL of THF was cooled to −78 °C and treated with 1.1 mL of 2.5 M <i>n-</i>BuLi in hexanes (2 equiv, 2.7 mmol). The mixture was stirred at −78 °C for 1.5 h and then treated with fresh small pieces of dry ice (CO<sub>2</sub>) and stirred at −78 °C for 30 min. The reaction was quenched with 1 N HCl and extracted 3× with ethyl acetate, dried over magnesiun sulfate, and concentrated to an oil. The oil was dissolved in methylene chloride (10 mL) and treated with 0.5 mL of 98% oxallyl chloride and 1 drop of DMF (bubbling observed). After 1 h, the reaction was quenched by addition of 10 mL of MeOH and then concentrated. The oil was purified by flash chromatography (5−60% ethyl acetate/heptane) to give methyl 4-bromo-2-(trifluoromethoxy)benzoate as a clear oil (292 mg, 72%). <sup>1</sup>H NMR (400 MHz, chloroform-<i>d</i>) δ ppm 3.94 (s, 3 H), 7.52 (s, 1 H), 7.55 (dd, <i>J</i> = 8.32, 1.88 Hz, 1 H), 7.86 (d, <i>J</i> = 8.32 Hz, 1 H).</div><div class="NLM_p">To a mixture of methyl 4-bromo-2-(trifluoromethoxy)benzoate (280 mg, 0.936 mmol), bis(pinacolato)diboron (262 mg, 1.03 mmol), potassium acetate (276 mg, 2.81 mmol), Pd(dppf)<sub>2</sub>Cl<sub>2</sub>·CH<sub>2</sub>Cl<sub>2</sub> complex (38.2 mg, 0.0468 mmol) was added DMF (10 mL), and the reaction vial was purged and filled with argon. The mixture was heated at 80 °C overnight. The mixture was cooled to room temperature, diluted with water, and extracted 3× with ethyl acetate. The organic layer was filtered through Celite, dried over magnesium sulfate, filtered, and concentrated. The residue was purified by flash chromatography, eluting with 2−50% ethyl acetate/hexanes to give a mixture of methyl 4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-2-(trifluoromethoxy)benzoate and 4-(methoxycarbonyl)-3-(trifluoromethoxy)phenylboronic acid as a semisolid (240 mg, ∼74%). ES-MS <i>m</i>/<i>z</i> 321 (M + H). Boronate ester: <sup>1</sup>H NMR (400 MHz, chloroform-<i>d</i>) δ ppm 1.36 (s, 12 H), 3.94 (s, 3 H), 7.69−7.74 (m, 1 H), 7.79 (dd, <i>J</i> = 7.72, 1.07 Hz, 1 H), 7.92 (d, <i>J</i> = 7.62 Hz, 1 H). Boronic acid: <sup>1</sup>H NMR (400 MHz, chloroform-<i>d</i>) δ ppm 3.98 (s, 3 H), 7.52−7.55 (m, 1 H), 7.62 (dd, <i>J</i> = 8.01, 1.76 Hz, 1 H), 8.09 (d, <i>J</i> = 8.21 Hz, 1 H).</div><div class="NLM_p last">A mixture of <i><b>R</b></i><b>-20</b> (160 mg, 0.519 mmol), methyl 4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-2-(trifluoromethoxy)benzoate/4-(methoxycarbonyl)-3-(trifluoromethoxy)phenylboronic acid (234 mg, 0.675 mmol), Pd(dppf)<sub>2</sub>Cl<sub>2</sub>·CH<sub>2</sub>Cl<sub>2</sub> complex (21.2 mg, 0.026 mmol), 2 M aqueous cesium carbonate (0.519 mL, 1.04 mmol), and DME (5 mL) was degassed and purged with Ar and was stirred at 80 °C for 4 h. The mixture was poured into water and extracted with ethyl acetate, washed with brine, dried over magnesium sulfate, filtered, and concentrated to give a brown oil. The residue was dissolved in 3 mL of THF, 1 mL of methanol, treated with 1 mL of 2.5 M NaOH, and stirred overnight under Ar. The solution was diluted with ethyl acetate and quenched with 1 N HCl. The organic layer was evaporated to give an oil. The oil was dissolved in DMSO and purified by reverse phase HPLC to give <i><b>R</b></i><b>-21c</b> as a yellow-orange solid (112 mg, 41%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 0.95−1.09 (m, 1 H), 1.20−1.67 (m, 6 H), 1.69−1.85 (m, 1 H), 2.39−2.50 (m, 1 H), 3.29 (dd, <i>J</i> = 18.17, 3.91 Hz, 1 H), 3.40−3.55 (m, 1 H), 4.95 (ddd, <i>J</i> = 11.38, 3.96, 3.81 Hz, 1 H), 7.25 (dd, <i>J</i> = 8.79, 2.15 Hz, 1 H), 7.45 (d, <i>J</i> = 2.15 Hz, 1 H), 7.74 (d, <i>J</i> = 8.79 Hz, 1 H), 7.83 (s, 1 H), 7.92 (dd, <i>J</i> = 8.21, 1.56 Hz, 1 H), 7.98−8.02 (m, <i>J</i> = 8.21 Hz, 1 H). ES-MS <i>m</i>/<i>z</i> 478 (M + H).</div></div><div id="sec5_71" class="NLM_sec NLM_sec_level_2"><div id="ac_i99" class="anchor-spacer"></div><h3 class="article-section__title" id="_i99"> {4-[(5<i>R</i>)-1-(3-Chloro-4-cyanophenyl)-5-cyclopentyl-4,5-dihydro-1<i>H</i>-pyrazol-3-yl]phenyl}acetic Acid (<i><b>R</b></i><b>-21d</b>)</h3><div class="NLM_p last">Chloropyrazoline <b>(±)-20</b> (0.7 mmol), 4-borono-2-fluorobenzoic acid (0.7 mmol), and palladium(0) tetrakis(triphenylphosphine) (0.05 mmol) were loaded in a vial. DMF (2 mL) was added, and the vial was purged with nitrogen. A degassed 2 M solution of cesium carbonate (2 equiv) was added under nitrogen, and the reaction mixture was heated at 85 °C for 8 h. The mixture was diluted with additional DMF, filtered, and purified by reverse-phase HPLC to give pure <b>(±)-21d</b> (230 mg). Chiral separation of <b>(±)-21d</b> on a Chiralpak AS-H column (30 mm × 250 mm) eluted with 50%IPA/CO<sub>2</sub>, 70 mL/min flow, yielded <i><b>R</b></i><b>-21d</b> as the later eluting peak. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 12.38 (br s, 1 H), 7.67−7.91 (m, 4 H), 7.23−7.43 (m, 3 H), 7.15 (dd, <i>J</i> = 8.98, 1.95 Hz, 1 H), 4.85 (ddd, <i>J</i> = 11.13, 3.71, 3.52 Hz, 1 H), 3.63 (s, 2 H), 3.23 (m, 1 H), 2.43 (m, 1 H), 1.76 (dd, <i>J</i> = 11.72, 4.30 Hz, 1 H), 1.59−1.68 (m, 1 H), 1.44−1.59 (m, 1 H), 1.21−1.44 (m, 4 H), 0.95−1.06 (m, 1 H). ES-MS <i>m</i>/<i>z</i> 408 (M + H). <i>t</i><sub>R</sub> = 8.60 min, >99.5% ee by chiral HPLC.</div></div><div id="sec5_72" class="NLM_sec NLM_sec_level_2"><div id="ac_i100" class="anchor-spacer"></div><h3 class="article-section__title" id="_i100"> 4-[(5<i>R</i>)-1-(3-Chloro-4-cyanophenyl)-5-cyclopentyl-4,5-dihydro-1<i>H</i>-pyrazol-3-yl]-2-(3-hydroxypropoxy)benzoic Acid (<i><b>R</b></i><b>-22</b>)</h3><div class="NLM_p last">To a solution of <i><b>R</b></i><b>-12o</b> (2.94 mmol) in 60 mL of anhydrous methylene chloride in an ice bath under nitrogen was added a solution of 1 M BBr<sub>3</sub> (7.35 mmol) in methylene chloride dropwise. After addition, the mixture was stirred for 1 h. The reaction was then quenched with 10 mL of methanol, and the mixture was diluted with water and extracted with ethyl acetate. The combined ethyl acetate phase was washed with brine, dried over Na<sub>2</sub>SO<sub>4</sub>, and concentrated. The crude product was purified by flash chromatography (0−10% MeOH/methylene chloride) to give 958 mg of solid product. A mixture of this solid (0.11 mmol), 2-(3-bromopropoxyl)tetrahydro-2<i>H</i>-pyran (0.25 mmol), and cesium carbonate (0.24 mmol) was evacuated and backfilled with Ar several times. Then 1.1 mL of anhydrous DMF was added and the resulting mixture was heated to 80 °C overnight. The mixture was cooled, and 10 mL of methanol was added along with 1 mL of 2.5 N NaOH. The mixture was poured into a diluted solution of HCl and extracted with ethyl acetate. The combined ethyl acetate phase was washed with brine, dried over Na<sub>2</sub>SO<sub>4</sub>, concentrated, and dried under vacuum. The residue was dissolved in 5 mL of THF, and 0.5 mL of concentrated HCl was added. The resulting mixture was stirred at room temperature for 4 h. The solvents were evaporated and the residue was purified by reverse phase HPLC to give pure <i><b>R</b></i><b>-22</b> (74%): <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 0.97−1.09 (m, 1 H), 1.27−1.37 (m, 3 H), 1.45−1.65 (m, 3 H), 1.71−1.82 (m, 1 H), 1.84−1.95 (m, 2 H), 2.37−2.48 (m, 1 H), 3.21−3.28 (m, 1 H), 3.43−3.52 (m, 1 H), 3.62 (t, <i>J</i> = 6.04 Hz, 2 H), 4.17−4.25 (m, 2 H), 4.84−4.94 (m, 1 H), 7.17−7.25 (m, 1 H), 7.37−7.47 (m, 3 H), 7.64−7.74 (m, 2 H). ES-MS <i>m</i>/<i>z</i> 468 (M + H).</div></div><div id="sec5_73" class="NLM_sec NLM_sec_level_2"><div id="ac_i101" class="anchor-spacer"></div><h3 class="article-section__title" id="_i101"> 4-[(4<i>S</i>,5<i>S</i>)-1-(3-Chloro-4-cyanophenyl)-5-cyclopentyl-4-methyl-4,5-dihydro-1<i>H</i>-pyrazol-3-yl]-2-methoxybenzoic Acid (<b>4</b><i><b>S</b></i><b>,5</b><i><b>S</b></i><b>-23</b>)</h3><div class="NLM_p last">To a solution of diisopropylamine (1.4 mmol) in 7 mL of anhydrous THF at −78 °C under nitrogen was added a solution of 2.5 M <i>n-</i>BuLi in hexanes (1.4 mmol), and the mixture was stirred for 10 min. Then 1.9 mL of the resulting LDA solution was added dropwise to a mixture of <i><b>R</b></i><b>-12o</b> (0.14 mmol) in 2.8 mL of anhydrous THF cooled at −78 °C under nitrogen and stirred for 30 min. Iodomethane (0.21 mmol) was then added to the mixture. After 30 min, the mixture was warmed to room temperature and stirred for additional 2.5 h. The mixture was poured into a diluted HCl solution and extracted with ethyl acetate. The combined ethyl acetate phase was washed with brine, dried over Na<sub>2</sub>SO<sub>4</sub>, and concentrated. The crude product was purified by reversed-phase HPLC to give <b>4</b><i><b>S</b></i><b>,5</b><i><b>S</b></i><b>-23</b> (37 mg, 60%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 0.95−1.08 (m, 1 H), 1.20 (d, <i>J</i> = 7.25 Hz, 3 H), 1.29−1.43 (m, 3 H), 1.44−1.67 (m, 3 H), 1.69−1.79 (m, 1 H), 2.30−2.42 (m, 1 H), 3.68 (ddd, <i>J</i> = 14.03, 7.05, 1.48 Hz, 1 H), 3.92 (s, 3 H), 4.49 (dd, <i>J</i> = 4.30, 1.88 Hz, 1 H), 7.25 (d, <i>J</i> = 8.59 Hz, 1 H), 7.43 (d, <i>J</i> = 1.88 Hz, 1 H), 7.49 (dd, <i>J</i> = 7.79, 1.61 Hz, 1 H), 7.51 (s, 1 H), 7.70 (d, <i>J</i> = 8.06 Hz, 1 H), 7.73 (d, <i>J</i> = 8.86 Hz, 1 H), 12.71 (br s, 1 H). ES-MS <i>m</i>/<i>z</i> 438 (M + H).</div></div><div id="sec5_74" class="NLM_sec NLM_sec_level_2"><div id="ac_i102" class="anchor-spacer"></div><h3 class="article-section__title" id="_i102"> Ethyl 6-(4-Fluorobenzylidene)-5-oxo-5,6,7,8-tetrahydronaphthalene-2-carboxylate (<b>25a</b>)</h3><div class="NLM_p last">The title compound was prepared according to method B4. The isolated crude precipitate was a mixture of ethyl 5-oxo-5,6,7,8-tetrahydronaphthalene-2-carboxylate, <b>25a</b>, and 6-(4-fluorobenzylidene)-5-oxo-5,6,7,8-tetrahydronaphthalene-2-carboxylic acid. The mixture was combined with 4-fluorobenzaldehyde (0.5 mL), ethanol (40 mL), and 4 N hydrogen chloride/dioxane (10 mL) and was refluxed for 20 h. The solution was poured into 200 mL of water, filtered, and dried to give <b>25a</b> as an off-white solid (826 mg, 2.55 mmol, 49% yield). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 1.33 (t, <i>J</i> = 7.12 Hz, 3 H), 3.06 (m, 4 H), 4.34 (q, <i>J</i> = 6.98 Hz, 2 H), 7.31 (t, <i>J</i> = 8.86 Hz, 2 H), 7.62 (dd, <i>J</i> = 8.59, 5.64 Hz, 2 H), 7.74 (s, 1 H), 7.94 (m, 2 H), 8.06 (d, <i>J</i> = 8.59 Hz, 1 H). ES-MS <i>m</i>/<i>z</i> 325 (M + H).</div></div><div id="sec5_75" class="NLM_sec NLM_sec_level_2"><div id="ac_i103" class="anchor-spacer"></div><h3 class="article-section__title" id="_i103"> Methyl 6-(Cyclopentylmethylene)-5-oxo-5,6,7,8-tetrahydronaphthalene-2-carboxylate (<b>25b</b>)</h3><div class="NLM_p last">To a solution of methyl 5-oxo-5,6,7,8-tetrahydronaphthalene-2-carboxylate (3.4 g, 16.7 mmol) in methanol (30 mL) were added cyclopentanecarboxaldehyde (3.3 g, 33.3 mmol) and pyrrolidine (2.78 mL, 33.3 mmol). The solution was stirred for 20 h at ambient temperature. The reaction was recharged with 0.5 mL of cyclopentanecarboxaldehyde. The resulting precipitate was collected by vacuum filtration to provide the title compound as a solid (2.8 g, 60% yield). ES-MS <i>m</i>/<i>z</i> 285 (M + H). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 1.24−1.39 (m, 2 H), 1.52−1.74 (m, 4 H), 1.76−1.89 (m, 2 H), 2.77 (t, <i>J</i> = 5.77 Hz, 2 H), 2.79−2.90 (m, 1 H), 2.97 (t, <i>J</i> = 6.44 Hz, 2 H), 3.85 (s, 3 H), 6.71 (d, <i>J</i> = 9.94 Hz, 1 H), 7.88 (d, <i>J</i> = 6.44 Hz, 1 H), 7.91 (s, 1 H), 7.98 (d, <i>J</i> = 8.06 Hz, 1 H).</div></div><div id="sec5_76" class="NLM_sec NLM_sec_level_2"><div id="ac_i104" class="anchor-spacer"></div><h3 class="article-section__title" id="_i104"> Methyl 6-(Cyclobutylmethylene)-5-oxo-5,6,7,8-tetrahydronaphthalene-2-carboxylate (<b>25c</b>)</h3><div class="NLM_p last">A solution of methyl 5-oxo-5,6,7,8-tetrahydronaphthalene-2-carboxylate (600 mg, 2.9 mmol) in tetrahydrofuran (10 mL) was cooled to ice bath temperature and treated with 1.0 M lithium hexamethyldisilazide in tetrahydrofuran (5 mL). After the mixture was stirred for 20 min, cyclobutanecarboxaldehyde<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> (24 mL of 0.5 M solution in tetrahydrofuran) was slowly added and the mixture allowed to warm to room temperature and stirred for 3 days. The mixture was poured into water, extracted three times with ethyl acetate, washed with brine, dried over magnesium sulfate, filtered, and concentrated. The crude product was purified by flash chromatography (5−50% ethyl acetate/hexanes). Pure fractions were pooled and concentrated in vacuo to yield the title compound (300 mg, 1.1 mmol, 38% yield). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 1.81−2.03 (m, 4 H), 2.14−2.27 (m, 2 H), 2.71 (t, <i>J</i> = 6.58 Hz, 2 H), 2.93−3.00 (m, 2 H), 3.34−3.44 (m, 1 H), 3.88 (s, 3 H), 6.91 (d, <i>J</i> = 9.13 Hz, 1 H), 7.84−7.95 (m, 2 H), 8.01 (d, <i>J</i> = 8.06 Hz, 1 H). ES-MS <i>m</i>/<i>z</i> 271 (M + H).</div></div><div id="sec5_77" class="NLM_sec NLM_sec_level_2"><div id="ac_i105" class="anchor-spacer"></div><h3 class="article-section__title" id="_i105"> Methyl 6-(Cyclopent-1-en-1-ylmethylene)-5-oxo-5,6,7,8-tetrahydronaphthalene-2-carboxylate (<b>25d</b>)</h3><div class="NLM_p last">To a solution of sodium periodate (28.3 g, 0.13 mol) in water (250 mL) was added an ethyl ether solution (150 mL) of 1,2-cyclohexanediol (12.0 g, 0.10 mol). The solution was stirred for 30 min at ambient temperature. To this solution was added 20% aqueous potassium hydroxide (40 mL), and the solution was stirred for 1 h. The layers were separated, and the organic layer was washed with water and brine and dried over magnesium sulfate. Concentration in vacuo provided cyclopent-1-enecarbaldehyde as a yellow oil (6.0 g, 62% yield). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 1.83−1.93 (m, 2 H), 2.36 (td, <i>J</i> = 7.65, 2.15 Hz, 2 H), 2.50−2.59 (m, 2 H), 7.01−7.08 (m, 1 H), 9.73 (s, 1 H). The title compound was prepared from 5-oxo-5,6,7,8-tetrahydronaphtalene-2-carboxylic acid methyl ester (396 mg, 1.9 mmol) and 1-cyclopentene carbaldehyde (220 mg, 2.0 mmol) according to method B5 in 70% yield. ES-MS <i>m</i>/<i>z</i> 283 (M + H).</div></div><div id="sec5_78" class="NLM_sec NLM_sec_level_2"><div id="ac_i106" class="anchor-spacer"></div><h3 class="article-section__title" id="_i106"> (±)-Methyl 5-Oxo-6-((tetrahydrofuran-3-yl)methylene)-5,6,7,8-tetrahydronaphthalene-2-carboxylate (<b>25e</b>)</h3><div class="NLM_p last">To a solution of methyl 5-oxo-5,6,7,8-tetrahydronaphthalene-2-carboxylate (240 mg, 1.2 mmol) in methanol (3 mL) was added (±)-tetrahydrofuran-3-carboxaldehyde (240 mg, 2.4 mmol) and pyrrolidine (0.20 mL, 2.4 mmol). The solution was stirred for 20 h at ambient temperature and for 4 h at 45 °C. The mixture was concentrated in vacuo. Flash chromatography (ethyl acetate/hexane) provided the title compound as an orange oil (200 mg, 58%). ES-MS <i>m</i>/<i>z</i> 287 (M + H).</div></div><div id="sec5_79" class="NLM_sec NLM_sec_level_2"><div id="ac_i107" class="anchor-spacer"></div><h3 class="article-section__title" id="_i107"> Methyl 5-Oxo-6-((tetrahydro-2<i>H</i>-pyran-4-yl)methylene)-5,6,7,8-tetrahydronaphthalene-2-carboxylate (<b>25f</b>)</h3><div class="NLM_p last">A solution of methyl 5-oxo-5,6,7,8-tetrahydronaphthalene-2-carboxylate (2.9 mmol), tetrahydropyran-4-carbaldehyde (3.2 mmol), and piperidine (3.2 mmol) in 6 mL of methanol was heated to 65 °C overnight. The cooled mixture was diluted with ethyl acetate, washed with water and brine, dried over sodium sulfate, and concentrated. The residue was purified by silica gel chromatography (10−40% ethyl acetate/hexane) to give the desired product (430 mg, 49%). ES-MS <i>m</i>/<i>z</i> 301 (M + H).</div></div><div id="sec5_80" class="NLM_sec NLM_sec_level_2"><div id="ac_i108" class="anchor-spacer"></div><h3 class="article-section__title" id="_i108"> Methyl 3-(4-Fluorobenzylidene)-4-oxochroman-7-carboxylate (<b>25g</b>)</h3><div class="NLM_p last">The title compound was prepared from methyl 4-oxochroman-7-carboxylate and 4-fluorobenzaldehyde according to method B4 using methanol and 4 N hydrogen chloride/dioxane to give an off-white solid (76%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 3.88 (s, 3 H), 5.48 (s, 1 H), 7.35 (t, <i>J</i> = 8.59 Hz, 2 H), 7.50−7.61 (m, 3 H), 7.66 (d, <i>J</i> = 7.25 Hz, 1 H), 7.80 (s, 1 H), 8.01 (d, <i>J</i> = 8.06 Hz, 1 H).</div></div><div id="sec5_81" class="NLM_sec NLM_sec_level_2"><div id="ac_i109" class="anchor-spacer"></div><h3 class="article-section__title" id="_i109"> Methyl 3-(Cyclopentylmethylene)-4-oxochroman-7-carboxylate (<b>25h</b>)</h3><div class="NLM_p last">The title compound was prepared according to method B3 from methyl 4-oxochroman-7-carboxylate<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> and cyclopentanecarboxaldehyde as an off-white solid (2.12 g, 7.42 mmol, 76% yield). ES-MS <i>m</i>/<i>z</i> 287 (M + H).</div></div><div id="sec5_82" class="NLM_sec NLM_sec_level_2"><div id="ac_i110" class="anchor-spacer"></div><h3 class="article-section__title" id="_i110"> (±)-<i>cis</i>-2-(4-Cyanophenyl)-3-(4-fluorophenyl)-2,3,3a,4-tetrahydroindeno[1,2-<i>c</i>]pyrazole-6-carboxylic Acid (<b>27a</b>)</h3><div class="NLM_p last">A mixture of ethyl 1-oxo-2,3-dihydro-1<i>H</i>-indene-5-carboxylate (1.2 mmol) and 4-fluorobenzaldehyde (1.2 mmol) in 5 mL of EtOH containing 0.5 mL of concentrated H<sub>2</sub>SO<sub>4</sub> was heated to 80 °C overnight. After the mixture was cooled, the solid was filtered, washed with cold EtOH, and dried to give 285 mg of solid chalcone product (0.92 mmol, 77%). A mixture of the chalcone (0.42 mmol) and 4-cyanophenylhydrazine hydrochloride (0.42 mmol) in 4.2 mL of EtOH was heated to 80 °C overnight. The mixture was cooled, filtered, washed with cold EtOH, and dried. The solid was suspended in 6 mL of THF, 2 mL of MeOH, and 2 mL of 2.5 N NaOH and stirred at room temperature overnight. The mixture was concentrated and purified by reverse-phase chromatography (56 mg, 0.14 mmol, 34%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 2.00 (dd, <i>J</i> = 16.25, 7.65 Hz, 1 H), 3.06 (dd, <i>J</i> = 16.51, 9.26 Hz, 1 H), 4.43 (ddd, <i>J</i> = 11.01, 8.86, 7.79 Hz, 1 H), 6.03 (d, <i>J</i> = 11.01 Hz, 1 H), 6.98−7.18 (m, 6 H), 7.58 (d, <i>J</i> = 9.13 Hz, 2 H), 7.82 (d, <i>J</i> = 8.06 Hz, 1 H), 7.87 (s, 1 H), 7.93 (dd, <i>J</i> = 7.92, 1.48 Hz, 1 H), 13.10 (br s, 1 H). HRMS (C<sub>24</sub>H<sub>17</sub>FN<sub>3</sub>O<sub>2</sub>) calcd, 398.1299; found, 398.1303.</div></div><div id="sec5_83" class="NLM_sec NLM_sec_level_2"><div id="ac_i111" class="anchor-spacer"></div><h3 class="article-section__title" id="_i111"> (±)-(3<i>RS</i>,3a<i>RS</i>)-2-(4-Cyanophenyl)-3-(4-fluorophenyl)-3,3a,4,5-tetrahydro-2<i>H</i>-benzo[<i>g</i>]indazole-7-carboxylic Acid (<b>27b</b>)</h3><div class="NLM_p last">The title compound was prepared from <b>25a</b> (324 mg, 1.0 mmol) and 4-hydrazinylbenzonitrile hydrochloride (254 mg, 1.5 mmol) according to method C3 and method D as a solid (294 mg, 0.72 mmol, 72% yield). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 0.70−0.88 (m, 1 H), 1.74−1.84 (m, 1 H), 2.82−3.01 (m, 2 H), 3.86−3.99 (m, 1 H), 5.87 (d, <i>J</i> = 11.28 Hz, 1 H), 7.13 (s, 6 H), 7.57 (d, <i>J</i> = 9.14 Hz, 2 H), 7.74 (s, 1 H), 7.78−7.83 (m, 1 H), 8.05 (d, <i>J</i> = 8.33 Hz, 1 H). ES-MS <i>m</i>/<i>z</i> 412 (M + H).</div></div><div id="sec5_84" class="NLM_sec NLM_sec_level_2"><div id="ac_i112" class="anchor-spacer"></div><h3 class="article-section__title" id="_i112"> (±)-(3<i>RS</i>,3a<i>RS</i>)-Ethyl 2-(3-chloro-4-cyanophenyl)-3-(4-fluorophenyl)-3,3a,4,5-tetrahydro-2<i>H</i>-benzo[<i>g</i>]indazole-7-carboxylate (<b>26a</b>)</h3><div class="NLM_p last">The title compound was prepared from <b>25a</b> (324 mg, 1.0 mmol) and 2-chloro-4-hydrazinylbenzonitrile hydrochloride (306 mg, 1.5 mmol) according to method C3 as a yellow solid (394 mg, 0.830 mmol, 83% yield). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 0.80 (m, 1 H), 1.31 (t, <i>J</i> = 7.12 Hz, 3 H), 1.79 (m, 1 H), 2.95 (m, 2 H), 3.97 (ddd, <i>J</i> = 13.49, 11.21, 4.83 Hz, 1 H), 4.31 (q, <i>J</i> = 6.98 Hz, 2 H), 5.94 (d, <i>J</i> = 11.28 Hz, 1 H), 7.15 (m, 6 H), 7.66 (d, <i>J</i> = 8.86 Hz, 1 H), 7.80 (s, 1 H), 7.85 (dd, <i>J</i> = 8.19, 1.75 Hz, 1 H), 8.16 (d, <i>J</i> = 8.06 Hz, 1 H). ES-MS <i>m</i>/<i>z</i> 474 (M + H).</div></div><div id="sec5_85" class="NLM_sec NLM_sec_level_2"><div id="ac_i113" class="anchor-spacer"></div><h3 class="article-section__title" id="_i113"> (±)-(3<i>RS</i>,3a<i>RS</i>)-2-(3-Chloro-4-cyanophenyl)-3-(4-fluorophenyl)-3,3a,4,5-tetrahydro-2<i>H</i>-benzo[<i>g</i>]indazole-7-carboxylic Acid (<i><b>cis</b></i><b>-27c</b>)</h3><div class="NLM_p last">The title compound was prepared from <b>26a</b> (330 mg, 0.696 mmol) according to method D as a yellow solid (297 mg, 0.666 mmol, 96% yield). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 0.80 (m, 1 H), 1.79 (m, 1 H), 2.93 (m, 2 H), 3.96 (m, 1 H), 5.93 (d, <i>J</i> = 11.01 Hz, 1 H), 7.15 (m, 6 H), 7.66 (d, <i>J</i> = 8.59 Hz, 1 H), 7.78 (s, 1 H), 7.83 (dd, <i>J</i> = 8.19, 1.48 Hz, 1 H), 8.14 (d, <i>J</i> = 8.06 Hz, 1 H), 13.07 (s, 1 H). ES-MS <i>m</i>/<i>z</i> 446 (M + H).</div></div><div id="sec5_86" class="NLM_sec NLM_sec_level_2"><div id="ac_i114" class="anchor-spacer"></div><h3 class="article-section__title" id="_i114"> (3<i>R</i>,3a<i>R</i>)-2-(3-Chloro-4-cyanophenyl)-3-(4-fluorophenyl)-3,3a,4,5-tetrahydro-2<i>H</i>-benzo[<i>g</i>]indazole-7-carboxylic Acid (<b>3</b><i><b>R</b></i><b>,3a</b><i><b>R</b></i><b>-27c</b>)</h3><div class="NLM_p last">The title compound was obtained by chiral resolution of <b>(±)-</b><i><b>cis</b></i><b>-27c</b> (Chiralcel OJ-H 30 mm × 250 mm, 50% ethanol/carbon dioxide, 70 mL/min). First eluting peak: chiral HPLC <i>t</i><sub>R</sub> = 2.3 min (Chiralcel OJ-H 4.6 mm × 250 mm, 50% ethanol/carbon dioxide, 3 mL/min). Anal. (C<sub>25</sub>H<sub>17</sub>ClFN<sub>3</sub>O<sub>2</sub>) C, H, N.</div></div><div id="sec5_87" class="NLM_sec NLM_sec_level_2"><div id="ac_i115" class="anchor-spacer"></div><h3 class="article-section__title" id="_i115"> (3<i>S</i>,3a<i>S</i>)-2-(3-Chloro-4-cyanophenyl)-3-(4-fluorophenyl)-3,3a,4,5-tetrahydro-2<i>H</i>-benzo[<i>g</i>]indazole-7-carboxylic acid (<b>3</b><i><b>S</b></i><b>,3a</b><i><b>S</b></i><b>-27c</b>)</h3><div class="NLM_p last">The title compound was obtained by chiral resolution of <b>(±)-</b><i><b>cis</b></i><b>-27c</b> (Chiralcel OJ-H 30 mm × 250 mm, 50% ethanol/carbon dioxide, 70 mL/min). Second eluting peak: chiral HPLC <i>t</i><sub>R</sub> = 4.0 min (Chiralcel OJ-H 4.6 mm × 250 mm, 50% ethanol/carbon dioxide, 3 mL/min). Anal. (C<sub>25</sub>H<sub>17</sub>ClFN<sub>3</sub>O<sub>2</sub>·0.25H<sub>2</sub>O) Calcd: C, 66.01; H, 3.88; N, 9.24. Found: C, 66.36; H, 3.42; N, 9.02.</div></div><div id="sec5_88" class="NLM_sec NLM_sec_level_2"><div id="ac_i116" class="anchor-spacer"></div><h3 class="article-section__title" id="_i116"> (±)-(3<i>SR</i>,3a<i>RS</i>)-2-(3-Chloro-4-cyanophenyl)-3-cyclopentyl-3,3a,4,5-tetrahydro-2<i>H</i>-benzo[<i>g</i>]indazole-7-carboxylic Acid (<b>27d</b>)</h3><div class="NLM_p"><b>25b</b> (2.8 g, 9.9 mmol) was suspended in ethanol (100 mL), and <b>9a</b> (2.6 g, 12.8 mmol) was added. The solution was heated to 80 °C for 8 h. The solution was returned to ambient temperature. The resulting solid was collected by vacuum filtration and washed with cold ethanol to provide only the cis isomer of the methyl ester (3.75 g, 87% yield). ES-MS <i>m</i>/<i>z</i> 434 (M + H). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 1.06−1.54 (m, 6 H), 1.62−1.74 (m, 1 H), 1.73−1.87 (m, 1 H), 1.99−2.09 (m, 1 H), 2.21 (dd, <i>J</i> = 7.79, 2.15 Hz, 1 H), 2.82−2.94 (m, 2 H), 3.09 (d, <i>J</i> = 16.92 Hz, 1 H), 3.54−3.66 (m, 1 H), 3.84 (s, 3 H), 4.95 (dd, <i>J</i> = 9.67, 5.64 Hz, 1 H), 7.19 (dd, <i>J</i> = 9.26, 1.75 Hz, 1 H), 7.39 (d, <i>J</i> = 2.15 Hz, 1 H), 7.67 (d, <i>J</i> = 8.86 Hz, 1 H), 7.82 (d, <i>J</i> = 8.32 Hz, 1 H), 7.86 (s, 1 H), 8.10 (d, <i>J</i> = 8.06 Hz, 1 H).</div><div class="NLM_p last">To a solution of the methyl ester (3.75 g, 8.6 mmol) in methanol (10 mL) and tetrahydrofuran (30 mL) was added 10% aqueous sodium hydroxide (10 mL). The solution was stirred for 20 h at ambient temperature. The resulting slurry was concentrated to half volume and acidified to pH 2 with 1 M hydrochloric acid. The resulting solid was collected by vacuum filtration to provide <b>(±)-27d</b> as a yellow solid (3.79 g, quantitative yield). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 1.10−1.55 (m, 6 H), 1.64−1.75 (m, 2 H), 1.75−1.87 (m, 1 H), 1.99−2.09 (m, 1 H), 2.15−2.23 (m, 1 H), 2.78−2.91 (m, 2 H), 3.00 (d, <i>J</i> = 16.11 Hz, 1 H), 4.89 (dd, <i>J</i> = 9.26, 5.77 Hz, 1 H), 7.14 (dd, <i>J</i> = 9.00, 1.75 Hz, 1 H), 7.34 (d, <i>J</i> = 1.88 Hz, 1 H), 7.63 (d, <i>J</i> = 8.86 Hz, 1 H), 7.73 (s, 1 H), 7.76 (s, 1 H), 7.94 (d, <i>J</i> = 7.79 Hz, 1 H). ES-MS <i>m</i>/<i>z</i> 420 (M + H). HRMS (C<sub>24</sub>H<sub>22</sub>ClN<sub>3</sub>O<sub>2</sub>) calcd, 420.1473; found, 420.1449. Anal. (C<sub>24</sub>H<sub>22</sub>ClN<sub>3</sub>O<sub>2</sub>) C, H, N.</div></div><div id="sec5_89" class="NLM_sec NLM_sec_level_2"><div id="ac_i117" class="anchor-spacer"></div><h3 class="article-section__title" id="_i117"> (3<i>S</i>,3a<i>R</i>)-2-(3-Chloro-4-cyanophenyl)-3-cyclopentyl-3,3a,4,5-tetrahydro-2<i>H</i>-benzo[<i>g</i>]indazole-7-carboxylic Acid (<b>3</b><i><b>S</b></i><b>,3a</b><i><b>R</b></i><b>-27d</b>)</h3><div class="NLM_p last">The title compound was obtained by chiral resolution of <b>(±)-27d</b> (Chiralpak AD-H 21 mm × 250 mm, 50% <i>n-</i>butanol/carbon dioxide, 50 mL/min). Second eluting peak: chiral HPLC <i>t</i><sub>R</sub> = 4.0 min (Chiralpak AD-H 4.6 mm × 250 mm, 50% <i>n-</i>butanol/carbon dioxide, 3 mL/min).</div></div><div id="sec5_90" class="NLM_sec NLM_sec_level_2"><div id="ac_i118" class="anchor-spacer"></div><h3 class="article-section__title" id="_i118"> (±)-(3<i>RS</i>,3a<i>SR</i>)-2-(3-Chloro-4-cyanophenyl)-3-cyclobutyl-3,3a,4,5-tetrahydro-2<i>H</i>-benzo[<i>g</i>]indazole-7-carboxylic Acid (<b>27e</b>)</h3><div class="NLM_p last">The title compound was prepared according to method C3 and method D from <b>25c</b> and <b>9a</b> to give only the cis diastereomer (150 mg, 0.36 mmol, 65% yield) as a yellow solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 1.56−1.77 (m, 4 H), 1.77−1.98 (m, 3 H), 2.07−2.18 (m, 1 H), 2.51−2.59 (m, 1 H), 2.80−2.93 (m, 1 H), 2.97−3.07 (m, 1 H), 3.44−3.56 (m, 1 H), 4.88 (dd, <i>J</i> = 9.40, 6.98 Hz, 1 H), 7.22 (dd, <i>J</i> = 8.86, 1.88 Hz, 1 H), 7.42 (d, <i>J</i> = 2.15 Hz, 1 H), 7.67 (d, <i>J</i> = 8.86 Hz, 1 H), 7.75−7.83 (m, 2 H), 8.01 (d, <i>J</i> = 8.06 Hz, 1 H). ES-MS <i>m</i>/<i>z</i> 420 (M + H).</div></div><div id="sec5_91" class="NLM_sec NLM_sec_level_2"><div id="ac_i119" class="anchor-spacer"></div><h3 class="article-section__title" id="_i119"> (±)-(3<i>RS</i>,3a<i>RS</i>)-2-(3-Chloro-4-cyanophenyl)-3-cyclopentenyl-3,3a,4,5-tetrahydro-2<i>H</i>-benzo[<i>g</i>]indazole-7-carboxylic Acid (<b>27f</b>)</h3><div class="NLM_p last">The title compound was prepared from <b>25d</b> (268 mg, 1.0 mmol) and <b>9a</b> (303 mg, 1.5 mmol) according to method C3 and method D (20%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 1.52 (dd, <i>J</i> = 13.09, 5.67 Hz, 1 H), 1.73 (dt, <i>J</i> = 17.59, 6.64 Hz, 2 H), 1.85 (m, 1 H), 1.90−2.00 (m, 1H), 2.07 (s, 1 H), 2.10 (dt, <i>J</i> = 5.86, 3.71 Hz, 1 H), 2.22 (br s, 2 H), 2.99−3.06 (m, 2H), 3.71−3.77 (m, 1H), 5.48 (d, <i>J</i> = 10.55 Hz, 1 H), 5.69 (br s, 1 H), 7.72 (d, <i>J</i> = 8.60 Hz, 1 H), 7.83 (d, <i>J</i> = 8.21 Hz, 1 H), 7.85 (s, 1 H), 8.09 (d, <i>J</i> = 8.21 Hz, 1 H). ES-MS <i>m</i>/<i>z</i> 418 (M + H). HRMS (C<sub>24</sub>H<sub>21</sub>ClN<sub>3</sub>O<sub>2</sub>) calcd, 418.1317; found, 418.1298.</div></div><div id="sec5_92" class="NLM_sec NLM_sec_level_2"><div id="ac_i120" class="anchor-spacer"></div><h3 class="article-section__title" id="_i120"> (±)-(3<i>RS</i>,3a<i>RS</i>)-2-(3-Chloro-4-cyanophenyl)-3-((<i>R</i>)-tetrahydrofuran-3-yl)-3,3a,4,5-tetrahydro-2<i>H</i>-benzo[<i>g</i>]indazole-7-carboxylic Acid and (±)-(3<i>RS</i>,3a<i>RS</i>)-2-(3-Chloro-4-cyanophenyl)-3-((<i>S</i>)-tetrahydrofuran-3-yl)-3,3a,4,5-tetrahydro-2<i>H</i>-benzo[<i>g</i>]indazole-7-carboxylic Acid (<b>27g</b>)</h3><div class="NLM_p last">The title compounds were prepared as a mixture of diastereomers according to method C3 and method D from <b>25e</b> and <b>9a</b> as a yellow solid (167 mg, quantitative yield). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 1.51−1.99 (m, 3 H), 2.11−2.27 (m, 1 H), 2.91 (dd, <i>J</i> = 12.35, 4.03 Hz, 1 H), 3.03−3.13 (m, 1 H), 3.38−3.47 (m, 1 H), 3.49−3.57 (m, 1 H), 3.58−3.69 (m, 1 H), 3.73 (t, <i>J</i> = 8.06 Hz, 1 H), 3.77−3.85 (m, 1 H), 4.75−4.83 (m, 1 H), 4.99 (dd, <i>J</i> = 9.40, 6.71 Hz, 1 H), 7.18 (td, <i>J</i> = 8.59, 2.15 Hz, 1 H), 7.39 (dd, <i>J</i> = 18.80, 2.15 Hz, 1 H), 7.69 (dd, <i>J</i> = 8.86, 5.10 Hz, 1 H), 7.80 (d, <i>J</i> = 8.06 Hz, 1 H), 7.84 (s, 1 H), 8.08 (d, <i>J</i> = 8.32 Hz, 1 H), 13.07 (br s, 1 H). ES-MS <i>m</i>/<i>z</i> 422 (M + H). HRMS (C<sub>23</sub>H<sub>20</sub>ClN<sub>3</sub>O<sub>3</sub>) calcd, 422.1266; found, 422.1257.</div></div><div id="sec5_93" class="NLM_sec NLM_sec_level_2"><div id="ac_i121" class="anchor-spacer"></div><h3 class="article-section__title" id="_i121"> (±)-(3<i>SR</i>,3a<i>RS</i>)-2-(3-Chloro-4-cyanophenyl)-3-(tetrahydro-2<i>H</i>-pyran-4-yl)-3,3a,4,5-tetrahydro-2<i>H</i>-benzo[<i>g</i>]indazole-7-carboxylic Acid (<b>27h</b>)</h3><div class="NLM_p last">The title compound was prepared from <b>25f</b> and <b>9a</b> according to method C3 and method D (250 mg, 0.57 mmol). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 1.24−1.33 (m, 2 H), 1.40 (ddd, <i>J</i> = 24.57, 12.08, 4.70 Hz, 1 H), 1.50−1.57 (m, 1 H), 1.86−1.99 (m, 2 H), 2.25−2.32 (m, 1 H), 2.85−2.95 (m, 1 H), 3.07−3.20 (m, 3 H), 3.61−3.79 (m, 3 H), 4.83 (dd, <i>J</i> = 9.67, 3.76 Hz, 1 H), 7.21 (d, <i>J</i> = 8.86 Hz, 1 H), 7.44 (d, <i>J</i> = 1.61 Hz, 1 H), 7.71 (d, <i>J</i> = 8.59 Hz, 1 H), 7.83 (dd, <i>J</i> = 8.32, 1.34 Hz, 1 H), 7.87 (s, 1 H), 8.09 (d, <i>J</i> = 8.32 Hz, 1 H), 13.07 (s, 1 H). HRMS <i>m</i>/<i>z</i> 436.1445 (M + H).</div></div><div id="sec5_94" class="NLM_sec NLM_sec_level_2"><div id="ac_i122" class="anchor-spacer"></div><h3 class="article-section__title" id="_i122"> (±)-(3<i>SR</i>,3a<i>RS</i>)-2-(4-Cyanophenyl)-3-cyclopentyl-3,3a,4,5-tetrahydro-2<i>H</i>-benzo[<i>g</i>]indazole-7-carboxylic Acid (<b>27i</b>)</h3><div class="NLM_p last">The title compound was prepared from <b>25b</b> and 4-hydrazinylbenzonitrile hydrochloride according to method C3 and method D (205 mg, 0.53 mmol). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 1.18−1.54 (m, 7 H), 1.65−1.74 (m, 1 H), 1.77−1.89 (m, 1 H), 2.04−2.12 (m, 1 H), 2.20−2.28 (m, 1 H), 2.83−2.95 (m, 1 H), 3.05−3.14 (m, 1 H), 3.55−3.63 (m, 1 H), 4.91 (dd, <i>J</i> = 9.53, 5.50 Hz, 1 H), 7.29 (d, <i>J</i> = 8.86 Hz, 2 H), 7.60 (d, <i>J</i> = 8.86 Hz, 2 H), 7.82 (dd, <i>J</i> = 8.19, 1.48 Hz, 1 H), 7.86 (s, 1 H), 8.06 (d, <i>J</i> = 8.06 Hz, 1 H), 12.99 (br s, 1 H). HRMS <i>m</i>/<i>z</i> 386.1838 (M + H).</div></div><div id="sec5_95" class="NLM_sec NLM_sec_level_2"><div id="ac_i123" class="anchor-spacer"></div><h3 class="article-section__title" id="_i123"> (3<i>S</i>,3a<i>R</i>)-2-(4-Cyanophenyl)-3-cyclopentyl-3,3a,4,5-tetrahydro-2<i>H</i>-benzo[<i>g</i>]indazole-7-carboxylic Acid (<b>3</b><i><b>S</b></i><b>,3a</b><i><b>R</b></i><b>-27i</b>)</h3><div class="NLM_p last">The title compound was obtained by chiral resolution of <b>(±)-27i</b> (Chiralcel OJ-H 21 mm × 250 mm, 50% methanol/carbon dioxide, 50 mL/min). First eluting peak: chiral HPLC <i>t</i><sub>R</sub> = 3.6 min (Chiralcel OJ-H 4.6 mm × 250 mm, 50% methanol/carbon dioxide, 3 mL/min).</div></div><div id="sec5_96" class="NLM_sec NLM_sec_level_2"><div id="ac_i124" class="anchor-spacer"></div><h3 class="article-section__title" id="_i124"> (±)-(3<i>SR</i>,3a<i>RS</i>)-2-(4-Cyano-3-methylphenyl)-3-cyclopentyl-3,3a,4,5-tetrahydro-2<i>H</i>-benzo[<i>g</i>]indazole-7-carboxylic Acid (<b>27j</b>)</h3><div class="NLM_p last">The title compound was prepared from <b>25b</b> (310.5 mg, 1.09 mmol) and <b>9c</b> (265 mg, 1.45 mmol) according to method C3 and method D (hydrolysis conducted at 60 °C). The crude precipitate was purified by reverse phase chromatography with 60−95% acetonitrile/water to give the title compound as a yellow solid (280 mg, 0.563 mmol, 64% yield). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 1.12−1.56 (m, 7 H), 1.64−1.74 (m, 1 H), 1.76−1.92 (m, <i>J</i> = 12.89, 4.30 Hz, 1 H), 2.01−2.14 (m, 1 H), 2.18−2.29 (m, 1 H), 2.41 (s, 3 H), 2.81−2.96 (m, 1 H), 3.04−3.14 (m, 1 H), 3.51−3.63 (m, 1 H), 4.89 (dd, <i>J</i> = 9.67, 5.37 Hz, 1 H), 7.09 (dd, <i>J</i> = 8.59, 2.15 Hz, 1 H), 7.22 (d, <i>J</i> = 1.88 Hz, 1 H), 7.52 (d, <i>J</i> = 8.59 Hz, 1 H), 7.82 (dd, <i>J</i> = 8.19, 1.48 Hz, 1 H), 7.85 (s, 1 H), 8.07 (d, <i>J</i> = 8.06 Hz, 1 H), 13.01 (s, 1 H). ES-MS <i>m</i>/<i>z</i> 400 (M + H).</div></div><div id="sec5_97" class="NLM_sec NLM_sec_level_2"><div id="ac_i125" class="anchor-spacer"></div><h3 class="article-section__title" id="_i125"> (±)-(3<i>SR</i>,3a<i>RS</i>)-2-(4-Cyano-3-methoxyphenyl)-3-cyclopentyl-3,3a,4,5-tetrahydro-2<i>H</i>-benzo[<i>g</i>]indazole-7-carboxylic Acid (<b>27k</b>)</h3><div class="NLM_p last">The title compound was prepared from <b>25b</b> (310 mg, 1.09 mmol) and <b>9f</b> (282 mg, 1.42 mmol) according to method C3 (methanol was used in place of ethanol as solvent) and method D. The crude precipitate was purified by reverse phase chromatography with 40−95% acetonitrile/water to give the title compound as a yellow solid (220 mg, 0.53 mmol, 49% yield). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 1.34 (m, 7 H), 1.65−1.90 (m, 2 H), 1.99−2.12 (m, 1 H), 2.18−2.27 (m, 1 H), 2.82−2.95 (m, 1 H), 3.04−3.13 (m, 1 H), 3.52−3.63 (m, 1 H), 3.90 (s, 3 H), 4.94 (dd, <i>J</i> = 9.67, 5.37 Hz, 1 H), 6.80 (dd, <i>J</i> = 8.59, 1.88 Hz, 1 H), 6.90 (d, <i>J</i> = 1.61 Hz, 1 H), 7.45 (d, <i>J</i> = 8.59 Hz, 1 H), 7.81 (dd, <i>J</i> = 8.19, 1.48 Hz, 1 H), 7.85 (s, 1 H), 8.08 (d, <i>J</i> = 8.06 Hz, 1 H), 13.02 (s, 1 H). ES-MS <i>m</i>/<i>z</i> 416 (M + H). Anal. (C<sub>25</sub>H<sub>25</sub>N<sub>3</sub>O<sub>3</sub>) C, H, N.</div></div><div id="sec5_98" class="NLM_sec NLM_sec_level_2"><div id="ac_i126" class="anchor-spacer"></div><h3 class="article-section__title" id="_i126"> (±)-(3<i>RS</i>,3a<i>SR</i>)-2-(4-Cyano-3-(methoxymethyl)phenyl)-3-cyclopentyl-3,3a,4,5-tetrahydro-2<i>H</i>-benzo[<i>g</i>]indazole-7-carboxylic Acid (<b>27l</b>)</h3><div class="NLM_p last">A mixture of <b>9g</b>, <b>25b</b> (209 mg, 0.73 mmol), and ethanol (4 mL) was stirred under argon at 80 °C for 4 h. The mixture was cooled to room temperature and concentrated to give the pyrazoline ester as a yellow solid. The ester was suspended in tetrahydrofuran (4 mL), methanol (1 mL) and treated with 2.5 N sodium hydroxide (1 mL) at room temperature. After 4 h the mixture was concentrated to half the original volume, treated with 6 N hydrogen chloride (2 mL), dimethyl sulfoxide (24 mL) and purified by reversed-phase HPLC (acetonitrile/water/0.05% trifluoroacetic acid) to give the title compound (65 mg, 0.015 mmol, 18%) as a yellow-orange solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 13.04 (s, 1 H), 8.07 (d, <i>J</i> = 8.06 Hz, 1 H), 7.80−7.87 (m, 2 H), 7.60 (d, <i>J</i> = 8.86 Hz, 1 H), 7.35 (d, <i>J</i> = 2.15 Hz, 1 H), 7.18 (dd, <i>J</i> = 8.86, 2.15 Hz, 1 H), 4.92 (dd, <i>J</i> = 9.80, 5.51 Hz, 1 H), 4.50 (s, 2 H), 3.59 (ddd, <i>J</i> = 13.83, 9.40, 4.70 Hz, 1 H), 3.36 (s, 3 H), 3.06−3.15 (m, 1 H), 2.82−2.96 (m, 1 H), 2.19−2.29 (m, 1 H), 2.00−2.13 (m, 1 H), 1.65−1.89 (m, 2 H), 1.14−1.54 (m, 7 H). ES-MS <i>m</i>/<i>z</i> 430 (M + H).</div></div><div id="sec5_99" class="NLM_sec NLM_sec_level_2"><div id="ac_i127" class="anchor-spacer"></div><h3 class="article-section__title" id="_i127"> (±)-(3<i>RS</i>,3a<i>SR</i>)-2-(3-(Benzyloxy)-4-cyanophenyl)-3-cyclopentyl-3,3a,4,5-tetrahydro-2<i>H</i>-benzo[<i>g</i>]indazole-7-carboxylic Acid (<b>27m</b>)</h3><div class="NLM_p last">The title compound was obtained from <b>25b</b> and <b>9h</b> according to method C3 followed by method D as a yellow-orange solid (90 mg, 0.18 mmol, 93% yield). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 1.03−1.51 (m, 7 H), 1.57−1.69 (m, 1 H), 1.74−1.89 (m, 1 H), 1.95−2.07 (m, 1 H), 2.18−2.29 (m, 1 H), 2.82−2.96 (m, 1 H), 3.03−3.14 (m, 1 H), 3.57 (ddd, <i>J</i> = 13.70, 9.40, 4.30 Hz, 1 H), 4.91 (dd, <i>J</i> = 9.53, 5.50 Hz, 1 H), 5.31 (q, <i>J</i> = 12.35 Hz, 2 H), 6.84 (d, <i>J</i> = 8.86 Hz, 1 H), 6.96 (s, 1 H), 7.35 (t, <i>J</i> = 7.25 Hz, 1 H), 7.40−7.53 (m, 5 H), 7.81−7.88 (m, 2 H), 8.09 (d, <i>J</i> = 8.06 Hz, 1 H), 13.03 (s, 1 H). ES-MS <i>m</i>/<i>z</i> 492 (M + H).</div></div><div id="sec5_100" class="NLM_sec NLM_sec_level_2"><div id="ac_i128" class="anchor-spacer"></div><h3 class="article-section__title" id="_i128"> (±)-(3<i>RS</i>,3a<i>SR</i>)-Methyl 2-(3-(Benzyloxy)-4-cyanophenyl)-3-cyclopentyl-3,3a,4,5-tetrahydro-2<i>H</i>-benzo[<i>g</i>]indazole-7-carboxylate (<b>27n</b>)</h3><div class="NLM_p last">A mixture of <b>27m</b> (70 mg, 0.14 mmol), ethyl acetate, tetrahydrofuran, and methanol was treated with 10% palladium on carbon (10 mg) and hydrogenated for 4 h at 30 psi of hydrogen. The mixture was filtered through Celite and concentrated to give the title compound (57 mg, 0.14 mmol, quant) as a yellow solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 1.10−1.58 (m, 8 H), 1.61−1.75 (m, 1 H), 1.74−1.90 (m, 1 H), 2.00−2.12 (m, 1 H), 2.16−2.30 (m, 1 H), 2.79−2.96 (m, 1 H), 3.09 (d, <i>J</i> = 16.11 Hz, 1 H), 3.57 (ddd, <i>J</i> = 13.76, 9.47, 4.70 Hz, 1 H), 4.76 (dd, <i>J</i> = 9.67, 5.37 Hz, 1 H), 6.69 (dd, <i>J</i> = 8.86, 1.61 Hz, 1 H), 6.82 (s, 1 H), 7.36 (d, <i>J</i> = 8.59 Hz, 1 H), 7.82−7.90 (m, 2 H), 8.00 (d, <i>J</i> = 8.06 Hz, 1 H), 10.70 (s, 1 H). ES-MS <i>m</i>/<i>z</i> 402 (M + H).</div></div><div id="sec5_101" class="NLM_sec NLM_sec_level_2"><div id="ac_i129" class="anchor-spacer"></div><h3 class="article-section__title" id="_i129"> (±)-(3<i>SR</i>,3a<i>SR</i>)-2-(3-Chloro-4-cyanophenyl)-3-(4-fluorophenyl)-2,3,3a,4-tetrahydrochromeno[4,3-<i>c</i>]pyrazole-7-carboxylic Acid (<b>27o</b>)</h3><div class="NLM_p last">The title compound was prepared from <b>25g</b> (155 mg, 0.50 mmol) and <b>9a</b> (153 mg, 0.75 mmol) according to method C3 and method D. The crude product was purified by reverse-phase HPLC (acetonitrile/water/0.05% trifluoroacetic acid) to give the title compound (41 mg, 0.09 mmol, 18%). ES-MS <i>m</i>/<i>z</i> 448 (M + H). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 3.16 (dd, <i>J</i> = 12.9, 10.5 Hz, 1 H), 4.20−4.31 (m, 1 H), 4.38 (dd, <i>J</i> = 10.5, 5.9 Hz, 1 H), 5.96 (d, <i>J</i> = 11.5 Hz, 1 H), 6.95−7.26 (m, 5 H), 7.39 (d, <i>J</i> = 1.6 Hz, 1 H), 7.55−7.63 (m, 3 H), 7.98 (d, <i>J</i> = 8.1 Hz, 1 H), 13.17 (s, 1 H).</div></div><div id="sec5_102" class="NLM_sec NLM_sec_level_2"><div id="ac_i130" class="anchor-spacer"></div><h3 class="article-section__title" id="_i130"> (±)-(3<i>RS</i>,3a<i>SR</i>)-2-(3-Chloro-4-cyanophenyl)-3-cyclopentyl-2,3,3a,4-tetrahydrochromeno[4,3-<i>c</i>]pyrazole-7-carboxylic Acid (<i><b>cis</b></i><b>-27p</b>)</h3><div class="NLM_p last">The title compound was prepared from <b>25h</b> (573 mg, 2.0 mmol) and <b>9a</b> (612 mg, 3.0 mmol) according to method C3 and method D. The crude precipitate was recrystallized from dimethylformamide and methanol to give the title compound as yellow crystals (237 mg, 0.563 mmol, 28% yield). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 13.20 (s, 1 H), 7.98 (d, <i>J</i> = 8.2 Hz, 1 H), 7.70 (d, <i>J</i> = 9.0 Hz, 1 H), 7.58 (dd, <i>J</i> = 8.2, 1.6 Hz, 1 H), 7.47 (d, <i>J</i> = 1.2 Hz, 1 H), 7.41 (d, <i>J</i> = 2.0 Hz, 1 H), 7.20 (dd, <i>J</i> = 8.8, 2.1 Hz, 1 H), 4.95 (dd, <i>J</i> = 9.4, 7.0 Hz, 1 H), 4.78 (dd, <i>J</i> = 10.2, 5.9 Hz, 1 H), 4.31 (dd, <i>J</i> = 13.3, 10.5 Hz, 1 H), 4.00 (ddd, <i>J</i> = 13.2, 9.7, 5.7 Hz, 1 H), 2.03−2.16 (m, 1 H), 1.13−1.68 (m, 8 H). ES-MS <i>m</i>/<i>z</i> 422 (M + H).</div></div><div id="sec5_103" class="NLM_sec NLM_sec_level_2"><div id="ac_i131" class="anchor-spacer"></div><h3 class="article-section__title" id="_i131"> (±)-(3<i>RS</i>,3a<i>RS</i>)-2-(3-Chloro-4-cyanophenyl)-3-cyclopentyl-2,3,3a,4-tetrahydrochromeno[4,3-<i>c</i>]pyrazole-7-carboxylic Acid (<i><b>trans</b></i><b>-27p</b>)</h3><div class="NLM_p last">The title compound was prepared by epimerization of <i><b>cis</b></i><b>-27p</b> (131 mg) in a solution of 0.5 M sodium methoxide/methanol (4 mL) and tetrahydrofuran (2 mL) at 50 °C. After 24 h, the mixture was concentrated under a stream of nitrogen and purified by reverse-phase HPLC (60 to 90% acetonitrile/water/0.05% trifluoroacetic acid) to give the trans diastereomer of the title compound as a yellow solid (26.7 mg, 0.0634 mmol, 20% yield). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 13.16 (br s, 1 H), 7.82 (d, <i>J</i> = 8.2 Hz, 1 H), 7.75 (d, <i>J</i> = 9.0 Hz, 1 H), 7.56 (dd, <i>J</i> = 7.8, 1.6 Hz, 1 H), 7.43 (d, <i>J</i> = 1.6 Hz, 1 H), 7.38 (d, <i>J</i> = 2.3 Hz, 1 H), 7.18 (dd, <i>J</i> = 9.0, 2.3 Hz, 1 H), 4.63 (dd, <i>J</i> = 10.5, 5.9 Hz, 1 H), 4.52 (dd, <i>J</i> = 8.2, 4.7 Hz, 1 H), 4.26 (dd, <i>J</i> = 12.5, 10.5 Hz, 1 H), 3.54−3.62 (m, 1 H), 2.68−2.85 (m, 1 H), 1.79−1.91 (m, 1 H), 1.20−1.71 (m, 7 H). ES-MS <i>m</i>/<i>z</i> 422 (M + H). Anal. (C<sub>23</sub>H<sub>20</sub>ClN<sub>3</sub>O<sub>3</sub>·0.2H<sub>2</sub>O) C, H, N.</div></div><div id="sec5_104" class="NLM_sec NLM_sec_level_2"><div id="ac_i132" class="anchor-spacer"></div><h3 class="article-section__title" id="_i132"> (±)-(3<i>RS</i>,3a<i>SR</i>)-2-(4-Cyano-3-methylphenyl)-3-cyclopentyl-2,3,3a,4-tetrahydrochromeno[4,3-<i>c</i>]pyrazole-7-carboxylic Acid (<b>27q</b>)</h3><div class="NLM_p last">The title compound was prepared according to method C3 and method D from <b>25h</b> and <b>9c</b> to give only the cis diastereomer as a yellow solid (301 mg, 0.751 mmol, 75% yield). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 13.15 (s, 1 H), 7.94 (d, <i>J</i> = 8.2 Hz, 1 H), 7.58 (dd, <i>J</i> = 8.2, 1.6 Hz, 1 H), 7.53 (d, <i>J</i> = 9.0 Hz, 1 H), 7.46 (d, <i>J</i> = 1.6 Hz, 1 H), 7.21 (d, <i>J</i> = 2.0 Hz, 1 H), 7.08 (dd, <i>J</i> = 8.8, 2.1 Hz, 1 H), 4.89 (dd, <i>J</i> = 9.8, 7.0 Hz, 1 H), 4.78 (dd, <i>J</i> = 10.2, 5.9 Hz, 1 H), 4.30 (dd, <i>J</i> = 12.9, 10.5 Hz, 1 H), 3.97 (ddd, <i>J</i> = 13.0, 9.9, 5.7 Hz, 1 H), 2.41 (s, 3 H), 2.01−2.16 (m, 1 H), 1.13−1.67 (m, 8 H). ES-MS <i>m</i>/<i>z</i> 402 (M + H). Anal. (C<sub>24</sub>H<sub>23</sub>N<sub>3</sub>O<sub>3</sub>) Calcd: C, 71.80; H, 5.78; N, 10.47. Found: C, 71.90; H, 5.28; N, 10.19.</div></div><div id="sec5_105" class="NLM_sec NLM_sec_level_2"><div id="ac_i133" class="anchor-spacer"></div><h3 class="article-section__title" id="_i133"> (3<i>S</i>,3a<i>R</i>)-2-(4-Cyano-3-methylphenyl)-3-cyclopentyl-2,3,3a,4-tetrahydrochromeno[4,3-<i>c</i>]pyrazole-7-carboxylic Acid (<b>3</b><i><b>S</b></i><b>,3a</b><i><b>R</b></i><b>-27q</b>)</h3><div class="NLM_p last">The title compound was obtained by chiral resolution of <b>(±)-27q</b> (Chiralcel OJ-H 30 mm × 250 mm, 50% methanol/carbon dioxide, 70 mL/min). First eluting peak: chiral HPLC <i>t</i><sub>R</sub> = 3.2 min (Chiralcel OJ-H 4.6 mm × 250 mm, 50% methanol/carbon dioxide, 3 mL/min).</div></div><div id="sec5_106" class="NLM_sec NLM_sec_level_2"><div id="ac_i134" class="anchor-spacer"></div><h3 class="article-section__title" id="_i134"> (3<i>S</i>,3a<i>R</i>)-Methyl 2-(3-Chloro-4-cyanophenyl)-3-cyclopentyl-3,3a,4,5-tetrahydro-2<i>H</i>-benzo[<i>g</i>]indazole-7-carboxylate (<b>28</b>)</h3><div class="NLM_p last">A solution of (trimethylsilyl)diazomethane (2.0 M in diethyl ether, 0.286 mL, 0.572 mmol) was added to a solution of <b>3</b><i><b>S</b></i><b>,3a</b><i><b>R</b></i><b>-27d</b> (200 mg, 0.476 mmol) in tetrahydrofuran (3 mL) and methanol (1 mL). After 90 min, the mixture was concentrated to give the crude methyl ester as a yellow solid (217 mg, quant.). ES-MS <i>m</i>/<i>z</i> 434 (M + H).</div></div><div id="sec5_107" class="NLM_sec NLM_sec_level_2"><div id="ac_i135" class="anchor-spacer"></div><h3 class="article-section__title" id="_i135"> (3<i>S</i>,3a<i>R</i>)-2-(3-Chloro-4-cyanophenyl)-3-cyclopentyl-3a-methyl-3,3a,4,5-tetrahydro-2<i>H</i>-benzo[<i>g</i>]indazole-7-carboxylic Acid (<b>3</b><i><b>S</b></i><b>,3a</b><i><b>R</b></i><b>-29</b>)</h3><div class="NLM_p last">To a solution of diisopropylamine (0.0772 mL, 0.551 mmol) in tetrahydrofuran (1.5 mL) at −78 °C was added <i>n-</i>butyllithium (2.5 M in hexanes, 0.206 mL, 0.514 mmol). After 10 min, a solution of <b>28</b> (159 mg, 0.367 mmol) in tetrahydrofuran (3.0 mL) was added dropwise. After 1 h at −78 °C, iodomethane (0.0343 mL, 0.551 mmol) was added. The mixture was kept at −78 °C and monitored by LCMS. After 2 h, another 0.015 mL of iodomethane was added. Lithium hexamethyldisilazide (1.0 M in tetrahydrofuran, 0.100 mL, 0.100 mmol) was added, followed by another 0.015 mL iodomethane. The mixture was allowed to slowly warm to room temperature overnight. The mixture was treated with 0.5 mL of methanol and 0.5 mL of 2.5 N NaOH. After 4 h, the reaction mixture was neutralized with 0.5 mL of 3 N hydrogen chloride and concentrated under a stream of nitrogen. The residue was dissolved in dimethylformamide/methanol, filtered through a syringe filter, and purified by reverse-phase HPLC (60−95% acetonitrile/water/0.05% trifluoroacetic acid) to give the title compound as a yellow solid and a single stereoisomer (48.6 mg, 0.112 mmol, 30.5% yield). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 13.06 (br s, 1 H), 8.10 (d, <i>J</i> = 8.2 Hz, 1 H), 7.87 (s, 1 H), 7.81 (d, <i>J</i> = 7.8 Hz, 1 H), 7.69 (d, <i>J</i> = 9.0 Hz, 1 H), 7.43 (s, 1 H), 7.23 (d, <i>J</i> = 9.0 Hz, 1 H), 4.57 (d, <i>J</i> = 5.9 Hz, 1 H), 3.01−3.10 (m, 2 H), 1.91−2.11 (m, 3 H), 1.71−1.82 (m, 1 H), 1.09−1.56 (m, 7 H), 1.06 (s, 3 H). ES-MS <i>m</i>/<i>z</i> 434 (M + H). HPLC purity 85%.</div></div><div id="sec6" class="NLM_sec NLM_sec_level_2"><div id="ac_i136" class="anchor-spacer"></div><h3 class="article-section__title" id="_i136"> Biological Assays</h3><div id="sec6_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i137" class="anchor-spacer"></div><h4 class="article-section__title" id="_i137"> Cell-Based Gal4 Response Element-Controlled Luciferase Reporter Assays</h4><div id="sec6_1_1" class="NLM_sec NLM_sec_level_4"><div id="ac_i138" class="anchor-spacer"></div><h5 class="article-section__title" id="_i138"> MR Luciferase Reporter Antagonist Assay</h5><div class="NLM_p last">HUH7 human hepatocyte cells were maintained in RPMI 1640 plus 10% FBS and transfected with Gal4-MRLBD construct and a luciferase reporter under Gal4 control. After transfection, compounds were added in RPMI 1640 media plus 10% heat-inactivated and charcoal dextran stripped FBS (Hyclone) with and without 1 nM aldosterone. Cells were harvested 20 h later for reporter activity as previously described.<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> IC<sub>50</sub> values were obtained through curve-fitting of dose response plots (<i>n</i> ≥ 3/concentration, 6−10 concentrations) using the four-parameter logistic model. Standard error of the IC<sub>50</sub> was generally less than 30%. Selectivity against other steroid receptors were assayed in the same manner using Gal4-driven luciferase as reporter.</div></div><div id="sec6_1_2" class="NLM_sec NLM_sec_level_4"><div id="ac_i139" class="anchor-spacer"></div><h5 class="article-section__title" id="_i139"> Radioligand Binding Assay</h5><div class="NLM_p last">Test compound affinity was expressed as IC<sub>50</sub> value, defined as the concentration of test compound required to decrease [<sup>3</sup>H]aldosterone binding by 50%. MR binding assays were performed in a final volume of 50 μL containing 1 nM MR (GST-LBD fusion, expressed in SF9 insect cells) and 1 nM [<sup>3</sup>H]aldosterone (PerkinElmer, NET419) plus varying concentrations of test compound or vehicle. Briefly, assays were prepared at 4 °C in 384-well plate (Costar, 3657) containing 1 μL of test compound in DMSO (or DMSO as vehicle). Assays were initiated by addition of 24 μL of 2 nM [<sup>3</sup>H]aldosterone followed by 25 μL of 2 nM GST-MR in binding-wash buffer (50 mM HEPES (pH 7.5), 50 mM KCl, 2 mM EDTA, 10% glycerol, and 5 mM DTT). The mixture was incubated at 4 °C for 4 h, then was transferred to a 384-well glass fiber filtration plate (Millipore, MZFCN0W50) previously treated with 0.5% PEI. The mixture was suctioned dry with vacuum and immediately washed three times with 100 μL of 4 °C binding-wash buffer. The plates were allowed to air-dry overnight at room temperature, and 7 μL of Ready Safe liquid scintillant (Beckman, 141349) was added to each well. The amount of receptor−ligand complex was determined by liquid scintillation counting using a 1450 Microbeta Trilux (Wallac). Radioligand binding filtration format assays for progesterone receptor (PR) were performed in an identical manner as described for MR except 4 nM (final concentration) full length PR (Invitrogen, P2835) was substituted for MR and 1 nM (final concentration) [<sup>3</sup>H]progesterone (PerkinElmer, NET381) was substituted for radiolabeled aldosterone.</div></div></div><div id="sec6_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i140" class="anchor-spacer"></div><h4 class="article-section__title" id="_i140"> Dahl Salt Sensitive Rat Model of Hypertension and Nephropathy<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a></h4><div class="NLM_p">All animals were outfitted with radiotelemetry units (Data Sciences Inc., St. Paul, MN) for conscious, unrestricted SBP measurements. After recovery from surgery, baseline SBP was measured and all animals were then randomized into various treatment groups and compounds were continued for 21 days. The vehicle group received 0.5% methylcellulose/0.1% Tween 80. All compounds given to the treatment groups were dissolved in 0.5% methylcellulose/0.1% Tween 80. For compound treated groups, animals were dosed with the compounds daily, via gavage. For eplerenone treated groups, eplerenone was incorporated into the 4% NaCl rodent chow at various concentrations (Research Diets, Inc., New Brunswick, NJ). Radiotelemetrized arterial SBP was measured with the DATAQUEST A.R.T., version 3.0, Gold software (Data Sciences International, St. Paul, MN).</div><div class="NLM_p">Twenty-four hours prior to the termination of the study, animals were placed in metabolism caging and urine was collected at 24 h. Animals were not fasted for the 24 h period. After 21 days of treatment, animals were exsanguinated using a 20 gauge needle inserted into the abdominal aorta. Blood samples were immediately transferred into Vacutainer collection tubes (Becton-Dickinson and Co., Franklin Lakes, NJ) and placed on wet ice. Blood was centrifuged for 15 min at 3000 rpm, 4 °C, and plasma collected and frozen at −80 °C until further analysis. Plasma and urine chemistries (e.g., albumin, creatine, and electrolytes) were analyzed with the Hitachi 912 automated diagnostic clinical chemistry analyzer (Roche Diagnostics Corp., Indianapolis, IN) according to standard procedures. Pathlogy scoring was conducted, as reported in ref <a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">23</a>.</div><div class="NLM_p last">The St. Louis Pfizer Institutional Animal Care and Use Committee reviewed and approved the animal use in these studies. The animal care and use program is fully accredited by the Association for Assessment and Accreditation of Laboratory Animal Care, International.</div></div><div id="sec6_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i141" class="anchor-spacer"></div><h4 class="article-section__title" id="_i141"> Molecular Modeling Studies</h4><div class="NLM_p last">Molecular modeling was conducted using the Schrodinger Suite 2006 and 2009 (Schrodinger Suite 2009 Induced Fit Docking protocol, Glide version 5.5, Prime version 2.1, Jaguar version 7.6; Schrodinger LLC, New York, NY). The 1.95 Å MR structure with bound corticosterone (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2A3I">2A3I</a>)<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> was prepared by removal of waters, addition of hydrogens, and restrained energy minimization. Conformationally restricted pyrazoline <b>3</b><i><b>S</b></i><b>,3a</b><i><b>R</b></i><b>-27d</b> was geometry-optimized using Jaguar (B3LYP/6-31G**//B3LYP/6-31G**) prior to docking into the receptor model. The induced fit docking protocol<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> used defaults except for trimming residues N770, L848, and F941 for the initial Glide docking; Prime side chain refinement out to 7.5 Å from docked poses (omitting Q776 and R817); and use of XP scoring on the redock step. No hydrogen bonding or other constraints were used. The top-scoring pose obtained was subjected to restrained energy minimization to produce the model shown. Pictures were generated using Maestro 9.0.211 (Schrodinger LLC).</div></div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i143"><a href="/doi/suppl/10.1021/jm100505n">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_16455" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_16455" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">X-ray crystallographic data for compounds <b><i>R</i>-17</b> and <b>3<i>R</i>,3a<i>R</i>-27c</b> and combustion analysis data. This material is available free of charge via the Internet at <a href="http://pubs.acs.org" class="extLink">http://pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm100505n/suppl_file/jm100505n_si_001.pdf">jm100505n_si_001.pdf (83.66 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/jm100505n" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_07560" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_07560" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Marvin J. Meyers</span> - <span class="hlFld-Affiliation affiliation">St. Louis Laboratories, Pfizer Global Research and Development, Pfizer, Inc., 700 Chesterfield Parkway West, Chesterfield, Missouri 63017</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#deb3b3bba7bbacade69eadb2abf0bbbaabfeb9acbfbdb7bbb2bff0bfacb6bfb0bdbbaa9eb0b1a8abadb7b0aaf0bdb1b3"><span class="__cf_email__" data-cfemail="b3deded6cad6c1c08bf3c0dfc69dd6d7c6">[email protected]</span> <span class="__cf_email__" data-cfemail="64031605070d0108054a05160c050a070110240a0b1211170d0a104a070b09">[email protected]</span></a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Graciela B. Arhancet</span> - <span class="hlFld-Affiliation affiliation">St. Louis Laboratories, Pfizer Global Research and Development, Pfizer, Inc., 700 Chesterfield Parkway West, Chesterfield, Missouri 63017</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#0c61616975697e7f344c7f6079226968792c6b7e6d6f6569606d226d7e646d626f69784c62637a797f656278226f6361"><span class="__cf_email__" data-cfemail="f895959d819d8a8bc0b88b948dd69d9c8d">[email protected]</span> <span class="__cf_email__" data-cfemail="583f2a393b313d343976392a3039363b3d2c1836372e2d2b31362c763b3735">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Susan L. Hockerman</span> - <span class="hlFld-Affiliation affiliation">St. Louis Laboratories, Pfizer Global Research and Development, Pfizer, Inc., 700 Chesterfield Parkway West, Chesterfield, Missouri 63017</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Xiangyang Chen</span> - <span class="hlFld-Affiliation affiliation">St. Louis Laboratories, Pfizer Global Research and Development, Pfizer, Inc., 700 Chesterfield Parkway West, Chesterfield, Missouri 63017</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Scott A. Long</span> - <span class="hlFld-Affiliation affiliation">St. Louis Laboratories, Pfizer Global Research and Development, Pfizer, Inc., 700 Chesterfield Parkway West, Chesterfield, Missouri 63017</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Matthew W. Mahoney</span> - <span class="hlFld-Affiliation affiliation">St. Louis Laboratories, Pfizer Global Research and Development, Pfizer, Inc., 700 Chesterfield Parkway West, Chesterfield, Missouri 63017</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Joseph R. Rico</span> - <span class="hlFld-Affiliation affiliation">St. Louis Laboratories, Pfizer Global Research and Development, Pfizer, Inc., 700 Chesterfield Parkway West, Chesterfield, Missouri 63017</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Danny J. Garland</span> - <span class="hlFld-Affiliation affiliation">St. Louis Laboratories, Pfizer Global Research and Development, Pfizer, Inc., 700 Chesterfield Parkway West, Chesterfield, Missouri 63017</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">James. R. Blinn</span> - <span class="hlFld-Affiliation affiliation">St. Louis Laboratories, Pfizer Global Research and Development, Pfizer, Inc., 700 Chesterfield Parkway West, Chesterfield, Missouri 63017</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Joe T. Collins</span> - <span class="hlFld-Affiliation affiliation">St. Louis Laboratories, Pfizer Global Research and Development, Pfizer, Inc., 700 Chesterfield Parkway West, Chesterfield, Missouri 63017</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Shengtian Yang</span> - <span class="hlFld-Affiliation affiliation">St. Louis Laboratories, Pfizer Global Research and Development, Pfizer, Inc., 700 Chesterfield Parkway West, Chesterfield, Missouri 63017</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Horng-Chih Huang</span> - <span class="hlFld-Affiliation affiliation">St. Louis Laboratories, Pfizer Global Research and Development, Pfizer, Inc., 700 Chesterfield Parkway West, Chesterfield, Missouri 63017</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Kevin F. McGee</span> - <span class="hlFld-Affiliation affiliation">Albany Molecular Research, Inc., 26 Corporate Circle, Albany, New York 12203</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jay M. Wendling</span> - <span class="hlFld-Affiliation affiliation">St. Louis Laboratories, Pfizer Global Research and Development, Pfizer, Inc., 700 Chesterfield Parkway West, Chesterfield, Missouri 63017</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jessica D. Dietz</span> - <span class="hlFld-Affiliation affiliation">St. Louis Laboratories, Pfizer Global Research and Development, Pfizer, Inc., 700 Chesterfield Parkway West, Chesterfield, Missouri 63017</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Maria A. Payne</span> - <span class="hlFld-Affiliation affiliation">St. Louis Laboratories, Pfizer Global Research and Development, Pfizer, Inc., 700 Chesterfield Parkway West, Chesterfield, Missouri 63017</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Bruce L. Homer</span> - <span class="hlFld-Affiliation affiliation">St. Louis Laboratories, Pfizer Global Research and Development, Pfizer, Inc., 700 Chesterfield Parkway West, Chesterfield, Missouri 63017</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Marcia I. Heron</span> - <span class="hlFld-Affiliation affiliation">St. Louis Laboratories, Pfizer Global Research and Development, Pfizer, Inc., 700 Chesterfield Parkway West, Chesterfield, Missouri 63017</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">David B. Reitz</span> - <span class="hlFld-Affiliation affiliation">St. Louis Laboratories, Pfizer Global Research and Development, Pfizer, Inc., 700 Chesterfield Parkway West, Chesterfield, Missouri 63017</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Xiao Hu</span> - <span class="hlFld-Affiliation affiliation">St. Louis Laboratories, Pfizer Global Research and Development, Pfizer, Inc., 700 Chesterfield Parkway West, Chesterfield, Missouri 63017</span></div></li></ul></li><li></li><li></li><li></li></ul></div><div class="ack"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i142">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_44048" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_44048" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The authors thank David Oburn, Hwang-Fun Lu, and Jeff Hitchcock of Pfizer Global Research and Development (PGRD) and Nadya Astakhova of Albany Molecular Research, Inc., for preparation of select compounds; Jon Bordner and Ivan Samardjiev of PGRD for determination of the X-ray crystal structures; Jenny Y. Zheng, Robert C. Chott, Mark E. Smith, Lesley Albin, Steve Wene, Tom McDonald, Chante Bolden, and Lance J. Heinle of PGRD for PK/PD analysis; Kimberly A. Foster and Anthony L. Young of PGRD Pharmaceutical Sciences for solubility measurements and formulations support; Monica L. Hultman of PGRD for steroid selectivity assay support; PGRD Drug Safety group for hERG and dofetilide assay support; Mary Ellen Banker and Natalia Schmidt of PGRD for radiolabeled binding assay and functional assay support; Lu Chen of PGRD for animal dosing and sample analysis; and Donna L. Romero, Charles A. McWherter, Charles W. Bolten, John W. Davis, and David W. Piotrowski of PGRD for helpful discussions and support.</p></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i144">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_73843" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_73843" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 24 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Martiniuk, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lawes, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ueshima, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suh, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lam, T. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gu, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feigin, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jamrozik, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohkubo, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woodward, M.</span><span> </span><span class="NLM_article-title">Hypertension: its prevalence and population-attributable fraction for mortality from cardiovascular disease in the Asia-Pacific region</span> <span class="citation_source-journal">J. Hypertens.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x">, </span> <span class="NLM_fpage">73</span><span class="NLM_x">–</span> <span class="NLM_lpage">79</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1a&amp;dbid=16&amp;doi=10.1021%2Fjm100505n&amp;key=10.1097%2FHJH.0b013e328010775f" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1a&amp;dbid=8&amp;doi=10.1021%2Fjm100505n&amp;key=17143176" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1a&amp;dbid=32&amp;doi=10.1021%2Fjm100505n&amp;key=1%3ACAS%3A528%3ADC%252BD28Xht1OhtrvO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2007&pages=73-79&author=A.+L.+Martiniukauthor=C.+M.+Leeauthor=C.+M.+Lawesauthor=H.+Ueshimaauthor=I.+Suhauthor=T.+H.+Lamauthor=D.+Guauthor=V.+Feiginauthor=K.+Jamrozikauthor=T.+Ohkuboauthor=M.+Woodward&title=Hypertension%3A+its+prevalence+and+population-attributable+fraction+for+mortality+from+cardiovascular+disease+in+the+Asia-Pacific+region"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1aR"><div class="casContent"><span class="casTitleNuber">1a</span><div class="casTitle"><span class="NLM_cas:atitle">Hypertension: its prevalence and population-attributable fraction for mortality from cardiovascular disease in the Asia-Pacific region</span></div><div class="casAuthors">Martiniuk, Alexandra L. C.; Lee, Crystal M. Y.; Lawes, Carlene M. M.; Ueshima, Hirotsugu; Suh, Il; Lam, Tai Hing; Gu, Dongfeng; Feigin, Valery; Jamrozik, Konrad; Ohkubo, Takayoshi; Woodward, Mark</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Hypertension</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">73-79</span>CODEN:
                <span class="NLM_cas:coden">JOHYD3</span>;
        ISSN:<span class="NLM_cas:issn">0263-6352</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">Objective: About half of the world's burden of cardiovascular disease is carried by countries in the Asia-Pacific region.  This study aimed to quantify the contribution of hypertension to cardiovascular diseases (CVD) at the country level, by calcg. the sex-specific, population-attributable fractions (PAFs) for fatal ischemic heart disease (IHD) and stroke (haemorrhagic and ischemic) for the World Health Organization Western Pacific and South-east Asian regions.  Methods: The most recent sex-specific prevalence data on hypertension were sought.  Age-adjusted hazard ratio (HR) ests. for fatal IHD and stroke assocd. with hypertension were obtained using Cox analyses of individual participant cohort data from 600 000 adult participants in the Asia-Pacific Cohort Studies Collaboration.  HR ests. and prevalence were then used to calc. sex-specific PAFs for fatal IHD and stroke, by country.  Results: In 15 countries with available data, the prevalence of hypertension ranged from 5-47% in men and from 7-38% in women.  Overall, the fraction of IHD attributable to hypertension ranged from 4-28% in men and from 8-39% in women.  Corresponding ranges for haemorrhagic stroke were 18-66% and 15-49%, and for ischemic stroke were 8-44% and 12-45%.  Conclusions: In the Asia-Pacific region, up to 66% of some subtypes of CVD can be attributed to hypertension, underscoring the immense impact that blood pressure-lowering strategies could have in this populous region.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoW2aOwp849frVg90H21EOLACvtfcHk0lgi-mUNpSsDfA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xht1OhtrvO&md5=6398a5a8d2458176a2bab59600616ba9</span></div><a href="/servlet/linkout?suffix=cit1a&amp;dbid=16384&amp;doi=10.1097%2FHJH.0b013e328010775f&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252FHJH.0b013e328010775f%26sid%3Dliteratum%253Aachs%26aulast%3DMartiniuk%26aufirst%3DA.%2BL.%26aulast%3DLee%26aufirst%3DC.%2BM.%26aulast%3DLawes%26aufirst%3DC.%2BM.%26aulast%3DUeshima%26aufirst%3DH.%26aulast%3DSuh%26aufirst%3DI.%26aulast%3DLam%26aufirst%3DT.%2BH.%26aulast%3DGu%26aufirst%3DD.%26aulast%3DFeigin%26aufirst%3DV.%26aulast%3DJamrozik%26aufirst%3DK.%26aulast%3DOhkubo%26aufirst%3DT.%26aulast%3DWoodward%26aufirst%3DM.%26atitle%3DHypertension%253A%2520its%2520prevalence%2520and%2520population-attributable%2520fraction%2520for%2520mortality%2520from%2520cardiovascular%2520disease%2520in%2520the%2520Asia-Pacific%2520region%26jtitle%3DJ.%2520Hypertens.%26date%3D2007%26volume%3D25%26spage%3D73%26epage%3D79" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit1b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Burt, V. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Whelton, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roccella, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cutler, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Higgins, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Horan, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Labarthe, D.</span><span> </span><span class="NLM_article-title">Prevalence of hypertension in the US adult population. Results from the Third National Health and Nutrition Examination Survey, 1988−1991</span> <span class="citation_source-journal">Hypertension</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x"> (</span><span class="NLM_issue">3</span><span class="NLM_x">) </span> <span class="NLM_fpage">305</span><span class="NLM_x">–</span> <span class="NLM_lpage">313</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=1995&pages=305-313&issue=3&author=V.+L.+Burtauthor=P.+Wheltonauthor=E.+J.+Roccellaauthor=C.+Brownauthor=J.+A.+Cutlerauthor=M.+Higginsauthor=M.+J.+Horanauthor=D.+Labarthe&title=Prevalence+of+hypertension+in+the+US+adult+population.+Results+from+the+Third+National+Health+and+Nutrition+Examination+Survey%2C+1988%E2%88%921991"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBurt%26aufirst%3DV.%2BL.%26aulast%3DWhelton%26aufirst%3DP.%26aulast%3DRoccella%26aufirst%3DE.%2BJ.%26aulast%3DBrown%26aufirst%3DC.%26aulast%3DCutler%26aufirst%3DJ.%2BA.%26aulast%3DHiggins%26aufirst%3DM.%26aulast%3DHoran%26aufirst%3DM.%2BJ.%26aulast%3DLabarthe%26aufirst%3DD.%26atitle%3DPrevalence%2520of%2520hypertension%2520in%2520the%2520US%2520adult%2520population.%2520Results%2520from%2520the%2520Third%2520National%2520Health%2520and%2520Nutrition%2520Examination%2520Survey%252C%25201988%25E2%2588%25921991%26jtitle%3DHypertension%26date%3D1995%26volume%3D25%26issue%3D3%26spage%3D305%26epage%3D313" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit1c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Hajjar, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Theodore, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kotchen, T. A.</span><span> </span><span class="NLM_article-title">Trends in prevalence, awareness, treatment, and control of hypertension in the United States, 1988−2000</span> <span class="citation_source-journal">JAMA, J. Am. Med. Assoc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">290</span><span class="NLM_x">, </span> <span class="NLM_fpage">199</span><span class="NLM_x">–</span> <span class="NLM_lpage">206</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=290&publication_year=2003&pages=199-206&author=I.+Hajjarauthor=A.+Theodoreauthor=T.+A.+Kotchen&title=Trends+in+prevalence%2C+awareness%2C+treatment%2C+and+control+of+hypertension+in+the+United+States%2C+1988%E2%88%922000"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHajjar%26aufirst%3DI.%26aulast%3DTheodore%26aufirst%3DA.%26aulast%3DKotchen%26aufirst%3DT.%2BA.%26atitle%3DTrends%2520in%2520prevalence%252C%2520awareness%252C%2520treatment%252C%2520and%2520control%2520of%2520hypertension%2520in%2520the%2520United%2520States%252C%25201988%25E2%2588%25922000%26jtitle%3DJAMA%252C%2520J.%2520Am.%2520Med.%2520Assoc.%26date%3D2003%26volume%3D290%26spage%3D199%26epage%3D206" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Williams, B.</span><span> </span><span class="NLM_article-title">Drug treatment of hypertension</span> <span class="citation_source-journal">Br. Med. J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">326</span><span class="NLM_x">, </span> <span class="NLM_fpage">61</span><span class="NLM_x">–</span> <span class="NLM_lpage">62</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2a&amp;dbid=16&amp;doi=10.1021%2Fjm100505n&amp;key=10.1136%2Fbmj.326.7380.61" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2a&amp;dbid=32&amp;doi=10.1021%2Fjm100505n&amp;key=1%3ACAS%3A280%3ADC%252BD3s%252FhsFCktw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=326&publication_year=2003&pages=61-62&author=B.+Williams&title=Drug+treatment+of+hypertension"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2aR"><div class="casContent"><span class="casTitleNuber">2a</span><div class="casTitle"><span class="NLM_cas:atitle">Drug treatment of hypertension</span></div><div class="casAuthors">Williams Bryan</div><div class="citationInfo"><span class="NLM_cas:title">BMJ (Clinical research ed.)</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">326</span>
        (<span class="NLM_cas:issue">7380</span>),
    <span class="NLM_cas:pages">61-2</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTtVwgfGO5ZiWPgL4LrC-0VfW6udTcc2eY2Sb7oMznXTbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD3s%252FhsFCktw%253D%253D&md5=e48bd5b465ba4fc20d849bdabf332bff</span></div><a href="/servlet/linkout?suffix=cit2a&amp;dbid=16384&amp;doi=10.1136%2Fbmj.326.7380.61&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1136%252Fbmj.326.7380.61%26sid%3Dliteratum%253Aachs%26aulast%3DWilliams%26aufirst%3DB.%26atitle%3DDrug%2520treatment%2520of%2520hypertension%26jtitle%3DBr.%2520Med.%2520J.%26date%3D2003%26volume%3D326%26spage%3D61%26epage%3D62" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit2b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Chobanian, A. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bakris, G. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Black, H. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cushman, W. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Green, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Izzo, J. L.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Materson, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oparil, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wright, J. T.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roccella, E. J.</span><span> </span><span class="NLM_article-title">The seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report</span> <span class="citation_source-journal">JAMA, J. Am. Med. Assoc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">289</span><span class="NLM_x">, </span> <span class="NLM_fpage">2560</span><span class="NLM_x">–</span> <span class="NLM_lpage">2572</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=289&publication_year=2003&pages=2560-2572&author=A.+V.+Chobanianauthor=G.+L.+Bakrisauthor=H.+R.+Blackauthor=W.+C.+Cushmanauthor=L.+A.+Greenauthor=J.+L.+Izzoauthor=D.+W.+Jonesauthor=B.+J.+Matersonauthor=S.+Oparilauthor=J.+T.+Wrightauthor=E.+J.+Roccella&title=The+seventh+report+of+the+Joint+National+Committee+on+Prevention%2C+Detection%2C+Evaluation%2C+and+Treatment+of+High+Blood+Pressure%3A+the+JNC+7+report"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DChobanian%26aufirst%3DA.%2BV.%26aulast%3DBakris%26aufirst%3DG.%2BL.%26aulast%3DBlack%26aufirst%3DH.%2BR.%26aulast%3DCushman%26aufirst%3DW.%2BC.%26aulast%3DGreen%26aufirst%3DL.%2BA.%26aulast%3DIzzo%26aufirst%3DJ.%2BL.%26aulast%3DJones%26aufirst%3DD.%2BW.%26aulast%3DMaterson%26aufirst%3DB.%2BJ.%26aulast%3DOparil%26aufirst%3DS.%26aulast%3DWright%26aufirst%3DJ.%2BT.%26aulast%3DRoccella%26aufirst%3DE.%2BJ.%26atitle%3DThe%2520seventh%2520report%2520of%2520the%2520Joint%2520National%2520Committee%2520on%2520Prevention%252C%2520Detection%252C%2520Evaluation%252C%2520and%2520Treatment%2520of%2520High%2520Blood%2520Pressure%253A%2520the%2520JNC%25207%2520report%26jtitle%3DJAMA%252C%2520J.%2520Am.%2520Med.%2520Assoc.%26date%3D2003%26volume%3D289%26spage%3D2560%26epage%3D2572" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group">Young, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Funder, J. W.</span><span> </span><span class="NLM_article-title">Aldosterone and the Heart</span> <span class="citation_source-journal">Trends Endocrinol. Metab.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">224</span><span class="NLM_x">–</span> <span class="NLM_lpage">226</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Fjm100505n&amp;key=10.1016%2FS1043-2760%2800%2900270-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Fjm100505n&amp;key=10878752" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Fjm100505n&amp;key=1%3ACAS%3A528%3ADC%252BD3cXks12rtbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2000&pages=224-226&author=M.+Youngauthor=J.+W.+Funder&title=Aldosterone+and+the+Heart"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Aldosterone and the Heart</span></div><div class="casAuthors">Young, M.; Funder, J. W.</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Endocrinology and Metabolism</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">224-226</span>CODEN:
                <span class="NLM_cas:coden">TENME4</span>;
        ISSN:<span class="NLM_cas:issn">1043-2760</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">A review with 35 refs.  Classically, aldosterone is a steroid hormone secreted from the adrenal cortex, which acts on kidney, colon and sweat/salivary glands to promote unidirectional sodium transport.  Currently, there is excellent exptl. evidence for aldosterone acting directly on the central nervous system to raise blood pressure, and on the heart to cause cardiac hypertrophy and fibrosis.  In addn., there is emerging evidence for aldosterone synthesis in the heart, and for as yet unexplained benefits of aldosterone antagonism in the treatment of cardiac failure.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGogjgONZBhWb7Vg90H21EOLACvtfcHk0lh3iaPx_3lYHA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXks12rtbg%253D&md5=cb40142aa246973a217ff37c7351c07f</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1016%2FS1043-2760%2800%2900270-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1043-2760%252800%252900270-8%26sid%3Dliteratum%253Aachs%26aulast%3DYoung%26aufirst%3DM.%26aulast%3DFunder%26aufirst%3DJ.%2BW.%26atitle%3DAldosterone%2520and%2520the%2520Heart%26jtitle%3DTrends%2520Endocrinol.%2520Metab.%26date%3D2000%26volume%3D11%26spage%3D224%26epage%3D226" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Voets, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Antes, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scherer, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Müller-Vieira, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Biemel, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barassin, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marchais-Oberwinkler, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hartmann, R. W.</span><span> </span><span class="NLM_article-title">Heteroaryl-substituted naphthalenes and structurally modified derivatives: selective inhibitors of CYR11B2 for the treatment of congestive heart failure and myocardial fibrosis</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">6632</span><span class="NLM_x">–</span> <span class="NLM_lpage">6642</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm0503704" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=6632-6642&author=M.+Voetsauthor=I.+Antesauthor=C.+Schererauthor=U.+M%C3%BCller-Vieiraauthor=K.+Biemelauthor=C.+Barassinauthor=S.+Marchais-Oberwinklerauthor=R.+W.+Hartmann&title=Heteroaryl-substituted+naphthalenes+and+structurally+modified+derivatives%3A+selective+inhibitors+of+CYR11B2+for+the+treatment+of+congestive+heart+failure+and+myocardial+fibrosis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4a&amp;dbid=16384&amp;doi=10.1021%2Fjm0503704&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0503704%26sid%3Dliteratum%253Aachs%26aulast%3DVoets%26aufirst%3DM.%26aulast%3DAntes%26aufirst%3DI.%26aulast%3DScherer%26aufirst%3DC.%26aulast%3DM%25C3%25BCller-Vieira%26aufirst%3DU.%26aulast%3DBiemel%26aufirst%3DK.%26aulast%3DBarassin%26aufirst%3DC.%26aulast%3DMarchais-Oberwinkler%26aufirst%3DS.%26aulast%3DHartmann%26aufirst%3DR.%2BW.%26atitle%3DHeteroaryl-substituted%2520naphthalenes%2520and%2520structurally%2520modified%2520derivatives%253A%2520selective%2520inhibitors%2520of%2520CYR11B2%2520for%2520the%2520treatment%2520of%2520congestive%2520heart%2520failure%2520and%2520myocardial%2520fibrosis%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2005%26volume%3D48%26spage%3D6632%26epage%3D6642" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit4b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Voets, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Antes, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scherer, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Müller-Vieira, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Biemel, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marchais-Oberwinkler, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hartmann, R. W.</span><span> </span><span class="NLM_article-title">Synthesis and evaluation of heteroaryl-substituted dihydronaphthalenes and indenes: potent and selective inhibitors of aldosterone synthase (CYP11B2) for the treatment of congestive heart failure and myocardial fibrosis</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">2222</span><span class="NLM_x">–</span> <span class="NLM_lpage">2231</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm060055x" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref4/cit4b&amp;dbid=32&amp;doi=10.1021%2Fjm100505n&amp;key=1%3ACAS%3A528%3ADC%252BD28XitVOisb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=2222-2231&author=M.+Voetsauthor=I.+Antesauthor=C.+Schererauthor=U.+M%C3%BCller-Vieiraauthor=K.+Biemelauthor=S.+Marchais-Oberwinklerauthor=R.+W.+Hartmann&title=Synthesis+and+evaluation+of+heteroaryl-substituted+dihydronaphthalenes+and+indenes%3A+potent+and+selective+inhibitors+of+aldosterone+synthase+%28CYP11B2%29+for+the+treatment+of+congestive+heart+failure+and+myocardial+fibrosis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4bR"><div class="casContent"><span class="casTitleNuber">4b</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and Evaluation of Heteroaryl-Substituted Dihydronaphthalenes and Indenes: Potent and Selective Inhibitors of Aldosterone Synthase (CYP11B2) for the Treatment of Congestive Heart Failure and Myocardial Fibrosis</span></div><div class="casAuthors">Voets, Marieke; Antes, Iris; Scherer, Christiane; Mueller-Vieira, Ursula; Biemel, Klaus; Marchais-Oberwinkler, Sandrine; Hartmann, Rolf W.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">2222-2231</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">In this study, the synthesis and biol. evaluation of heteroaryl-substituted dihydronaphthalenes and indenes is described.  The compds. were tested for activity by use of human CYP11B2 expressed in fission yeast and V79 MZh cells and for selectivity by use of human CYP11B1, CYP17, and CYP19.  The most active inhibitor was 2-(3-pyridinyl)-6-methoxy-3,4-dihydronaphthalene (I) (IC50 = 2 nM), showing a Ki value of 1.3 nM and a competitive type of inhibition.  2-(3-Pyridinyl)-5-methoxy-1H-indene was found to be the most selective CYP11B2 inhibitor (IC50 = 4 nM; CYP11B1 IC50 = 5684 nM), which also showed only marginal inhibition of human CYP3A4 and CYP2D6.  Docking and mol. dynamics studies using a homol.-modeled CYP11B2 structure were performed to understand some structure-activity relationships.  Caco-2 cell expts. revealed highly cell-permeable compds., and metabolic studies with I using rat liver microsomes showed sufficient stability.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpQStS_NR31QrVg90H21EOLACvtfcHk0lh3iaPx_3lYHA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XitVOisb4%253D&md5=53d9d6484f3c559128a136f398d7cbd4</span></div><a href="/servlet/linkout?suffix=cit4b&amp;dbid=16384&amp;doi=10.1021%2Fjm060055x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm060055x%26sid%3Dliteratum%253Aachs%26aulast%3DVoets%26aufirst%3DM.%26aulast%3DAntes%26aufirst%3DI.%26aulast%3DScherer%26aufirst%3DC.%26aulast%3DM%25C3%25BCller-Vieira%26aufirst%3DU.%26aulast%3DBiemel%26aufirst%3DK.%26aulast%3DMarchais-Oberwinkler%26aufirst%3DS.%26aulast%3DHartmann%26aufirst%3DR.%2BW.%26atitle%3DSynthesis%2520and%2520evaluation%2520of%2520heteroaryl-substituted%2520dihydronaphthalenes%2520and%2520indenes%253A%2520potent%2520and%2520selective%2520inhibitors%2520of%2520aldosterone%2520synthase%2520%2528CYP11B2%2529%2520for%2520the%2520treatment%2520of%2520congestive%2520heart%2520failure%2520and%2520myocardial%2520fibrosis%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D2222%26epage%3D2231" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit4c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Heim, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lucas, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grombein, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ries, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schewe, K. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Negri, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Müller-Vieira, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Birk, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hartmann, R. W.</span><span> </span><span class="NLM_article-title">Overcoming undesirable CYP1A2 inhibition of pyridylnaphthalene-type aldosterone synthase inhibitors: influence of heteroaryl derivatization on potency and selectivity</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">5064</span><span class="NLM_x">–</span> <span class="NLM_lpage">5074</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm800377h" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=5064-5074&author=R.+Heimauthor=S.+Lucasauthor=C.+M.+Grombeinauthor=C.+Riesauthor=K.+E.+Scheweauthor=M.+Negriauthor=U.+M%C3%BCller-Vieiraauthor=B.+Birkauthor=R.+W.+Hartmann&title=Overcoming+undesirable+CYP1A2+inhibition+of+pyridylnaphthalene-type+aldosterone+synthase+inhibitors%3A+influence+of+heteroaryl+derivatization+on+potency+and+selectivity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4c&amp;dbid=16384&amp;doi=10.1021%2Fjm800377h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm800377h%26sid%3Dliteratum%253Aachs%26aulast%3DHeim%26aufirst%3DR.%26aulast%3DLucas%26aufirst%3DS.%26aulast%3DGrombein%26aufirst%3DC.%2BM.%26aulast%3DRies%26aufirst%3DC.%26aulast%3DSchewe%26aufirst%3DK.%2BE.%26aulast%3DNegri%26aufirst%3DM.%26aulast%3DM%25C3%25BCller-Vieira%26aufirst%3DU.%26aulast%3DBirk%26aufirst%3DB.%26aulast%3DHartmann%26aufirst%3DR.%2BW.%26atitle%3DOvercoming%2520undesirable%2520CYP1A2%2520inhibition%2520of%2520pyridylnaphthalene-type%2520aldosterone%2520synthase%2520inhibitors%253A%2520influence%2520of%2520heteroaryl%2520derivatization%2520on%2520potency%2520and%2520selectivity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D5064%26epage%3D5074" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit4d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Lucas, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heim, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Negri, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Antes, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ries, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schewe, K. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bisi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gobbi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hartmann, R. W.</span><span> </span><span class="NLM_article-title">Novel aldosterone synthase inhibitors with extended carbocyclic skeleton by a combined ligand-based and structure-based drug design approach</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">6138</span><span class="NLM_x">–</span> <span class="NLM_lpage">6149</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm800683c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=6138-6149&author=S.+Lucasauthor=R.+Heimauthor=M.+Negriauthor=I.+Antesauthor=C.+Riesauthor=K.+E.+Scheweauthor=A.+Bisiauthor=S.+Gobbiauthor=R.+W.+Hartmann&title=Novel+aldosterone+synthase+inhibitors+with+extended+carbocyclic+skeleton+by+a+combined+ligand-based+and+structure-based+drug+design+approach"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4d&amp;dbid=16384&amp;doi=10.1021%2Fjm800683c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm800683c%26sid%3Dliteratum%253Aachs%26aulast%3DLucas%26aufirst%3DS.%26aulast%3DHeim%26aufirst%3DR.%26aulast%3DNegri%26aufirst%3DM.%26aulast%3DAntes%26aufirst%3DI.%26aulast%3DRies%26aufirst%3DC.%26aulast%3DSchewe%26aufirst%3DK.%2BE.%26aulast%3DBisi%26aufirst%3DA.%26aulast%3DGobbi%26aufirst%3DS.%26aulast%3DHartmann%26aufirst%3DR.%2BW.%26atitle%3DNovel%2520aldosterone%2520synthase%2520inhibitors%2520with%2520extended%2520carbocyclic%2520skeleton%2520by%2520a%2520combined%2520ligand-based%2520and%2520structure-based%2520drug%2520design%2520approach%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D6138%26epage%3D6149" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit4e"><span><span class="NLM_label">(e) </span><span class="NLM_contrib-group">Lucas, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heim, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ries, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schewe, K. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Birk, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hartmann, R. W.</span><span> </span><span class="NLM_article-title">In vivo active aldosterone synthase inhibitors with improved selectivity: lead optimization providing a series of pyridine substituted 3,4-dihydro-1<i>H</i>-quinolin-2-one derivatives</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">8077</span><span class="NLM_x">–</span> <span class="NLM_lpage">8087</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm800888q" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=8077-8087&author=S.+Lucasauthor=R.+Heimauthor=C.+Riesauthor=K.+E.+Scheweauthor=B.+Birkauthor=R.+W.+Hartmann&title=In+vivo+active+aldosterone+synthase+inhibitors+with+improved+selectivity%3A+lead+optimization+providing+a+series+of+pyridine+substituted+3%2C4-dihydro-1H-quinolin-2-one+derivatives"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4e&amp;dbid=16384&amp;doi=10.1021%2Fjm800888q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm800888q%26sid%3Dliteratum%253Aachs%26aulast%3DLucas%26aufirst%3DS.%26aulast%3DHeim%26aufirst%3DR.%26aulast%3DRies%26aufirst%3DC.%26aulast%3DSchewe%26aufirst%3DK.%2BE.%26aulast%3DBirk%26aufirst%3DB.%26aulast%3DHartmann%26aufirst%3DR.%2BW.%26atitle%3DIn%2520vivo%2520active%2520aldosterone%2520synthase%2520inhibitors%2520with%2520improved%2520selectivity%253A%2520lead%2520optimization%2520providing%2520a%2520series%2520of%2520pyridine%2520substituted%25203%252C4-dihydro-1H-quinolin-2-one%2520derivatives%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D8077%26epage%3D8087" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit4f"><span><span class="NLM_label">(f) </span><span class="NLM_contrib-group">Ries, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lucas, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heim, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Birk, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hartmann, R. W.</span><span> </span><span class="NLM_article-title">Selective aldosterone synthase inhibitors reduce aldosterone formation <i>in vitro</i> and <i>in vivo</i></span> <span class="citation_source-journal">J. Steroid Biochem. Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">116</span><span class="NLM_x">, </span> <span class="NLM_fpage">121</span><span class="NLM_x">–</span> <span class="NLM_lpage">126</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4f&amp;dbid=16&amp;doi=10.1021%2Fjm100505n&amp;key=10.1016%2Fj.jsbmb.2009.04.013" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4f&amp;dbid=8&amp;doi=10.1021%2Fjm100505n&amp;key=19427380" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4f&amp;dbid=32&amp;doi=10.1021%2Fjm100505n&amp;key=1%3ACAS%3A528%3ADC%252BD1MXptVGmt70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=116&publication_year=2009&pages=121-126&author=C.+Riesauthor=S.+Lucasauthor=R.+Heimauthor=B.+Birkauthor=R.+W.+Hartmann&title=Selective+aldosterone+synthase+inhibitors+reduce+aldosterone+formation+in+vitro+and+in+vivo"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4fR"><div class="casContent"><span class="casTitleNuber">4f</span><div class="casTitle"><span class="NLM_cas:atitle">Selective aldosterone synthase inhibitors reduce aldosterone formation in vitro and in vivo</span></div><div class="casAuthors">Ries, Christina; Lucas, Simon; Heim, Ralf; Birk, Barbara; Hartmann, Rolf W.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Steroid Biochemistry and Molecular Biology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">116</span>
        (<span class="NLM_cas:issue">3-5</span>),
    <span class="NLM_cas:pages">121-126</span>CODEN:
                <span class="NLM_cas:coden">JSBBEZ</span>;
        ISSN:<span class="NLM_cas:issn">0960-0760</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Aldosterone plays a crucial role in salt and water homeostasis but in case of pathol. increased plasma aldosterone levels it is also involved in the development and the progression of severe cardiovascular diseases like heart failure and myocardial fibrosis.  For the treatment of these diseases we propose inhibition of the aldosterone forming enzyme CYP11B2 as a new pharmacol. strategy.  We recently developed in vitro highly potent and selective inhibitors of human CYP11B2, but the evidence of their in vivo activity is still missing.  For this purpose, rat aldosterone synthase gene was cloned and expressed in V79MZ cells to establish a new screening assay for the identification of "rat-active" substances.  Compds. from the class of heteroaryl substituted 3,4-dihydro-1H-quinolin-2-ones showed a moderate inhibitory effect (65% at 2 μM) on rat CYP11B2 in vitro.  Furthermore, it diminished the conversion of deoxycorticosterone to aldosterone in rat adrenals and significantly reduced plasma aldosterone levels in vivo.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp4yOGn0kT937Vg90H21EOLACvtfcHk0lh1hDHOMZ61lw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXptVGmt70%253D&md5=a03f287e26dc3bfff893dd9f3e5d0541</span></div><a href="/servlet/linkout?suffix=cit4f&amp;dbid=16384&amp;doi=10.1016%2Fj.jsbmb.2009.04.013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jsbmb.2009.04.013%26sid%3Dliteratum%253Aachs%26aulast%3DRies%26aufirst%3DC.%26aulast%3DLucas%26aufirst%3DS.%26aulast%3DHeim%26aufirst%3DR.%26aulast%3DBirk%26aufirst%3DB.%26aulast%3DHartmann%26aufirst%3DR.%2BW.%26atitle%3DSelective%2520aldosterone%2520synthase%2520inhibitors%2520reduce%2520aldosterone%2520formation%2520in%2520vitro%2520and%2520in%2520vivo%26jtitle%3DJ.%2520Steroid%2520Biochem.%2520Mol.%2520Biol.%26date%3D2009%26volume%3D116%26spage%3D121%26epage%3D126" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Weinberger, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roniker, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krause, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weiss, R. J.</span><span> </span><span class="NLM_article-title">Eplerenone, a selective aldosterone blocker, in mild-to-moderate hypertension</span> <span class="citation_source-journal">Am. J. Hypertens.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">709</span><span class="NLM_x">–</span> <span class="NLM_lpage">716</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5a&amp;dbid=16&amp;doi=10.1021%2Fjm100505n&amp;key=10.1016%2FS0895-7061%2802%2902957-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5a&amp;dbid=8&amp;doi=10.1021%2Fjm100505n&amp;key=12160194" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5a&amp;dbid=32&amp;doi=10.1021%2Fjm100505n&amp;key=1%3ACAS%3A528%3ADC%252BD38Xms1aisLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2002&pages=709-716&author=M.+H.+Weinbergerauthor=B.+Ronikerauthor=S.+L.+Krauseauthor=R.+J.+Weiss&title=Eplerenone%2C+a+selective+aldosterone+blocker%2C+in+mild-to-moderate+hypertension"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5aR"><div class="casContent"><span class="casTitleNuber">5a</span><div class="casTitle"><span class="NLM_cas:atitle">Eplerenone, a selective aldosterone blocker, in mild-to-moderate hypertension</span></div><div class="casAuthors">Weinberger, Myron H.; Roniker, Barbara; Krause, Scott L.; Weiss, Robert J.</div><div class="citationInfo"><span class="NLM_cas:title">American Journal of Hypertension</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">709-716</span>CODEN:
                <span class="NLM_cas:coden">AJHYE6</span>;
        ISSN:<span class="NLM_cas:issn">0895-7061</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Inc.</span>)
        </div><div class="casAbstract">Eplerenone, a selective aldosterone blocker (SAB) that is highly specific for the aldosterone receptor, has the potential to be efficacious in the treatment of hypertension.  This 8-wk, multicenter, double-blind, placebo-controlled trial assessed the efficacy, safety, and tolerability of eplerenone in eligible patients randomized to eplerenone 50, 100, or 400 mg once daily; eplerenone 25, 50, or 200 mg twice daily; spironolactone 50 mg twice daily; or placebo.  The primary efficacy variable was the adjusted mean change in baseline to final visit for seated diastolic blood pressure (DBP).  Of 417 randomized patients, 409 were evaluated for efficacy.  The adjusted mean change from baseline to final visit in seated and standing systolic blood pressure (SBP) and DBP was significantly greater (P <.05) in all eplerenone groups than in the placebo group.  The adjusted mean change in 24-h ambulatory blood pressure monitoring (ABPM) measurements of SBP and DBP also documented a 24-h duration significantly greater (P <.05) than placebo in eplerenone-treated patients.  For all measurements, the antihypertensive effect of eplerenone increased in a dose-response fashion.  Eplerenone (100 mg) reduced BP by 75% compared with spironolactone (100 mg) and had an adverse events incidence rate similar to placebo.  No antiandrogenic or progestational effects or clin. relevant safety issues were obsd. in eplerenone-treated patients.  However, one spironolactone-treated patient reported menstrual irregularities.  Eplerenone doses of 50 to 400 mg once daily are well tolerated and effective in reducing BP in patients with mild-to-moderate hypertension during a 24-h period.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpP2CB2JlWpG7Vg90H21EOLACvtfcHk0lh1hDHOMZ61lw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38Xms1aisLw%253D&md5=cee8929b94677bfd82aea7994664833a</span></div><a href="/servlet/linkout?suffix=cit5a&amp;dbid=16384&amp;doi=10.1016%2FS0895-7061%2802%2902957-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0895-7061%252802%252902957-6%26sid%3Dliteratum%253Aachs%26aulast%3DWeinberger%26aufirst%3DM.%2BH.%26aulast%3DRoniker%26aufirst%3DB.%26aulast%3DKrause%26aufirst%3DS.%2BL.%26aulast%3DWeiss%26aufirst%3DR.%2BJ.%26atitle%3DEplerenone%252C%2520a%2520selective%2520aldosterone%2520blocker%252C%2520in%2520mild-to-moderate%2520hypertension%26jtitle%3DAm.%2520J.%2520Hypertens.%26date%3D2002%26volume%3D15%26spage%3D709%26epage%3D716" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit5b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Pitt, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Remme, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zannad, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neaton, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martinez, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roniker, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bittman, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hurley, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kleiman, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gatlin, M.</span><span> </span><span class="NLM_article-title">Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction</span> <span class="citation_source-journal">N. Engl. J. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">348</span><span class="NLM_x">, </span> <span class="NLM_fpage">1309</span><span class="NLM_x">–</span> <span class="NLM_lpage">1321</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5b&amp;dbid=16&amp;doi=10.1021%2Fjm100505n&amp;key=10.1056%2FNEJMoa030207" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5b&amp;dbid=8&amp;doi=10.1021%2Fjm100505n&amp;key=12668699" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5b&amp;dbid=32&amp;doi=10.1021%2Fjm100505n&amp;key=1%3ACAS%3A528%3ADC%252BD3sXis1ehurY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=348&publication_year=2003&pages=1309-1321&author=B.+Pittauthor=W.+Remmeauthor=F.+Zannadauthor=J.+Neatonauthor=F.+Martinezauthor=B.+Ronikerauthor=R.+Bittmanauthor=S.+Hurleyauthor=J.+Kleimanauthor=M.+Gatlin&title=Eplerenone%2C+a+selective+aldosterone+blocker%2C+in+patients+with+left+ventricular+dysfunction+after+myocardial+infarction"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5bR"><div class="casContent"><span class="casTitleNuber">5b</span><div class="casTitle"><span class="NLM_cas:atitle">Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction</span></div><div class="casAuthors">Pitt, Bertram; Remme, Willem; Zannad, Faiez; Neaton, James; Martinez, Felipe; Roniker, Barbara; Bittman, Richard; Hurley, Steve; Kleiman, Jay; Gatlin, Marjorie; Ambrosioni, E.; Anderson, J. L.; Apetrei, E.; Aschermann, M.; Banas, J.; Cardoso, S.; Caspi, A.; Chung, N.; Corbalan, R.; Dargie, H. J.; Bietz, R.; Erhardt, L.; Garcia-Castillo, A.; Gheorghiade, M.; Hernandez, E.; Hess, O.; Jamerson, K.; Kjekshus, J.; Klug, E.; Krum, H.; Lee, Y.-T.; Lopez, N.; Lopez-Sendon, J.-L.; Martinez, F.; Murin, J.; Neaton, J.; Nicolau, J.-C.; Ostor, E.; Parkhomenko, A.; Pitt, B.; Ross, H.; Stepinska, J.; Torp-Pedersen, C.; Van Mieghem, W.; van Veldhuisen, D.-J.; White, H.; Wilvox, R. G.; Willenbrock, R.; Yotov, Y.-T.; Zannad, F.; Boissel, J.-P.; Furberg, C.; Julian, D.; Kulbertus, H.; Pocock, S.; Wittes, J.; Battler, A.; Blumenfeld, J.; Brilla, C.; Duprez, D.; Fowler, M.; Gavazzi, A.; Hildebrandt, P.; Komajda, M.; Korewicki, J.; Kosturakis, D.; Marin-Neto, J. A.; Miller, A.; Munoz Aguilera, R.; Oliveri, R.; Remme, W.; White, M.; Widimsky, P.; Bakris, G.; Castaigne, A.; Deedwania, P.; Duprez, D.; Ketelslegers, J. M.; Liu, P.; Mancia, G.; Nicklas, J.; Rouleau, J.-L.; Ruilope, L.; Sasayama, S.; Schiffrin, E.; Spertus, J.; Struthers, A.; Vaughan, D.; Weber, M.; Williams, G.; Abinader, E.; Adams, J.; Adams, P. C.; Adamus, J.; Ahlstrom, P.; Akesson, H. S.; Akhmedzhanov, N.; Alcasena Juango, S.; Ali Khan, S.; Alonso Garcia, A.; Amat, G.; Amerena, J.; Arnosova, K. M.; Andreoli, L.; Angelo-Nielsen, K.; Antonio de Velasco, J.; Apetrei, E.; Aroutiounov, G.; Aschermann, M.; Asklund, M.; Assmann, I.; Aumont, M.-C.; Avtandilov, A.; Azarin, O.; Bada, V.; Bakoumov, P.; Balazovjech, L.; Baldjiev, E.; Baluda, M.; Barrazueta, R.; Barsi, B.; Bashir, Y.; Batin, P. D.; Belenky, D.; Belyi, Y.; Bendermacher, P. E. F.; Berget, K.; Bergmeier, C.; Berning, J.; Berrazueta-Fernandez, J. R.; Block, P.; Boberg, G.; Bocek, P.; Bohlscheid, V.; Bokarev, I.; Bolinska, H.; Boman, K.; Bondarev, S.; Bonzel, T.; Boreux, J.-L.; Borggrefe, M.; Borisov, M.; Boxho, G.; Boyarkin, M.; Brachmann, J.; Brack, M.; Branea, I.; Breivik, K.; Brigden, G. S.; Bronzwaer, P. N. A.; Bruce, D.; Bruckner, I.; Brunvand, H.; Bryukhovetski, A.; Buser, P.; Campbell, T.; Campeanu, A.; Capucci, A.; Carasca, E.; Cardoso, J.; Carrageta, M.; Caspi, A.; Cassim, S.; Caturla, J.; Ceia, F.; Cernosek, B.; Channer, K.; Chati, Z.; Christensen, P. D.; Chung, N. S.; Cinteza, M.; Cleland, J. G. F.; Cocchieri, M.; Commerford, P.; Conti, U.; Corsini, G.; Cortina Liosa, A.; Coupez, J.-M.; Cribier, A.; Csillag, J.; Cyran, J.; Dahlstrom, U.; Dalby, A.; Dalin, L. J.; Dalkowski, M.; Dargie, H. J.; Darius, H.; Datcu, D. M.; David, D.; De Myttenaere, M.; De Teresa, E.; De Velasco, J.; de Vries, A. G.; den Hartog, F. R.; Desjoyaux, E.; Dezerbi, A.; Dhawan, J.; Biaz Molina, B.; Dickstein, K.; Dorobantu, M.; Doschitsin, V.; Doubell, A.; Dovgalevsky, P.; Dragulescu, S. I.; Drapkina, O.; Dubourg, O.; Dunselman, P. H. J. M.; Dyadyk, O. I.; Dykun, Y. V.; Dzyak, G. V.; Egorova, L. P.; Egstrup, K.; Eha, J.; Ehrenbergerova, M.; El Allaf, D.; Elenkova, A.; Ellis, C. J.; Engbers, J. G.; Fainyk, A. F.; Falck, G.; Fanelli, R.; Farre-Mun, J.; Favier, J.; Ferrari, G.; Ferreira, I.; Rischer, H.; Fotyanov, S.; Freericks, M. P.; Froeland, G.; Galve, E.; Garcia, M. M.; Garcia, A. A.; Garnier, L. F.; Gazaryan, G.; Georgescu, C.; Geraedts, J.; Glezer, M. G.; Goloborodko, B. I.; Goloshchekin, B.; Gonsorcik, J.; Gotchev, D.; Gotcheva, N.; Gottwik, M. G.; Grande, P.; Gratsiansky, N.; Grishina, E. I.; Groch, L.; Gruzdev, A.; Guenova, D.; Gundersen, T.; Hagerman, I.; Hambrecht, R.; Hammermann, H.; Hansen, O.; Hansteen, V.; Hart, H.; Hauf, G. F.; Hecker, U.; Hegyi, I.; Herlitz, J.; Hertzberger, D. P.; Herweijer, A. H.; Heyndrickx, G. R.; Hittinger, L.; Hoang, V.; Hobbach, H.-P.; Hofman-Bang, C.; Holwerda, N. J.; Hong, K. P.; Horacek, T.; Hormann, J.; Horowitz, J. D.; Hradec, J.; Hurtig, U.; Ikram, H.; Ioan, A.; Jaarsma, W.; Jadraque, L. M.; Jakobsen, T. J.; Janicki, K. J.; Jankelow, D.; Janosi, A.; Jansky, P.; Janssens, L.; Janzen, I.; Jensen, P.; Jirmar, R.; Jobic, Y.; Jones, A.; Jonsson, J.; Kahles, H.; Kaliska, G.; Kamensky, G.; Kappenberger, L.; Karlsson, J. E.; Karpati, P.; Karpenko, O. I.; Karpov, Y.; Kawecka-Jaszcz, J.; Keeling, P. J.; Keren, G.; Khalife, K.; Khrakovskaya, M.; Khrustalev, O. A.; Klarlund, K. K.; Kleber, E.-X.; Klug, E.; Koenig, W.; Komarek, J.; Kononenko, L. G.; Konz, K.; Komacewicz-Jach, Z.; Kostenko, V.; Kotous, J.; Kovalsky, I.; Kozak, P.; Kreider-Stempfle, H. U.; Kromer, E. P.; Krum, H.; Krzeminska-Pakula, M.; Kuc, K.; Kucera, P.; Kurowski, M.; Lach, L.; Lai, C.; Lane, G.; Lang, E.; Lankes, W.; Lankisch, P.-G.; Laraudogoitia, E.; Larsen, J.; Larsson, L.-E.; Laruelle, C.; Lazar, A.; Lee, Y.-T.; Legkonogov, A. V.; Leitch, J.; Lengfelder, W.; Lescot, C. D.; Lewis, B. S.; Lewis, P.; Libov, I. A.; Liel-Cohen, N.; Lim, H. K.; Lin, C.-S.; Linssen, G. C. M.; Liu, C.-P.; Lok, D. J. A.; Lopatin, Y. M.; Lopez De Sa, E.; Lotan, C.; Lousada, N.; Lucas, C.; Lucatti, A.; Lusov, V.; Mabin, T. A.; Macleod, D. C.; Maeurer, W.; Magnusson, J.-O.; Maisch, B.; Malinski, A.; Maltchougine, M.; Manga, P.; Mantov, S.; Marchi, S.; Marcinowska-Suchowierska, E.; Marenne, F.; Maresca, F. S.; Markov, V.; Marmor, A. T.; Martines, C.; Martinez, A.; Martin-Jadraque, L.; Martins, L. F. R.; Martos Ferres, R.; Mary, D. A. S. G.; Masini, F.; Matta, F.; Maurer, W.; Mazzini, A. C.; McDonald, K. M. A.; Meeder, J. G.; Melandri, F.; Melin, J.; Menezes, C.; Michels, H. R.; Missault, L.; Mitrovic, V.; Mntla, P.; Mobilij, A.; Mogilevsky, A.; Moiseev, V.; Mokan, M.; Moeller, B.; Moreira, I.; Mouhoub, D.; Moura, B.; Muders, E.; Mudra, H.; Munz, J.; Murin, J.; Musial, W. J.; Myburgh, D. P.; Naqvi, N.; Naumann, G.; Nazimov, S. V.; Nadelec, G.; Nedogoda, S. V.; Nielsen, I.; Nielsen, T.; Nierop, P. R.; Nilsson, G.; Notaristefano, A.; Novitsky, I. N.; Nykl, L.; Ofner, P.; Olariu, C.; Olbrich, H. G.; Oldroyd, K. G.; Olinic, N.; Oliveira, J.; Omland, T.; Orus, J.; Owensby, D.; Page, A.; Park, K. S.; Parkhomenko, O. M.; Pasotti, C.; Pasowicz, M.; Pecce, P.; Pell, A. C. H.; Penkov, N. I.; Perez de Juan, M.; Perez, H.; Petersen, M.; Petrov, A. A.; Peuhkurinen, K.; Philonenko, X.; Pieper, M.; Pieske, B.; Pluta, W.; Podzemska, B.; Popeye, R.; Prost, C.; Purcaro, A.; Put, P.; Radchenko, V.; Radoi, M.; Rae, A. P.; Raev, D.; Ramik, C.; Rasmussen, S. L.; Reisin, L.; Renker, B.; Ribeiro, V. G.; Richardt, G.; Rjecansky, I.; Risenfors, M.; Rivis, I. A.; Robson, R. H.; Rocher, R.; Rodriquez Padial, L.; Rose, E. L.; Rosen, S. D.; Rosenfeld, T.; Rowlands, D. B.; Rozkovec, A.; Rudas, L.; Rudenko, L. V.; Ruiz-Rejon, F.; Rutsch, W.; Rybar, R.; Rybka, J.; Saetre, H. A.; Sarosi, I.; Savalle, L. H.; Schmidt, A.; Schuren, K. P.; Schwartz, Y.; Schwinger, R.; Schwob, J. P.; Scott, D.; Sechtem, U.; Sela, O.; Semrad, B.; Senni, M.; Shilkina, N. P.; Shpektor, A.; Silas, J.; Sindone, A.; Sinescu, C. J.; Sipila, R.; Sirek, J.; Skagen, K.; Shura, M.; Slanina, M.; Slowinski, S.; Smid, J.; Smielak-Korombel, W.; Solodky, A.; Spacek, R.; Squire, I.; Steingo, L.; Stepinska, J.; Stogowski, A.; Storzhakov, G.; Striouk, R.; Strunge, P.; Suter, T.; Svitil, P.; Swedberg, K.; Swidzinski, M.; Syvolap, V. D.; Sztajzel, J.; Tahk, S. J.; Tans, A. C.; Tans, J. G. M.; Targonski, R.; Tarjan, J.; Tartagni, F.; Tchartchoglian, R.; Tebloev, K.; Teesalu, R.; Ten Kate, J. B. L.; Terrosu, P.; Thompson, P. L.; Thybo, N. K.; Thygesen, K.; Tilon, P. A.; Timar, S.; Titkov, Y.; Titlbach, O. J.; Torp-Pedersen, C.; Torvik, D. T.; Touboul, P.; Trelawny, J. M.; Trillo Nouche, R.; Trochina, E.; Trojnar, R.; Tzekova, M. L.; Tzivoni, D.; Vahula, V.; Valagussa, F.; Valdes, M.; Van Der Heijden, R.; Van Der Sloot, J. A. P.; Van Hal, J. M. C.; Van Kempen, L. H. J.; Van Mieghem, W.; Van Rugge, F. P.; Van Veldhuisen, D. J.; Van Vlies, B.; Van Wijk, L. M.; Vasyuk, Y.; Vatutin, M.; Vered, Z.; Vergoni, W.; Vertkine, A.; Vigholt, E.; Vishnevskiy, A.; Voegelin, H.-P.; Voipio-Pulkki, L. M.; Von Mengden, H.-J.; Waites, J.; Watson, R. D. S.; Weiss, A. T.; Werner, H. A.; Wesdorp, J. C. L.; White, H.; Wiggers, P.; Wilcox, R. G.; Wilkinson, P.; Willems, A. R.; Willenbrock, R.; Wirth, M.; Wojciechowski, D.; Worth, H.; Wray, R.; Wu, C.-J.; Yakusevich, V. V.; Yang, S.-P.; Yarohno, N.; Zadionchenko, V. S.; Zaleska, T.; Zalewski, M.; Zannad, F.; Zateyshchikov, D.; Zeltin-Abramov, E.; Zeymer, U.; Zimmermann, R.; Albuquerque, D. C.; Alcaino, M.; Allall, O. A.; Beer, N.; Bortman, G.; Botero, R.; Cardoso, J. S.; Carrageta, M.; Carrillo, E.; Carvalho, A. C.; Castano, R.; Ceia, F.; Cesar, L. A. M.; Chevez, E.; Coelho, O. R.; Colombo, H. R.; Corbalan, R.; Doval, H.; Dutra, O.; Franken, R. A.; Gallardo, L.; Garcia, A.; Garcia, J.; Gomez, E. A.; Gomez, E.; Gonzalez, J.; Gonzalez, R. A.; Greque, G. V.; Guzman, L.; Haiek, J. C.; Hernandez, E.; Hominal, M. A.; Isea, J.; Lanas, F.; Leiva, J. L.; Lemus, J.; Llancaqueo, A.; Lopez, N.; Lousada, N.; Maia, L. N.; Maranhao, M. F.; Martinez, J. A.; Martinez, F. A.; Martins, F. A.; Martins, L.; Matadamas, N.; Matiz, H.; Mendoza, I.; Menezes, C.; Moises, O.; Moreira, J. I.; Moura, J. C.; Nicolau, J. C.; Nobrega, J.; Null, D.; Oliveira, M. S.; Palacios, A. O.; Pazin Filho, A.; Perrone, S. V.; Peigas, L. S.; Prieto, J. C.; Junior, A. R.; Rassi, S.; Ribeiro, V. G.; Rico, J. N.; Rivera, J. M.; Robledo, G.; Rodriguez, H.; Rosenthal, J.; Rossi, P. R. F.; Saraiva, J. F.; Soifer, S.; Sosa Liprandi, A.; Torres, H. G.; Uruchurtu, E.; Velasco, R. G.; Velasquez, J. G.; Vita, N.; Waich, S.; Zelaya, F. R.; Abariotis, N.; Abdollah, H.; Abraham, W.; Alaie, D.; Allison, W.; Ameen, A.; Amidi, M.; Anand, I.; Anderson, J. L.; Andreae, G. E.; Aquino, V.; Ballard, W.; Banas, J. S.; Baron, S. B.; Bata, I.; Berk, M. R.; Bhesania, T.; Binkley, P.; Booth, D. C.; Borts, D.; Brookfield, L. A.; Brown, C. S.; Browne, K. F.; Butman, S. M.; Capodilupo, R. C.; Caralis, D. G.; Carr, K. W.; Castan, R.; Chadow, H.; Chalavarya, G. K.; Chua, G. L.; Cinderella, J. A.; Clavette, P.; Clemson, B. S.; Cohen, T. J.; Colfer, H. T.; Corder, C. N.; Courtade, D. J.; Courtney, D. L.; Coutu, B.; Cucher, F. H.; Czarnecki, W.; Danisa, K.; D'Astous, M.; Dauber, I.; Davies, R.; Deedwania, P. C.; Delehanty, J. M.; Denny, D. M.; Denys, B. G.; DeYoung, P. J. P.; Dion, D.; Donohue, T. J.; El Shahawy, M.; Elkayam, U.; Escabi, J.; Essandoh, L. K.; Felicetta, J. V.; Fintel, D.; Fontaine, J. M.; Foster, R. E.; Frank, T. A.; Gin, K.; Goldberg, M. C.; Goldman, S.; Gossard, D.; Gosselin, G.; Gradman, A. H.; Grandmont, D.; Hack, T.; Hagar, J.; Haikal, M.; Hall, S. A.; Halpern, S.; Hanley, H. G.; Hanovich, G. D.; Hargrove, J. L.; Harlamert, E. A.; Hastings, T. E.; Hathaway, W. R.; Haught, W. H.; Hilliard, G. K.; Hodsden, J.; Hui, W.; Hurley, W.; Ibrahim, H. M.; Jafri, S.; Jain, A.; Jennison, S.; Jesse, R. L.; Joseph, J.; Kalman, J.; Karisberg, R. P.; Khant, R.; Koren, M.; Kosinski, E. J.; Kosolcharoen, P.; Kostuk, W. J.; Kouz, S. M.; Lai, C.; Langholz, D. E.; LeJemtel, T. H.; Leader, R.; Leblanc, M.-H.; Lee, H.; Lepage, S.; Lopez, M.; Lu, D. Y.; Lubelsky, B. J.; Luckasen, G. J.; Ma, P.-T.-S.; MacCallum, C. G.; Madu, E. C.; Maisel, A. S.; Mallis, G. I.; Mann, J. T.; Marr, D. R.; McGrew, F. A., III; McKay, R. J.; Mclellan, B.; Meisner, J.; Meyer, T.; Mikati, I.; Miller, L. A.; Miller, L. W.; Moe, G. W.; Mohiuddin, S. M.; Moir, G. D.; Morgan, A. W.; Morris, A.; Murphy, B. J.; Nallasivan, M.; Narula, J.; Nicklas, J. M.; Niederman, A. L.; Nitkin, R.; O'Keefe, J. H.; Oken, K. R.; O'Neill, P. G.; Orchard, R. C.; O'Riordan, W. D.; Paraboschi, C. F.; Patel, R. I.; Pennock, G.; Pesant, Y.; Phaneuf, D.; Phillips, D. F.; Plehn, J.; Promisloff, S.; Rajakumar, A. J.; Ramadurai, R.; Rashkow, A.; Rauh, R. A.; Rebane, T. M.; Riba, A. L.; Richard, C.; Riddle, J. C.; Ringuette, G.; Rivera, E.; Rockson, S.; Rogers, E.; Ross, H.; Roux, R.; Rupka, D.; Saenz, A.; Sampson, J.; Schulman, S. P.; Schuyler, G.; Sequeira, R. F.; Shah, A. R.; Shah, P. K.; Shakar, S. F.; Shalev, Y.; Sheikh, K. H.; Shettigar, U. R.; Siegel, R. M.; Sigal, S. L.; Singh, V. N.; Sotolongo, C. M.; Soucier, R. J.; Stagaman, D. J.; Stephan, W. J.; Stine, M.; Stoever, W. W.; Talano, J. V.; Tan, J. L.; Tanser, P. H.; Taussig, A. S.; Thadani, U.; Timmis, S. B. H.; Timothee, J. R.; Tragoon, S.; Tremblay, B.; Upadhya, K. J.; Vijay, N. K.; Wagoner, L. E.; Walker, J. L.; Wickemeyer, W. J.; Williams, G. A.; Williams, M. B.; Williams, R. E.; Wiseman, A. H.; Wool, K. J.; Yasin, M.; Zabalgoitia, M.; Zarich, S.; Zimmermann, R.; Zucker, R. P.</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">348</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">1309-1321</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">Background: Aldosterone blockade reduces mortality and morbidity among patients with severe heart failure.  We conducted a double-blind, placebo-controlled study evaluating the effect of eplerenone, a selective aldosterone blocker, on morbidity and mortality among patients with acute myocardial infarction complicated by left ventricular dysfunction and heart failure.  Methods: Patients were randomly assigned to eplerenone (25 mg per day initially, titrated to a max. of 50 mg per day; 3313 patients) or placebo (3319 patients) in addn. to optimal medical therapy.  The study continued until 1012 deaths occurred.  The primary end points were death from any cause and death from cardiovascular causes or hospitalization for heart failure, acute myocardial infarction, stroke, or ventricular arrhythmia.  Results: During a mean follow-up of 16 mo, there were 478 deaths in the eplerenone group and 554 deaths in the placebo group (relative risk, 0.85; 95 percent confidence interval, 0.75 to 0.96; P=0.008).  Of these deaths, 407 in the eplerenone group and 483 in the placebo group were attributed to cardiovascular causes (relative risk, 0.83; 95 percent confidence interval, 0.72 to 0.94; P= 0.005).  The rate of the other primary end point, death from cardiovascular causes or hospitalization for cardiovascular events, was reduced by eplerenone (relative risk, 0.87; 95 percent confidence interval, 0.79 to 0.95; P=0.002), as was the secondary end point of death from any cause or any hospitalization (relative risk, 0.92; 95 percent confidence interval, 0.86 to 0.98; P=0.02).  There was also a redn. in the rate of sudden death from cardiac causes (relative risk, 0.79; 95 percent confidence interval, 0.64 to 0.97; P=0.03).  The rate of serious hyperkalemia was 5.5 percent in the eplerenone group and 3.9 percent in the placebo group (P=0.002), whereas the rate of hypokalemia was 8.4 percent in the eplerenone group and 13.1 percent in the placebo group (P<0.001).  Conclusions: The addn. of eplerenone to optimal medical therapy reduces morbidity and mortality among patients with acute myocardial infarction complicated by left ventricular dysfunction and heart failure.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoTXvg9fCdjlrVg90H21EOLACvtfcHk0lg4rwmXs76GIA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXis1ehurY%253D&md5=cee432bc75bcca5f33098fe3bc8575df</span></div><a href="/servlet/linkout?suffix=cit5b&amp;dbid=16384&amp;doi=10.1056%2FNEJMoa030207&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMoa030207%26sid%3Dliteratum%253Aachs%26aulast%3DPitt%26aufirst%3DB.%26aulast%3DRemme%26aufirst%3DW.%26aulast%3DZannad%26aufirst%3DF.%26aulast%3DNeaton%26aufirst%3DJ.%26aulast%3DMartinez%26aufirst%3DF.%26aulast%3DRoniker%26aufirst%3DB.%26aulast%3DBittman%26aufirst%3DR.%26aulast%3DHurley%26aufirst%3DS.%26aulast%3DKleiman%26aufirst%3DJ.%26aulast%3DGatlin%26aufirst%3DM.%26atitle%3DEplerenone%252C%2520a%2520selective%2520aldosterone%2520blocker%252C%2520in%2520patients%2520with%2520left%2520ventricular%2520dysfunction%2520after%2520myocardial%2520infarction%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2003%26volume%3D348%26spage%3D1309%26epage%3D1321" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit5c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Hu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McMahon, E. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lala, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rudolph, A. E.</span><span> </span><span class="NLM_article-title">Molecular mechanisms of mineralocorticoid receptor antagonism by eplerenone</span> <span class="citation_source-journal">Mini-Rev. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">709</span><span class="NLM_x">–</span> <span class="NLM_lpage">718</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2005&pages=709-718&author=X.+Huauthor=S.+Liauthor=E.+G.+McMahonauthor=D.+S.+Lalaauthor=A.+E.+Rudolph&title=Molecular+mechanisms+of+mineralocorticoid+receptor+antagonism+by+eplerenone"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHu%26aufirst%3DX.%26aulast%3DLi%26aufirst%3DS.%26aulast%3DMcMahon%26aufirst%3DE.%2BG.%26aulast%3DLala%26aufirst%3DD.%2BS.%26aulast%3DRudolph%26aufirst%3DA.%2BE.%26atitle%3DMolecular%2520mechanisms%2520of%2520mineralocorticoid%2520receptor%2520antagonism%2520by%2520eplerenone%26jtitle%3DMini-Rev.%2520Med.%2520Chem.%26date%3D2005%26volume%3D5%26spage%3D709%26epage%3D718" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Mehdi, U. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adams-Huet, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raskin, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vega, G. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toto, R. D.</span><span> </span><span class="NLM_article-title">Addition of angiotensin receptor blockade or mineralocorticoid antagonism to maximal angiotensin-converting enzyme inhibition in diabetic nephropathy</span> <span class="citation_source-journal">J. Am. Soc. Nephrol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">2641</span><span class="NLM_x">–</span> <span class="NLM_lpage">2650</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6a&amp;dbid=16&amp;doi=10.1021%2Fjm100505n&amp;key=10.1681%2FASN.2009070737" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6a&amp;dbid=8&amp;doi=10.1021%2Fjm100505n&amp;key=19926893" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6a&amp;dbid=32&amp;doi=10.1021%2Fjm100505n&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhs1Witb3P" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2009&pages=2641-2650&author=U.+F.+Mehdiauthor=B.+Adams-Huetauthor=P.+Raskinauthor=G.+L.+Vegaauthor=R.+D.+Toto&title=Addition+of+angiotensin+receptor+blockade+or+mineralocorticoid+antagonism+to+maximal+angiotensin-converting+enzyme+inhibition+in+diabetic+nephropathy"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6aR"><div class="casContent"><span class="casTitleNuber">6a</span><div class="casTitle"><span class="NLM_cas:atitle">Addition of angiotensin receptor blockade or mineralocorticoid antagonism to maximal angiotensin-converting enzyme inhibition in diabetic nephropathy</span></div><div class="casAuthors">Mehdi, Uzma F.; Adams-Huet, Beverley; Raskin, Philip; Vega, Gloria L.; Toto, Robert D.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Society of Nephrology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">2641-2650</span>CODEN:
                <span class="NLM_cas:coden">JASNEU</span>;
        ISSN:<span class="NLM_cas:issn">1046-6673</span>.
    
            (<span class="NLM_cas:orgname">American Society of Nephrology</span>)
        </div><div class="casAbstract">Aldosterone promotes glomerular and tubular sclerosis independent of angiotensin II in animal models of diabetic nephropathy.  Most human studies testing the renoprotective benefit of adding an angiotensin receptor blocker or a mineralocorticoid receptor antagonist to a regimen based on inhibition of angiotensin-converting enzyme (ACE) used relatively low doses of ACE inhibitors.  Furthermore, these studies did not det. whether antiproteinuric effects were independent of BP lowering.  We conducted a double-blind, placebo-controlled trial in 81 patients with diabetes, hypertension, and albuminuria (urine albumin-to-creatinine ratio ≥300 mg/g) who all received lisinopril (80 mg once daily).  We randomly assigned the patients to placebo, losartan (100 mg daily), or spironolactone (25 mg daily) for 48 wk.  We obtained blood and urine albumin, urea, creatinine, electrolytes, A1c, and ambulatory BP at baseline, 24, and 48 wk.  Compared with placebo, the urine albumin-to-creatinine ratio decreased by 34.0% (95% CI, -51.0%, -11.2%, P = 0.007) in the group assigned to spironolactone and by 16.8% (95% CI, -37.3%, +10.5%, P = 0.20) in the group assigned to losartan.  Clinic and ambulatory BP, creatinine clearance, sodium and protein intake, and glycemic control did not differ between groups.  Serum potassium level was significantly higher with the addn. of either spironolactone or losartan.  In conclusion, the addn. of spironolactone, but not losartan, to a regimen including maximal ACE inhibition affords greater renoprotection in diabetic nephropathy despite a similar effect on BP.  These results support the need to conduct a long-term, large-scale, renal failure outcomes trial.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpBfOkzs-qpvrVg90H21EOLACvtfcHk0lg4rwmXs76GIA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhs1Witb3P&md5=311c4cb35c7cc5458aefd79b1398362f</span></div><a href="/servlet/linkout?suffix=cit6a&amp;dbid=16384&amp;doi=10.1681%2FASN.2009070737&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1681%252FASN.2009070737%26sid%3Dliteratum%253Aachs%26aulast%3DMehdi%26aufirst%3DU.%2BF.%26aulast%3DAdams-Huet%26aufirst%3DB.%26aulast%3DRaskin%26aufirst%3DP.%26aulast%3DVega%26aufirst%3DG.%2BL.%26aulast%3DToto%26aufirst%3DR.%2BD.%26atitle%3DAddition%2520of%2520angiotensin%2520receptor%2520blockade%2520or%2520mineralocorticoid%2520antagonism%2520to%2520maximal%2520angiotensin-converting%2520enzyme%2520inhibition%2520in%2520diabetic%2520nephropathy%26jtitle%3DJ.%2520Am.%2520Soc.%2520Nephrol.%26date%3D2009%26volume%3D20%26spage%3D2641%26epage%3D2650" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit6b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Williams, G. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burgess, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kolloch, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ruilope, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Niegowska, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kipnes, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roniker, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patrick, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krause, S. L.</span><span> </span><span class="NLM_article-title">Efficacy of eplerenone versus enalapril as monotherapy in systemic hypertension</span> <span class="citation_source-journal">Clin. Exp. Pharmacol. Physiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">33</span><span class="NLM_x">, </span> <span class="NLM_fpage">990</span><span class="NLM_x">–</span> <span class="NLM_lpage">996</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6b&amp;dbid=16&amp;doi=10.1021%2Fjm100505n&amp;key=10.1111%2Fj.1440-1681.2006.04354.x" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2006&pages=990-996&author=G.+H.+Williamsauthor=E.+Burgessauthor=R.+E.+Kollochauthor=L.+M.+Ruilopeauthor=J.+Niegowskaauthor=M.+S.+Kipnesauthor=B.+Ronikerauthor=J.+L.+Patrickauthor=S.+L.+Krause&title=Efficacy+of+eplerenone+versus+enalapril+as+monotherapy+in+systemic+hypertension"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6b&amp;dbid=16384&amp;doi=10.1111%2Fj.1440-1681.2006.04354.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1440-1681.2006.04354.x%26sid%3Dliteratum%253Aachs%26aulast%3DWilliams%26aufirst%3DG.%2BH.%26aulast%3DBurgess%26aufirst%3DE.%26aulast%3DKolloch%26aufirst%3DR.%2BE.%26aulast%3DRuilope%26aufirst%3DL.%2BM.%26aulast%3DNiegowska%26aufirst%3DJ.%26aulast%3DKipnes%26aufirst%3DM.%2BS.%26aulast%3DRoniker%26aufirst%3DB.%26aulast%3DPatrick%26aufirst%3DJ.%2BL.%26aulast%3DKrause%26aufirst%3DS.%2BL.%26atitle%3DEfficacy%2520of%2520eplerenone%2520versus%2520enalapril%2520as%2520monotherapy%2520in%2520systemic%2520hypertension%26jtitle%3DClin.%2520Exp.%2520Pharmacol.%2520Physiol.%26date%3D2006%26volume%3D33%26spage%3D990%26epage%3D996" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group">De Gasparo, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Whitebread, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Preiswerk, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jeunemaitre, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Corvol, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Menard, J.</span><span> </span><span class="NLM_article-title">Antialdosterones: incidence and prevention of sexual side effects</span> <span class="citation_source-journal">J. Steroid Biochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1989</span><span class="NLM_x">, </span> <span class="NLM_volume">32</span><span class="NLM_x"> (</span><span class="NLM_issue">1B</span><span class="NLM_x">) </span> <span class="NLM_fpage">223</span><span class="NLM_x">–</span> <span class="NLM_lpage">227</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Fjm100505n&amp;key=10.1016%2F0022-4731%2889%2990169-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Fjm100505n&amp;key=2913412" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Fjm100505n&amp;key=1%3ACAS%3A528%3ADyaL1MXht1yktbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=1989&pages=223-227&issue=1B&author=M.+De+Gasparoauthor=S.+E.+Whitebreadauthor=G.+Preiswerkauthor=X.+Jeunemaitreauthor=P.+Corvolauthor=J.+Menard&title=Antialdosterones%3A+incidence+and+prevention+of+sexual+side+effects"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Antialdosterones:  incidence and prevention of sexual side effects</span></div><div class="casAuthors">De Gasparo, M.; Whitebread, S. E.; Preiswerk, G.; Jeunemaitre, X.; Corvol, P.; Menard, J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Steroid Biochemistry</span>
        (<span class="NLM_cas:date">1989</span>),
    <span class="NLM_cas:volume">32</span>
        (<span class="NLM_cas:issue">1B</span>),
    <span class="NLM_cas:pages">223-7</span>CODEN:
                <span class="NLM_cas:coden">JSTBBK</span>;
        ISSN:<span class="NLM_cas:issn">0022-4731</span>.
    </div><div class="casAbstract">The use of spironolactone in the treatment of hypertension has been limited by the occurrence of sexual effects, mainly menstrual disturbances in women and gynecomastia in men.  To minimize this limitation on the use of an effective K-sparing antihypertensive agent, 2 strategies were proposed: a decrease in the daily dose of spironolactone and improvement in the receptor-binding specificity of spironolactone.  In 182 patients with essential hypertension treated with spironolactone alone for a mean follow-up period of 23 mo, daily doses of 75-100 mg were as effective on blood pressure as doses of 150-300 mg.  In contrast, the development of gynaecomastia (91 cases among 699 men) was dose-related in 6.9% (50 mg/day) to 52.2% (≥150 mg/day) of the cases.  Two 9α,11α-epoxy derivs. were characterized in vitro in rats and in rabbits.  They exhibited a 3-10-fold decrease of the antiandrogenic and progestagenic effect, compared with spironolactone.  In humans, 1 of these derivs., epoxymexrenone (I) counteracted the fall in urinary Na/K ratio induced by 9α-fluorohydrocortisone at a 25 mg dose.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrFvlSJXHUb_rVg90H21EOLACvtfcHk0liw8w7v4klJ-w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL1MXht1yktbk%253D&md5=9800827e17521944a6566df8972960cd</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1016%2F0022-4731%2889%2990169-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0022-4731%252889%252990169-6%26sid%3Dliteratum%253Aachs%26aulast%3DDe%2BGasparo%26aufirst%3DM.%26aulast%3DWhitebread%26aufirst%3DS.%2BE.%26aulast%3DPreiswerk%26aufirst%3DG.%26aulast%3DJeunemaitre%26aufirst%3DX.%26aulast%3DCorvol%26aufirst%3DP.%26aulast%3DMenard%26aufirst%3DJ.%26atitle%3DAntialdosterones%253A%2520incidence%2520and%2520prevention%2520of%2520sexual%2520side%2520effects%26jtitle%3DJ.%2520Steroid%2520Biochem.%26date%3D1989%26volume%3D32%26issue%3D1B%26spage%3D223%26epage%3D227" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="note"><p class="first last">For a recent review, see the following: </p></div><div class="NLM_citation" id="cit8a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Meyers, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hu, X.</span><span> </span><span class="NLM_article-title">Non-steroidal mineralocorticoid receptor antagonists</span> <span class="citation_source-journal">Expert Opin. Ther. Pat.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">17</span><span class="NLM_x">–</span> <span class="NLM_lpage">23</span><div class="note"><p class="first last"> and references therein</p></div></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8a&amp;dbid=16&amp;doi=10.1021%2Fjm100505n&amp;key=10.1517%2F13543776.17.1.17" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8a&amp;dbid=32&amp;doi=10.1021%2Fjm100505n&amp;key=1%3ACAS%3A528%3ADC%252BD2sXitFSqtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2007&pages=17-23&author=M.+J.+Meyersauthor=X.+Hu&title=Non-steroidal+mineralocorticoid+receptor+antagonists"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8aR"><div class="casContent"><span class="casTitleNuber">8a</span><div class="casTitle"><span class="NLM_cas:atitle">Non-steroidal mineralocorticoid receptor antagonists</span></div><div class="casAuthors">Meyers, Marvin J.; Hu, Xiao</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Therapeutic Patents</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">17-23</span>CODEN:
                <span class="NLM_cas:coden">EOTPEG</span>;
        ISSN:<span class="NLM_cas:issn">1354-3776</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  The mineralocorticoid hormone aldosterone is essential in regulating the body's salt and water balance.  However, abnormal activation of the mineralocorticoid receptor (MR) by elevated levels of aldosterone and salt imbalance cause hypertension and other effects detrimental to the cardiovascular system.  Thus, MR antagonists are expected to be beneficial to patients with high blood pressure and other cardiovascular diseases, such as heart failure.  Until recently, only steroidal MR antagonists have been developed for therapeutic use.  However, due to complexity in chem. synthesis, limited scope for selectivity vs. other steroid hormone receptors, and undesirable phys. and chem. properties, appropriate steroidal compds. have been difficult to identify and develop.  Despite > 40 years of research, only two major steroidal MR antagonists, spironolactone and eplerenone, have been brought to the market for the treatment of hypertension and heart failure.  Novel classes of non-steroidal MR antagonists have just begun to emerge over the past few years.  This review summarizes the existing information available on non-steroidal MR antagonists from patent applications and the scientific literature published since 2003.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrLrmKDsJ1HeLVg90H21EOLACvtfcHk0liw8w7v4klJ-w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXitFSqtA%253D%253D&md5=f32f0c05796b3681f3236ad133e0cf24</span></div><a href="/servlet/linkout?suffix=cit8a&amp;dbid=16384&amp;doi=10.1517%2F13543776.17.1.17&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F13543776.17.1.17%26sid%3Dliteratum%253Aachs%26aulast%3DMeyers%26aufirst%3DM.%2BJ.%26aulast%3DHu%26aufirst%3DX.%26atitle%3DNon-steroidal%2520mineralocorticoid%2520receptor%2520antagonists%26jtitle%3DExpert%2520Opin.%2520Ther.%2520Pat.%26date%3D2007%26volume%3D17%26spage%3D17%26epage%3D23" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit8b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Bell, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gernert, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grese, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Belvo, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borromeo, P. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kelley, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kennedy, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kolis, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lander, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Richey, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sharp, V. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stephenson, G. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zimmerman, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steinberg, M. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jadhav, P. K.</span><span> </span><span class="NLM_article-title">(<i>S</i>)-<i>N</i>-{3-[1-Cyclopropyl-1-(2,4-difluoro-phenyl)-ethyl]-1<i>H</i>-indol-7-yl}-methanesulfonamide: a potent, nonsteroidal, functional antagonist of the mineralocorticoid receptor</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">6443</span><span class="NLM_x">–</span> <span class="NLM_lpage">6445</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm701186z" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2007&pages=6443-6445&author=M.+G.+Bellauthor=D.+L.+Gernertauthor=T.+A.+Greseauthor=M.+D.+Belvoauthor=P.+S.+Borromeoauthor=S.+A.+Kelleyauthor=J.+H.+Kennedyauthor=S.+P.+Kolisauthor=P.+A.+Landerauthor=R.+Richeyauthor=V.+S.+Sharpauthor=G.+A.+Stephensonauthor=J.+D.+Williamsauthor=H.+Yuauthor=K.+M.+Zimmermanauthor=M.+I.+Steinbergauthor=P.+K.+Jadhav&title=%28S%29-N-%7B3-%5B1-Cyclopropyl-1-%282%2C4-difluoro-phenyl%29-ethyl%5D-1H-indol-7-yl%7D-methanesulfonamide%3A+a+potent%2C+nonsteroidal%2C+functional+antagonist+of+the+mineralocorticoid+receptor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8b&amp;dbid=16384&amp;doi=10.1021%2Fjm701186z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm701186z%26sid%3Dliteratum%253Aachs%26aulast%3DBell%26aufirst%3DM.%2BG.%26aulast%3DGernert%26aufirst%3DD.%2BL.%26aulast%3DGrese%26aufirst%3DT.%2BA.%26aulast%3DBelvo%26aufirst%3DM.%2BD.%26aulast%3DBorromeo%26aufirst%3DP.%2BS.%26aulast%3DKelley%26aufirst%3DS.%2BA.%26aulast%3DKennedy%26aufirst%3DJ.%2BH.%26aulast%3DKolis%26aufirst%3DS.%2BP.%26aulast%3DLander%26aufirst%3DP.%2BA.%26aulast%3DRichey%26aufirst%3DR.%26aulast%3DSharp%26aufirst%3DV.%2BS.%26aulast%3DStephenson%26aufirst%3DG.%2BA.%26aulast%3DWilliams%26aufirst%3DJ.%2BD.%26aulast%3DYu%26aufirst%3DH.%26aulast%3DZimmerman%26aufirst%3DK.%2BM.%26aulast%3DSteinberg%26aufirst%3DM.%2BI.%26aulast%3DJadhav%26aufirst%3DP.%2BK.%26atitle%3D%2528S%2529-N-%257B3-%255B1-Cyclopropyl-1-%25282%252C4-difluoro-phenyl%2529-ethyl%255D-1H-indol-7-yl%257D-methanesulfonamide%253A%2520a%2520potent%252C%2520nonsteroidal%252C%2520functional%2520antagonist%2520of%2520the%2520mineralocorticoid%2520receptor%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2007%26volume%3D50%26spage%3D6443%26epage%3D6445" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Dietz, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Du, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bolten, C. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Payne, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xia, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blinn, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Funder, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hu, X.</span><span> </span><span class="NLM_article-title">A number of marketed dihydropyridine calcium channel blockers have mineralocorticoid receptor antagonist activity</span> <span class="citation_source-journal">Hypertension</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">42</span><span class="NLM_x">–</span> <span class="NLM_lpage">748</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=42-748&author=J.+D.+Dietzauthor=S.+Duauthor=C.+W.+Boltenauthor=M.+A.+Payneauthor=C.+Xiaauthor=J.+R.+Blinnauthor=J.+W.+Funderauthor=X.+Hu&title=A+number+of+marketed+dihydropyridine+calcium+channel+blockers+have+mineralocorticoid+receptor+antagonist+activity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDietz%26aufirst%3DJ.%2BD.%26aulast%3DDu%26aufirst%3DS.%26aulast%3DBolten%26aufirst%3DC.%2BW.%26aulast%3DPayne%26aufirst%3DM.%2BA.%26aulast%3DXia%26aufirst%3DC.%26aulast%3DBlinn%26aufirst%3DJ.%2BR.%26aulast%3DFunder%26aufirst%3DJ.%2BW.%26aulast%3DHu%26aufirst%3DX.%26atitle%3DA%2520number%2520of%2520marketed%2520dihydropyridine%2520calcium%2520channel%2520blockers%2520have%2520mineralocorticoid%2520receptor%2520antagonist%2520activity%26jtitle%3DHypertension%26date%3D2008%26volume%3D51%26spage%3D42%26epage%3D748" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit9b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Fukumoto, S.; Ohra, T.; Sakamoto, J.</span><span> </span><span class="NLM_article-title">Aldosterone Receptor Antagonists</span>. WO2005/097118, October 20,<span class="NLM_x"> </span><span class="NLM_year">2005</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2005&author=S.+Fukumoto&author=T.+Ohra&author=J.+Sakamoto&title=Aldosterone+Receptor+Antagonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DFukumoto%26aufirst%3DS.%26atitle%3DAldosterone%2520Receptor%2520Antagonists%26date%3D2005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit9c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Bärfacker, L.; Kolkhof, P.; Schlemmer, K.-H.; Grosser, R.; Nitsche, A.; Klein, M.; Münter, K.; Albrecht-Küpper, B.; Hartmann, E.</span><span> </span><span class="NLM_article-title">Substituted 4-Aryl-1,4-dihydro-1,6-naphthyridinamides and Use Thereof</span>. WO2008/104306, September 4,<span class="NLM_x"> </span><span class="NLM_year">2008</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2008&author=L.+B%C3%A4rfacker&author=P.+Kolkhof&author=K.-H.+Schlemmer&author=R.+Grosser&author=A.+Nitsche&author=M.+Klein&author=K.+M%C3%BCnter&author=B.+Albrecht-K%C3%BCpper&author=E.+Hartmann&title=Substituted+4-Aryl-1%2C4-dihydro-1%2C6-naphthyridinamides+and+Use+Thereof"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DB%25C3%25A4rfacker%26aufirst%3DL.%26atitle%3DSubstituted%25204-Aryl-1%252C4-dihydro-1%252C6-naphthyridinamides%2520and%2520Use%2520Thereof%26date%3D2008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit9d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Arhancet, G. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woodard, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dietz, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garland, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wagner, G. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iyanar, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Collins, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blinn, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Numann, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, H.-C.</span><span> </span><span class="NLM_article-title">Stereochemical Requirements for the Mineralocorticoid Receptor Antagonist Activity of Dihydropyridines</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">4300</span><span class="NLM_x">–</span> <span class="NLM_lpage">4304</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm1002827" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=4300-4304&author=G.+B.+Arhancetauthor=S.+S.+Woodardauthor=J.+D.+Dietzauthor=D.+J.+Garlandauthor=G.+M.+Wagnerauthor=K.+Iyanarauthor=J.+T.+Collinsauthor=J.+R.+Blinnauthor=R.+E.+Numannauthor=X.+Huauthor=H.-C.+Huang&title=Stereochemical+Requirements+for+the+Mineralocorticoid+Receptor+Antagonist+Activity+of+Dihydropyridines"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9d&amp;dbid=16384&amp;doi=10.1021%2Fjm1002827&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm1002827%26sid%3Dliteratum%253Aachs%26aulast%3DArhancet%26aufirst%3DG.%2BB.%26aulast%3DWoodard%26aufirst%3DS.%2BS.%26aulast%3DDietz%26aufirst%3DJ.%2BD.%26aulast%3DGarland%26aufirst%3DD.%2BJ.%26aulast%3DWagner%26aufirst%3DG.%2BM.%26aulast%3DIyanar%26aufirst%3DK.%26aulast%3DCollins%26aufirst%3DJ.%2BT.%26aulast%3DBlinn%26aufirst%3DJ.%2BR.%26aulast%3DNumann%26aufirst%3DR.%2BE.%26aulast%3DHu%26aufirst%3DX.%26aulast%3DHuang%26aufirst%3DH.-C.%26atitle%3DStereochemical%2520Requirements%2520for%2520the%2520Mineralocorticoid%2520Receptor%2520Antagonist%2520Activity%2520of%2520Dihydropyridines%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D4300%26epage%3D4304" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit9e"><span><span class="NLM_label">(e) </span><span class="NLM_contrib-group">Arhancet, G. B.; Woodard, S. S.; Iyanar, K.; Case, B. L.; Woerndle, R.; Dietz, J. D.; Garland, D. J.; Collins, J. T.; Payne, M. A.; Blinn, J. R.; Pomposiello, S. I.; Hu, X.; Heron, M. I.; Huang, H.-C.; Lee, L. F.</span><span> </span><span class="NLM_article-title">Discovery of Novel Cyanodihydropyridines as Potent Mineralocorticoid Receptor Antagonists</span>.  <span class="citation_source-journal">J. Med. Chem.</span> DOI: <span class="refDoi"> DOI: 10.1021/jm100506y</span> .</span><div class="citationLinks">[<a href="/doi/10.1021/jm100506y" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Arhancet%2C+G.+B.%3B+Woodard%2C+S.+S.%3B+Iyanar%2C+K.%3B+Case%2C+B.+L.%3B+Woerndle%2C+R.%3B+Dietz%2C+J.+D.%3B+Garland%2C+D.+J.%3B+Collins%2C+J.+T.%3B+Payne%2C+M.+A.%3B+Blinn%2C+J.+R.%3B+Pomposiello%2C+S.+I.%3B+Hu%2C+X.%3B+Heron%2C+M.+I.%3B+Huang%2C+H.-C.%3B+Lee%2C+L.+F.+Discovery+of+Novel+Cyanodihydropyridines+as+Potent+Mineralocorticoid+Receptor+Antagonists.+J.+Med.+Chem.+DOI%3A+10.1021%2Fjm100506y."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9e&amp;dbid=16384&amp;doi=10.1021%2Fjm100506y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm100506y%26sid%3Dliteratum%253Aachs%26aulast%3DArhancet%26aufirst%3DG.%2BB.%26atitle%3DDiscovery%2520of%2520Novel%2520Cyanodihydropyridines%2520as%2520Potent%2520Mineralocorticoid%2520Receptor%2520Antagonists%26jtitle%3DJ.%2520Med.%2520Chem.%26doi%3D10.1021%2Fjm100506y" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="note"><p class="first last">For examples, see the following: </p></div><div class="NLM_citation" id="cit10a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Zhang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Allan, G. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sbriscia, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Linton, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lundeen, S. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sui, Z.</span><span> </span><span class="NLM_article-title">Design, synthesis, and in vivo SAR of a novel series of pyrazolines as potent selective androgen receptor modulators</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">3857</span><span class="NLM_x">–</span> <span class="NLM_lpage">3869</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm0613976" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2007&pages=3857-3869&author=X.+Zhangauthor=X.+Liauthor=G.+F.+Allanauthor=T.+Sbrisciaauthor=O.+Lintonauthor=S.+G.+Lundeenauthor=Z.+Sui&title=Design%2C+synthesis%2C+and+in+vivo+SAR+of+a+novel+series+of+pyrazolines+as+potent+selective+androgen+receptor+modulators"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10a&amp;dbid=16384&amp;doi=10.1021%2Fjm0613976&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0613976%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DLi%26aufirst%3DX.%26aulast%3DAllan%26aufirst%3DG.%2BF.%26aulast%3DSbriscia%26aufirst%3DT.%26aulast%3DLinton%26aufirst%3DO.%26aulast%3DLundeen%26aufirst%3DS.%2BG.%26aulast%3DSui%26aufirst%3DZ.%26atitle%3DDesign%252C%2520synthesis%252C%2520and%2520in%2520vivo%2520SAR%2520of%2520a%2520novel%2520series%2520of%2520pyrazolines%2520as%2520potent%2520selective%2520androgen%2520receptor%2520modulators%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2007%26volume%3D50%26spage%3D3857%26epage%3D3869" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit10b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Zhang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Allan, G. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sbriscia, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Linton, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lundeen, S. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sui, Z.</span><span> </span><span class="NLM_article-title">Serendipitous discovery of novel imidazolopyrazole scaffold as selective androgen receptor modulators</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">439</span><span class="NLM_x">–</span> <span class="NLM_lpage">443</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2007&pages=439-443&author=X.+Zhangauthor=X.+Liauthor=G.+F.+Allanauthor=T.+Sbrisciaauthor=O.+Lintonauthor=S.+G.+Lundeenauthor=Z.+Sui&title=Serendipitous+discovery+of+novel+imidazolopyrazole+scaffold+as+selective+androgen+receptor+modulators"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DLi%26aufirst%3DX.%26aulast%3DAllan%26aufirst%3DG.%2BF.%26aulast%3DSbriscia%26aufirst%3DT.%26aulast%3DLinton%26aufirst%3DO.%26aulast%3DLundeen%26aufirst%3DS.%2BG.%26aulast%3DSui%26aufirst%3DZ.%26atitle%3DSerendipitous%2520discovery%2520of%2520novel%2520imidazolopyrazole%2520scaffold%2520as%2520selective%2520androgen%2520receptor%2520modulators%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2007%26volume%3D17%26spage%3D439%26epage%3D443" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit10c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Jones, D. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stewart, E. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Noe, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kallander, L. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Madauss, K. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thompson, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gray, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoekstra, W. J.</span><span> </span><span class="NLM_article-title">Discovery of non-steroidal mifepristone mimetics: pyrazoline-based PR antagonists</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">3203</span><span class="NLM_x">–</span> <span class="NLM_lpage">3206</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2005&pages=3203-3206&author=D.+G.+Jonesauthor=X.+Liangauthor=E.+L.+Stewartauthor=R.+A.+Noeauthor=L.+S.+Kallanderauthor=K.+P.+Madaussauthor=S.+P.+Williamsauthor=S.+K.+Thompsonauthor=D.+W.+Grayauthor=W.+J.+Hoekstra&title=Discovery+of+non-steroidal+mifepristone+mimetics%3A+pyrazoline-based+PR+antagonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DJones%26aufirst%3DD.%2BG.%26aulast%3DLiang%26aufirst%3DX.%26aulast%3DStewart%26aufirst%3DE.%2BL.%26aulast%3DNoe%26aufirst%3DR.%2BA.%26aulast%3DKallander%26aufirst%3DL.%2BS.%26aulast%3DMadauss%26aufirst%3DK.%2BP.%26aulast%3DWilliams%26aufirst%3DS.%2BP.%26aulast%3DThompson%26aufirst%3DS.%2BK.%26aulast%3DGray%26aufirst%3DD.%2BW.%26aulast%3DHoekstra%26aufirst%3DW.%2BJ.%26atitle%3DDiscovery%2520of%2520non-steroidal%2520mifepristone%2520mimetics%253A%2520pyrazoline-based%2520PR%2520antagonists%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2005%26volume%3D15%26spage%3D3203%26epage%3D3206" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit10d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Combs, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reese, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cornelius, L. A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gunnet, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cryan, E. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Granger, K. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jordan, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Demarest, K. T.</span><span> </span><span class="NLM_article-title">Nonsteroidal progesterone receptor ligands. 2. High-affinity ligands with selectivity for bone cell progesterone receptors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">38</span><span class="NLM_x">, </span> <span class="NLM_fpage">4880</span><span class="NLM_x">–</span> <span class="NLM_lpage">4884</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm00025a004" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=1995&pages=4880-4884&author=D.+W.+Combsauthor=K.+Reeseauthor=L.+A.+M.+Corneliusauthor=J.+W.+Gunnetauthor=E.+V.+Cryanauthor=K.+S.+Grangerauthor=J.+J.+Jordanauthor=K.+T.+Demarest&title=Nonsteroidal+progesterone+receptor+ligands.+2.+High-affinity+ligands+with+selectivity+for+bone+cell+progesterone+receptors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10d&amp;dbid=16384&amp;doi=10.1021%2Fjm00025a004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00025a004%26sid%3Dliteratum%253Aachs%26aulast%3DCombs%26aufirst%3DD.%2BW.%26aulast%3DReese%26aufirst%3DK.%26aulast%3DCornelius%26aufirst%3DL.%2BA.%2BM.%26aulast%3DGunnet%26aufirst%3DJ.%2BW.%26aulast%3DCryan%26aufirst%3DE.%2BV.%26aulast%3DGranger%26aufirst%3DK.%2BS.%26aulast%3DJordan%26aufirst%3DJ.%2BJ.%26aulast%3DDemarest%26aufirst%3DK.%2BT.%26atitle%3DNonsteroidal%2520progesterone%2520receptor%2520ligands.%25202.%2520High-affinity%2520ligands%2520with%2520selectivity%2520for%2520bone%2520cell%2520progesterone%2520receptors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1995%26volume%3D38%26spage%3D4880%26epage%3D4884" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit10e"><span><span class="NLM_label">(e) </span><span class="NLM_contrib-group">Stauffer, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, Y. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aron, Z. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coletta, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Katzenellenbogen, B. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Katzenellenbogen, J. A.</span><span> </span><span class="NLM_article-title">Triarylpyrazoles with basic side chains: development of pyrazole-based estrogen receptor antagonists</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">151</span><span class="NLM_x">–</span> <span class="NLM_lpage">161</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2001&pages=151-161&author=S.+R.+Staufferauthor=Y.+R.+Huangauthor=Z.+A.+Aronauthor=C.+J.+Colettaauthor=J.+Sunauthor=B.+S.+Katzenellenbogenauthor=J.+A.+Katzenellenbogen&title=Triarylpyrazoles+with+basic+side+chains%3A+development+of+pyrazole-based+estrogen+receptor+antagonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10e&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DStauffer%26aufirst%3DS.%2BR.%26aulast%3DHuang%26aufirst%3DY.%2BR.%26aulast%3DAron%26aufirst%3DZ.%2BA.%26aulast%3DColetta%26aufirst%3DC.%2BJ.%26aulast%3DSun%26aufirst%3DJ.%26aulast%3DKatzenellenbogen%26aufirst%3DB.%2BS.%26aulast%3DKatzenellenbogen%26aufirst%3DJ.%2BA.%26atitle%3DTriarylpyrazoles%2520with%2520basic%2520side%2520chains%253A%2520development%2520of%2520pyrazole-based%2520estrogen%2520receptor%2520antagonists%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2001%26volume%3D9%26spage%3D151%26epage%3D161" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Dahl, L. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heine, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tassinari, L.</span><span> </span><span class="NLM_article-title">Effects of chronic excess salt ingestion. Evidence that genetic factors play an important role in susceptibility to experimental hypertension</span> <span class="citation_source-journal">J. Exp. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1962</span><span class="NLM_x">, </span> <span class="NLM_volume">115</span><span class="NLM_x">, </span> <span class="NLM_fpage">1173</span><span class="NLM_x">–</span> <span class="NLM_lpage">1190</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=115&publication_year=1962&pages=1173-1190&author=L.+K.+Dahlauthor=M.+Heineauthor=L.+Tassinari&title=Effects+of+chronic+excess+salt+ingestion.+Evidence+that+genetic+factors+play+an+important+role+in+susceptibility+to+experimental+hypertension"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDahl%26aufirst%3DL.%2BK.%26aulast%3DHeine%26aufirst%3DM.%26aulast%3DTassinari%26aufirst%3DL.%26atitle%3DEffects%2520of%2520chronic%2520excess%2520salt%2520ingestion.%2520Evidence%2520that%2520genetic%2520factors%2520play%2520an%2520important%2520role%2520in%2520susceptibility%2520to%2520experimental%2520hypertension%26jtitle%3DJ.%2520Exp.%2520Med.%26date%3D1962%26volume%3D115%26spage%3D1173%26epage%3D1190" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit11b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Meyers, M. J.; Arhancet, G. B.; Chen, X.; Hockerman, S. L.; Long, S. A.; Mahoney, M. W.; Reitz, D. B.; Rico, J. G.</span><span> </span><span class="NLM_article-title">Pyrazoline Compounds as Mineralocorticoid Receptor Antagonists</span>. WO 2008/053300, May 8,<span class="NLM_x"> </span><span class="NLM_year">2008</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2008&author=M.+J.+Meyers&author=G.+B.+Arhancet&author=X.+Chen&author=S.+L.+Hockerman&author=S.+A.+Long&author=M.+W.+Mahoney&author=D.+B.+Reitz&author=J.+G.+Rico&title=Pyrazoline+Compounds+as+Mineralocorticoid+Receptor+Antagonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DMeyers%26aufirst%3DM.%2BJ.%26atitle%3DPyrazoline%2520Compounds%2520as%2520Mineralocorticoid%2520Receptor%2520Antagonists%26date%3D2008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group">Hultman, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krasnoperova, N. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Du, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xia, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dietz, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lala, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Welsch, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hu, X.</span><span> </span><span class="NLM_article-title">The ligand-dependent interaction of mineralocorticoid receptor with coactivator and corepressor peptides suggests multiple activation mechanisms</span> <span class="citation_source-journal">Mol. Endocrinol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">1460</span><span class="NLM_x">–</span> <span class="NLM_lpage">1473</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Fjm100505n&amp;key=10.1210%2Fme.2004-0537" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Fjm100505n&amp;key=15761029" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Fjm100505n&amp;key=1%3ACAS%3A528%3ADC%252BD2MXkslyqtrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2005&pages=1460-1473&author=M.+L.+Hultmanauthor=N.+V.+Krasnoperovaauthor=S.+Liauthor=S.+Duauthor=C.+Xiaauthor=J.+D.+Dietzauthor=D.+S.+Lalaauthor=D.+J.+Welschauthor=X.+Hu&title=The+ligand-dependent+interaction+of+mineralocorticoid+receptor+with+coactivator+and+corepressor+peptides+suggests+multiple+activation+mechanisms"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">The ligand-dependent interaction of mineralocorticoid receptor with coactivator and corepressor peptides suggests multiple activation mechanisms</span></div><div class="casAuthors">Hultman, Monica L.; Krasnoperova, Nataliia V.; Li, Suzhen; Du, Sarah; Xia, Chunsheng; Dietz, Jessica D.; Lala, Deepak S.; Welsch, Dean J.; Hu, Xiao</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Endocrinology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1460-1473</span>CODEN:
                <span class="NLM_cas:coden">MOENEN</span>;
        ISSN:<span class="NLM_cas:issn">0888-8809</span>.
    
            (<span class="NLM_cas:orgname">Endocrine Society</span>)
        </div><div class="casAbstract">We investigated the coregulator (coactivator and corepressor) interactions with the mineralocorticoid receptor (MR) that lead to activation and inhibition of the receptor in the presence of agonist and/or antagonist.  Our results indicate that MR ligand binding domain (LBD) interacts strongly with only a few specific coactivator peptides in the presence of the agonist aldosterone and that these interactions are blocked by the antagonist eplerenone.  We also discovered that cortisol, the preferred physiol. ligand for the glucocorticoid receptor in humans, is a partial MR agonist/antagonist, providing a possible mol. explanation of the tissue-selective effects of glucocorticoids on MR.  However, when we examd. the coactivator and corepressor peptide interactions in the presence of cortisol, we found that MR bound with cortisol or aldosterone interacted with the same set of peptides.  Thus, the partial agonism shown by cortisol is unlikely to be the result of differential interaction with known coactivators and corepressors.  On the other hand, we have identified coactivator binding groove mutations that are crit. for cortisol activation but not for aldosterone activation, suggesting that the two steroids induce different MR LBD conformations.  In addn., we also show that cortisol becomes full agonist when S810L mutation is introduced in the LBD of MR.  Interestingly, MR antagonists, such as eplerenone and progesterone, become partial agonist/antagonist of S810L but are still able to recruit LXXLL peptides to the mutant receptor.  Together, these findings suggest a model to explain the MR activation by various ligands.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqDY358OY2yLbVg90H21EOLACvtfcHk0lglx1TCihD8nA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXkslyqtrs%253D&md5=f29e9129e4dc69f90c71a4c41335aa5e</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1210%2Fme.2004-0537&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1210%252Fme.2004-0537%26sid%3Dliteratum%253Aachs%26aulast%3DHultman%26aufirst%3DM.%2BL.%26aulast%3DKrasnoperova%26aufirst%3DN.%2BV.%26aulast%3DLi%26aufirst%3DS.%26aulast%3DDu%26aufirst%3DS.%26aulast%3DXia%26aufirst%3DC.%26aulast%3DDietz%26aufirst%3DJ.%2BD.%26aulast%3DLala%26aufirst%3DD.%2BS.%26aulast%3DWelsch%26aufirst%3DD.%2BJ.%26aulast%3DHu%26aufirst%3DX.%26atitle%3DThe%2520ligand-dependent%2520interaction%2520of%2520mineralocorticoid%2520receptor%2520with%2520coactivator%2520and%2520corepressor%2520peptides%2520suggests%2520multiple%2520activation%2520mechanisms%26jtitle%3DMol.%2520Endocrinol.%26date%3D2005%26volume%3D19%26spage%3D1460%26epage%3D1473" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group">Powers, D. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Casebier, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fokas, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ryan, W. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Troth, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coffen, D. L.</span><span> </span><span class="NLM_article-title">Automated parallel synthesis of chalcone-based screening libraries</span> <span class="citation_source-journal">Tetrahedron</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">4085</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=1998&pages=4085&author=D.+G.+Powersauthor=D.+S.+Casebierauthor=D.+Fokasauthor=W.+J.+Ryanauthor=J.+R.+Trothauthor=D.+L.+Coffen&title=Automated+parallel+synthesis+of+chalcone-based+screening+libraries"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPowers%26aufirst%3DD.%2BG.%26aulast%3DCasebier%26aufirst%3DD.%2BS.%26aulast%3DFokas%26aufirst%3DD.%26aulast%3DRyan%26aufirst%3DW.%2BJ.%26aulast%3DTroth%26aufirst%3DJ.%2BR.%26aulast%3DCoffen%26aufirst%3DD.%2BL.%26atitle%3DAutomated%2520parallel%2520synthesis%2520of%2520chalcone-based%2520screening%2520libraries%26jtitle%3DTetrahedron%26date%3D1998%26volume%3D54%26spage%3D4085" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Bach, K. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">El-Seedi, H. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jensen, H. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nielsen, H. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomsen, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Torssell, K. B. G.</span><span> </span><span class="NLM_article-title">1,3-Dipolar cycloadditions of ethoxycarbonyl-nitrile benzylimine, EtOOC≡CN<sup>+</sup>−N<sup>−</sup>CH<sub>2</sub>C<sub>6</sub>H<sub>5</sub>, and synthesis of β-amino acids. Synthesis and reactions of ethyl 2-chloro-2-ethoxyacetate and 2-chloro-2-ethoxyacetyl chloride</span> <span class="citation_source-journal">Tetrahedron</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">7543</span><span class="NLM_x">–</span> <span class="NLM_lpage">7556</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=1994&pages=7543-7556&author=K.+K.+Bachauthor=H.+R.+El-Seediauthor=H.+M.+Jensenauthor=H.+B.+Nielsenauthor=I.+Thomsenauthor=K.+B.+G.+Torssell&title=1%2C3-Dipolar+cycloadditions+of+ethoxycarbonyl-nitrile+benzylimine%2C+EtOOC%E2%89%A1CN%2B%E2%88%92N%E2%88%92CH2C6H5%2C+and+synthesis+of+%CE%B2-amino+acids.+Synthesis+and+reactions+of+ethyl+2-chloro-2-ethoxyacetate+and+2-chloro-2-ethoxyacetyl+chloride"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBach%26aufirst%3DK.%2BK.%26aulast%3DEl-Seedi%26aufirst%3DH.%2BR.%26aulast%3DJensen%26aufirst%3DH.%2BM.%26aulast%3DNielsen%26aufirst%3DH.%2BB.%26aulast%3DThomsen%26aufirst%3DI.%26aulast%3DTorssell%26aufirst%3DK.%2BB.%2BG.%26atitle%3D1%252C3-Dipolar%2520cycloadditions%2520of%2520ethoxycarbonyl-nitrile%2520benzylimine%252C%2520EtOOC%25E2%2589%25A1CN%252B%25E2%2588%2592N%25E2%2588%2592CH2C6H5%252C%2520and%2520synthesis%2520of%2520%25CE%25B2-amino%2520acids.%2520Synthesis%2520and%2520reactions%2520of%2520ethyl%25202-chloro-2-ethoxyacetate%2520and%25202-chloro-2-ethoxyacetyl%2520chloride%26jtitle%3DTetrahedron%26date%3D1994%26volume%3D50%26spage%3D7543%26epage%3D7556" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit14b"><span><span class="NLM_label">(b) </span><div class="note"><p class="first last">For a general review of nitrilimine cycloadditions, see the following:</p></div> <span class="citation_source-book">1,3-Dipolar Cycloaddition Chemistry</span>; <span class="NLM_contrib-group">Padwa, A.</span>, Ed.; <span class="NLM_publisher-name">Wiley</span>: <span class="NLM_publisher-loc">New York</span>,<span class="NLM_x"> </span><span class="NLM_year">1984</span><span class="NLM_x">; </span>Chapter 7.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1984&author=A.+Padwa&title=1%2C3-Dipolar+Cycloaddition+Chemistry"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26btitle%3D1%252C3-Dipolar%2520Cycloaddition%2520Chemistry%26aulast%3DPadwa%26aufirst%3DA.%26pub%3DWiley%26date%3D1984" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit14c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Manyem, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sibi, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lushington, G. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neuenswander, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schoenen, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aubé, J.</span><span> </span><span class="NLM_article-title">Solution-phase parallel synthesis of a library of Δ<sup>2</sup>-pyrazolines</span> <span class="citation_source-journal">J. Comb. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">20</span><span class="NLM_x">–</span> <span class="NLM_lpage">28</span></span><div class="citationLinks">[<a href="/doi/10.1021/cc0601175" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref14/cit14c&amp;dbid=32&amp;doi=10.1021%2Fjm100505n&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtFOmtLrO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2007&pages=20-28&author=S.+Manyemauthor=M.+P.+Sibiauthor=G.+H.+Lushingtonauthor=B.+Neuenswanderauthor=F.+Schoenenauthor=J.+Aub%C3%A9&title=Solution-phase+parallel+synthesis+of+a+library+of+%CE%942-pyrazolines"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14cR"><div class="casContent"><span class="casTitleNuber">14c</span><div class="casTitle"><span class="NLM_cas:atitle">Solution-Phase Parallel Synthesis of a Library of Δ2-Pyrazolines</span></div><div class="casAuthors">Manyem, Shankar; Sibi, Mukund P.; Lushington, Gerald H.; Neuenswander, Benjamin; Schoenen, Frank; Aube, Jeffrey</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Combinatorial Chemistry</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">20-28</span>CODEN:
                <span class="NLM_cas:coden">JCCHFF</span>;
        ISSN:<span class="NLM_cas:issn">1520-4766</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A parallel synthesis of a library (80 members) of 2-pyrazolines in soln. phase is described.  The 2-pyrazoline core was accessed through the [3 + 2] cycloaddn. of nitrilimines R1CX:NNHR2 (R1 = Ph, 3-MeC6H4, 3-ClC6H4, 4-FC6H4; R2 = Ph, X = Cl; R2 = 4-BrC6H4, X = Br) with enoyl oxazolidinones I (R3 = Me, Et, Ph, 4-ClC6H4, 4-FC6H4, 4-O2NC6H4, 2-MeOC6H4).  The cycloaddn. provided two regioisomers, the major product being the C regioisomer II.  The oxazolidinone moiety was further reduced to the primary alc., producing another library of 5-hydroxymethyl-2-pyrazolines.  The Lipinski profiles and calcd. ADME properties of the compds. are also reported.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrQth4QgyJqCrVg90H21EOLACvtfcHk0lhlu91TfjoGIQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtFOmtLrO&md5=fb752e9bc6f11dc7b2b97c3f488e5494</span></div><a href="/servlet/linkout?suffix=cit14c&amp;dbid=16384&amp;doi=10.1021%2Fcc0601175&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcc0601175%26sid%3Dliteratum%253Aachs%26aulast%3DManyem%26aufirst%3DS.%26aulast%3DSibi%26aufirst%3DM.%2BP.%26aulast%3DLushington%26aufirst%3DG.%2BH.%26aulast%3DNeuenswander%26aufirst%3DB.%26aulast%3DSchoenen%26aufirst%3DF.%26aulast%3DAub%25C3%25A9%26aufirst%3DJ.%26atitle%3DSolution-phase%2520parallel%2520synthesis%2520of%2520a%2520library%2520of%2520%25CE%25942-pyrazolines%26jtitle%3DJ.%2520Comb.%2520Chem.%26date%3D2007%26volume%3D9%26spage%3D20%26epage%3D28" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group">Foti, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grassi, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Risitano, F.</span><span> </span><span class="NLM_article-title">First synthesis of a bromonitrilimine. Direct formation of 3-bromopyrazole derivatives</span> <span class="citation_source-journal">Tetrahedron Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">40</span><span class="NLM_x">, </span> <span class="NLM_fpage">2605</span><span class="NLM_x">–</span> <span class="NLM_lpage">2606</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=1999&pages=2605-2606&author=F.+Fotiauthor=G.+Grassiauthor=F.+Risitano&title=First+synthesis+of+a+bromonitrilimine.+Direct+formation+of+3-bromopyrazole+derivatives"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFoti%26aufirst%3DF.%26aulast%3DGrassi%26aufirst%3DG.%26aulast%3DRisitano%26aufirst%3DF.%26atitle%3DFirst%2520synthesis%2520of%2520a%2520bromonitrilimine.%2520Direct%2520formation%2520of%25203-bromopyrazole%2520derivatives%26jtitle%3DTetrahedron%2520Lett.%26date%3D1999%26volume%3D40%26spage%3D2605%26epage%3D2606" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group">Freudenberger, J. H.; Lahm, G. P.; Selby, T. P.; Stevenson, T. M.</span><span> </span><span class="NLM_article-title">Substituted Dihydro 3-Halo-1<i>H</i>-pyrazole-5-carboxylates Their Preparation and Use</span>. WO 03/016283, February 27,<span class="NLM_x"> </span><span class="NLM_year">2003</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2003&author=J.+H.+Freudenberger&author=G.+P.+Lahm&author=T.+P.+Selby&author=T.+M.+Stevenson&title=Substituted+Dihydro+3-Halo-1H-pyrazole-5-carboxylates+Their+Preparation+and+Use"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DFreudenberger%26aufirst%3DJ.%2BH.%26atitle%3DSubstituted%2520Dihydro%25203-Halo-1H-pyrazole-5-carboxylates%2520Their%2520Preparation%2520and%2520Use%26date%3D2003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Jamieson, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moir, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rankovic, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wishart, G.</span><span> </span><span class="NLM_article-title">Medicinal chemistry of hERG optimizations: highlights and hang-ups</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">5029</span><span class="NLM_x">–</span> <span class="NLM_lpage">5046</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2006&pages=5029-5046&author=C.+Jamiesonauthor=E.+M.+Moirauthor=Z.+Rankovicauthor=G.+Wishart&title=Medicinal+chemistry+of+hERG+optimizations%3A+highlights+and+hang-ups"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DJamieson%26aufirst%3DC.%26aulast%3DMoir%26aufirst%3DE.%2BM.%26aulast%3DRankovic%26aufirst%3DZ.%26aulast%3DWishart%26aufirst%3DG.%26atitle%3DMedicinal%2520chemistry%2520of%2520hERG%2520optimizations%253A%2520highlights%2520and%2520hang-ups%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D17%26spage%3D5029%26epage%3D5046" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit17b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Jalaie, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holsworth, D. D.</span><span> </span><span class="NLM_article-title">QT interval prolongation: and the beat goes on</span> <span class="citation_source-journal">Mini-Rev. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">1083</span><span class="NLM_x">–</span> <span class="NLM_lpage">1091</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2005&pages=1083-1091&author=M.+Jalaieauthor=D.+D.+Holsworth&title=QT+interval+prolongation%3A+and+the+beat+goes+on"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DJalaie%26aufirst%3DM.%26aulast%3DHolsworth%26aufirst%3DD.%2BD.%26atitle%3DQT%2520interval%2520prolongation%253A%2520and%2520the%2520beat%2520goes%2520on%26jtitle%3DMini-Rev.%2520Med.%2520Chem.%26date%3D2005%26volume%3D5%26spage%3D1083%26epage%3D1091" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit17c"><span><span class="NLM_label">(c) </span><div class="note"><p class="first last">The dofetilide assay was performed as previously reported: </p></div><span class="NLM_contrib-group">Singleton, D. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boyd, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steidl-Nichols, J. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deacon, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Groot, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Price, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nettleton, D. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wallace, N. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Troutman, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boyd, J. G.</span><span> </span><span class="NLM_article-title">Fluorescently labeled analogues of dofetilide as high-affinity fluorescence polarization ligands for the human ether-a-go-go-related gene (hERG) channel</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">2931</span><span class="NLM_x">–</span> <span class="NLM_lpage">2941</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm0700565" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2007&pages=2931-2941&author=D.+H.+Singletonauthor=H.+Boydauthor=J.+V.+Steidl-Nicholsauthor=M.+Deaconauthor=M.+J.+de+Grootauthor=D.+Priceauthor=D.+O.+Nettletonauthor=N.+K.+Wallaceauthor=M.+D.+Troutmanauthor=C.+Williamsauthor=J.+G.+Boyd&title=Fluorescently+labeled+analogues+of+dofetilide+as+high-affinity+fluorescence+polarization+ligands+for+the+human+ether-a-go-go-related+gene+%28hERG%29+channel"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17c&amp;dbid=16384&amp;doi=10.1021%2Fjm0700565&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0700565%26sid%3Dliteratum%253Aachs%26aulast%3DSingleton%26aufirst%3DD.%2BH.%26aulast%3DBoyd%26aufirst%3DH.%26aulast%3DSteidl-Nichols%26aufirst%3DJ.%2BV.%26aulast%3DDeacon%26aufirst%3DM.%26aulast%3Dde%2BGroot%26aufirst%3DM.%2BJ.%26aulast%3DPrice%26aufirst%3DD.%26aulast%3DNettleton%26aufirst%3DD.%2BO.%26aulast%3DWallace%26aufirst%3DN.%2BK.%26aulast%3DTroutman%26aufirst%3DM.%2BD.%26aulast%3DWilliams%26aufirst%3DC.%26aulast%3DBoyd%26aufirst%3DJ.%2BG.%26atitle%3DFluorescently%2520labeled%2520analogues%2520of%2520dofetilide%2520as%2520high-affinity%2520fluorescence%2520polarization%2520ligands%2520for%2520the%2520human%2520ether-a-go-go-related%2520gene%2520%2528hERG%2529%2520channel%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2007%26volume%3D50%26spage%3D2931%26epage%3D2941" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit17d"><span><span class="NLM_label">(d) </span><div class="note"><p class="first last">The hERG patch-clamp assay was performed as previously reported: </p></div><span class="NLM_contrib-group">Volberg, W. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koci, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Su, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zho, J.</span><span> </span><span class="NLM_article-title">Blockade of human cardiac potassium channel human ether-a-go-go-related gene (HERG) by macrolide antibiotics</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">302</span><span class="NLM_x">, </span> <span class="NLM_fpage">320</span><span class="NLM_x">–</span> <span class="NLM_lpage">327</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17d&amp;dbid=16&amp;doi=10.1021%2Fjm100505n&amp;key=10.1124%2Fjpet.302.1.320" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17d&amp;dbid=8&amp;doi=10.1021%2Fjm100505n&amp;key=12065733" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17d&amp;dbid=32&amp;doi=10.1021%2Fjm100505n&amp;key=1%3ACAS%3A528%3ADC%252BD38Xlt1SnsL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=302&publication_year=2002&pages=320-327&author=W.+A.+Volbergauthor=B.+J.+Kociauthor=W.+Suauthor=J.+Linauthor=J.+Zho&title=Blockade+of+human+cardiac+potassium+channel+human+ether-a-go-go-related+gene+%28HERG%29+by+macrolide+antibiotics"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17dR"><div class="casContent"><span class="casTitleNuber">17d</span><div class="casTitle"><span class="NLM_cas:atitle">Blockade of human cardiac potassium channel human ether-a-go-go-related gene (HERG) by macrolide antibiotics</span></div><div class="casAuthors">Volberg, Walter A.; Koci, Bryan J.; Su, Weiguo; Lin, Jing; Zhou, Jun</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">302</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">320-327</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Several macrolides have been reported to cause QT prolongation and ventricular arrhythmias such as torsades de pointes.  To clarify the underlying ionic mechanisms, we examd. the effects of six macrolides on the human ether-a-go-go-related gene (HERG)-encoded potassium current stably expressed in human embryonic kidney-293 cells.  All six drugs showed a concn.-dependent inhibition of the current with the following IC50 values: clarithromycin, 32.9 μM; roxithromycin, 36.5 μM; erythromycin, 72.2 μM; josamycin, 102.4 μM; erythromycylamine, 273.9 μM; and oleandomycin, 339.6 μM.  A metabolite of erythromycin, des-Me erythromycin, was also found to inhibit HERG current with an IC50 of 147.1 μM.  These findings imply that the blockade of HERG may be a common feature of macrolides and may contribute to the QT prolongation obsd. clin. with some of these compds.  Mechanistic studies showed that inhibition of HERG current by clarithromycin did not require activation of the channel and was both voltage- and time-dependent.  The blocking time course could be described by a first-order reaction between the drug and the channel.  Both binding and unbinding processes appeared to speed up as the membrane was more depolarized, indicating that the drug-channel interaction may be affected by electrostatic responses.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqaR7kRksuR47Vg90H21EOLACvtfcHk0ljyN-p5xzx7BQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38Xlt1SnsL4%253D&md5=313db7019efd02abcf6f40db06a433b0</span></div><a href="/servlet/linkout?suffix=cit17d&amp;dbid=16384&amp;doi=10.1124%2Fjpet.302.1.320&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.302.1.320%26sid%3Dliteratum%253Aachs%26aulast%3DVolberg%26aufirst%3DW.%2BA.%26aulast%3DKoci%26aufirst%3DB.%2BJ.%26aulast%3DSu%26aufirst%3DW.%26aulast%3DLin%26aufirst%3DJ.%26aulast%3DZho%26aufirst%3DJ.%26atitle%3DBlockade%2520of%2520human%2520cardiac%2520potassium%2520channel%2520human%2520ether-a-go-go-related%2520gene%2520%2528HERG%2529%2520by%2520macrolide%2520antibiotics%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2002%26volume%3D302%26spage%3D320%26epage%3D327" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group">Li, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suino, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Daugherty, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, H. E.</span><span> </span><span class="NLM_article-title">Structural and biochemical mechanisms for the specificity of hormone binding and coactivator assembly by mineralocorticoid receptor</span> <span class="citation_source-journal">Mol. Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">367</span><span class="NLM_x">–</span> <span class="NLM_lpage">380</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2005&pages=367-380&author=Y.+Liauthor=K.+Suinoauthor=J.+Daughertyauthor=H.+E.+Xu&title=Structural+and+biochemical+mechanisms+for+the+specificity+of+hormone+binding+and+coactivator+assembly+by+mineralocorticoid+receptor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DY.%26aulast%3DSuino%26aufirst%3DK.%26aulast%3DDaugherty%26aufirst%3DJ.%26aulast%3DXu%26aufirst%3DH.%2BE.%26atitle%3DStructural%2520and%2520biochemical%2520mechanisms%2520for%2520the%2520specificity%2520of%2520hormone%2520binding%2520and%2520coactivator%2520assembly%2520by%2520mineralocorticoid%2520receptor%26jtitle%3DMol.%2520Cell%26date%3D2005%26volume%3D19%26spage%3D367%26epage%3D380" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Sun, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robl, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, T. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuhns, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lupisella, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beehler, B. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Golla, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sleph, P. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seethala, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fura, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krystek, S. R.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">An, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malley, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sack, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salvati, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grover, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ostrowski, J. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamann, L. G.</span><span> </span><span class="NLM_article-title">Discovery of potent, orally-active, and muscle-selective androgen receptor modulators based on an <i>N</i>-aryl-hydroxybicyclohydantoin scaffold</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">7596</span><span class="NLM_x">–</span> <span class="NLM_lpage">7599</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm061101w" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=7596-7599&author=C.+Sunauthor=J.+A.+Roblauthor=T.+C.+Wangauthor=Y.+Huangauthor=J.+E.+Kuhnsauthor=J.+A.+Lupisellaauthor=B.+C.+Beehlerauthor=R.+Gollaauthor=P.+G.+Slephauthor=R.+Seethalaauthor=A.+Furaauthor=S.+R.+Krystekauthor=Y.+Anauthor=M.+F.+Malleyauthor=J.+S.+Sackauthor=M.+E.+Salvatiauthor=G.+J.+Groverauthor=J.+O.+Ostrowskiauthor=L.+G.+Hamann&title=Discovery+of+potent%2C+orally-active%2C+and+muscle-selective+androgen+receptor+modulators+based+on+an+N-aryl-hydroxybicyclohydantoin+scaffold"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19a&amp;dbid=16384&amp;doi=10.1021%2Fjm061101w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm061101w%26sid%3Dliteratum%253Aachs%26aulast%3DSun%26aufirst%3DC.%26aulast%3DRobl%26aufirst%3DJ.%2BA.%26aulast%3DWang%26aufirst%3DT.%2BC.%26aulast%3DHuang%26aufirst%3DY.%26aulast%3DKuhns%26aufirst%3DJ.%2BE.%26aulast%3DLupisella%26aufirst%3DJ.%2BA.%26aulast%3DBeehler%26aufirst%3DB.%2BC.%26aulast%3DGolla%26aufirst%3DR.%26aulast%3DSleph%26aufirst%3DP.%2BG.%26aulast%3DSeethala%26aufirst%3DR.%26aulast%3DFura%26aufirst%3DA.%26aulast%3DKrystek%26aufirst%3DS.%2BR.%26aulast%3DAn%26aufirst%3DY.%26aulast%3DMalley%26aufirst%3DM.%2BF.%26aulast%3DSack%26aufirst%3DJ.%2BS.%26aulast%3DSalvati%26aufirst%3DM.%2BE.%26aulast%3DGrover%26aufirst%3DG.%2BJ.%26aulast%3DOstrowski%26aufirst%3DJ.%2BO.%26aulast%3DHamann%26aufirst%3DL.%2BG.%26atitle%3DDiscovery%2520of%2520potent%252C%2520orally-active%252C%2520and%2520muscle-selective%2520androgen%2520receptor%2520modulators%2520based%2520on%2520an%2520N-aryl-hydroxybicyclohydantoin%2520scaffold%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D7596%26epage%3D7599" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit19b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Nirschl, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zou, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krystek, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sutton, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simpkins, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lupisella, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuhns, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seethala, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Golla, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sleph, P. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beehler, B. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grover, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Egan, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fura, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vyas, V. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Y. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sack, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kish, K. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">An, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bryson, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gougoutas, J. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DiMarco, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zahler, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ostrowski, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamann, L. G.</span><span> </span><span class="NLM_article-title"><i>N</i>-Aryl-oxazolidin-2-imine muscle selective androgen receptor modulators enhance potency through pharmacophore reorientation</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">2794</span><span class="NLM_x">–</span> <span class="NLM_lpage">2798</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm801583j" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=2794-2798&author=A.+A.+Nirschlauthor=Y.+Zouauthor=S.+R.+Krystekauthor=J.+C.+Suttonauthor=L.+M.+Simpkinsauthor=J.+A.+Lupisellaauthor=J.+E.+Kuhnsauthor=R.+Seethalaauthor=R.+Gollaauthor=P.+G.+Slephauthor=B.+C.+Beehlerauthor=G.+J.+Groverauthor=D.+Eganauthor=A.+Furaauthor=V.+P.+Vyasauthor=Y.+X.+Liauthor=J.+S.+Sackauthor=K.+F.+Kishauthor=Y.+Anauthor=J.+A.+Brysonauthor=J.+Z.+Gougoutasauthor=J.+DiMarcoauthor=R.+Zahlerauthor=J.+Ostrowskiauthor=L.+G.+Hamann&title=N-Aryl-oxazolidin-2-imine+muscle+selective+androgen+receptor+modulators+enhance+potency+through+pharmacophore+reorientation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19b&amp;dbid=16384&amp;doi=10.1021%2Fjm801583j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm801583j%26sid%3Dliteratum%253Aachs%26aulast%3DNirschl%26aufirst%3DA.%2BA.%26aulast%3DZou%26aufirst%3DY.%26aulast%3DKrystek%26aufirst%3DS.%2BR.%26aulast%3DSutton%26aufirst%3DJ.%2BC.%26aulast%3DSimpkins%26aufirst%3DL.%2BM.%26aulast%3DLupisella%26aufirst%3DJ.%2BA.%26aulast%3DKuhns%26aufirst%3DJ.%2BE.%26aulast%3DSeethala%26aufirst%3DR.%26aulast%3DGolla%26aufirst%3DR.%26aulast%3DSleph%26aufirst%3DP.%2BG.%26aulast%3DBeehler%26aufirst%3DB.%2BC.%26aulast%3DGrover%26aufirst%3DG.%2BJ.%26aulast%3DEgan%26aufirst%3DD.%26aulast%3DFura%26aufirst%3DA.%26aulast%3DVyas%26aufirst%3DV.%2BP.%26aulast%3DLi%26aufirst%3DY.%2BX.%26aulast%3DSack%26aufirst%3DJ.%2BS.%26aulast%3DKish%26aufirst%3DK.%2BF.%26aulast%3DAn%26aufirst%3DY.%26aulast%3DBryson%26aufirst%3DJ.%2BA.%26aulast%3DGougoutas%26aufirst%3DJ.%2BZ.%26aulast%3DDiMarco%26aufirst%3DJ.%26aulast%3DZahler%26aufirst%3DR.%26aulast%3DOstrowski%26aufirst%3DJ.%26aulast%3DHamann%26aufirst%3DL.%2BG.%26atitle%3DN-Aryl-oxazolidin-2-imine%2520muscle%2520selective%2520androgen%2520receptor%2520modulators%2520enhance%2520potency%2520through%2520pharmacophore%2520reorientation%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D2794%26epage%3D2798" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit19c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Bohl, C. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mohler, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hwang, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mustafa, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, D. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bell, C. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dalton, J. T.</span><span> </span><span class="NLM_article-title">Effect of B-ring substitution pattern on binding mode of propionamide selective androgen receptor modulators</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">5567</span><span class="NLM_x">–</span> <span class="NLM_lpage">5570</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2008&pages=5567-5570&author=C.+E.+Bohlauthor=Z.+Wuauthor=J.+Chenauthor=M.+L.+Mohlerauthor=J.+Yangauthor=D.+J.+Hwangauthor=S.+Mustafaauthor=D.+D.+Millerauthor=C.+E.+Bellauthor=J.+T.+Dalton&title=Effect+of+B-ring+substitution+pattern+on+binding+mode+of+propionamide+selective+androgen+receptor+modulators"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBohl%26aufirst%3DC.%2BE.%26aulast%3DWu%26aufirst%3DZ.%26aulast%3DChen%26aufirst%3DJ.%26aulast%3DMohler%26aufirst%3DM.%2BL.%26aulast%3DYang%26aufirst%3DJ.%26aulast%3DHwang%26aufirst%3DD.%2BJ.%26aulast%3DMustafa%26aufirst%3DS.%26aulast%3DMiller%26aufirst%3DD.%2BD.%26aulast%3DBell%26aufirst%3DC.%2BE.%26aulast%3DDalton%26aufirst%3DJ.%2BT.%26atitle%3DEffect%2520of%2520B-ring%2520substitution%2520pattern%2520on%2520binding%2520mode%2520of%2520propionamide%2520selective%2520androgen%2520receptor%2520modulators%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2008%26volume%3D18%26spage%3D5567%26epage%3D5570" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit19d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Ostrowski, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuhns, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lupisella, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Manfredi, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beehler, B. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krystek, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bi, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seethala, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Golla, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sleph, P. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fura, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">An, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kish, K. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sack, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mookhtiar, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grover, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamann, L. G.</span><span> </span><span class="NLM_article-title">Pharmacological and X-ray structural characterization of a novel selective androgen receptor modulator: potent hyperanabolic stimulation of skeletal muscle with hypostimulation of prostate in rats</span> <span class="citation_source-journal">Endocrinolgy</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">148</span><span class="NLM_x">, </span> <span class="NLM_fpage">4</span><span class="NLM_x">–</span> <span class="NLM_lpage">12</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19d&amp;dbid=16&amp;doi=10.1021%2Fjm100505n&amp;key=10.1210%2Fen.2006-0843" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19d&amp;dbid=8&amp;doi=10.1021%2Fjm100505n&amp;key=17008401" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19d&amp;dbid=32&amp;doi=10.1021%2Fjm100505n&amp;key=1%3ACAS%3A528%3ADC%252BD2sXjsV2kug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=148&publication_year=2007&pages=4-12&author=J.+Ostrowskiauthor=J.+E.+Kuhnsauthor=J.+A.+Lupisellaauthor=M.+C.+Manfrediauthor=B.+C.+Beehlerauthor=S.+R.+Krystekauthor=Y.+Biauthor=C.+Sunauthor=R.+Seethalaauthor=R.+Gollaauthor=P.+G.+Slephauthor=A.+Furaauthor=Y.+Anauthor=K.+F.+Kishauthor=J.+S.+Sackauthor=K.+A.+Mookhtiarauthor=G.+J.+Groverauthor=L.+G.+Hamann&title=Pharmacological+and+X-ray+structural+characterization+of+a+novel+selective+androgen+receptor+modulator%3A+potent+hyperanabolic+stimulation+of+skeletal+muscle+with+hypostimulation+of+prostate+in+rats"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19dR"><div class="casContent"><span class="casTitleNuber">19d</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacological and X-ray structural characterization of a novel selective androgen receptor modulator: potent hyperanabolic stimulation of skeletal muscle with hypostimulation of prostate in rats</span></div><div class="casAuthors">Ostrowski, Jacek; Kuhns, Joyce E.; Lupisella, John A.; Manfredi, Mark C.; Beehler, Blake C.; Krystek, Stanley R., Jr.; Bi, Yingzhi; Sun, Chongqing; Seethala, Ramakrishna; Golla, Rajasree; Sleph, Paul G.; Fura, Aberra; An, Yongmi; Kish, Kevin F.; Sack, John S.; Mookhtiar, Kasim A.; Grover, Gary J.; Hamann, Lawrence G.</div><div class="citationInfo"><span class="NLM_cas:title">Endocrinology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">148</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">4-12</span>CODEN:
                <span class="NLM_cas:coden">ENDOAO</span>;
        ISSN:<span class="NLM_cas:issn">0013-7227</span>.
    
            (<span class="NLM_cas:orgname">Endocrine Society</span>)
        </div><div class="casAbstract">A novel, highly potent, orally active, nonsteroidal tissue selective androgen receptor (AR) modulator (BMS-564929) has been identified, and this compd. has been advanced to clin. trials for the treatment of age-related functional decline.  BMS-564929 is a subnanomolar AR agonist in vitro, is highly selective for the AR vs. other steroid hormone receptors, and exhibits no significant interactions with SHBG or aromatase.  Dose response studies in castrated male rats show that BMS-564929 is substantially more potent than testosterone (T) in stimulating the growth of the levator ani muscle, and unlike T, highly selective for muscle vs. prostate.  Key differences in the binding interactions of BMS-564929 with the AR relative to the native hormones were revealed through x-ray crystallog., including several unique contacts located in specific helixes of the ligand binding domain important for coregulatory protein recruitment.  Results from addnl. pharmacol. studies effectively exclude alternative mechanistic contributions to the obsd. tissue selectivity of this unique, orally active androgen.  Because concerns regarding the potential hyperstimulatory effects on prostate and an inconvenient route of administration are major drawbacks that limit the clin. use of T, the potent oral activity and tissue selectivity exhibited by BMS-564929 are expected to yield a clin. profile that provides the demonstrated beneficial effects of T in muscle and other tissues with a more favorable safety window.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoPlMZ4uH6ck7Vg90H21EOLACvtfcHk0ljARG2-BGU0Lw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXjsV2kug%253D%253D&md5=ae52cf587505a3f2e4debf60f9a885d9</span></div><a href="/servlet/linkout?suffix=cit19d&amp;dbid=16384&amp;doi=10.1210%2Fen.2006-0843&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1210%252Fen.2006-0843%26sid%3Dliteratum%253Aachs%26aulast%3DOstrowski%26aufirst%3DJ.%26aulast%3DKuhns%26aufirst%3DJ.%2BE.%26aulast%3DLupisella%26aufirst%3DJ.%2BA.%26aulast%3DManfredi%26aufirst%3DM.%2BC.%26aulast%3DBeehler%26aufirst%3DB.%2BC.%26aulast%3DKrystek%26aufirst%3DS.%2BR.%26aulast%3DBi%26aufirst%3DY.%26aulast%3DSun%26aufirst%3DC.%26aulast%3DSeethala%26aufirst%3DR.%26aulast%3DGolla%26aufirst%3DR.%26aulast%3DSleph%26aufirst%3DP.%2BG.%26aulast%3DFura%26aufirst%3DA.%26aulast%3DAn%26aufirst%3DY.%26aulast%3DKish%26aufirst%3DK.%2BF.%26aulast%3DSack%26aufirst%3DJ.%2BS.%26aulast%3DMookhtiar%26aufirst%3DK.%2BA.%26aulast%3DGrover%26aufirst%3DG.%2BJ.%26aulast%3DHamann%26aufirst%3DL.%2BG.%26atitle%3DPharmacological%2520and%2520X-ray%2520structural%2520characterization%2520of%2520a%2520novel%2520selective%2520androgen%2520receptor%2520modulator%253A%2520potent%2520hyperanabolic%2520stimulation%2520of%2520skeletal%2520muscle%2520with%2520hypostimulation%2520of%2520prostate%2520in%2520rats%26jtitle%3DEndocrinolgy%26date%3D2007%26volume%3D148%26spage%3D4%26epage%3D12" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit19e"><span><span class="NLM_label">(e) </span><span class="NLM_contrib-group">Bohl, C. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gao, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, D. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bell, C. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dalton, J. T.</span><span> </span><span class="NLM_article-title">Structural basis for antagonism and resistance of bicalutamide in prostate cancer</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">102</span><span class="NLM_x">, </span> <span class="NLM_fpage">6201</span><span class="NLM_x">–</span> <span class="NLM_lpage">6206</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19e&amp;dbid=16&amp;doi=10.1021%2Fjm100505n&amp;key=10.1073%2Fpnas.0500381102" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19e&amp;dbid=8&amp;doi=10.1021%2Fjm100505n&amp;key=15833816" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19e&amp;dbid=32&amp;doi=10.1021%2Fjm100505n&amp;key=1%3ACAS%3A528%3ADC%252BD2MXkt1ClsLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=102&publication_year=2005&pages=6201-6206&author=C.+E.+Bohlauthor=W.+Gaoauthor=D.+D.+Millerauthor=C.+E.+Bellauthor=J.+T.+Dalton&title=Structural+basis+for+antagonism+and+resistance+of+bicalutamide+in+prostate+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19eR"><div class="casContent"><span class="casTitleNuber">19e</span><div class="casTitle"><span class="NLM_cas:atitle">Structural basis for antagonism and resistance of bicalutamide in prostate cancer</span></div><div class="casAuthors">Bohl, Casey E.; Gao, Wenqing; Miller, Duane D.; Bell, Charles E.; Dalton, James T.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">102</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">6201-6206</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Carcinoma of the prostate is the most commonly diagnosed cancer in men.  The current pharmacol. treatment of choice for progressive androgen-dependent prostate cancer is the nonsteroidal antiandrogen, bicalutamide, either as monotherapy or with adjuvant castration or LH-releasing hormone superagonists to block the synthesis of endogenous testosterone.  To date, no nonsteroidal or antagonist-bound androgen receptor (AR) structure is available.  The authors solved the x-ray crystal structure of the mutant W741L AR ligand-binding domain bound to R-bicalutamide at 1.8-Å resoln.  This mutation confers agonist activity to bicalutamide and is likely involved in bicalutamide withdrawal syndrome.  The three-dimensional structure demonstrates that the B ring of R-bicalutamide in the W741L mutant is accommodated at the location of the indole ring of Trp-741 in the WT AR bound to dihydrotestosterone.  Knowledge of the binding mechanism for R-bicalutamide will provide mol. rationale for the development of new antiandrogens and selective AR modulators.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrCQ1V6LCoc07Vg90H21EOLACvtfcHk0ljARG2-BGU0Lw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXkt1ClsLs%253D&md5=0ca230450eba66abd4136bfb95928ce0</span></div><a href="/servlet/linkout?suffix=cit19e&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0500381102&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0500381102%26sid%3Dliteratum%253Aachs%26aulast%3DBohl%26aufirst%3DC.%2BE.%26aulast%3DGao%26aufirst%3DW.%26aulast%3DMiller%26aufirst%3DD.%2BD.%26aulast%3DBell%26aufirst%3DC.%2BE.%26aulast%3DDalton%26aufirst%3DJ.%2BT.%26atitle%3DStructural%2520basis%2520for%2520antagonism%2520and%2520resistance%2520of%2520bicalutamide%2520in%2520prostate%2520cancer%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2005%26volume%3D102%26spage%3D6201%26epage%3D6206" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit19f"><span><span class="NLM_label">(f) </span><span class="NLM_contrib-group">Zhang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olland, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cohen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berrodin, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chippari, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Appavu, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilhem, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chopra, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fensome, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wrobel, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Unwalla, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lyttle, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Winneker, R. C.</span><span> </span><span class="NLM_article-title">Molecular and pharmacological properties of a potent and selective novel nonsteroidal progesterone receptor agonist tanaproget</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">280</span><span class="NLM_x">, </span> <span class="NLM_fpage">28468</span><span class="NLM_x">–</span> <span class="NLM_lpage">28475</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=280&publication_year=2005&pages=28468-28475&author=Z.+Zhangauthor=A.+M.+Ollandauthor=Y.+Zhuauthor=J.+Cohenauthor=T.+Berrodinauthor=S.+Chippariauthor=C.+Appavuauthor=S.+Liauthor=J.+Wilhemauthor=R.+Chopraauthor=A.+Fensomeauthor=P.+Zhangauthor=J.+Wrobelauthor=R.+J.+Unwallaauthor=C.+R.+Lyttleauthor=R.+C.+Winneker&title=Molecular+and+pharmacological+properties+of+a+potent+and+selective+novel+nonsteroidal+progesterone+receptor+agonist+tanaproget"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19f&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DZ.%26aulast%3DOlland%26aufirst%3DA.%2BM.%26aulast%3DZhu%26aufirst%3DY.%26aulast%3DCohen%26aufirst%3DJ.%26aulast%3DBerrodin%26aufirst%3DT.%26aulast%3DChippari%26aufirst%3DS.%26aulast%3DAppavu%26aufirst%3DC.%26aulast%3DLi%26aufirst%3DS.%26aulast%3DWilhem%26aufirst%3DJ.%26aulast%3DChopra%26aufirst%3DR.%26aulast%3DFensome%26aufirst%3DA.%26aulast%3DZhang%26aufirst%3DP.%26aulast%3DWrobel%26aufirst%3DJ.%26aulast%3DUnwalla%26aufirst%3DR.%2BJ.%26aulast%3DLyttle%26aufirst%3DC.%2BR.%26aulast%3DWinneker%26aufirst%3DR.%2BC.%26atitle%3DMolecular%2520and%2520pharmacological%2520properties%2520of%2520a%2520potent%2520and%2520selective%2520novel%2520nonsteroidal%2520progesterone%2520receptor%2520agonist%2520tanaproget%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2005%26volume%3D280%26spage%3D28468%26epage%3D28475" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group">Bledsoe, R. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Madauss, K. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holt, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Apolito, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lambert, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pearce, K. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stanley, T. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stewart, E. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trump, R. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Willson, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams., S. P.</span><span> </span><span class="NLM_article-title">A ligand-mediated hydrogen bond network required for the activation of the mineralocorticoid receptor</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">280</span><span class="NLM_x">, </span> <span class="NLM_fpage">31283</span><span class="NLM_x">–</span> <span class="NLM_lpage">31293</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Fjm100505n&amp;key=10.1074%2Fjbc.M504098200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Fjm100505n&amp;key=15967794" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Fjm100505n&amp;key=1%3ACAS%3A528%3ADC%252BD2MXpsVCmu7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=280&publication_year=2005&pages=31283-31293&author=R.+K.+Bledsoeauthor=K.+P.+Madaussauthor=J.+A.+Holtauthor=C.+J.+Apolitoauthor=M.+H.+Lambertauthor=K.+H.+Pearceauthor=T.+B.+Stanleyauthor=E.+L.+Stewartauthor=R.+P.+Trumpauthor=T.+M.+Willsonauthor=S.+P.+Williams.&title=A+ligand-mediated+hydrogen+bond+network+required+for+the+activation+of+the+mineralocorticoid+receptor"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">A Ligand-mediated Hydrogen Bond Network Required for the Activation of the Mineralocorticoid Receptor</span></div><div class="casAuthors">Bledsoe, Randy K.; Madauss, Kevin P.; Holt, Jason A.; Apolito, Christopher J.; Lambert, Millard H.; Pearce, Kenneth H.; Stanley, Thomas B.; Stewart, Eugene L.; Trump, Ryan P.; Willson, Timothy M.; Williams, Shawn P.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">280</span>
        (<span class="NLM_cas:issue">35</span>),
    <span class="NLM_cas:pages">31283-31293</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Ligand binding is the first step in hormone regulation of mineralocorticoid receptor (MR) activity.  Here, the authors report multiple crystal structures of MR (NR3C2) bound to both agonist and antagonists.  These structures combined with mutagenesis studies reveal that maximal receptor activation involves an intricate ligand-mediated hydrogen bond network with Asn770 which serves dual roles: stabilization of the loop preceding the C-terminal activation function-2 helix and direct contact with the hormone ligand.  In addn., most activating ligands hydrogen bond to Thr945 on helix 10.  Structural characterization of the naturally occurring S810L mutant explains how stabilization of a helix 3/helix 5 interaction can circumvent the requirement for this hydrogen bond network.  Taken together, these results explain the potency of MR activation by aldosterone, the weak activation induced by progesterone and the antihypertensive agent spironolactone, and the binding selectivity of cortisol over cortisone.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqE7HiXGk8tJLVg90H21EOLACvtfcHk0ljgGfX7ifao7w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXpsVCmu7g%253D&md5=36afe797ab0337f5309aec7652f45012</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M504098200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M504098200%26sid%3Dliteratum%253Aachs%26aulast%3DBledsoe%26aufirst%3DR.%2BK.%26aulast%3DMadauss%26aufirst%3DK.%2BP.%26aulast%3DHolt%26aufirst%3DJ.%2BA.%26aulast%3DApolito%26aufirst%3DC.%2BJ.%26aulast%3DLambert%26aufirst%3DM.%2BH.%26aulast%3DPearce%26aufirst%3DK.%2BH.%26aulast%3DStanley%26aufirst%3DT.%2BB.%26aulast%3DStewart%26aufirst%3DE.%2BL.%26aulast%3DTrump%26aufirst%3DR.%2BP.%26aulast%3DWillson%26aufirst%3DT.%2BM.%26aulast%3DWilliams.%26aufirst%3DS.%2BP.%26atitle%3DA%2520ligand-mediated%2520hydrogen%2520bond%2520network%2520required%2520for%2520the%2520activation%2520of%2520the%2520mineralocorticoid%2520receptor%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2005%26volume%3D280%26spage%3D31283%26epage%3D31293" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group">Collins, P. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gasiecki, A. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perkins, W. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gullikson, G. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, P. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bauer, R. F.</span><span> </span><span class="NLM_article-title">18-Cycloalkyl analogues of enisoprost</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1989</span><span class="NLM_x">, </span> <span class="NLM_volume">32</span><span class="NLM_x">, </span> <span class="NLM_fpage">1001</span><span class="NLM_x">–</span> <span class="NLM_lpage">1006</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm00125a013" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=1989&pages=1001-1006&author=P.+W.+Collinsauthor=A.+F.+Gasieckiauthor=W.+E.+Perkinsauthor=G.+W.+Gulliksonauthor=P.+H.+Jonesauthor=R.+F.+Bauer&title=18-Cycloalkyl+analogues+of+enisoprost"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1021%2Fjm00125a013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00125a013%26sid%3Dliteratum%253Aachs%26aulast%3DCollins%26aufirst%3DP.%2BW.%26aulast%3DGasiecki%26aufirst%3DA.%2BF.%26aulast%3DPerkins%26aufirst%3DW.%2BE.%26aulast%3DGullikson%26aufirst%3DG.%2BW.%26aulast%3DJones%26aufirst%3DP.%2BH.%26aulast%3DBauer%26aufirst%3DR.%2BF.%26atitle%3D18-Cycloalkyl%2520analogues%2520of%2520enisoprost%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1989%26volume%3D32%26spage%3D1001%26epage%3D1006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group">Koch, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Biggers, M. S.</span><span> </span><span class="NLM_article-title">General preparation of 7-substituted 4-chromanones: synthesis of a potent aldose reductase inhibitor</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">59</span><span class="NLM_x">, </span> <span class="NLM_fpage">1216</span><span class="NLM_x">–</span> <span class="NLM_lpage">1218</span></span><div class="citationLinks">[<a href="/doi/10.1021/jo00084a050" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=1994&pages=1216-1218&author=K.+Kochauthor=M.+S.+Biggers&title=General+preparation+of+7-substituted+4-chromanones%3A+synthesis+of+a+potent+aldose+reductase+inhibitor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1021%2Fjo00084a050&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo00084a050%26sid%3Dliteratum%253Aachs%26aulast%3DKoch%26aufirst%3DK.%26aulast%3DBiggers%26aufirst%3DM.%2BS.%26atitle%3DGeneral%2520preparation%2520of%25207-substituted%25204-chromanones%253A%2520synthesis%2520of%2520a%2520potent%2520aldose%2520reductase%2520inhibitor%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D1994%26volume%3D59%26spage%3D1216%26epage%3D1218" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group">Rodríguez-Iturbe, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferrebuz, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vanegas, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quiroz, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Espinoza, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pons, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vaziri, N. D.</span><span> </span><span class="NLM_article-title">Early treatment with cGMP phosphodiesterase inhibitor ameliorates progression of renal damage</span> <span class="citation_source-journal">Kidney Int.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">68</span><span class="NLM_x">, </span> <span class="NLM_fpage">2131</span><span class="NLM_x">–</span> <span class="NLM_lpage">2142</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Fjm100505n&amp;key=1%3ACAS%3A528%3ADC%252BD2MXht1SgtbbO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=68&publication_year=2005&pages=2131-2142&author=B.+Rodr%C3%ADguez-Iturbeauthor=A.+Ferrebuzauthor=V.+Vanegasauthor=Y.+Quirozauthor=F.+Espinozaauthor=H.+Ponsauthor=N.+D.+Vaziri&title=Early+treatment+with+cGMP+phosphodiesterase+inhibitor+ameliorates+progression+of+renal+damage"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Early treatment with cGMP phosphodiesterase inhibitor ameliorates progression of renal damage</span></div><div class="casAuthors">Rodriguez-Iturbe, Bernardo; Ferrebuz, Atilio; Vanegas, Valentina; Quiroz, Yasmir; Espinoza, Fabiana; Pons, Hector; Vaziri, Nosratola D.</div><div class="citationInfo"><span class="NLM_cas:title">Kidney International</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">68</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">2131-2142</span>CODEN:
                <span class="NLM_cas:coden">KDYIA5</span>;
        ISSN:<span class="NLM_cas:issn">0085-2538</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing, Inc.</span>)
        </div><div class="casAbstract">Chronic renal disease is assocd. with oxidative stress and reduced nitric oxide availability which, in turn, promotes hypertension and further progression of renal damage.  Most actions of nitric oxide are mediated by cyclic 3',5' guanosine monophosphate (cGMP) which is rapidly degraded by phosphodiesterases (PDE).  Therefore, we investigated if inhibition of PDE-5 would retard the progression of chronic renal failure.  We studied rats with 5/6 nephrectomy treated with sildenafil (2.5 mg/kg-1/day-1) in two exptl. protocols.  In the first protocol, we started sildenafil therapy immediately after renal ablation and continued treatment for 8 wk.  Control groups consisted of rats with renal ablation treated with drug-free vehicle and sham-operated rats with and without sildenafil treatment.  In these studies, sildenafil treatment prevented hypertension and deterioration of renal function, reduced histol. damage, inflammation and apoptosis, delayed the onset of proteinuria, and preserved renal capillary integrity.  In the second protocol we compared sildenafil with losartan (7.5 mg/kg-1/day-1) and the combination of both drugs in established renal disease, starting these drugs 4 wk after 5/6 nephrectomy.  Delayed sildenafil treatment failed to improve proteinuria and glomerulosclerosis but ameliorated hypertension and azotemia.  These observations suggest that currently available PDE-5 inhibitors have potential clin. value in the treatment of chronic renal disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpitMKMSUBemLVg90H21EOLACvtfcHk0lgoS_xNB85z0A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXht1SgtbbO&md5=26fe2c91f38e675cdc2ec2081319491a</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRodr%25C3%25ADguez-Iturbe%26aufirst%3DB.%26aulast%3DFerrebuz%26aufirst%3DA.%26aulast%3DVanegas%26aufirst%3DV.%26aulast%3DQuiroz%26aufirst%3DY.%26aulast%3DEspinoza%26aufirst%3DF.%26aulast%3DPons%26aufirst%3DH.%26aulast%3DVaziri%26aufirst%3DN.%2BD.%26atitle%3DEarly%2520treatment%2520with%2520cGMP%2520phosphodiesterase%2520inhibitor%2520ameliorates%2520progression%2520of%2520renal%2520damage%26jtitle%3DKidney%2520Int.%26date%3D2005%26volume%3D68%26spage%3D2131%26epage%3D2142" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group">Sherman, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Day, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobson, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Friesner, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Farid, R.</span><span> </span><span class="NLM_article-title">Novel procedure for modeling ligand/receptor induced fit effects</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">534</span><span class="NLM_x">–</span> <span class="NLM_lpage">553</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm050540c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Fjm100505n&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtlCgsr7I" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=534-553&author=W.+Shermanauthor=T.+Dayauthor=M.+P.+Jacobsonauthor=R.+A.+Friesnerauthor=R.+Farid&title=Novel+procedure+for+modeling+ligand%2Freceptor+induced+fit+effects"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Novel Procedure for Modeling Ligand/Receptor Induced Fit Effects</span></div><div class="casAuthors">Sherman, Woody; Day, Tyler; Jacobson, Matthew P.; Friesner, Richard A.; Farid, Ramy</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">534-553</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">We present a novel protein-ligand docking method that accurately accounts for both ligand and receptor flexibility by iteratively combining rigid receptor docking (Glide) with protein structure prediction (Prime) techniques.  While traditional rigid-receptor docking methods are useful when the receptor structure does not change substantially upon ligand binding, success is limited when the protein must be "induced" into the correct binding conformation for a given ligand.  We provide an in-depth description of our novel methodol. and present results for 21 pharmaceutically relevant examples.  Traditional rigid-receptor docking for these 21 cases yields an av. RMSD of 5.5 Å.  The av. ligand RMSD for docking to a flexible receptor for the 21 pairs is 1.4 Å; the RMSD is ≤1.8 Å for 18 of the cases.  For the three cases with RMSDs greater than 1.8 Å, the core of the ligand is properly docked and all key protein/ligand interactions are captured.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqm3E6ctnPGSrVg90H21EOLACvtfcHk0lgoS_xNB85z0A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtlCgsr7I&md5=388811ead5cee1fd460951263de486cb</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1021%2Fjm050540c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm050540c%26sid%3Dliteratum%253Aachs%26aulast%3DSherman%26aufirst%3DW.%26aulast%3DDay%26aufirst%3DT.%26aulast%3DJacobson%26aufirst%3DM.%2BP.%26aulast%3DFriesner%26aufirst%3DR.%2BA.%26aulast%3DFarid%26aufirst%3DR.%26atitle%3DNovel%2520procedure%2520for%2520modeling%2520ligand%252Freceptor%2520induced%2520fit%2520effects%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D534%26epage%3D553" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1a','cit1b','cit1c'],'ref2':['cit2a','cit2b'],'ref3':['cit3'],'ref4':['cit4a','cit4b','cit4c','cit4d','cit4e','cit4f'],'ref5':['cit5a','cit5b','cit5c'],'ref6':['cit6a','cit6b'],'ref7':['cit7'],'ref8':['cit8a','cit8b'],'ref9':['cit9a','cit9b','cit9c','cit9d','cit9e'],'ref10':['cit10a','cit10b','cit10c','cit10d','cit10e'],'ref11':['cit11a','cit11b'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14a','cit14b','cit14c'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17a','cit17b','cit17c','cit17d'],'ref18':['cit18'],'ref19':['cit19a','cit19b','cit19c','cit19d','cit19e','cit19f'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 79 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">David W.  Piotrowski</span>, <span class="hlFld-ContribAuthor ">Kentaro  Futatsugi</span>, <span class="hlFld-ContribAuthor ">Agustin  Casimiro-Garcia</span>, <span class="hlFld-ContribAuthor ">Liuqing  Wei</span>, <span class="hlFld-ContribAuthor ">Matthew F.  Sammons</span>, <span class="hlFld-ContribAuthor ">Michael  Herr</span>, <span class="hlFld-ContribAuthor ">Wenhua  Jiao</span>, <span class="hlFld-ContribAuthor ">Sophie Y.  Lavergne</span>, <span class="hlFld-ContribAuthor ">Steven B.  Coffey</span>, <span class="hlFld-ContribAuthor ">Stephen W.  Wright</span>, <span class="hlFld-ContribAuthor ">Kun  Song</span>, <span class="hlFld-ContribAuthor ">Paula M.  Loria</span>, <span class="hlFld-ContribAuthor ">Mary Ellen  Banker</span>, <span class="hlFld-ContribAuthor ">Donna N.  Petersen</span>, and <span class="hlFld-ContribAuthor ">Jonathan  Bauman</span>  . </span><span class="cited-content_cbyCitation_article-title">Identification of Morpholino-2H-pyrido[3,2-b][1,4]oxazin-3(4H)-ones as Nonsteroidal Mineralocorticoid Antagonists. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2018,</strong> <em>61 </em>
                                    (3)
                                     , 1086-1097. <a href="https://doi.org/10.1021/acs.jmedchem.7b01515" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.7b01515</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.7b01515&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.7b01515%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DIdentification%252Bof%252BMorpholino-2H-pyrido%25255B3%25252C2-b%25255D%25255B1%25252C4%25255Doxazin-3%2525284H%252529-ones%252Bas%252BNonsteroidal%252BMineralocorticoid%252BAntagonists%26aulast%3DPiotrowski%26aufirst%3DDavid%2BW.%26date%3D2018%26date%3D2018%26date%3D2017%26date%3D16102017%26date%3D23012018%26date%3D08022018%26date%3D04012018%26volume%3D61%26issue%3D3%26spage%3D1086%26epage%3D1097" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mercedes  Martín-Martínez</span>, <span class="hlFld-ContribAuthor ">Felipe L.  Pérez-Gordillo</span>, <span class="hlFld-ContribAuthor ">Diego  Álvarez de la Rosa</span>, <span class="hlFld-ContribAuthor ">Yoel  Rodríguez</span>, <span class="hlFld-ContribAuthor ">Guillermo  Gerona-Navarro</span>, <span class="hlFld-ContribAuthor ">Rosario  González-Muñiz</span>, and <span class="hlFld-ContribAuthor ">Ming-Ming  Zhou</span>  . </span><span class="cited-content_cbyCitation_article-title">Modulating Mineralocorticoid Receptor with Non-steroidal Antagonists. New Opportunities for the Development of Potent and Selective Ligands without Off-Target Side Effects. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2017,</strong> <em>60 </em>
                                    (7)
                                     , 2629-2650. <a href="https://doi.org/10.1021/acs.jmedchem.6b01065" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.6b01065</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.6b01065&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.6b01065%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DModulating%252BMineralocorticoid%252BReceptor%252Bwith%252BNon-steroidal%252BAntagonists.%252BNew%252BOpportunities%252Bfor%252Bthe%252BDevelopment%252Bof%252BPotent%252Band%252BSelective%252BLigands%252Bwithout%252BOff-Target%252BSide%252BEffects%26aulast%3DMart%25C3%25ADn-Mart%25C3%25ADnez%26aufirst%3DMercedes%26date%3D2017%26date%3D2017%26date%3D2016%26date%3D17072016%26date%3D24012017%26date%3D13042017%26date%3D04012017%26volume%3D60%26issue%3D7%26spage%3D2629%26epage%3D2650" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Christine  Yang</span>, <span class="hlFld-ContribAuthor ">Jaume  Balsells</span>, <span class="hlFld-ContribAuthor ">Hong D.  Chu</span>, <span class="hlFld-ContribAuthor ">Jason M.  Cox</span>, <span class="hlFld-ContribAuthor ">Alejandro  Crespo</span>, <span class="hlFld-ContribAuthor ">Xiuying  Ma</span>, <span class="hlFld-ContribAuthor ">Lisa  Contino</span>, <span class="hlFld-ContribAuthor ">Patricia  Brown</span>, <span class="hlFld-ContribAuthor ">Sheng  Gao</span>, <span class="hlFld-ContribAuthor ">Beata  Zamlynny</span>, <span class="hlFld-ContribAuthor ">Judyann  Wiltsie</span>, <span class="hlFld-ContribAuthor ">Joseph  Clemas</span>, <span class="hlFld-ContribAuthor ">JeanMarie  Lisnock</span>, <span class="hlFld-ContribAuthor ">Jack  Gibson</span>, <span class="hlFld-ContribAuthor ">Gaochao  Zhou</span>, <span class="hlFld-ContribAuthor ">Margarita  Garcia-Calvo</span>, <span class="hlFld-ContribAuthor ">Thomas J.  Bateman</span>, <span class="hlFld-ContribAuthor ">Vincent  Tong</span>, <span class="hlFld-ContribAuthor ">Ling  Xu</span>, <span class="hlFld-ContribAuthor ">Martin  Crook</span>, <span class="hlFld-ContribAuthor ">Peter  Sinclair</span>, and <span class="hlFld-ContribAuthor ">Hong C.  Shen</span>  . </span><span class="cited-content_cbyCitation_article-title">Discovery of Benzimidazole Oxazolidinediones as Novel and Selective Nonsteroidal Mineralocorticoid Receptor Antagonists. </span><span class="cited-content_cbyCitation_journal-name">ACS Medicinal Chemistry Letters</span><span> <strong>2015,</strong> <em>6 </em>
                                    (4)
                                     , 461-465. <a href="https://doi.org/10.1021/acsmedchemlett.5b00010" title="DOI URL">https://doi.org/10.1021/acsmedchemlett.5b00010</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsmedchemlett.5b00010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsmedchemlett.5b00010%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDiscovery%252Bof%252BBenzimidazole%252BOxazolidinediones%252Bas%252BNovel%252Band%252BSelective%252BNonsteroidal%252BMineralocorticoid%252BReceptor%252BAntagonists%26aulast%3DYang%26aufirst%3DChristine%26date%3D2015%26date%3D2015%26date%3D2015%26date%3D2015%26date%3D13012015%26date%3D06032015%26date%3D10032015%26date%3D09042015%26date%3D06032015%26volume%3D6%26issue%3D4%26spage%3D461%26epage%3D465" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Masahiro  Hori</span>, <span class="hlFld-ContribAuthor ">Akira  Sakakura</span>, and <span class="hlFld-ContribAuthor ">Kazuaki  Ishihara</span>  . </span><span class="cited-content_cbyCitation_article-title">Enantioselective 1,3-Dipolar Cycloaddition of Azomethine Imines with Propioloylpyrazoles Induced by Chiral π–Cation Catalysts. </span><span class="cited-content_cbyCitation_journal-name">Journal of the American Chemical Society</span><span> <strong>2014,</strong> <em>136 </em>
                                    (38)
                                     , 13198-13201. <a href="https://doi.org/10.1021/ja508441t" title="DOI URL">https://doi.org/10.1021/ja508441t</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/ja508441t&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fja508441t%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520the%2520American%2520Chemical%2520Society%26atitle%3DEnantioselective%252B1%25252C3-Dipolar%252BCycloaddition%252Bof%252BAzomethine%252BImines%252Bwith%252BPropioloylpyrazoles%252BInduced%252Bby%252BChiral%252B%2525CF%252580%2525E2%252580%252593Cation%252BCatalysts%26aulast%3DHori%26aufirst%3DMasahiro%26date%3D2014%26date%3D2014%26date%3D2014%26date%3D18082014%26date%3D16092014%26date%3D24092014%26date%3D08092014%26volume%3D136%26issue%3D38%26spage%3D13198%26epage%3D13201" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Orazio A.  Attanasi</span>, <span class="hlFld-ContribAuthor ">Lucia  De Crescentini</span>, <span class="hlFld-ContribAuthor ">Gianfranco  Favi</span>, <span class="hlFld-ContribAuthor ">Fabio  Mantellini</span>, <span class="hlFld-ContribAuthor ">Serena  Mantenuto</span>, and <span class="hlFld-ContribAuthor ">Simona  Nicolini</span>  . </span><span class="cited-content_cbyCitation_article-title">Interceptive [4 + 1] Annulation of in Situ Generated 1,2-Diaza-1,3-dienes with Diazo Esters: Direct Access to Substituted Mono-, Bi-, and Tricyclic 4,5-Dihydropyrazoles. </span><span class="cited-content_cbyCitation_journal-name">The Journal of Organic Chemistry</span><span> <strong>2014,</strong> <em>79 </em>
                                    (17)
                                     , 8331-8338. <a href="https://doi.org/10.1021/jo5016097" title="DOI URL">https://doi.org/10.1021/jo5016097</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jo5016097&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjo5016097%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DInterceptive%252B%25255B4%252B%25252B%252B1%25255D%252BAnnulation%252Bof%252Bin%252BSitu%252BGenerated%252B1%25252C2-Diaza-1%25252C3-dienes%252Bwith%252BDiazo%252BEsters%25253A%252BDirect%252BAccess%252Bto%252BSubstituted%252BMono-%25252C%252BBi-%25252C%252Band%252BTricyclic%252B4%25252C5-Dihydropyrazoles%26aulast%3DAttanasi%26aufirst%3DOrazio%2BA.%26date%3D2014%26date%3D2014%26date%3D2014%26date%3D17072014%26date%3D12082014%26date%3D05092014%26date%3D06082014%26volume%3D79%26issue%3D17%26spage%3D8331%26epage%3D8338" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Shuwen  He</span>, <span class="hlFld-ContribAuthor ">Zhong  Lai</span>, <span class="hlFld-ContribAuthor ">Zhixiong  Ye</span>, <span class="hlFld-ContribAuthor ">Peter H.  Dobbelaar</span>, <span class="hlFld-ContribAuthor ">Shrenik K.  Shah</span>, <span class="hlFld-ContribAuthor ">Quang  Truong</span>, <span class="hlFld-ContribAuthor ">Wu  Du</span>, <span class="hlFld-ContribAuthor ">Liangqin  Guo</span>, <span class="hlFld-ContribAuthor ">Jian  Liu</span>, <span class="hlFld-ContribAuthor ">Tianying  Jian</span>, <span class="hlFld-ContribAuthor ">Hongbo  Qi</span>, <span class="hlFld-ContribAuthor ">Raman K.  Bakshi</span>, <span class="hlFld-ContribAuthor ">Qingmei  Hong</span>, <span class="hlFld-ContribAuthor ">James  Dellureficio</span>, <span class="hlFld-ContribAuthor ">Mikhail  Reibarkh</span>, <span class="hlFld-ContribAuthor ">Koppara  Samuel</span>, <span class="hlFld-ContribAuthor ">Vijay B.  Reddy</span>, <span class="hlFld-ContribAuthor ">Stan  Mitelman</span>, <span class="hlFld-ContribAuthor ">Sharon X.  Tong</span>, <span class="hlFld-ContribAuthor ">Gary G.  Chicchi</span>, <span class="hlFld-ContribAuthor ">Kwei-Lan  Tsao</span>, <span class="hlFld-ContribAuthor ">Dorina  Trusca</span>, <span class="hlFld-ContribAuthor ">Margaret  Wu</span>, <span class="hlFld-ContribAuthor ">Qing  Shao</span>, <span class="hlFld-ContribAuthor ">Maria E.  Trujillo</span>, <span class="hlFld-ContribAuthor ">Guillermo  Fernandez</span>, <span class="hlFld-ContribAuthor ">Donald  Nelson</span>, <span class="hlFld-ContribAuthor ">Patricia  Bunting</span>, <span class="hlFld-ContribAuthor ">Janet  Kerr</span>, <span class="hlFld-ContribAuthor ">Patrick  Fitzgerald</span>, <span class="hlFld-ContribAuthor ">Pierre  Morissette</span>, <span class="hlFld-ContribAuthor ">Sylvia  Volksdorf</span>, <span class="hlFld-ContribAuthor ">George J.  Eiermann</span>, <span class="hlFld-ContribAuthor ">Cai  Li</span>, <span class="hlFld-ContribAuthor ">Bei  Zhang</span>, <span class="hlFld-ContribAuthor ">Andrew D.  Howard</span>, <span class="hlFld-ContribAuthor ">Yun-Ping  Zhou</span>, <span class="hlFld-ContribAuthor ">Ravi P.  Nargund</span>, and <span class="hlFld-ContribAuthor ">William K.  Hagmann</span>  . </span><span class="cited-content_cbyCitation_article-title">Investigation of Cardiovascular Effects of Tetrahydro-β-carboline sstr3 antagonists. </span><span class="cited-content_cbyCitation_journal-name">ACS Medicinal Chemistry Letters</span><span> <strong>2014,</strong> <em>5 </em>
                                    (7)
                                     , 748-753. <a href="https://doi.org/10.1021/ml500028c" title="DOI URL">https://doi.org/10.1021/ml500028c</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/ml500028c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fml500028c%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DInvestigation%252Bof%252BCardiovascular%252BEffects%252Bof%252BTetrahydro-%2525CE%2525B2-carboline%252Bsstr3%252Bantagonists%26aulast%3DHe%26aufirst%3DShuwen%26date%3D2014%26date%3D2014%26date%3D2014%26date%3D2014%26date%3D22012014%26date%3D21042014%26date%3D28042014%26date%3D10072014%26date%3D21042014%26volume%3D5%26issue%3D7%26spage%3D748%26epage%3D753" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Agustin  Casimiro-Garcia</span>, <span class="hlFld-ContribAuthor ">David W.  Piotrowski</span>, <span class="hlFld-ContribAuthor ">Catherine  Ambler</span>, <span class="hlFld-ContribAuthor ">Graciela B.  Arhancet</span>, <span class="hlFld-ContribAuthor ">Mary Ellen  Banker</span>, <span class="hlFld-ContribAuthor ">Tereece  Banks</span>, <span class="hlFld-ContribAuthor ">Carine M.  Boustany-Kari</span>, <span class="hlFld-ContribAuthor ">Cuiman  Cai</span>, <span class="hlFld-ContribAuthor ">Xiangyang  Chen</span>, <span class="hlFld-ContribAuthor ">Rena  Eudy</span>, <span class="hlFld-ContribAuthor ">David  Hepworth</span>, <span class="hlFld-ContribAuthor ">Catherine A.  Hulford</span>, <span class="hlFld-ContribAuthor ">Sandra M.  Jennings</span>, <span class="hlFld-ContribAuthor ">Paula M.  Loria</span>, <span class="hlFld-ContribAuthor ">Marvin J.  Meyers</span>, <span class="hlFld-ContribAuthor ">Donna N.  Petersen</span>, <span class="hlFld-ContribAuthor ">Neil K.  Raheja</span>, <span class="hlFld-ContribAuthor ">Matthew  Sammons</span>, <span class="hlFld-ContribAuthor ">Li  She</span>, <span class="hlFld-ContribAuthor ">Kun  Song</span>, <span class="hlFld-ContribAuthor ">Derek  Vrieze</span>, and <span class="hlFld-ContribAuthor ">Liuqing  Wei</span>  . </span><span class="cited-content_cbyCitation_article-title">Identification of (R)-6-(1-(4-Cyano-3-methylphenyl)-5-cyclopentyl-4,5-dihydro-1H-pyrazol-3-yl)-2-methoxynicotinic Acid, a Highly Potent and Selective Nonsteroidal Mineralocorticoid Receptor Antagonist. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2014,</strong> <em>57 </em>
                                    (10)
                                     , 4273-4288. <a href="https://doi.org/10.1021/jm500206r" title="DOI URL">https://doi.org/10.1021/jm500206r</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm500206r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm500206r%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DIdentification%252Bof%252B%252528R%252529-6-%2525281-%2525284-Cyano-3-methylphenyl%252529-5-cyclopentyl-4%25252C5-dihydro-1H-pyrazol-3-yl%252529-2-methoxynicotinic%252BAcid%25252C%252Ba%252BHighly%252BPotent%252Band%252BSelective%252BNonsteroidal%252BMineralocorticoid%252BReceptor%252BAntagonist%26aulast%3DCasimiro-Garcia%26aufirst%3DAgustin%26date%3D2014%26date%3D2014%26date%3D2014%26date%3D07022014%26date%3D30042014%26date%3D22052014%26date%3D16042014%26volume%3D57%26issue%3D10%26spage%3D4273%26epage%3D4288" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Matthew  Sammons</span>, <span class="hlFld-ContribAuthor ">Sandra M.  Jennings</span>, <span class="hlFld-ContribAuthor ">Michael  Herr</span>, <span class="hlFld-ContribAuthor ">Catherine A.  Hulford</span>, <span class="hlFld-ContribAuthor ">Liuqing  Wei</span>, <span class="hlFld-ContribAuthor ">James F.  Hallissey</span>, <span class="hlFld-ContribAuthor ">E. Jason  Kiser</span>, <span class="hlFld-ContribAuthor ">Stephen W.  Wright</span>, and <span class="hlFld-ContribAuthor ">David W.  Piotrowski</span>  . </span><span class="cited-content_cbyCitation_article-title">Synthesis of a cis 2,5-Disubstituted Morpholine by De-epimerization: Application to the Multigram Scale Synthesis of a Mineralocorticoid Antagonist. </span><span class="cited-content_cbyCitation_journal-name">Organic Process Research & Development</span><span> <strong>2013,</strong> <em>17 </em>
                                    (6)
                                     , 934-939. <a href="https://doi.org/10.1021/op400101p" title="DOI URL">https://doi.org/10.1021/op400101p</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/op400101p&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fop400101p%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Process%2520Research%2520%2526%2520Development%26atitle%3DSynthesis%252Bof%252Ba%252Bcis%252B2%25252C5-Disubstituted%252BMorpholine%252Bby%252BDe-epimerization%25253A%252BApplication%252Bto%252Bthe%252BMultigram%252BScale%252BSynthesis%252Bof%252Ba%252BMineralocorticoid%252BAntagonist%26aulast%3DSammons%26aufirst%3DMatthew%26date%3D2013%26date%3D2013%26date%3D2013%26date%3D18042013%26date%3D20052013%26date%3D21062013%26volume%3D17%26issue%3D6%26spage%3D934%26epage%3D939" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">David W.  Piotrowski</span>  . </span><span class="cited-content_cbyCitation_article-title">Mineralocorticoid Receptor Antagonists for the Treatment of Hypertension and Diabetic Nephropathy. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2012,</strong> <em>55 </em>
                                    (18)
                                     , 7957-7966. <a href="https://doi.org/10.1021/jm300806c" title="DOI URL">https://doi.org/10.1021/jm300806c</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm300806c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm300806c%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DMineralocorticoid%252BReceptor%252BAntagonists%252Bfor%252Bthe%252BTreatment%252Bof%252BHypertension%252Band%252BDiabetic%252BNephropathy%26aulast%3DPiotrowski%26aufirst%3DDavid%2BW.%26date%3D2012%26date%3D2012%26date%3D2012%26date%3D07062012%26date%3D15082012%26date%3D27092012%26date%3D06082012%26volume%3D55%26issue%3D18%26spage%3D7957%26epage%3D7966" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yves L.  Janin</span>  . </span><span class="cited-content_cbyCitation_article-title">Preparation and Chemistry of 3/5-Halogenopyrazoles. </span><span class="cited-content_cbyCitation_journal-name">Chemical Reviews</span><span> <strong>2012,</strong> <em>112 </em>
                                    (7)
                                     , 3924-3958. <a href="https://doi.org/10.1021/cr200427q" title="DOI URL">https://doi.org/10.1021/cr200427q</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/cr200427q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fcr200427q%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Reviews%26atitle%3DPreparation%252Band%252BChemistry%252Bof%252B3%25252F5-Halogenopyrazoles%26aulast%3DJanin%26aufirst%3DYves%2BL.%26date%3D2012%26date%3D2012%26date%3D2011%26date%3D10112011%26date%3D01052012%26date%3D11072012%26volume%3D112%26issue%3D7%26spage%3D3924%26epage%3D3958" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Tomoaki  Hasui</span>, <span class="hlFld-ContribAuthor ">Nobuyuki  Matsunaga</span>, <span class="hlFld-ContribAuthor ">Taiichi  Ora</span>, <span class="hlFld-ContribAuthor ">Norio  Ohyabu</span>, <span class="hlFld-ContribAuthor ">Nobuhiro  Nishigaki</span>, <span class="hlFld-ContribAuthor ">Yoshimi  Imura</span>, <span class="hlFld-ContribAuthor ">Yumiko  Igata</span>, <span class="hlFld-ContribAuthor ">Hideki  Matsui</span>, <span class="hlFld-ContribAuthor ">Takashi  Motoyaji</span>, <span class="hlFld-ContribAuthor ">Toshimasa  Tanaka</span>, <span class="hlFld-ContribAuthor ">Noriyuki  Habuka</span>, <span class="hlFld-ContribAuthor ">Satoshi  Sogabe</span>, <span class="hlFld-ContribAuthor ">Midori  Ono</span>, <span class="hlFld-ContribAuthor ">Christopher S.  Siedem</span>, <span class="hlFld-ContribAuthor ">Tony P.  Tang</span>, <span class="hlFld-ContribAuthor ">Cassandra  Gauthier</span>, <span class="hlFld-ContribAuthor ">Lisa A.  De Meese</span>, <span class="hlFld-ContribAuthor ">Steven A.  Boyd</span>, and <span class="hlFld-ContribAuthor ">Shoji  Fukumoto</span>  . </span><span class="cited-content_cbyCitation_article-title">Identification of Benzoxazin-3-one Derivatives as Novel, Potent, and Selective Nonsteroidal Mineralocorticoid Receptor Antagonists. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2011,</strong> <em>54 </em>
                                    (24)
                                     , 8616-8631. <a href="https://doi.org/10.1021/jm2011645" title="DOI URL">https://doi.org/10.1021/jm2011645</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm2011645&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm2011645%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DIdentification%252Bof%252BBenzoxazin-3-one%252BDerivatives%252Bas%252BNovel%25252C%252BPotent%25252C%252Band%252BSelective%252BNonsteroidal%252BMineralocorticoid%252BReceptor%252BAntagonists%26aulast%3DHasui%26aufirst%3DTomoaki%26date%3D2011%26date%3D2011%26date%3D2011%26date%3D02092011%26date%3D29112011%26date%3D22122011%26date%3D10112011%26volume%3D54%26issue%3D24%26spage%3D8616%26epage%3D8631" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Teymour  Vahedpour</span>, <span class="hlFld-ContribAuthor ">Maryam  Hamzeh‐Mivehroud</span>, <span class="hlFld-ContribAuthor ">Salar  Hemmati</span>, <span class="hlFld-ContribAuthor ">Siavoush  Dastmalchi</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis of 2‐Pyrazolines from Hydrazines: Mechanisms Explained. </span><span class="cited-content_cbyCitation_journal-name">ChemistrySelect</span><span> <strong>2021,</strong> <em>6 </em>
                                    (25)
                                     , 6483-6506. <a href="https://doi.org/10.1002/slct.202101467" title="DOI URL">https://doi.org/10.1002/slct.202101467</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/slct.202101467&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fslct.202101467%26sid%3Dliteratum%253Aachs%26jtitle%3DChemistrySelect%26atitle%3DSynthesis%252Bof%252B2%2525E2%252580%252590Pyrazolines%252Bfrom%252BHydrazines%25253A%252BMechanisms%252BExplained%26aulast%3DVahedpour%26aufirst%3DTeymour%26date%3D2021%26date%3D2021%26volume%3D6%26issue%3D25%26spage%3D6483%26epage%3D6506" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Szymon P.  Rekowski</span>, <span class="hlFld-ContribAuthor ">Bettina K.  Kroener</span>, <span class="hlFld-ContribAuthor ">Deepika  Kathuria</span>, <span class="hlFld-ContribAuthor ">Aabid A.  Wani</span>, <span class="hlFld-ContribAuthor ">Sumit S.  Chourasiya</span>, <span class="hlFld-ContribAuthor ">Jürgen  Conrad</span>, <span class="hlFld-ContribAuthor ">Prasad V.  Bharatam</span>, <span class="hlFld-ContribAuthor ">Wolfgang  Frey</span>, <span class="hlFld-ContribAuthor ">Uwe  Beifuss</span>. </span><span class="cited-content_cbyCitation_article-title">A novel copper-catalyzed, hydrazine-free synthesis of N-1 unsubstituted 1H-indazoles using stable guanylhydrazone salts as substrates. </span><span class="cited-content_cbyCitation_journal-name">Tetrahedron</span><span> <strong>2021,</strong> <em>91 </em>, 132192. <a href="https://doi.org/10.1016/j.tet.2021.132192" title="DOI URL">https://doi.org/10.1016/j.tet.2021.132192</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tet.2021.132192&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tet.2021.132192%26sid%3Dliteratum%253Aachs%26jtitle%3DTetrahedron%26atitle%3DA%252Bnovel%252Bcopper-catalyzed%25252C%252Bhydrazine-free%252Bsynthesis%252Bof%252BN-1%252Bunsubstituted%252B1H-indazoles%252Busing%252Bstable%252Bguanylhydrazone%252Bsalts%252Bas%252Bsubstrates%26aulast%3DRekowski%26aufirst%3DSzymon%2BP.%26date%3D2021%26volume%3D91%26spage%3D132192" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Qiu-Ya  Wang</span>, <span class="hlFld-ContribAuthor ">Zun-Ting  Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">Syntheses and Crystal Structures of Two 2H-dibenzo[e, g]indazoles. </span><span class="cited-content_cbyCitation_journal-name">Journal of Chemical Crystallography</span><span> <strong>2021,</strong> <em>51 </em>
                                    (2)
                                     , 161-168. <a href="https://doi.org/10.1007/s10870-020-00835-4" title="DOI URL">https://doi.org/10.1007/s10870-020-00835-4</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s10870-020-00835-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs10870-020-00835-4%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Chemical%2520Crystallography%26atitle%3DSyntheses%252Band%252BCrystal%252BStructures%252Bof%252BTwo%252B2H-dibenzo%25255Be%25252C%252Bg%25255Dindazoles%26aulast%3DWang%26aufirst%3DQiu-Ya%26date%3D2021%26date%3D2020%26volume%3D51%26issue%3D2%26spage%3D161%26epage%3D168" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hao  Ma</span>, <span class="hlFld-ContribAuthor ">Songlin  Liu</span>, <span class="hlFld-ContribAuthor ">Lin  Zhu</span>, <span class="hlFld-ContribAuthor ">Chao  Ma</span>, <span class="hlFld-ContribAuthor ">Xiaoxia  Han</span>, <span class="hlFld-ContribAuthor ">Chengyan  He</span>, <span class="hlFld-ContribAuthor ">Bing  Zhao</span>. </span><span class="cited-content_cbyCitation_article-title">Vibrational spectroscopy and DFT analysis of 4-cyanophenylhydrazine: A potential SERS probe. </span><span class="cited-content_cbyCitation_journal-name">Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy</span><span> <strong>2021,</strong> <em>253 </em>, 119574. <a href="https://doi.org/10.1016/j.saa.2021.119574" title="DOI URL">https://doi.org/10.1016/j.saa.2021.119574</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.saa.2021.119574&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.saa.2021.119574%26sid%3Dliteratum%253Aachs%26jtitle%3DSpectrochimica%2520Acta%2520Part%2520A%253A%2520Molecular%2520and%2520Biomolecular%2520Spectroscopy%26atitle%3DVibrational%252Bspectroscopy%252Band%252BDFT%252Banalysis%252Bof%252B4-cyanophenylhydrazine%25253A%252BA%252Bpotential%252BSERS%252Bprobe%26aulast%3DMa%26aufirst%3DHao%26date%3D2021%26volume%3D253%26spage%3D119574" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Muhammad  Afzal</span>. </span><span class="cited-content_cbyCitation_article-title">Recent updates on novel therapeutic targets of cardiovascular diseases. </span><span class="cited-content_cbyCitation_journal-name">Molecular and Cellular Biochemistry</span><span> <strong>2021,</strong> <em>476 </em>
                                    (1)
                                     , 145-155. <a href="https://doi.org/10.1007/s11010-020-03891-8" title="DOI URL">https://doi.org/10.1007/s11010-020-03891-8</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s11010-020-03891-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs11010-020-03891-8%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520and%2520Cellular%2520Biochemistry%26atitle%3DRecent%252Bupdates%252Bon%252Bnovel%252Btherapeutic%252Btargets%252Bof%252Bcardiovascular%252Bdiseases%26aulast%3DAfzal%26aufirst%3DMuhammad%26date%3D2021%26date%3D2020%26volume%3D476%26issue%3D1%26spage%3D145%26epage%3D155" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yanduan  Lin</span>, <span class="hlFld-ContribAuthor ">Ziwei  Zhang</span>, <span class="hlFld-ContribAuthor ">Siyu  Wang</span>, <span class="hlFld-ContribAuthor ">Jinyan  Cai</span>, <span class="hlFld-ContribAuthor ">Jiao  Guo</span>. </span><span class="cited-content_cbyCitation_article-title">Hypothalamus-pituitary-adrenal Axis in Glucolipid metabolic disorders. </span><span class="cited-content_cbyCitation_journal-name">Reviews in Endocrine and Metabolic Disorders</span><span> <strong>2020,</strong> <em>21 </em>
                                    (4)
                                     , 421-429. <a href="https://doi.org/10.1007/s11154-020-09586-1" title="DOI URL">https://doi.org/10.1007/s11154-020-09586-1</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s11154-020-09586-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs11154-020-09586-1%26sid%3Dliteratum%253Aachs%26jtitle%3DReviews%2520in%2520Endocrine%2520and%2520Metabolic%2520Disorders%26atitle%3DHypothalamus-pituitary-adrenal%252BAxis%252Bin%252BGlucolipid%252Bmetabolic%252Bdisorders%26aulast%3DLin%26aufirst%3DYanduan%26date%3D2020%26date%3D2020%26volume%3D21%26issue%3D4%26spage%3D421%26epage%3D429" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Federica  Ianni</span>, <span class="hlFld-ContribAuthor ">Bruno  Cerra</span>, <span class="hlFld-ContribAuthor ">Shiva Tali  Shandiz</span>, <span class="hlFld-ContribAuthor ">Alessandro Di  Michele</span>, <span class="hlFld-ContribAuthor ">Giorgio  Saluti</span>, <span class="hlFld-ContribAuthor ">Roberta  Galarini</span>, <span class="hlFld-ContribAuthor ">Antimo  Gioiello</span>, <span class="hlFld-ContribAuthor ">Roccaldo  Sardella</span>, <span class="hlFld-ContribAuthor ">Andrea  Carotti</span>. </span><span class="cited-content_cbyCitation_article-title">Integrating experimental and computational techniques to study chromatographic enantioresolutions of chiral tetrahydroindazole derivatives. </span><span class="cited-content_cbyCitation_journal-name">Journal of Chromatography A</span><span> <strong>2020,</strong> <em>1625 </em>, 461310. <a href="https://doi.org/10.1016/j.chroma.2020.461310" title="DOI URL">https://doi.org/10.1016/j.chroma.2020.461310</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.chroma.2020.461310&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.chroma.2020.461310%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Chromatography%2520A%26atitle%3DIntegrating%252Bexperimental%252Band%252Bcomputational%252Btechniques%252Bto%252Bstudy%252Bchromatographic%252Benantioresolutions%252Bof%252Bchiral%252Btetrahydroindazole%252Bderivatives%26aulast%3DIanni%26aufirst%3DFederica%26date%3D2020%26volume%3D1625%26spage%3D461310" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Marina  Sagnou</span>, <span class="hlFld-ContribAuthor ">Fedor N.  Novikov</span>, <span class="hlFld-ContribAuthor ">Ekaterina S.  Ivanova</span>, <span class="hlFld-ContribAuthor ">Polyxeni  Alexiou</span>, <span class="hlFld-ContribAuthor ">Victor S.  Stroylov</span>, <span class="hlFld-ContribAuthor ">Ilya Y.  Titov</span>, <span class="hlFld-ContribAuthor ">Victor V.  Tatarskiy</span>, <span class="hlFld-ContribAuthor ">Murad S.  Vagida</span>, <span class="hlFld-ContribAuthor ">Maria  Pelecanou</span>, <span class="hlFld-ContribAuthor ">Alexander A.  Shtil</span>, <span class="hlFld-ContribAuthor ">Ghermes G.  Chilov</span>. </span><span class="cited-content_cbyCitation_article-title">Novel curcumin derivatives as P-glycoprotein inhibitors: Molecular modeling, synthesis and sensitization of multidrug resistant cells to doxorubicin. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>198 </em>, 112331. <a href="https://doi.org/10.1016/j.ejmech.2020.112331" title="DOI URL">https://doi.org/10.1016/j.ejmech.2020.112331</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2020.112331&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2020.112331%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DNovel%252Bcurcumin%252Bderivatives%252Bas%252BP-glycoprotein%252Binhibitors%25253A%252BMolecular%252Bmodeling%25252C%252Bsynthesis%252Band%252Bsensitization%252Bof%252Bmultidrug%252Bresistant%252Bcells%252Bto%252Bdoxorubicin%26aulast%3DSagnou%26aufirst%3DMarina%26date%3D2020%26volume%3D198%26spage%3D112331" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Felipe  L. Pérez-Gordillo</span>, <span class="hlFld-ContribAuthor ">Maria  Jesús Pérez de Vega</span>, <span class="hlFld-ContribAuthor ">Guillermo  Gerona-Navarro</span>, <span class="hlFld-ContribAuthor ">Yoel  Rodríguez</span>, <span class="hlFld-ContribAuthor ">Diego  Alvarez de la Rosa</span>, <span class="hlFld-ContribAuthor ">Rosario  González-Muñiz</span>, <span class="hlFld-ContribAuthor ">Mercedes  Martín-Martínez</span>. </span><span class="cited-content_cbyCitation_article-title">Advances in the Development of Non-steroidal Mineralocorticoid-receptor Antagonists. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2019,</strong>,<a href="https://doi.org/10.5772/intechopen.88417" title="DOI URL">https://doi.org/10.5772/intechopen.88417</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.5772/intechopen.88417&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.5772%2Fintechopen.88417%26sid%3Dliteratum%253Aachs%26atitle%3DAdvances%252Bin%252Bthe%252BDevelopment%252Bof%252BNon-steroidal%252BMineralocorticoid-receptor%252BAntagonists%26aulast%3DL.%2BP%25C3%25A9rez-Gordillo%26aufirst%3DFelipe%26date%3D2019%26date%3D2019%26pub%3DIntechOpen%26atitle%3DAldosterone-Mineralocorticoid%252BReceptor%252B-%252BCell%252BBiology%252Bto%252BTranslational%252BMedicine%26aulast%3DHarvey%26aufirst%3DBrian%26date%3D2019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Anneli  Nordqvist</span>, <span class="hlFld-ContribAuthor ">Kenneth L.  Granberg</span>. </span><span class="cited-content_cbyCitation_article-title">Mineralocorticoid Receptor Antagonists. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2019,</strong>,, 151-188. <a href="https://doi.org/10.1016/bs.vh.2018.10.008" title="DOI URL">https://doi.org/10.1016/bs.vh.2018.10.008</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/bs.vh.2018.10.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fbs.vh.2018.10.008%26sid%3Dliteratum%253Aachs%26atitle%3DMineralocorticoid%252BReceptor%252BAntagonists%26aulast%3DNordqvist%26aufirst%3DAnneli%26date%3D2019%26spage%3D151%26epage%3D188%26pub%3DElsevier%26atitle%3DAldosterone%26date%3D2019%26volume%3D109" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Raquib  Alam</span>, <span class="hlFld-ContribAuthor ">Aftab  Alam</span>, <span class="hlFld-ContribAuthor ">Amulya K.  Panda</span>, <span class="hlFld-ContribAuthor ">Rahisuddin</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis and cytotoxicity evaluation of pyrazolyl pyrazoline and pyrazolyl aminopyrimidine derivatives as potential anticancer agents. </span><span class="cited-content_cbyCitation_journal-name">Medicinal Chemistry Research</span><span> <strong>2018,</strong> <em>27 </em>
                                    (2)
                                     , 560-570. <a href="https://doi.org/10.1007/s00044-017-2082-8" title="DOI URL">https://doi.org/10.1007/s00044-017-2082-8</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s00044-017-2082-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs00044-017-2082-8%26sid%3Dliteratum%253Aachs%26jtitle%3DMedicinal%2520Chemistry%2520Research%26atitle%3DDesign%25252C%252Bsynthesis%252Band%252Bcytotoxicity%252Bevaluation%252Bof%252Bpyrazolyl%252Bpyrazoline%252Band%252Bpyrazolyl%252Baminopyrimidine%252Bderivatives%252Bas%252Bpotential%252Banticancer%252Bagents%26aulast%3DAlam%26aufirst%3DRaquib%26date%3D2018%26date%3D2017%26volume%3D27%26issue%3D2%26spage%3D560%26epage%3D570" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Clarice K.  Fujihara</span>, <span class="hlFld-ContribAuthor ">M. C.  Kowala</span>, <span class="hlFld-ContribAuthor ">M. D.  Breyer</span>, <span class="hlFld-ContribAuthor ">Claudia R.  Sena</span>, <span class="hlFld-ContribAuthor ">Mariliza V.  Rodrigues</span>, <span class="hlFld-ContribAuthor ">Simone C. A.  Arias</span>, <span class="hlFld-ContribAuthor ">Camilla  Fanelli</span>, <span class="hlFld-ContribAuthor ">Denise M.  Malheiros</span>, <span class="hlFld-ContribAuthor ">P. K.  Jadhav</span>, <span class="hlFld-ContribAuthor ">Chahrzad  Montrose-Rafizadeh</span>, <span class="hlFld-ContribAuthor ">Jose E.  Krieger</span>, <span class="hlFld-ContribAuthor ">Roberto  Zatz</span>. </span><span class="cited-content_cbyCitation_article-title">A Novel Aldosterone Antagonist Limits Renal Injury in 5/6 Nephrectomy. </span><span class="cited-content_cbyCitation_journal-name">Scientific Reports</span><span> <strong>2017,</strong> <em>7 </em>
                                    (1)
                                     <a href="https://doi.org/10.1038/s41598-017-08383-2" title="DOI URL">https://doi.org/10.1038/s41598-017-08383-2</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/s41598-017-08383-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fs41598-017-08383-2%26sid%3Dliteratum%253Aachs%26jtitle%3DScientific%2520Reports%26atitle%3DA%252BNovel%252BAldosterone%252BAntagonist%252BLimits%252BRenal%252BInjury%252Bin%252B5%25252F6%252BNephrectomy%26aulast%3DFujihara%26aufirst%3DClarice%2BK.%26date%3D2017%26date%3D2017%26volume%3D7%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Daniel A.  Aparicio</span>, <span class="hlFld-ContribAuthor ">Gricela M.  Lobo</span>, <span class="hlFld-ContribAuthor ">Jennifer L.  Sánchez</span>, <span class="hlFld-ContribAuthor ">Melina C.  Monasterios</span>, <span class="hlFld-ContribAuthor ">María E.  Acosta</span>, <span class="hlFld-ContribAuthor ">Lola  De Lima</span>, <span class="hlFld-ContribAuthor ">Ligia J.  Llovera</span>, <span class="hlFld-ContribAuthor ">Jorge E.  Ángel</span>, <span class="hlFld-ContribAuthor ">Jaime E.  Charris</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis of Trans- and
              cis
              -2-acetyl-3-phenyl-3,3a,4,5-tetrahydro-2
              H
              -benzo[
              g
              ] Indazoles: Evaluation as Inhibitors of β-hematin Formation. </span><span class="cited-content_cbyCitation_journal-name">Journal of Chemical Research</span><span> <strong>2017,</strong> <em>41 </em>
                                    (11)
                                     , 668-672. <a href="https://doi.org/10.3184/174751917X15105690662845" title="DOI URL">https://doi.org/10.3184/174751917X15105690662845</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3184/174751917X15105690662845&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3184%2F174751917X15105690662845%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Chemical%2520Research%26atitle%3DSynthesis%252Bof%252BTrans-%252Band%252Bcis%252B-2-acetyl-3-phenyl-3%25252C3a%25252C4%25252C5-tetrahydro-2%252BH%252B-benzo%25255B%252Bg%252B%25255D%252BIndazoles%25253A%252BEvaluation%252Bas%252BInhibitors%252Bof%252B%2525CE%2525B2-hematin%252BFormation%26aulast%3DAparicio%26aufirst%3DDaniel%2BA.%26date%3D2017%26date%3D2017%26volume%3D41%26issue%3D11%26spage%3D668%26epage%3D672" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Dongsoo  Koh</span>, <span class="hlFld-ContribAuthor ">Soon Young  Shin</span>, <span class="hlFld-ContribAuthor ">Jiha  Sung</span>, <span class="hlFld-ContribAuthor ">Seunghyun  Ahn</span>, <span class="hlFld-ContribAuthor ">Yoongho  Lim</span>. </span><span class="cited-content_cbyCitation_article-title">1
              H and
              13
              C NMR spectral assignments for 24 novel naphthalenylphenylpyrazolines. </span><span class="cited-content_cbyCitation_journal-name">Magnetic Resonance in Chemistry</span><span> <strong>2017,</strong> <em>55 </em>
                                    (9)
                                     , 856-863. <a href="https://doi.org/10.1002/mrc.4603" title="DOI URL">https://doi.org/10.1002/mrc.4603</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/mrc.4603&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fmrc.4603%26sid%3Dliteratum%253Aachs%26jtitle%3DMagnetic%2520Resonance%2520in%2520Chemistry%26atitle%3D1%252BH%252Band%252B13%252BC%252BNMR%252Bspectral%252Bassignments%252Bfor%252B24%252Bnovel%252Bnaphthalenylphenylpyrazolines%26aulast%3DKoh%26aufirst%3DDongsoo%26date%3D2017%26date%3D2017%26volume%3D55%26issue%3D9%26spage%3D856%26epage%3D863" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Farheen K.  Dojki</span>, <span class="hlFld-ContribAuthor ">George  Bakris</span>. </span><span class="cited-content_cbyCitation_article-title">Nonsteroidal mineralocorticoid antagonists in diabetic kidney disease. </span><span class="cited-content_cbyCitation_journal-name">Current Opinion in Nephrology and Hypertension</span><span> <strong>2017,</strong> <em>26 </em>
                                    (5)
                                     , 368-374. <a href="https://doi.org/10.1097/MNH.0000000000000340" title="DOI URL">https://doi.org/10.1097/MNH.0000000000000340</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1097/MNH.0000000000000340&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1097%2FMNH.0000000000000340%26sid%3Dliteratum%253Aachs%26jtitle%3DCurrent%2520Opinion%2520in%2520Nephrology%2520and%2520Hypertension%26atitle%3DNonsteroidal%252Bmineralocorticoid%252Bantagonists%252Bin%252Bdiabetic%252Bkidney%252Bdisease%26aulast%3DDojki%26aufirst%3DFarheen%2BK.%26date%3D2017%26volume%3D26%26issue%3D5%26spage%3D368%26epage%3D374" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Daniel  Meyer</span>, <span class="hlFld-ContribAuthor ">Philippe  Renaud</span>. </span><span class="cited-content_cbyCitation_article-title">Enantioselective Hydroazidation of Trisubstituted Non-Activated Alkenes. </span><span class="cited-content_cbyCitation_journal-name">Angewandte Chemie</span><span> <strong>2017,</strong> <em>129 </em>
                                    (36)
                                     , 10998-11001. <a href="https://doi.org/10.1002/ange.201703340" title="DOI URL">https://doi.org/10.1002/ange.201703340</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ange.201703340&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fange.201703340%26sid%3Dliteratum%253Aachs%26jtitle%3DAngewandte%2520Chemie%26atitle%3DEnantioselective%252BHydroazidation%252Bof%252BTrisubstituted%252BNon-Activated%252BAlkenes%26aulast%3DMeyer%26aufirst%3DDaniel%26date%3D2017%26date%3D2017%26volume%3D129%26issue%3D36%26spage%3D10998%26epage%3D11001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Daniel  Meyer</span>, <span class="hlFld-ContribAuthor ">Philippe  Renaud</span>. </span><span class="cited-content_cbyCitation_article-title">Enantioselective Hydroazidation of Trisubstituted Non-Activated Alkenes. </span><span class="cited-content_cbyCitation_journal-name">Angewandte Chemie International Edition</span><span> <strong>2017,</strong> <em>56 </em>
                                    (36)
                                     , 10858-10861. <a href="https://doi.org/10.1002/anie.201703340" title="DOI URL">https://doi.org/10.1002/anie.201703340</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/anie.201703340&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fanie.201703340%26sid%3Dliteratum%253Aachs%26jtitle%3DAngewandte%2520Chemie%2520International%2520Edition%26atitle%3DEnantioselective%252BHydroazidation%252Bof%252BTrisubstituted%252BNon-Activated%252BAlkenes%26aulast%3DMeyer%26aufirst%3DDaniel%26date%3D2017%26date%3D2017%26volume%3D56%26issue%3D36%26spage%3D10858%26epage%3D10861" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Raquib  Alam</span>, <span class="hlFld-ContribAuthor ">Md. Aftab  Alam</span>, <span class="hlFld-ContribAuthor ">Amulya K.  Panda</span>, <span class="hlFld-ContribAuthor ">Rahisuddin</span>. </span><span class="cited-content_cbyCitation_article-title">Design, Synthesis, and Cytotoxicity Evaluation of 3‐(5‐(3‐(aryl)‐1‐phenyl‐1H‐pyrazol‐4‐yl)‐1‐phenyl‐4,5‐dihydro‐1H‐pyrazol‐3‐yl)pyridine and 5‐(3‐(aryl)‐1‐phenyl‐1H‐pyrazol‐4‐yl)‐3‐(pyridin‐3‐yl)‐4,5‐dihydropyrazole‐1‐carbaldehyde Derivatives as Potential Anticancer Agents. </span><span class="cited-content_cbyCitation_journal-name">Journal of Heterocyclic Chemistry</span><span> <strong>2017,</strong> <em>54 </em>
                                    (3)
                                     , 1812-1821. <a href="https://doi.org/10.1002/jhet.2768" title="DOI URL">https://doi.org/10.1002/jhet.2768</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/jhet.2768&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fjhet.2768%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Heterocyclic%2520Chemistry%26atitle%3DDesign%25252C%252BSynthesis%25252C%252Band%252BCytotoxicity%252BEvaluation%252Bof%252B3%2525E2%252580%252590%2525285%2525E2%252580%252590%2525283%2525E2%252580%252590%252528aryl%252529%2525E2%252580%2525901%2525E2%252580%252590phenyl%2525E2%252580%2525901H%2525E2%252580%252590pyrazol%2525E2%252580%2525904%2525E2%252580%252590yl%252529%2525E2%252580%2525901%2525E2%252580%252590phenyl%2525E2%252580%2525904%25252C5%2525E2%252580%252590dihydro%2525E2%252580%2525901H%2525E2%252580%252590pyrazol%2525E2%252580%2525903%2525E2%252580%252590yl%252529pyridine%252Band%252B5%2525E2%252580%252590%2525283%2525E2%252580%252590%252528aryl%252529%2525E2%252580%2525901%2525E2%252580%252590phenyl%2525E2%252580%2525901H%2525E2%252580%252590pyrazol%2525E2%252580%2525904%2525E2%252580%252590yl%252529%2525E2%252580%2525903%2525E2%252580%252590%252528pyridin%2525E2%252580%2525903%2525E2%252580%252590yl%252529%2525E2%252580%2525904%25252C5%2525E2%252580%252590dihydropyrazole%2525E2%252580%2525901%2525E2%252580%252590carbaldehyde%252BDerivatives%252Bas%252BPotential%252BAnticancer%252BAgents%26aulast%3DAlam%26aufirst%3DRaquib%26date%3D2017%26date%3D2016%26volume%3D54%26issue%3D3%26spage%3D1812%26epage%3D1821" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Gül  Yakalı</span>, <span class="hlFld-ContribAuthor ">Abban  Çakıcı</span>, <span class="hlFld-ContribAuthor ">Canel  Eke</span>, <span class="hlFld-ContribAuthor ">Günseli Turgut  Cin</span>, <span class="hlFld-ContribAuthor ">Muhittin  Aygün</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis, spectroscopic and X-ray structural characterization, quantum chemical studies and investigation of gama-irradiated effects of the novel hydrazone compound: [(E)-3-(2-nitrophenyl)-(E)-1-(2-phenylhydrazono)]-1-phenylallylidene. </span><span class="cited-content_cbyCitation_journal-name">Journal of Molecular Structure</span><span> <strong>2017,</strong> <em>1134 </em>, 244-252. <a href="https://doi.org/10.1016/j.molstruc.2016.12.092" title="DOI URL">https://doi.org/10.1016/j.molstruc.2016.12.092</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.molstruc.2016.12.092&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.molstruc.2016.12.092%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Molecular%2520Structure%26atitle%3DSynthesis%25252C%252Bspectroscopic%252Band%252BX-ray%252Bstructural%252Bcharacterization%25252C%252Bquantum%252Bchemical%252Bstudies%252Band%252Binvestigation%252Bof%252Bgama-irradiated%252Beffects%252Bof%252Bthe%252Bnovel%252Bhydrazone%252Bcompound%25253A%252B%25255B%252528E%252529-3-%2525282-nitrophenyl%252529-%252528E%252529-1-%2525282-phenylhydrazono%252529%25255D-1-phenylallylidene%26aulast%3DYakal%25C4%25B1%26aufirst%3DG%25C3%25BCl%26date%3D2017%26volume%3D1134%26spage%3D244%26epage%3D252" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">E. A.  Soboleva</span>, <span class="hlFld-ContribAuthor ">N. A.  Orlova</span>, <span class="hlFld-ContribAuthor ">V. V.  Shelkovnikov</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis of 1-[4-(1,3-diaryl-4,5-dihydro-1H-pyrazol-5-yl)-2,3,5,6-tetrafluorophenyl]piperidin-4-ols and their acrylates. </span><span class="cited-content_cbyCitation_journal-name">Russian Journal of Organic Chemistry</span><span> <strong>2017,</strong> <em>53 </em>
                                    (3)
                                     , 398-406. <a href="https://doi.org/10.1134/S1070428017030149" title="DOI URL">https://doi.org/10.1134/S1070428017030149</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1134/S1070428017030149&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1134%2FS1070428017030149%26sid%3Dliteratum%253Aachs%26jtitle%3DRussian%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DSynthesis%252Bof%252B1-%25255B4-%2525281%25252C3-diaryl-4%25252C5-dihydro-1H-pyrazol-5-yl%252529-2%25252C3%25252C5%25252C6-tetrafluorophenyl%25255Dpiperidin-4-ols%252Band%252Btheir%252Bacrylates%26aulast%3DSoboleva%26aufirst%3DE.%2BA.%26date%3D2017%26date%3D2017%26volume%3D53%26issue%3D3%26spage%3D398%26epage%3D406" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">W.  Michael Seganish</span>, <span class="hlFld-ContribAuthor ">J.J.  Lynch</span>, <span class="hlFld-ContribAuthor ">S.  Sorota</span>. </span><span class="cited-content_cbyCitation_article-title">Treatments for Heart Failure. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2017,</strong>,, 628-662. <a href="https://doi.org/10.1016/B978-0-12-409547-2.12434-5" title="DOI URL">https://doi.org/10.1016/B978-0-12-409547-2.12434-5</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-12-409547-2.12434-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-12-409547-2.12434-5%26sid%3Dliteratum%253Aachs%26atitle%3DTreatments%252Bfor%252BHeart%252BFailure%26aulast%3DMichael%2BSeganish%26aufirst%3DW.%26date%3D2017%26spage%3D628%26epage%3D662%26pub%3DElsevier%26atitle%3DComprehensive%252BMedicinal%252BChemistry%252BIII%26date%3D2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Vincenzo  Mollace</span>, <span class="hlFld-ContribAuthor ">Micaela  Gliozzi</span>, <span class="hlFld-ContribAuthor ">Annalisa  Capuano</span>, <span class="hlFld-ContribAuthor ">Francesco  Rossi</span>. </span><span class="cited-content_cbyCitation_article-title">Modulation of RAAS-natriuretic peptides in the treatment of HF: Old guys and newcomers. </span><span class="cited-content_cbyCitation_journal-name">International Journal of Cardiology</span><span> <strong>2017,</strong> <em>226 </em>, 126-131. <a href="https://doi.org/10.1016/j.ijcard.2016.03.085" title="DOI URL">https://doi.org/10.1016/j.ijcard.2016.03.085</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ijcard.2016.03.085&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ijcard.2016.03.085%26sid%3Dliteratum%253Aachs%26jtitle%3DInternational%2520Journal%2520of%2520Cardiology%26atitle%3DModulation%252Bof%252BRAAS-natriuretic%252Bpeptides%252Bin%252Bthe%252Btreatment%252Bof%252BHF%25253A%252BOld%252Bguys%252Band%252Bnewcomers%26aulast%3DMollace%26aufirst%3DVincenzo%26date%3D2017%26volume%3D226%26spage%3D126%26epage%3D131" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Gopal  Sathishkannan</span>, <span class="hlFld-ContribAuthor ">V. John  Tamilarasan</span>, <span class="hlFld-ContribAuthor ">Kannupal  Srinivasan</span>. </span><span class="cited-content_cbyCitation_article-title">Nucleophilic ring-opening reactions of trans-2-aroyl-3-aryl-cyclopropane-1,1-dicarboxylates with hydrazines. </span><span class="cited-content_cbyCitation_journal-name">Organic & Biomolecular Chemistry</span><span> <strong>2017,</strong> <em>15 </em>
                                    (6)
                                     , 1400-1406. <a href="https://doi.org/10.1039/C6OB02552H" title="DOI URL">https://doi.org/10.1039/C6OB02552H</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C6OB02552H&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC6OB02552H%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520%2526%2520Biomolecular%2520Chemistry%26atitle%3DNucleophilic%252Bring-opening%252Breactions%252Bof%252Btrans-2-aroyl-3-aryl-cyclopropane-1%25252C1-dicarboxylates%252Bwith%252Bhydrazines%26aulast%3DSathishkannan%26aufirst%3DGopal%26date%3D2017%26date%3D2017%26volume%3D15%26issue%3D6%26spage%3D1400%26epage%3D1406" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Tarek  Yousfi</span>, <span class="hlFld-ContribAuthor ">Alysha  Elliott</span>, <span class="hlFld-ContribAuthor ">Messiad  Hanane</span>, <span class="hlFld-ContribAuthor ">Rachid  Merdes</span>, <span class="hlFld-ContribAuthor ">Albert  Moyano</span>. </span><span class="cited-content_cbyCitation_article-title">Expedient Organocatalytic Syntheses of 4-Substituted Pyrazolidines and Isoxazolidines. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2016,</strong> <em>21 </em>
                                    (12)
                                     , 1655. <a href="https://doi.org/10.3390/molecules21121655" title="DOI URL">https://doi.org/10.3390/molecules21121655</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules21121655&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules21121655%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DExpedient%252BOrganocatalytic%252BSyntheses%252Bof%252B4-Substituted%252BPyrazolidines%252Band%252BIsoxazolidines%26aulast%3DYousfi%26aufirst%3DTarek%26date%3D2016%26date%3D2016%26volume%3D21%26issue%3D12%26spage%3D1655" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Niloy  Bhattacharjee</span>, <span class="hlFld-ContribAuthor ">Sujata  Barma</span>, <span class="hlFld-ContribAuthor ">Nandita  Konwar</span>, <span class="hlFld-ContribAuthor ">Saikat  Dewanjee</span>, <span class="hlFld-ContribAuthor ">Prasenjit  Manna</span>. </span><span class="cited-content_cbyCitation_article-title">Mechanistic insight of diabetic nephropathy and its pharmacotherapeutic targets: An update. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Pharmacology</span><span> <strong>2016,</strong> <em>791 </em>, 8-24. <a href="https://doi.org/10.1016/j.ejphar.2016.08.022" title="DOI URL">https://doi.org/10.1016/j.ejphar.2016.08.022</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejphar.2016.08.022&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejphar.2016.08.022%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Pharmacology%26atitle%3DMechanistic%252Binsight%252Bof%252Bdiabetic%252Bnephropathy%252Band%252Bits%252Bpharmacotherapeutic%252Btargets%25253A%252BAn%252Bupdate%26aulast%3DBhattacharjee%26aufirst%3DNiloy%26date%3D2016%26volume%3D791%26spage%3D8%26epage%3D24" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Matthieu  Collin</span>, <span class="hlFld-ContribAuthor ">Frédéric  Jaisser</span>. </span><span class="cited-content_cbyCitation_article-title">Mineralocorticoid receptor antagonists: a patent evaluation of US20150284376A1. </span><span class="cited-content_cbyCitation_journal-name">Expert Opinion on Therapeutic Patents</span><span> <strong>2016,</strong> <em>26 </em>
                                    (10)
                                     , 1111-1114. <a href="https://doi.org/10.1080/13543776.2016.1227320" title="DOI URL">https://doi.org/10.1080/13543776.2016.1227320</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/13543776.2016.1227320&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F13543776.2016.1227320%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opinion%2520on%2520Therapeutic%2520Patents%26atitle%3DMineralocorticoid%252Breceptor%252Bantagonists%25253A%252Ba%252Bpatent%252Bevaluation%252Bof%252BUS20150284376A1%26aulast%3DCollin%26aufirst%3DMatthieu%26date%3D2016%26date%3D2016%26volume%3D26%26issue%3D10%26spage%3D1111%26epage%3D1114" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Abdullah S.  Al-Bogami</span>. </span><span class="cited-content_cbyCitation_article-title">Mechanochemical synthesis of cyclohexenones and indazoles as potential antimicrobial agents. </span><span class="cited-content_cbyCitation_journal-name">Research on Chemical Intermediates</span><span> <strong>2016,</strong> <em>42 </em>
                                    (6)
                                     , 5457-5477. <a href="https://doi.org/10.1007/s11164-015-2379-5" title="DOI URL">https://doi.org/10.1007/s11164-015-2379-5</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s11164-015-2379-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs11164-015-2379-5%26sid%3Dliteratum%253Aachs%26jtitle%3DResearch%2520on%2520Chemical%2520Intermediates%26atitle%3DMechanochemical%252Bsynthesis%252Bof%252Bcyclohexenones%252Band%252Bindazoles%252Bas%252Bpotential%252Bantimicrobial%252Bagents%26aulast%3DAl-Bogami%26aufirst%3DAbdullah%2BS.%26date%3D2016%26date%3D2015%26volume%3D42%26issue%3D6%26spage%3D5457%26epage%3D5477" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Pervez  Ahmad</span>, <span class="hlFld-ContribAuthor ">Hyunjung  Woo</span>, <span class="hlFld-ContribAuthor ">Kyu-Yeon  Jun</span>, <span class="hlFld-ContribAuthor ">Adnan A.  Kadi</span>, <span class="hlFld-ContribAuthor ">Hatem A.  Abdel-Aziz</span>, <span class="hlFld-ContribAuthor ">Youngjoo  Kwon</span>, <span class="hlFld-ContribAuthor ">A.F.M. Motiur  Rahman</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis, topoisomerase I & II inhibitory activity, antiproliferative activity, and structure–activity relationship study of pyrazoline derivatives: An ATP-competitive human topoisomerase IIα catalytic inhibitor. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2016,</strong> <em>24 </em>
                                    (8)
                                     , 1898-1908. <a href="https://doi.org/10.1016/j.bmc.2016.03.017" title="DOI URL">https://doi.org/10.1016/j.bmc.2016.03.017</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2016.03.017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2016.03.017%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DDesign%25252C%252Bsynthesis%25252C%252Btopoisomerase%252BI%252B%252526%252BII%252Binhibitory%252Bactivity%25252C%252Bantiproliferative%252Bactivity%25252C%252Band%252Bstructure%2525E2%252580%252593activity%252Brelationship%252Bstudy%252Bof%252Bpyrazoline%252Bderivatives%25253A%252BAn%252BATP-competitive%252Bhuman%252Btopoisomerase%252BII%2525CE%2525B1%252Bcatalytic%252Binhibitor%26aulast%3DAhmad%26aufirst%3DPervez%26date%3D2016%26volume%3D24%26issue%3D8%26spage%3D1898%26epage%3D1908" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Peter  Bramlage</span>, <span class="hlFld-ContribAuthor ">Stephanie L.  Swift</span>, <span class="hlFld-ContribAuthor ">Martin  Thoenes</span>, <span class="hlFld-ContribAuthor ">Joan  Minguet</span>, <span class="hlFld-ContribAuthor ">Carmen  Ferrero</span>, <span class="hlFld-ContribAuthor ">Roland E.  Schmieder</span>. </span><span class="cited-content_cbyCitation_article-title">Non-steroidal mineralocorticoid receptor antagonism for the treatment of cardiovascular and renal disease. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Heart Failure</span><span> <strong>2016,</strong> <em>18 </em>
                                    (1)
                                     , 28-37. <a href="https://doi.org/10.1002/ejhf.444" title="DOI URL">https://doi.org/10.1002/ejhf.444</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ejhf.444&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fejhf.444%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Heart%2520Failure%26atitle%3DNon-steroidal%252Bmineralocorticoid%252Breceptor%252Bantagonism%252Bfor%252Bthe%252Btreatment%252Bof%252Bcardiovascular%252Band%252Brenal%252Bdisease%26aulast%3DBramlage%26aufirst%3DPeter%26date%3D2016%26date%3D2015%26volume%3D18%26issue%3D1%26spage%3D28%26epage%3D37" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Peter  Kolkhof</span>, <span class="hlFld-ContribAuthor ">Frederic  Jaisser</span>, <span class="hlFld-ContribAuthor ">So-Young  Kim</span>, <span class="hlFld-ContribAuthor ">Gerasimos  Filippatos</span>, <span class="hlFld-ContribAuthor ">Christina  Nowack</span>, <span class="hlFld-ContribAuthor ">Bertram  Pitt</span>. </span><span class="cited-content_cbyCitation_article-title">Steroidal and Novel Non-steroidal Mineralocorticoid Receptor Antagonists in Heart Failure and Cardiorenal Diseases: Comparison at Bench and Bedside. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2016,</strong>,, 271-305. <a href="https://doi.org/10.1007/164_2016_76" title="DOI URL">https://doi.org/10.1007/164_2016_76</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/164_2016_76&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2F164_2016_76%26sid%3Dliteratum%253Aachs%26atitle%3DSteroidal%252Band%252BNovel%252BNon-steroidal%252BMineralocorticoid%252BReceptor%252BAntagonists%252Bin%252BHeart%252BFailure%252Band%252BCardiorenal%252BDiseases%25253A%252BComparison%252Bat%252BBench%252Band%252BBedside%26aulast%3DKolkhof%26aufirst%3DPeter%26date%3D2016%26date%3D2016%26spage%3D271%26epage%3D305%26pub%3DSpringer%2520International%2520Publishing%26atitle%3DHeart%252BFailure%26aulast%3DBauersachs%26aufirst%3DJohann%26date%3D2017%26volume%3D243" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Rainer E.  Martin</span>, <span class="hlFld-ContribAuthor ">Johannes  Lehmann</span>, <span class="hlFld-ContribAuthor ">Thibaut  Alzieu</span>, <span class="hlFld-ContribAuthor ">Mario  Lenz</span>, <span class="hlFld-ContribAuthor ">Marjorie A.  Carnero Corrales</span>, <span class="hlFld-ContribAuthor ">Johannes D.  Aebi</span>, <span class="hlFld-ContribAuthor ">Hans Peter  Märki</span>, <span class="hlFld-ContribAuthor ">Bernd  Kuhn</span>, <span class="hlFld-ContribAuthor ">Kurt  Amrein</span>, <span class="hlFld-ContribAuthor ">Alexander V.  Mayweg</span>, <span class="hlFld-ContribAuthor ">Robert  Britton</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis of annulated pyridines as inhibitors of aldosterone synthase (CYP11B2). </span><span class="cited-content_cbyCitation_journal-name">Organic & Biomolecular Chemistry</span><span> <strong>2016,</strong> <em>14 </em>
                                    (25)
                                     , 5922-5927. <a href="https://doi.org/10.1039/C6OB00848H" title="DOI URL">https://doi.org/10.1039/C6OB00848H</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C6OB00848H&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC6OB00848H%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520%2526%2520Biomolecular%2520Chemistry%26atitle%3DSynthesis%252Bof%252Bannulated%252Bpyridines%252Bas%252Binhibitors%252Bof%252Baldosterone%252Bsynthase%252B%252528CYP11B2%252529%26aulast%3DMartin%26aufirst%3DRainer%2BE.%26date%3D2016%26date%3D2016%26volume%3D14%26issue%3D25%26spage%3D5922%26epage%3D5927" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Takeshi  Mori</span>, <span class="hlFld-ContribAuthor ">Hitoshi  Saomoto</span>, <span class="hlFld-ContribAuthor ">Koji  Machitani</span>, <span class="hlFld-ContribAuthor ">Kaname  Inoue</span>, <span class="hlFld-ContribAuthor ">Yasunori  Aoki</span>, <span class="hlFld-ContribAuthor ">Takeshi  Koshitani</span>, <span class="hlFld-ContribAuthor ">Nagatoshi  Koumura</span>, <span class="hlFld-ContribAuthor ">Takurou N.  Murakami</span>. </span><span class="cited-content_cbyCitation_article-title">Influence of the non-conjugated 5-position substituent of 1,3,5-triaryl-2-pyrazoline-based photosensitizers on the photophysical properties and performance of a dye-sensitized solar cell. </span><span class="cited-content_cbyCitation_journal-name">RSC Advances</span><span> <strong>2016,</strong> <em>6 </em>
                                    (17)
                                     , 13964-13970. <a href="https://doi.org/10.1039/C6RA00738D" title="DOI URL">https://doi.org/10.1039/C6RA00738D</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C6RA00738D&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC6RA00738D%26sid%3Dliteratum%253Aachs%26jtitle%3DRSC%2520Advances%26atitle%3DInfluence%252Bof%252Bthe%252Bnon-conjugated%252B5-position%252Bsubstituent%252Bof%252B1%25252C3%25252C5-triaryl-2-pyrazoline-based%252Bphotosensitizers%252Bon%252Bthe%252Bphotophysical%252Bproperties%252Band%252Bperformance%252Bof%252Ba%252Bdye-sensitized%252Bsolar%252Bcell%26aulast%3DMori%26aufirst%3DTakeshi%26date%3D2016%26date%3D2016%26volume%3D6%26issue%3D17%26spage%3D13964%26epage%3D13970" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Elise P.  Gomez-Sanchez</span>. </span><span class="cited-content_cbyCitation_article-title">Third-generation Mineralocorticoid Receptor Antagonists. </span><span class="cited-content_cbyCitation_journal-name">Journal of Cardiovascular Pharmacology</span><span> <strong>2016,</strong> <em>67 </em>
                                    (1)
                                     , 26-38. <a href="https://doi.org/10.1097/FJC.0000000000000329" title="DOI URL">https://doi.org/10.1097/FJC.0000000000000329</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1097/FJC.0000000000000329&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1097%2FFJC.0000000000000329%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Cardiovascular%2520Pharmacology%26atitle%3DThird-generation%252BMineralocorticoid%252BReceptor%252BAntagonists%26aulast%3DGomez-Sanchez%26aufirst%3DElise%2BP.%26date%3D2016%26volume%3D67%26issue%3D1%26spage%3D26%26epage%3D38" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Peter  Kolkhof</span>, <span class="hlFld-ContribAuthor ">Christina  Nowack</span>, <span class="hlFld-ContribAuthor ">Frank  Eitner</span>. </span><span class="cited-content_cbyCitation_article-title">Nonsteroidal antagonists of the mineralocorticoid receptor. </span><span class="cited-content_cbyCitation_journal-name">Current Opinion in Nephrology and Hypertension</span><span> <strong>2015,</strong> <em>24 </em>
                                    (5)
                                     , 417-424. <a href="https://doi.org/10.1097/MNH.0000000000000147" title="DOI URL">https://doi.org/10.1097/MNH.0000000000000147</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1097/MNH.0000000000000147&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1097%2FMNH.0000000000000147%26sid%3Dliteratum%253Aachs%26jtitle%3DCurrent%2520Opinion%2520in%2520Nephrology%2520and%2520Hypertension%26atitle%3DNonsteroidal%252Bantagonists%252Bof%252Bthe%252Bmineralocorticoid%252Breceptor%26aulast%3DKolkhof%26aufirst%3DPeter%26date%3D2015%26volume%3D24%26issue%3D5%26spage%3D417%26epage%3D424" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">S. K.  Thaslim Basha</span>, <span class="hlFld-ContribAuthor ">Devineni  Subba Rao</span>, <span class="hlFld-ContribAuthor ">Golla  Madhava</span>, <span class="hlFld-ContribAuthor ">Shaik Thahir  Basha</span>, <span class="hlFld-ContribAuthor ">Mundla Nagalakshmi  Devamma</span>, <span class="hlFld-ContribAuthor ">Madhu Sudhana  Saddala</span>, <span class="hlFld-ContribAuthor ">Usha Rani  Asupatri</span>, <span class="hlFld-ContribAuthor ">Chamarthi Naga  Raju</span>. </span><span class="cited-content_cbyCitation_article-title">N
              -Phosphorylated Derivatives of 5-Nitroindazole as Antimicrobial and Antioxidant Agents and Docking Study Against DNA Gyrasea. </span><span class="cited-content_cbyCitation_journal-name">Phosphorus, Sulfur, and Silicon and the Related Elements</span><span> <strong>2015,</strong> <em>190 </em>
                                    (7)
                                     , 1064-1074. <a href="https://doi.org/10.1080/10426507.2014.965818" title="DOI URL">https://doi.org/10.1080/10426507.2014.965818</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/10426507.2014.965818&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F10426507.2014.965818%26sid%3Dliteratum%253Aachs%26jtitle%3DPhosphorus%252C%2520Sulfur%252C%2520and%2520Silicon%2520and%2520the%2520Related%2520Elements%26atitle%3DN%252B-Phosphorylated%252BDerivatives%252Bof%252B5-Nitroindazole%252Bas%252BAntimicrobial%252Band%252BAntioxidant%252BAgents%252Band%252BDocking%252BStudy%252BAgainst%252BDNA%252BGyrasea%26aulast%3DThaslim%2BBasha%26aufirst%3DS.%2BK.%26date%3D2015%26date%3D2015%26volume%3D190%26issue%3D7%26spage%3D1064%26epage%3D1074" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Tetsuro  Nariai</span>, <span class="hlFld-ContribAuthor ">Katsuya  Fujita</span>, <span class="hlFld-ContribAuthor ">Kenji  Kawane</span>, <span class="hlFld-ContribAuthor ">Masaya  Mori</span>, <span class="hlFld-ContribAuthor ">Ryo  Nakayama</span>, <span class="hlFld-ContribAuthor ">Koichi  Matsuda</span>, <span class="hlFld-ContribAuthor ">Seiji  Katayama</span>, <span class="hlFld-ContribAuthor ">Nobuhisa  Fukuda</span>, <span class="hlFld-ContribAuthor ">Seiji  Hori</span>, <span class="hlFld-ContribAuthor ">Masato  Iwata</span>, <span class="hlFld-ContribAuthor ">Futoshi  Hasegawa</span>, <span class="hlFld-ContribAuthor ">Kuniko  Suzuki</span>, <span class="hlFld-ContribAuthor ">Hiroshi  Kato</span>. </span><span class="cited-content_cbyCitation_article-title">DSR-71167, a Novel Mineralocorticoid Receptor Antagonist with Carbonic Anhydrase Inhibitory Activity, Separates Urinary Sodium Excretion and Serum Potassium Elevation in Rats. </span><span class="cited-content_cbyCitation_journal-name">Journal of Pharmacology and Experimental Therapeutics</span><span> <strong>2015,</strong> <em>354 </em>
                                    (1)
                                     , 2-9. <a href="https://doi.org/10.1124/jpet.114.221341" title="DOI URL">https://doi.org/10.1124/jpet.114.221341</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1124/jpet.114.221341&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1124%2Fjpet.114.221341%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Pharmacology%2520and%2520Experimental%2520Therapeutics%26atitle%3DDSR-71167%25252C%252Ba%252BNovel%252BMineralocorticoid%252BReceptor%252BAntagonist%252Bwith%252BCarbonic%252BAnhydrase%252BInhibitory%252BActivity%25252C%252BSeparates%252BUrinary%252BSodium%252BExcretion%252Band%252BSerum%252BPotassium%252BElevation%252Bin%252BRats%26aulast%3DNariai%26aufirst%3DTetsuro%26date%3D2015%26date%3D2015%26volume%3D354%26issue%3D1%26spage%3D2%26epage%3D9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Zarife Sibel  Şahin</span>, <span class="hlFld-ContribAuthor ">Hülya  Şenöz</span>, <span class="hlFld-ContribAuthor ">Habibe  Tezcan</span>, <span class="hlFld-ContribAuthor ">Orhan  Büyükgüngör</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis, spectral analysis, structural elucidation and quantum chemical studies of (E)-methyl-4-[(2-phenylhydrazono)methyl]benzoate. </span><span class="cited-content_cbyCitation_journal-name">Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy</span><span> <strong>2015,</strong> <em>143 </em>, 91-100. <a href="https://doi.org/10.1016/j.saa.2015.02.032" title="DOI URL">https://doi.org/10.1016/j.saa.2015.02.032</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.saa.2015.02.032&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.saa.2015.02.032%26sid%3Dliteratum%253Aachs%26jtitle%3DSpectrochimica%2520Acta%2520Part%2520A%253A%2520Molecular%2520and%2520Biomolecular%2520Spectroscopy%26atitle%3DSynthesis%25252C%252Bspectral%252Banalysis%25252C%252Bstructural%252Belucidation%252Band%252Bquantum%252Bchemical%252Bstudies%252Bof%252B%252528E%252529-methyl-4-%25255B%2525282-phenylhydrazono%252529methyl%25255Dbenzoate%26aulast%3D%25C5%259Eahin%26aufirst%3DZarife%2BSibel%26date%3D2015%26volume%3D143%26spage%3D91%26epage%3D100" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">ARAVA VEERA  REDDY</span>, <span class="hlFld-ContribAuthor ">SURENDRAREDDY  GOGIREDDY</span>, <span class="hlFld-ContribAuthor ">P K  DUBEY</span>, <span class="hlFld-ContribAuthor ">MADHAVA REDDY  B</span>, <span class="hlFld-ContribAuthor ">VEERESH  B</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis and characterization of 1 H-pyridin-4-yl-3, 5-disubstituted indazoles and their anti-inflammatory and analgesic activity. </span><span class="cited-content_cbyCitation_journal-name">Journal of Chemical Sciences</span><span> <strong>2015,</strong> <em>127 </em>
                                    (3)
                                     , 433-438. <a href="https://doi.org/10.1007/s12039-015-0792-3" title="DOI URL">https://doi.org/10.1007/s12039-015-0792-3</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s12039-015-0792-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs12039-015-0792-3%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Chemical%2520Sciences%26atitle%3DDesign%25252C%252Bsynthesis%252Band%252Bcharacterization%252Bof%252B1%252BH-pyridin-4-yl-3%25252C%252B5-disubstituted%252Bindazoles%252Band%252Btheir%252Banti-inflammatory%252Band%252Banalgesic%252Bactivity%26aulast%3DREDDY%26aufirst%3DARAVA%2BVEERA%26date%3D2015%26date%3D2015%26volume%3D127%26issue%3D3%26spage%3D433%26epage%3D438" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Meng  Lv</span>, <span class="hlFld-ContribAuthor ">Zhuo  Chen</span>, <span class="hlFld-ContribAuthor ">Gaoyun  Hu</span>, <span class="hlFld-ContribAuthor ">Qianbin  Li</span>. </span><span class="cited-content_cbyCitation_article-title">Therapeutic strategies of diabetic nephropathy: recent progress and future perspectives. </span><span class="cited-content_cbyCitation_journal-name">Drug Discovery Today</span><span> <strong>2015,</strong> <em>20 </em>
                                    (3)
                                     , 332-346. <a href="https://doi.org/10.1016/j.drudis.2014.10.007" title="DOI URL">https://doi.org/10.1016/j.drudis.2014.10.007</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.drudis.2014.10.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.drudis.2014.10.007%26sid%3Dliteratum%253Aachs%26jtitle%3DDrug%2520Discovery%2520Today%26atitle%3DTherapeutic%252Bstrategies%252Bof%252Bdiabetic%252Bnephropathy%25253A%252Brecent%252Bprogress%252Band%252Bfuture%252Bperspectives%26aulast%3DLv%26aufirst%3DMeng%26date%3D2015%26volume%3D20%26issue%3D3%26spage%3D332%26epage%3D346" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Peter J.  Fuller</span>, <span class="hlFld-ContribAuthor ">Jun  Yang</span>, <span class="hlFld-ContribAuthor ">Morag J.  Young</span>. </span><span class="cited-content_cbyCitation_article-title">Corticosteroid Receptors. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2015,</strong>,, 17-39. <a href="https://doi.org/10.1007/978-3-319-18729-7_2" title="DOI URL">https://doi.org/10.1007/978-3-319-18729-7_2</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/978-3-319-18729-7_2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2F978-3-319-18729-7_2%26sid%3Dliteratum%253Aachs%26atitle%3DCorticosteroid%252BReceptors%26aulast%3DFuller%26aufirst%3DPeter%2BJ.%26date%3D2015%26date%3D2015%26spage%3D17%26epage%3D39%26pub%3DSpringer%2520International%2520Publishing%26atitle%3DNuclear%252BReceptors%25253A%252BFrom%252BStructure%252Bto%252Bthe%252BClinic%26aulast%3DMcEwan%26aufirst%3DIain%2BJ.%26date%3D2015%26volume%3D277" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Federico  Carbone</span>, <span class="hlFld-ContribAuthor ">Fabrizio  Montecucco</span>. </span><span class="cited-content_cbyCitation_article-title">Mineralcorticoid Receptor Antagonists. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2015,</strong>,, 145-154. <a href="https://doi.org/10.1016/B978-0-12-800039-7.00010-4" title="DOI URL">https://doi.org/10.1016/B978-0-12-800039-7.00010-4</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-12-800039-7.00010-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-12-800039-7.00010-4%26sid%3Dliteratum%253Aachs%26atitle%3DMineralcorticoid%252BReceptor%252BAntagonists%26aulast%3DCarbone%26aufirst%3DFederico%26date%3D2015%26spage%3D145%26epage%3D154%26pub%3DElsevier%26atitle%3DInflammation%252Bin%252BHeart%252BFailure%26date%3D2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Layla A.  Taib</span>, <span class="hlFld-ContribAuthor ">Hassan M.  Faidallah</span>, <span class="hlFld-ContribAuthor ">Zarife Sibel  Şahin</span>, <span class="hlFld-ContribAuthor ">Abdullah M.  Asiri</span>, <span class="hlFld-ContribAuthor ">Onur  Şahin</span>, <span class="hlFld-ContribAuthor ">Muhammad Nadeem  Arshad</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis, spectral analysis, X-ray crystal structures and evaluation of chemical reactivity of five new benzoindazole derivatives through experimental and theoretical studies. </span><span class="cited-content_cbyCitation_journal-name">Journal of Molecular Structure</span><span> <strong>2014,</strong> <em>1076 </em>, 272-279. <a href="https://doi.org/10.1016/j.molstruc.2014.07.033" title="DOI URL">https://doi.org/10.1016/j.molstruc.2014.07.033</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.molstruc.2014.07.033&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.molstruc.2014.07.033%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Molecular%2520Structure%26atitle%3DSynthesis%25252C%252Bspectral%252Banalysis%25252C%252BX-ray%252Bcrystal%252Bstructures%252Band%252Bevaluation%252Bof%252Bchemical%252Breactivity%252Bof%252Bfive%252Bnew%252Bbenzoindazole%252Bderivatives%252Bthrough%252Bexperimental%252Band%252Btheoretical%252Bstudies%26aulast%3DTaib%26aufirst%3DLayla%2BA.%26date%3D2014%26volume%3D1076%26spage%3D272%26epage%3D279" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Tomoaki  Hasui</span>, <span class="hlFld-ContribAuthor ">Norio  Ohyabu</span>, <span class="hlFld-ContribAuthor ">Taiichi  Ohra</span>, <span class="hlFld-ContribAuthor ">Koji  Fuji</span>, <span class="hlFld-ContribAuthor ">Takahiro  Sugimoto</span>, <span class="hlFld-ContribAuthor ">Jun  Fujimoto</span>, <span class="hlFld-ContribAuthor ">Kouhei  Asano</span>, <span class="hlFld-ContribAuthor ">Masato  Oosawa</span>, <span class="hlFld-ContribAuthor ">Sachiko  Shiotani</span>, <span class="hlFld-ContribAuthor ">Nobuhiro  Nishigaki</span>, <span class="hlFld-ContribAuthor ">Keiji  Kusumoto</span>, <span class="hlFld-ContribAuthor ">Hideki  Matsui</span>, <span class="hlFld-ContribAuthor ">Atsushi  Mizukami</span>, <span class="hlFld-ContribAuthor ">Noriyuki  Habuka</span>, <span class="hlFld-ContribAuthor ">Satoshi  Sogabe</span>, <span class="hlFld-ContribAuthor ">Satoshi  Endo</span>, <span class="hlFld-ContribAuthor ">Midori  Ono</span>, <span class="hlFld-ContribAuthor ">Christopher S.  Siedem</span>, <span class="hlFld-ContribAuthor ">Tony P.  Tang</span>, <span class="hlFld-ContribAuthor ">Cassandra  Gauthier</span>, <span class="hlFld-ContribAuthor ">Lisa A.  De Meese</span>, <span class="hlFld-ContribAuthor ">Steven A.  Boyd</span>, <span class="hlFld-ContribAuthor ">Shoji  Fukumoto</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of 6-[5-(4-fluorophenyl)-3-methyl-pyrazol-4-yl]-benzoxazin-3-one derivatives as novel selective nonsteroidal mineralocorticoid receptor antagonists. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2014,</strong> <em>22 </em>
                                    (19)
                                     , 5428-5445. <a href="https://doi.org/10.1016/j.bmc.2014.07.038" title="DOI URL">https://doi.org/10.1016/j.bmc.2014.07.038</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2014.07.038&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2014.07.038%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252B6-%25255B5-%2525284-fluorophenyl%252529-3-methyl-pyrazol-4-yl%25255D-benzoxazin-3-one%252Bderivatives%252Bas%252Bnovel%252Bselective%252Bnonsteroidal%252Bmineralocorticoid%252Breceptor%252Bantagonists%26aulast%3DHasui%26aufirst%3DTomoaki%26date%3D2014%26volume%3D22%26issue%3D19%26spage%3D5428%26epage%3D5445" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">James M.  Luther</span>. </span><span class="cited-content_cbyCitation_article-title">Is there a new dawn for selective mineralocorticoid receptor antagonism?. </span><span class="cited-content_cbyCitation_journal-name">Current Opinion in Nephrology and Hypertension</span><span> <strong>2014,</strong> <em>23 </em>
                                    (5)
                                     , 456-461. <a href="https://doi.org/10.1097/MNH.0000000000000051" title="DOI URL">https://doi.org/10.1097/MNH.0000000000000051</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1097/MNH.0000000000000051&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1097%2FMNH.0000000000000051%26sid%3Dliteratum%253Aachs%26jtitle%3DCurrent%2520Opinion%2520in%2520Nephrology%2520and%2520Hypertension%26atitle%3DIs%252Bthere%252Ba%252Bnew%252Bdawn%252Bfor%252Bselective%252Bmineralocorticoid%252Breceptor%252Bantagonism%25253F%26aulast%3DLuther%26aufirst%3DJames%2BM.%26date%3D2014%26volume%3D23%26issue%3D5%26spage%3D456%26epage%3D461" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Juan  Tamargo</span>, <span class="hlFld-ContribAuthor ">Anna  Solini</span>, <span class="hlFld-ContribAuthor ">Luis M.  Ruilope</span>. </span><span class="cited-content_cbyCitation_article-title">Comparison of Agents That Affect Aldosterone Action. </span><span class="cited-content_cbyCitation_journal-name">Seminars in Nephrology</span><span> <strong>2014,</strong> <em>34 </em>
                                    (3)
                                     , 285-306. <a href="https://doi.org/10.1016/j.semnephrol.2014.04.005" title="DOI URL">https://doi.org/10.1016/j.semnephrol.2014.04.005</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.semnephrol.2014.04.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.semnephrol.2014.04.005%26sid%3Dliteratum%253Aachs%26jtitle%3DSeminars%2520in%2520Nephrology%26atitle%3DComparison%252Bof%252BAgents%252BThat%252BAffect%252BAldosterone%252BAction%26aulast%3DTamargo%26aufirst%3DJuan%26date%3D2014%26volume%3D34%26issue%3D3%26spage%3D285%26epage%3D306" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jason M.  Cox</span>, <span class="hlFld-ContribAuthor ">Hong D.  Chu</span>, <span class="hlFld-ContribAuthor ">Christine  Yang</span>, <span class="hlFld-ContribAuthor ">Hong C.  Shen</span>, <span class="hlFld-ContribAuthor ">Zhicai  Wu</span>, <span class="hlFld-ContribAuthor ">Jaume  Balsells</span>, <span class="hlFld-ContribAuthor ">Alejandro  Crespo</span>, <span class="hlFld-ContribAuthor ">Patricia  Brown</span>, <span class="hlFld-ContribAuthor ">Beata  Zamlynny</span>, <span class="hlFld-ContribAuthor ">Judyann  Wiltsie</span>, <span class="hlFld-ContribAuthor ">Joseph  Clemas</span>, <span class="hlFld-ContribAuthor ">Jack  Gibson</span>, <span class="hlFld-ContribAuthor ">Lisa  Contino</span>, <span class="hlFld-ContribAuthor ">JeanMarie  Lisnock</span>, <span class="hlFld-ContribAuthor ">Gaochao  Zhou</span>, <span class="hlFld-ContribAuthor ">Margarita  Garcia-Calvo</span>, <span class="hlFld-ContribAuthor ">Thomas  Bateman</span>, <span class="hlFld-ContribAuthor ">Ling  Xu</span>, <span class="hlFld-ContribAuthor ">Xinchun  Tong</span>, <span class="hlFld-ContribAuthor ">Martin  Crook</span>, <span class="hlFld-ContribAuthor ">Peter  Sinclair</span>. </span><span class="cited-content_cbyCitation_article-title">Mineralocorticoid receptor antagonists: Identification of heterocyclic amide replacements in the oxazolidinedione series. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2014,</strong> <em>24 </em>
                                    (7)
                                     , 1681-1684. <a href="https://doi.org/10.1016/j.bmcl.2014.02.057" title="DOI URL">https://doi.org/10.1016/j.bmcl.2014.02.057</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2014.02.057&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2014.02.057%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DMineralocorticoid%252Breceptor%252Bantagonists%25253A%252BIdentification%252Bof%252Bheterocyclic%252Bamide%252Breplacements%252Bin%252Bthe%252Boxazolidinedione%252Bseries%26aulast%3DCox%26aufirst%3DJason%2BM.%26date%3D2014%26volume%3D24%26issue%3D7%26spage%3D1681%26epage%3D1684" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Matthieu  Collin</span>, <span class="hlFld-ContribAuthor ">Frederic  Niemann</span>, <span class="hlFld-ContribAuthor ">Frédéric  Jaisser</span>. </span><span class="cited-content_cbyCitation_article-title">Mineralocorticoid receptor modulators: a patent review (2007 – 2012). </span><span class="cited-content_cbyCitation_journal-name">Expert Opinion on Therapeutic Patents</span><span> <strong>2014,</strong> <em>24 </em>
                                    (2)
                                     , 177-183. <a href="https://doi.org/10.1517/13543776.2014.854772" title="DOI URL">https://doi.org/10.1517/13543776.2014.854772</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1517/13543776.2014.854772&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1517%2F13543776.2014.854772%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opinion%2520on%2520Therapeutic%2520Patents%26atitle%3DMineralocorticoid%252Breceptor%252Bmodulators%25253A%252Ba%252Bpatent%252Breview%252B%2525282007%252B%2525E2%252580%252593%252B2012%252529%26aulast%3DCollin%26aufirst%3DMatthieu%26date%3D2014%26date%3D2013%26volume%3D24%26issue%3D2%26spage%3D177%26epage%3D183" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Maricica  Pacurari</span>, <span class="hlFld-ContribAuthor ">Ramzi  Kafoury</span>, <span class="hlFld-ContribAuthor ">Paul B.  Tchounwou</span>, <span class="hlFld-ContribAuthor ">Kenneth  Ndebele</span>. </span><span class="cited-content_cbyCitation_article-title">The Renin-Angiotensin-Aldosterone System in Vascular Inflammation and Remodeling. </span><span class="cited-content_cbyCitation_journal-name">International Journal of Inflammation</span><span> <strong>2014,</strong> <em>2014 </em>, 1-13. <a href="https://doi.org/10.1155/2014/689360" title="DOI URL">https://doi.org/10.1155/2014/689360</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1155/2014/689360&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1155%2F2014%2F689360%26sid%3Dliteratum%253Aachs%26jtitle%3DInternational%2520Journal%2520of%2520Inflammation%26atitle%3DThe%252BRenin-Angiotensin-Aldosterone%252BSystem%252Bin%252BVascular%252BInflammation%252Band%252BRemodeling%26aulast%3DPacurari%26aufirst%3DMaricica%26date%3D2014%26volume%3D2014%26spage%3D1%26epage%3D13" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Kentaro  Futatsugi</span>, <span class="hlFld-ContribAuthor ">David W.  Piotrowski</span>, <span class="hlFld-ContribAuthor ">Agustin  Casimiro-Garcia</span>, <span class="hlFld-ContribAuthor ">Shaughn  Robinson</span>, <span class="hlFld-ContribAuthor ">Matthew  Sammons</span>, <span class="hlFld-ContribAuthor ">Paula M.  Loria</span>, <span class="hlFld-ContribAuthor ">Mary E.  Banker</span>, <span class="hlFld-ContribAuthor ">Donna N.  Petersen</span>, <span class="hlFld-ContribAuthor ">Natalia J.  Schmidt</span>. </span><span class="cited-content_cbyCitation_article-title">Design and synthesis of aryl sulfonamide-based nonsteroidal mineralocorticoid receptor antagonists. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2013,</strong> <em>23 </em>
                                    (23)
                                     , 6239-6242. <a href="https://doi.org/10.1016/j.bmcl.2013.09.099" title="DOI URL">https://doi.org/10.1016/j.bmcl.2013.09.099</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2013.09.099&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2013.09.099%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDesign%252Band%252Bsynthesis%252Bof%252Baryl%252Bsulfonamide-based%252Bnonsteroidal%252Bmineralocorticoid%252Breceptor%252Bantagonists%26aulast%3DFutatsugi%26aufirst%3DKentaro%26date%3D2013%26volume%3D23%26issue%3D23%26spage%3D6239%26epage%3D6242" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hong-Ping  Zhao</span>, <span class="hlFld-ContribAuthor ">Hong-Min  Jiang</span>, <span class="hlFld-ContribAuthor ">Bing-Ren  Xiang</span>. </span><span class="cited-content_cbyCitation_article-title">Discontinued drugs in 2012: cardiovascular drugs. </span><span class="cited-content_cbyCitation_journal-name">Expert Opinion on Investigational Drugs</span><span> <strong>2013,</strong> <em>22 </em>
                                    (11)
                                     , 1437-1451. <a href="https://doi.org/10.1517/13543784.2013.832198" title="DOI URL">https://doi.org/10.1517/13543784.2013.832198</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1517/13543784.2013.832198&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1517%2F13543784.2013.832198%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opinion%2520on%2520Investigational%2520Drugs%26atitle%3DDiscontinued%252Bdrugs%252Bin%252B2012%25253A%252Bcardiovascular%252Bdrugs%26aulast%3DZhao%26aufirst%3DHong-Ping%26date%3D2013%26date%3D2013%26volume%3D22%26issue%3D11%26spage%3D1437%26epage%3D1451" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Tomoaki  Hasui</span>, <span class="hlFld-ContribAuthor ">Taiichi  Ohra</span>, <span class="hlFld-ContribAuthor ">Norio  Ohyabu</span>, <span class="hlFld-ContribAuthor ">Kouhei  Asano</span>, <span class="hlFld-ContribAuthor ">Hideki  Matsui</span>, <span class="hlFld-ContribAuthor ">Atsushi  Mizukami</span>, <span class="hlFld-ContribAuthor ">Noriyuki  Habuka</span>, <span class="hlFld-ContribAuthor ">Satoshi  Sogabe</span>, <span class="hlFld-ContribAuthor ">Satoshi  Endo</span>, <span class="hlFld-ContribAuthor ">Christopher S.  Siedem</span>, <span class="hlFld-ContribAuthor ">Tony P.  Tang</span>, <span class="hlFld-ContribAuthor ">Cassandra  Gauthier</span>, <span class="hlFld-ContribAuthor ">Lisa A.  De Meese</span>, <span class="hlFld-ContribAuthor ">Steven A.  Boyd</span>, <span class="hlFld-ContribAuthor ">Shoji  Fukumoto</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis, and structure–activity relationships of dihydrofuran-2-one and dihydropyrrol-2-one derivatives as novel benzoxazin-3-one-based mineralocorticoid receptor antagonists. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2013,</strong> <em>21 </em>
                                    (19)
                                     , 5983-5994. <a href="https://doi.org/10.1016/j.bmc.2013.07.043" title="DOI URL">https://doi.org/10.1016/j.bmc.2013.07.043</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2013.07.043&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2013.07.043%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DDesign%25252C%252Bsynthesis%25252C%252Band%252Bstructure%2525E2%252580%252593activity%252Brelationships%252Bof%252Bdihydrofuran-2-one%252Band%252Bdihydropyrrol-2-one%252Bderivatives%252Bas%252Bnovel%252Bbenzoxazin-3-one-based%252Bmineralocorticoid%252Breceptor%252Bantagonists%26aulast%3DHasui%26aufirst%3DTomoaki%26date%3D2013%26volume%3D21%26issue%3D19%26spage%3D5983%26epage%3D5994" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jerry R  Colca</span>. </span><span class="cited-content_cbyCitation_article-title">Discontinued drugs in 2012: endocrine and metabolic. </span><span class="cited-content_cbyCitation_journal-name">Expert Opinion on Investigational Drugs</span><span> <strong>2013,</strong> <em>22 </em>
                                    (10)
                                     , 1305-1313. <a href="https://doi.org/10.1517/13543784.2013.829038" title="DOI URL">https://doi.org/10.1517/13543784.2013.829038</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1517/13543784.2013.829038&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1517%2F13543784.2013.829038%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opinion%2520on%2520Investigational%2520Drugs%26atitle%3DDiscontinued%252Bdrugs%252Bin%252B2012%25253A%252Bendocrine%252Band%252Bmetabolic%26aulast%3DColca%26aufirst%3DJerry%2BR%26date%3D2013%26date%3D2013%26volume%3D22%26issue%3D10%26spage%3D1305%26epage%3D1313" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ana  Pou</span>, <span class="hlFld-ContribAuthor ">Albert  Moyano</span>. </span><span class="cited-content_cbyCitation_article-title">Stereoselective Organocatalytic Approach to α,β-Disubstituted-β-amino Acids: A Short Enantioselective Synthesis of Cispentacin. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Organic Chemistry</span><span> <strong>2013,</strong> <em>2013 </em>
                                    (15)
                                     , 3103-3111. <a href="https://doi.org/10.1002/ejoc.201300197" title="DOI URL">https://doi.org/10.1002/ejoc.201300197</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ejoc.201300197&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fejoc.201300197%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DStereoselective%252BOrganocatalytic%252BApproach%252Bto%252B%2525CE%2525B1%25252C%2525CE%2525B2-Disubstituted-%2525CE%2525B2-amino%252BAcids%25253A%252BA%252BShort%252BEnantioselective%252BSynthesis%252Bof%252BCispentacin%26aulast%3DPou%26aufirst%3DAna%26date%3D2013%26date%3D2013%26volume%3D2013%26issue%3D15%26spage%3D3103%26epage%3D3111" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Morag J  Young</span>. </span><span class="cited-content_cbyCitation_article-title">Targeting the mineralocorticoid receptor in cardiovascular disease. </span><span class="cited-content_cbyCitation_journal-name">Expert Opinion on Therapeutic Targets</span><span> <strong>2013,</strong> <em>17 </em>
                                    (3)
                                     , 321-331. <a href="https://doi.org/10.1517/14728222.2013.748750" title="DOI URL">https://doi.org/10.1517/14728222.2013.748750</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1517/14728222.2013.748750&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1517%2F14728222.2013.748750%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opinion%2520on%2520Therapeutic%2520Targets%26atitle%3DTargeting%252Bthe%252Bmineralocorticoid%252Breceptor%252Bin%252Bcardiovascular%252Bdisease%26aulast%3DYoung%26aufirst%3DMorag%2BJ%26date%3D2013%26date%3D2013%26volume%3D17%26issue%3D3%26spage%3D321%26epage%3D331" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Pradeep D.  Lokhande</span>, <span class="hlFld-ContribAuthor ">Kamal  Hasanzadeh</span>, <span class="hlFld-ContribAuthor ">Hamid  Khaledi</span>, <span class="hlFld-ContribAuthor ">Hapipah  Mohd Ali</span>. </span><span class="cited-content_cbyCitation_article-title">Aromatization and Halogenation of 3,3a,4,5-Tetrahydro-3-aryl-2-phenyl-2
              H
              -benzo[g]indazole Using I
              2
              /DMSO, CuCl
              2
              /DMSO, and
              N
              -Bromosuccinimide. </span><span class="cited-content_cbyCitation_journal-name">Journal of Heterocyclic Chemistry</span><span> <strong>2012,</strong> <em>49 </em>
                                    (6)
                                     , 1398-1406. <a href="https://doi.org/10.1002/jhet.1049" title="DOI URL">https://doi.org/10.1002/jhet.1049</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/jhet.1049&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fjhet.1049%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Heterocyclic%2520Chemistry%26atitle%3DAromatization%252Band%252BHalogenation%252Bof%252B3%25252C3a%25252C4%25252C5-Tetrahydro-3-aryl-2-phenyl-2%252BH%252B-benzo%25255Bg%25255Dindazole%252BUsing%252BI%252B2%252B%25252FDMSO%25252C%252BCuCl%252B2%252B%25252FDMSO%25252C%252Band%252BN%252B-Bromosuccinimide%26aulast%3DLokhande%26aufirst%3DPradeep%2BD.%26date%3D2012%26date%3D2012%26volume%3D49%26issue%3D6%26spage%3D1398%26epage%3D1406" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Lars  Bärfacker</span>, <span class="hlFld-ContribAuthor ">Alexander  Kuhl</span>, <span class="hlFld-ContribAuthor ">Alexander  Hillisch</span>, <span class="hlFld-ContribAuthor ">Rolf  Grosser</span>, <span class="hlFld-ContribAuthor ">Santiago  Figueroa-Pérez</span>, <span class="hlFld-ContribAuthor ">Heike  Heckroth</span>, <span class="hlFld-ContribAuthor ">Adam  Nitsche</span>, <span class="hlFld-ContribAuthor ">Jens-Kerim  Ergüden</span>, <span class="hlFld-ContribAuthor ">Heike  Gielen-Haertwig</span>, <span class="hlFld-ContribAuthor ">Karl-Heinz  Schlemmer</span>, <span class="hlFld-ContribAuthor ">Joachim  Mittendorf</span>, <span class="hlFld-ContribAuthor ">Holger  Paulsen</span>, <span class="hlFld-ContribAuthor ">Johannes  Platzek</span>, <span class="hlFld-ContribAuthor ">Peter  Kolkhof</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of BAY 94-8862: A Nonsteroidal Antagonist of the Mineralocorticoid Receptor for the Treatment of Cardiorenal Diseases. </span><span class="cited-content_cbyCitation_journal-name">ChemMedChem</span><span> <strong>2012,</strong> <em>7 </em>
                                    (8)
                                     , 1385-1403. <a href="https://doi.org/10.1002/cmdc.201200081" title="DOI URL">https://doi.org/10.1002/cmdc.201200081</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/cmdc.201200081&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fcmdc.201200081%26sid%3Dliteratum%253Aachs%26jtitle%3DChemMedChem%26atitle%3DDiscovery%252Bof%252BBAY%252B94-8862%25253A%252BA%252BNonsteroidal%252BAntagonist%252Bof%252Bthe%252BMineralocorticoid%252BReceptor%252Bfor%252Bthe%252BTreatment%252Bof%252BCardiorenal%252BDiseases%26aulast%3DB%25C3%25A4rfacker%26aufirst%3DLars%26date%3D2012%26date%3D2012%26volume%3D7%26issue%3D8%26spage%3D1385%26epage%3D1403" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ananda  Thangadurai</span>, <span class="hlFld-ContribAuthor ">Maninder  Minu</span>, <span class="hlFld-ContribAuthor ">Sharad  Wakode</span>, <span class="hlFld-ContribAuthor ">Shyam  Agrawal</span>, <span class="hlFld-ContribAuthor ">Balasubramanian  Narasimhan</span>. </span><span class="cited-content_cbyCitation_article-title">Indazole: a medicinally important heterocyclic moiety. </span><span class="cited-content_cbyCitation_journal-name">Medicinal Chemistry Research</span><span> <strong>2012,</strong> <em>21 </em>
                                    (7)
                                     , 1509-1523. <a href="https://doi.org/10.1007/s00044-011-9631-3" title="DOI URL">https://doi.org/10.1007/s00044-011-9631-3</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s00044-011-9631-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs00044-011-9631-3%26sid%3Dliteratum%253Aachs%26jtitle%3DMedicinal%2520Chemistry%2520Research%26atitle%3DIndazole%25253A%252Ba%252Bmedicinally%252Bimportant%252Bheterocyclic%252Bmoiety%26aulast%3DThangadurai%26aufirst%3DAnanda%26date%3D2012%26date%3D2011%26volume%3D21%26issue%3D7%26spage%3D1509%26epage%3D1523" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Doron  Aronson</span>, <span class="hlFld-ContribAuthor ">Henry  Krum</span>. </span><span class="cited-content_cbyCitation_article-title">Novel therapies in acute and chronic heart failure. </span><span class="cited-content_cbyCitation_journal-name">Pharmacology & Therapeutics</span><span> <strong>2012,</strong> <em>135 </em>
                                    (1)
                                     , 1-17. <a href="https://doi.org/10.1016/j.pharmthera.2012.03.002" title="DOI URL">https://doi.org/10.1016/j.pharmthera.2012.03.002</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.pharmthera.2012.03.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.pharmthera.2012.03.002%26sid%3Dliteratum%253Aachs%26jtitle%3DPharmacology%2520%2526%2520Therapeutics%26atitle%3DNovel%252Btherapies%252Bin%252Bacute%252Band%252Bchronic%252Bheart%252Bfailure%26aulast%3DAronson%26aufirst%3DDoron%26date%3D2012%26volume%3D135%26issue%3D1%26spage%3D1%26epage%3D17" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Kenichi  Murai</span>, <span class="hlFld-ContribAuthor ">Shuji  Miyazaki</span>, <span class="hlFld-ContribAuthor ">Hiromichi  Fujioka</span>. </span><span class="cited-content_cbyCitation_article-title">Reactivity of the ester group attached isoxazoline, benzisoxazole, and isoxazole: a facial preparation of 3-acyl-substituted these heterocycles. </span><span class="cited-content_cbyCitation_journal-name">Tetrahedron Letters</span><span> <strong>2012,</strong> <em>53 </em>
                                    (29)
                                     , 3746-3749. <a href="https://doi.org/10.1016/j.tetlet.2012.05.006" title="DOI URL">https://doi.org/10.1016/j.tetlet.2012.05.006</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tetlet.2012.05.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tetlet.2012.05.006%26sid%3Dliteratum%253Aachs%26jtitle%3DTetrahedron%2520Letters%26atitle%3DReactivity%252Bof%252Bthe%252Bester%252Bgroup%252Battached%252Bisoxazoline%25252C%252Bbenzisoxazole%25252C%252Band%252Bisoxazole%25253A%252Ba%252Bfacial%252Bpreparation%252Bof%252B3-acyl-substituted%252Bthese%252Bheterocycles%26aulast%3DMurai%26aufirst%3DKenichi%26date%3D2012%26volume%3D53%26issue%3D29%26spage%3D3746%26epage%3D3749" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Peter  Kolkhof</span>, <span class="hlFld-ContribAuthor ">Steffen A.  Borden</span>. </span><span class="cited-content_cbyCitation_article-title">Molecular pharmacology of the mineralocorticoid receptor: Prospects for novel therapeutics. </span><span class="cited-content_cbyCitation_journal-name">Molecular and Cellular Endocrinology</span><span> <strong>2012,</strong> <em>350 </em>
                                    (2)
                                     , 310-317. <a href="https://doi.org/10.1016/j.mce.2011.06.025" title="DOI URL">https://doi.org/10.1016/j.mce.2011.06.025</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.mce.2011.06.025&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.mce.2011.06.025%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520and%2520Cellular%2520Endocrinology%26atitle%3DMolecular%252Bpharmacology%252Bof%252Bthe%252Bmineralocorticoid%252Breceptor%25253A%252BProspects%252Bfor%252Bnovel%252Btherapeutics%26aulast%3DKolkhof%26aufirst%3DPeter%26date%3D2012%26volume%3D350%26issue%3D2%26spage%3D310%26epage%3D317" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jessica  Huyet</span>, <span class="hlFld-ContribAuthor ">Grégory Maurice  Pinon</span>, <span class="hlFld-ContribAuthor ">Michel Raymond  Fay</span>, <span class="hlFld-ContribAuthor ">Marie-Edith  Rafestin-Oblin</span>, <span class="hlFld-ContribAuthor ">Jérôme  Fagart</span>. </span><span class="cited-content_cbyCitation_article-title">Structural determinants of ligand binding to the mineralocorticoid receptor. </span><span class="cited-content_cbyCitation_journal-name">Molecular and Cellular Endocrinology</span><span> <strong>2012,</strong> <em>350 </em>
                                    (2)
                                     , 187-195. <a href="https://doi.org/10.1016/j.mce.2011.07.035" title="DOI URL">https://doi.org/10.1016/j.mce.2011.07.035</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.mce.2011.07.035&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.mce.2011.07.035%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520and%2520Cellular%2520Endocrinology%26atitle%3DStructural%252Bdeterminants%252Bof%252Bligand%252Bbinding%252Bto%252Bthe%252Bmineralocorticoid%252Breceptor%26aulast%3DHuyet%26aufirst%3DJessica%26date%3D2012%26volume%3D350%26issue%3D2%26spage%3D187%26epage%3D195" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Pei-Yang  Gu</span>, <span class="hlFld-ContribAuthor ">Cai-Jian  Lu</span>, <span class="hlFld-ContribAuthor ">Qing-Feng  Xu</span>, <span class="hlFld-ContribAuthor ">Gao-Jie  Ye</span>, <span class="hlFld-ContribAuthor ">Wei-Qiang  Chen</span>, <span class="hlFld-ContribAuthor ">Xuan-Ming  Duan</span>, <span class="hlFld-ContribAuthor ">Li-Hua  Wang</span>, <span class="hlFld-ContribAuthor ">Jian-Mei  Lu</span>. </span><span class="cited-content_cbyCitation_article-title">Star-shaped polymer PFStODO by atom transfer radical polymerization: Its synthesis, characterization, and fluorescence property. </span><span class="cited-content_cbyCitation_journal-name">Journal of Polymer Science Part A: Polymer Chemistry</span><span> <strong>2012,</strong> <em>50 </em>
                                    (3)
                                     , 480-487. <a href="https://doi.org/10.1002/pola.25055" title="DOI URL">https://doi.org/10.1002/pola.25055</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/pola.25055&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fpola.25055%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Polymer%2520Science%2520Part%2520A%253A%2520Polymer%2520Chemistry%26atitle%3DStar-shaped%252Bpolymer%252BPFStODO%252Bby%252Batom%252Btransfer%252Bradical%252Bpolymerization%25253A%252BIts%252Bsynthesis%25252C%252Bcharacterization%25252C%252Band%252Bfluorescence%252Bproperty%26aulast%3DGu%26aufirst%3DPei-Yang%26date%3D2012%26date%3D2011%26volume%3D50%26issue%3D3%26spage%3D480%26epage%3D487" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Kohei  Kikkawa</span>. </span><span class="cited-content_cbyCitation_article-title">Revisiting the therapeutic concept of a mineralocorticoid receptor antagonist ^|^mdash; focusing on resistant hypertension and chronic renal failure. </span><span class="cited-content_cbyCitation_journal-name">Folia Pharmacologica Japonica</span><span> <strong>2012,</strong> <em>139 </em>
                                    (6)
                                     , 241-245. <a href="https://doi.org/10.1254/fpj.139.241" title="DOI URL">https://doi.org/10.1254/fpj.139.241</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1254/fpj.139.241&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1254%2Ffpj.139.241%26sid%3Dliteratum%253Aachs%26jtitle%3DFolia%2520Pharmacologica%2520Japonica%26atitle%3DRevisiting%252Bthe%252Btherapeutic%252Bconcept%252Bof%252Ba%252Bmineralocorticoid%252Breceptor%252Bantagonist%252B%25255E%25257C%25255Emdash%25253B%252Bfocusing%252Bon%252Bresistant%252Bhypertension%252Band%252Bchronic%252Brenal%252Bfailure%26aulast%3DKikkawa%26aufirst%3DKohei%26date%3D2012%26volume%3D139%26issue%3D6%26spage%3D241%26epage%3D245" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Tsuyoshi  HOMMA</span>, <span class="hlFld-ContribAuthor ">Michio  FUJISAWA</span>, <span class="hlFld-ContribAuthor ">Kiyoshi  ARAI</span>, <span class="hlFld-ContribAuthor ">Marie  ISHII</span>, <span class="hlFld-ContribAuthor ">Toshio  SADA</span>, <span class="hlFld-ContribAuthor ">Masahiro  IKEDA</span>. </span><span class="cited-content_cbyCitation_article-title">Spironolactone, but not Eplerenone, Impairs Glucose Tolerance in a Rat Model of Metabolic Syndrome. </span><span class="cited-content_cbyCitation_journal-name">Journal of Veterinary Medical Science</span><span> <strong>2012,</strong> <em>74 </em>
                                    (8)
                                     , 1015-1022. <a href="https://doi.org/10.1292/jvms.12-0007" title="DOI URL">https://doi.org/10.1292/jvms.12-0007</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1292/jvms.12-0007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1292%2Fjvms.12-0007%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Veterinary%2520Medical%2520Science%26atitle%3DSpironolactone%25252C%252Bbut%252Bnot%252BEplerenone%25252C%252BImpairs%252BGlucose%252BTolerance%252Bin%252Ba%252BRat%252BModel%252Bof%252BMetabolic%252BSyndrome%26aulast%3DHOMMA%26aufirst%3DTsuyoshi%26date%3D2012%26volume%3D74%26issue%3D8%26spage%3D1015%26epage%3D1022" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Charles  Boos</span>, <span class="hlFld-ContribAuthor ">Daniel M.  Bowles</span>, <span class="hlFld-ContribAuthor ">Cuiman  Cai</span>, <span class="hlFld-ContribAuthor ">Agustin  Casimiro-Garcia</span>, <span class="hlFld-ContribAuthor ">Xiangyang  Chen</span>, <span class="hlFld-ContribAuthor ">Catherine A.  Hulford</span>, <span class="hlFld-ContribAuthor ">Sandra M.  Jennings</span>, <span class="hlFld-ContribAuthor ">E.  Jason Kiser</span>, <span class="hlFld-ContribAuthor ">David W.  Piotrowski</span>, <span class="hlFld-ContribAuthor ">Matthew  Sammons</span>, <span class="hlFld-ContribAuthor ">Robert A.  Wade</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and cross coupling of a highly substituted 2-pyridylboronate: application to the large scale synthesis of a mineralocorticoid antagonist. </span><span class="cited-content_cbyCitation_journal-name">Tetrahedron Letters</span><span> <strong>2011,</strong> <em>52 </em>
                                    (52)
                                     , 7025-7029. <a href="https://doi.org/10.1016/j.tetlet.2011.10.052" title="DOI URL">https://doi.org/10.1016/j.tetlet.2011.10.052</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tetlet.2011.10.052&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tetlet.2011.10.052%26sid%3Dliteratum%253Aachs%26jtitle%3DTetrahedron%2520Letters%26atitle%3DSynthesis%252Band%252Bcross%252Bcoupling%252Bof%252Ba%252Bhighly%252Bsubstituted%252B2-pyridylboronate%25253A%252Bapplication%252Bto%252Bthe%252Blarge%252Bscale%252Bsynthesis%252Bof%252Ba%252Bmineralocorticoid%252Bantagonist%26aulast%3DBoos%26aufirst%3DCharles%26date%3D2011%26volume%3D52%26issue%3D52%26spage%3D7025%26epage%3D7029" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Nathaniel R.  Campbell</span>, <span class="hlFld-ContribAuthor ">Bingfeng  Sun</span>, <span class="hlFld-ContribAuthor ">Ravi P.  Singh</span>, <span class="hlFld-ContribAuthor ">Li  Deng</span>. </span><span class="cited-content_cbyCitation_article-title">Cinchona Alkaloid-Catalyzed Enantioselective Amination of α,β-Unsaturated Ketones: An Asymmetric Approach to Δ2-Pyrazolines. </span><span class="cited-content_cbyCitation_journal-name">Advanced Synthesis & Catalysis</span><span> <strong>2011,</strong> <em>353 </em>
                                    (17)
                                     , 3123-3128. <a href="https://doi.org/10.1002/adsc.201100447" title="DOI URL">https://doi.org/10.1002/adsc.201100447</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/adsc.201100447&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fadsc.201100447%26sid%3Dliteratum%253Aachs%26jtitle%3DAdvanced%2520Synthesis%2520%2526%2520Catalysis%26atitle%3DCinchona%252BAlkaloid-Catalyzed%252BEnantioselective%252BAmination%252Bof%252B%2525CE%2525B1%25252C%2525CE%2525B2-Unsaturated%252BKetones%25253A%252BAn%252BAsymmetric%252BApproach%252Bto%252B%2525CE%2525942-Pyrazolines%26aulast%3DCampbell%26aufirst%3DNathaniel%2BR.%26date%3D2011%26date%3D2011%26volume%3D353%26issue%3D17%26spage%3D3123%26epage%3D3128" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xue-Ming  Cheng</span>, <span class="hlFld-ContribAuthor ">Zhi-Tang  Huang</span>, <span class="hlFld-ContribAuthor ">Qi-Yu  Zheng</span>. </span><span class="cited-content_cbyCitation_article-title">Topochemical photodimerization of (E)-3-benzylidene-4-chromanone derivatives from β-type structures directed by halogen groups. </span><span class="cited-content_cbyCitation_journal-name">Tetrahedron</span><span> <strong>2011,</strong> <em>67 </em>
                                    (47)
                                     , 9093-9098. <a href="https://doi.org/10.1016/j.tet.2011.09.087" title="DOI URL">https://doi.org/10.1016/j.tet.2011.09.087</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tet.2011.09.087&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tet.2011.09.087%26sid%3Dliteratum%253Aachs%26jtitle%3DTetrahedron%26atitle%3DTopochemical%252Bphotodimerization%252Bof%252B%252528E%252529-3-benzylidene-4-chromanone%252Bderivatives%252Bfrom%252B%2525CE%2525B2-type%252Bstructures%252Bdirected%252Bby%252Bhalogen%252Bgroups%26aulast%3DCheng%26aufirst%3DXue-Ming%26date%3D2011%26volume%3D67%26issue%3D47%26spage%3D9093%26epage%3D9098" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Katerina  Leftheris</span>, <span class="hlFld-ContribAuthor ">Yajun  Zheng</span>, <span class="hlFld-ContribAuthor ">Deepak S.  Lala</span>. </span><span class="cited-content_cbyCitation_article-title">Recent Advances in Mineralocorticoid Receptor Antagonists. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2011,</strong>,, 89-102. <a href="https://doi.org/10.1016/B978-0-12-386009-5.00021-7" title="DOI URL">https://doi.org/10.1016/B978-0-12-386009-5.00021-7</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-12-386009-5.00021-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-12-386009-5.00021-7%26sid%3Dliteratum%253Aachs%26atitle%3DRecent%252BAdvances%252Bin%252BMineralocorticoid%252BReceptor%252BAntagonists%26aulast%3DLeftheris%26aufirst%3DKaterina%26date%3D2011%26spage%3D89%26epage%3D102%26pub%3DElsevier%26date%3D2011%26volume%3D46" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_tgr1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-16/jm100505n/production/images/medium/jm-2010-00505n_0012.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-16/jm100505n/production/images/large/jm-2010-00505n_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm100505n&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="cht1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Chart 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-16/jm100505n/production/images/medium/jm-2010-00505n_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-16/jm100505n/production/images/large/jm-2010-00505n_0013.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Chart 1. Steroidal and Nonsteroidal MR Antagonists</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-16/jm100505n/production/images/large/jm-2010-00505n_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm100505n&amp;id=cht1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="cht2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Chart 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-16/jm100505n/production/images/medium/jm-2010-00505n_0014.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-16/jm100505n/production/images/large/jm-2010-00505n_0014.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Chart 2. Pyrazoline HTS Hit</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-16/jm100505n/production/images/large/jm-2010-00505n_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm100505n&amp;id=cht2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-16/jm100505n/production/images/medium/jm-2010-00505n_0015.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-16/jm100505n/production/images/large/jm-2010-00505n_0015.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of Trisubstituted Pyrazolines <b>4a</b>−<b>k</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-16/jm100505n/production/images/large/jm-2010-00505n_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm100505n&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) NaOH, EtOH; (b) <b>7</b>·HCl, EtOH, 80 °C; (c) <b>7</b>, H<sub>2</sub>SO<sub>4</sub> or HCl, EtOH, reflux; (d) (i) <b>7</b>, HCl, <i>n</i>-BuOH, reflux; (ii) KOH or NaOH; (e) HCl, EtOH, reflux; (f) <b>7</b>, AcOH, 80 °C; (g) Si(OEt)<sub>4</sub>, KF, DMF, 50 °C; (h) chiral SFC.</p></p></figure><figure data-id="sch2" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-16/jm100505n/production/images/medium/jm-2010-00505n_0016.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-16/jm100505n/production/images/large/jm-2010-00505n_0016.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of Benzoic Acid Substituted Pyrazolines <b>12a</b>−<b>p</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-16/jm100505n/production/images/large/jm-2010-00505n_0016.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm100505n&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) (i) hydrazine monohydrate, EtOH; (ii) HCl; (b) EtOH, 80 °C; (c) NaOH, EtOH, 80 °C; (d) NaOH; (e) chiral SFC.</p></p></figure><figure data-id="sch3" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-16/jm100505n/production/images/medium/jm-2010-00505n_0017.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-16/jm100505n/production/images/large/jm-2010-00505n_0017.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Synthesis of Benzoic Acid Substituted Pyrazolines <b>15a</b>−<b>g</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-16/jm100505n/production/images/large/jm-2010-00505n_0017.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm100505n&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) <b>9</b>·HCl, Et<sub>3</sub>N, DMF; (b) NBS, Me<sub>2</sub>S, ClCH<sub>2</sub>CH<sub>2</sub>Cl, 0 °C to room temp; (c) Et<sub>3</sub>N, THF; (d) NaOH.</p></p></figure><figure data-id="sch4" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-16/jm100505n/production/images/medium/jm-2010-00505n_0018.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-16/jm100505n/production/images/large/jm-2010-00505n_0018.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Synthesis of Pyrazoline Intermediate <i><b>R</b></i><b>-17</b> and Pyrazoline Lead <i><b>R</b></i><b>-4g</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-16/jm100505n/production/images/large/jm-2010-00505n_0018.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm100505n&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) glyoxylic acid, aq HCl (74%); (b) (i) NBS, DMF, 0 °C to room temp; (ii) 4-fluorostyrene, Et<sub>3</sub>N (20%); (c) chiral SFC; (d) 4-carboxyphenylboronic acid, Pd(PPh<sub>3</sub>)<sub>4</sub>, aq Cs<sub>2</sub>CO<sub>3</sub>, DMF.</p></p></figure><figure data-id="fig1" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-16/jm100505n/production/images/medium/jm-2010-00505n_0019.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-16/jm100505n/production/images/large/jm-2010-00505n_0019.jpeg" id="rightTab-gr12" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. X-ray crystal structure of advanced intermediate <i><b>R</b></i><b>-17</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-16/jm100505n/production/images/large/jm-2010-00505n_0019.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm100505n&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch5" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Scheme 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-16/jm100505n/production/images/medium/jm-2010-00505n_0020.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-16/jm100505n/production/images/large/jm-2010-00505n_0020.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 5. Synthesis of Pyrazoline Intermediate <i><b>R</b></i><b>-20</b> and Pyrazolines <i><b>R</b></i><b>-15g</b> and <i><b>R</b></i><b>-21a</b>−<b>d</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-16/jm100505n/production/images/large/jm-2010-00505n_0020.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm100505n&amp;id=sch5"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions. (a) (EtO)<sub>2</sub>POCH<sub>2</sub>CO<sub>2</sub>Et, NaOEt (87%); (b) <b>9a</b>, NaOEt (79%); (c) POCl<sub>3</sub>, CH<sub>3</sub>CN, 80 °C (88%); (d) chiral SFC; (e) (i) Pd(PPh<sub>3</sub>)<sub>4</sub> or Pd(dppf)<sub>2</sub>Cl<sub>2</sub>, aq Na<sub>2</sub>CO<sub>3</sub> or Cs<sub>2</sub>CO<sub>3</sub>, DME or DMF; if necessary, (ii) NaOH.</p></p></figure><figure data-id="sch6" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Scheme 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-16/jm100505n/production/images/medium/jm-2010-00505n_0021.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-16/jm100505n/production/images/large/jm-2010-00505n_0021.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 6. Synthesis of Pyrazolines <b>22</b> and <b>23</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-16/jm100505n/production/images/large/jm-2010-00505n_0021.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm100505n&amp;id=sch6"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) BBr<sub>3</sub>, CH<sub>2</sub>Cl<sub>2</sub>; (b) (i) Br(CH<sub>2</sub>)<sub>3</sub>OTHP, Cs<sub>2</sub>CO<sub>3</sub>, DMF, 80 °C; (ii) NaOH; (c) HCl, THF (74% over steps a−c); (d) (i) LDA, THF; (ii) iodomethane; (e) NaOH (60% over steps d and e).</p></p></figure><figure data-id="sch7" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Scheme 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-16/jm100505n/production/images/medium/jm-2010-00505n_0022.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-16/jm100505n/production/images/large/jm-2010-00505n_0022.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 7. Synthesis of Conformationally Restricted Pyrazolines <b>27a</b>−<b>q</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-16/jm100505n/production/images/large/jm-2010-00505n_0022.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm100505n&amp;id=sch7"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) R<sup>3</sup>CHO, H<sub>2</sub>SO<sub>4</sub> or HCl, EtOH, 80 °C; (b) R<sup>3</sup>CHO, pyrrolidine, MeOH; (c) (i) LiHMDS, THF, 0 °C; (ii) R<sup>3</sup>CHO; (d) <b>9a</b>−<b>g</b>·HCl, EtOH, 80 °C; (e) aq NaOH, MeOH, THF; (f) chiral SFC.</p></p></figure><figure data-id="fig2" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-16/jm100505n/production/images/medium/jm-2010-00505n_0023.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-16/jm100505n/production/images/large/jm-2010-00505n_0023.jpeg" id="rightTab-gr13" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. X-ray crystal structure of <b>3</b><i><b>R</b></i><b>,3a</b><i><b>R</b></i><b>-27c</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-16/jm100505n/production/images/large/jm-2010-00505n_0023.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm100505n&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch8" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Scheme 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-16/jm100505n/production/images/medium/jm-2010-00505n_0024.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-16/jm100505n/production/images/large/jm-2010-00505n_0024.jpeg" id="rightTab-gr10" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 8. Epimerization of <b><i>cis</i>-27p</b> to <b><i>trans</i>-27p</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-16/jm100505n/production/images/large/jm-2010-00505n_0024.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm100505n&amp;id=sch8"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) NaOMe, MeOH, THF, 50 °C, 24 h (20%).</p></p></figure><figure data-id="sch9" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Scheme 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-16/jm100505n/production/images/medium/jm-2010-00505n_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-16/jm100505n/production/images/large/jm-2010-00505n_0001.jpeg" id="rightTab-gr11" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 9. Synthesis of Methylated Conformationally Restricted Pyrazoline <b>3</b><i><b>S</b></i><b>,3a</b><i><b>R</b></i><b>-29</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-16/jm100505n/production/images/large/jm-2010-00505n_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm100505n&amp;id=sch9"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) trimethylsilyldiazomethane, THF, MeOH (quant); (b) (i) LiHMDS, THF, −78 °C; (ii) iodomethane, −78 °C; (c) NaOH (31% over steps b and c).</p></p></figure><figure data-id="fig3" data-index="14" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-16/jm100505n/production/images/medium/jm-2010-00505n_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-16/jm100505n/production/images/large/jm-2010-00505n_0004.jpeg" id="rightTab-gr14" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. SAR analysis of physical properties, hERG potential, and MR potency in non-conformationally restricted pyrazolines: identification of compound <i><b>R-</b></i><b>4g</b>. Individual pyrazolines shaped by compound class are amides (◼), esters (▲), carboxylic acids (☼), and miscellaneous (e.g., heterocycles, phenols, etc.) (●) and are colored by aqueous solubility: ≤3 μM (red), 3−30 μM (yellow), >30 μM (green), not determined (gray). Dofetilide = dofetilide-Cy3B competitive binding assay, with % inhibition at 10 μM compound (see ref <a onclick="showRef(event, 'cit17c'); return false;" href="javascript:void(0);" class="ref cit17c">17c</a>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-16/jm100505n/production/images/large/jm-2010-00505n_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm100505n&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="15" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-16/jm100505n/production/images/medium/jm-2010-00505n_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-16/jm100505n/production/images/large/jm-2010-00505n_0008.jpeg" id="rightTab-gr15" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Induced-fit model of <b>3</b><i><b>S</b></i><b>,3a</b><i><b>R</b></i><b>-27d</b> in MR: (a) compound <b>3</b><i><b>S</b></i><b>,3a</b><i><b>R</b></i><b>-27d</b>, ball and stick, showing residues L960 (helix 12), F941 (helix 11), N770 (helix 3), Q776 and R817 (ketosteroid recognition), and F829, tube; (b) overlay of native crystal MR/corticosterone crystal structure 2A3I (red) with the <b>3</b><i><b>S</b></i><b>,3a</b><i><b>R</b></i><b>-27d</b>/MR induced-fit model. The congruence of the cyanophenyl ring with the steroid A/B ring system is apparent, as is the disruption of the N770 and L960 side chains by the cyclopentyl, and the movement of F941 caused by the carboxylate.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-16/jm100505n/production/images/large/jm-2010-00505n_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm100505n&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="16" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-16/jm100505n/production/images/medium/jm-2010-00505n_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-16/jm100505n/production/images/large/jm-2010-00505n_0010.jpeg" id="rightTab-gr16" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Blood pressure lowering effect of <b>3</b><i><b>S</b></i><b>,3a</b><i><b>R</b></i><b>-7d</b> in Dahl SS rats: vehicle (◆); eplerenone, 100 mpk/d, chow (●); <b>3</b><i><b>S</b></i><b>,3a</b><i><b>R</b></i><b>-27d</b>, 10 mpk/d, b.i.d. (△); <b>3</b><i><b>S</b></i><b>,3a</b><i><b>R</b></i><b>-27d</b>, 40 mpk/d, b.i.d. (▲); <b>3</b><i><b>S</b></i><b>,3a</b><i><b>R</b></i><b>-27d</b>, 100 mpk/d, b.i.d. (◻). Radiotelemetrized arterial systolic blood pressure (SBP) was measured with the DATAQUEST A.R.T., version 3.0, Gold software. The values represent the average of all data points collected from each animal every 15 min for a 10 s interval over a 24 h period. SBP data were collected continuously over the course of the entire study (days 1−21). <i>n</i> = 6 for the <b>3</b><i><b>S</b></i><b>,3a</b><i><b>R</b></i><b>-27d</b> 100 mpk group, and <i>n</i> = 9 for all other groups: <i>P</i> < 0.05 versus vehicle (∗); <i>P</i> < 0.05 versus eplerenone (∗∗).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-16/jm100505n/production/images/large/jm-2010-00505n_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm100505n&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="17" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-16/jm100505n/production/images/medium/jm-2010-00505n_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-16/jm100505n/production/images/large/jm-2010-00505n_0011.jpeg" id="rightTab-gr17" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Renal protective effects of <b>3</b><i><b>S</b></i><b>,3a</b><i><b>R</b></i><b>-27d</b> in Dahl SS rats. (a) The 24 h urines were collected using metabolic cage. Urinary albumin was analyzed with the Hitachi 912 automated diagnostic clinical chemistry analyzer according to standard procedures: <i>P</i> < 0.05 versus vehicle (∗). (b) Glomerulosclerosis was evaluated by assessing 100 glomeruli and scoring severity of individual glomeruli from 0 to 4. The total glomerular score for each animal was calculated as follows: 1<i>X</i> (number of glomeruli with severity score 1) + 2<i>X</i> (number of glomeruli with severity score 2) + 3<i>X</i> (number of glomeruli with severity score 3) + 4<i>X</i> (number of glomeruli with severity score 4): <i>P</i> < 0.05 versus vehicle (∗); <i>P</i> < 0.05 versus eplerenone (∗∗). (c) Effect of <b>3</b><i><b>S</b></i><b>,3a</b><i><b>R</b></i><b>-27d</b> on serum potassium (K<sup>+</sup>): <i>P</i> < 0.05 versus vehicle (∗); <i>P</i> < 0.05 versus eplerenone (∗∗); <i>P</i> = 0.058 versus eplerenone (∗∗∗).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-16/jm100505n/production/images/large/jm-2010-00505n_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm100505n&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i144">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_37000" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_37000" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 24 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Martiniuk, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lawes, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ueshima, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suh, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lam, T. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gu, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feigin, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jamrozik, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohkubo, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woodward, M.</span><span> </span><span class="NLM_article-title">Hypertension: its prevalence and population-attributable fraction for mortality from cardiovascular disease in the Asia-Pacific region</span> <span class="citation_source-journal">J. Hypertens.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x">, </span> <span class="NLM_fpage">73</span><span class="NLM_x">–</span> <span class="NLM_lpage">79</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1a&amp;dbid=16&amp;doi=10.1021%2Fjm100505n&amp;key=10.1097%2FHJH.0b013e328010775f" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1a&amp;dbid=8&amp;doi=10.1021%2Fjm100505n&amp;key=17143176" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1a&amp;dbid=32&amp;doi=10.1021%2Fjm100505n&amp;key=1%3ACAS%3A528%3ADC%252BD28Xht1OhtrvO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2007&pages=73-79&author=A.+L.+Martiniukauthor=C.+M.+Leeauthor=C.+M.+Lawesauthor=H.+Ueshimaauthor=I.+Suhauthor=T.+H.+Lamauthor=D.+Guauthor=V.+Feiginauthor=K.+Jamrozikauthor=T.+Ohkuboauthor=M.+Woodward&title=Hypertension%3A+its+prevalence+and+population-attributable+fraction+for+mortality+from+cardiovascular+disease+in+the+Asia-Pacific+region"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1aR"><div class="casContent"><span class="casTitleNuber">1a</span><div class="casTitle"><span class="NLM_cas:atitle">Hypertension: its prevalence and population-attributable fraction for mortality from cardiovascular disease in the Asia-Pacific region</span></div><div class="casAuthors">Martiniuk, Alexandra L. C.; Lee, Crystal M. Y.; Lawes, Carlene M. M.; Ueshima, Hirotsugu; Suh, Il; Lam, Tai Hing; Gu, Dongfeng; Feigin, Valery; Jamrozik, Konrad; Ohkubo, Takayoshi; Woodward, Mark</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Hypertension</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">73-79</span>CODEN:
                <span class="NLM_cas:coden">JOHYD3</span>;
        ISSN:<span class="NLM_cas:issn">0263-6352</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">Objective: About half of the world's burden of cardiovascular disease is carried by countries in the Asia-Pacific region.  This study aimed to quantify the contribution of hypertension to cardiovascular diseases (CVD) at the country level, by calcg. the sex-specific, population-attributable fractions (PAFs) for fatal ischemic heart disease (IHD) and stroke (haemorrhagic and ischemic) for the World Health Organization Western Pacific and South-east Asian regions.  Methods: The most recent sex-specific prevalence data on hypertension were sought.  Age-adjusted hazard ratio (HR) ests. for fatal IHD and stroke assocd. with hypertension were obtained using Cox analyses of individual participant cohort data from 600 000 adult participants in the Asia-Pacific Cohort Studies Collaboration.  HR ests. and prevalence were then used to calc. sex-specific PAFs for fatal IHD and stroke, by country.  Results: In 15 countries with available data, the prevalence of hypertension ranged from 5-47% in men and from 7-38% in women.  Overall, the fraction of IHD attributable to hypertension ranged from 4-28% in men and from 8-39% in women.  Corresponding ranges for haemorrhagic stroke were 18-66% and 15-49%, and for ischemic stroke were 8-44% and 12-45%.  Conclusions: In the Asia-Pacific region, up to 66% of some subtypes of CVD can be attributed to hypertension, underscoring the immense impact that blood pressure-lowering strategies could have in this populous region.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoW2aOwp849frVg90H21EOLACvtfcHk0ljoAZ1dD5xqzw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xht1OhtrvO&md5=6398a5a8d2458176a2bab59600616ba9</span></div><a href="/servlet/linkout?suffix=cit1a&amp;dbid=16384&amp;doi=10.1097%2FHJH.0b013e328010775f&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252FHJH.0b013e328010775f%26sid%3Dliteratum%253Aachs%26aulast%3DMartiniuk%26aufirst%3DA.%2BL.%26aulast%3DLee%26aufirst%3DC.%2BM.%26aulast%3DLawes%26aufirst%3DC.%2BM.%26aulast%3DUeshima%26aufirst%3DH.%26aulast%3DSuh%26aufirst%3DI.%26aulast%3DLam%26aufirst%3DT.%2BH.%26aulast%3DGu%26aufirst%3DD.%26aulast%3DFeigin%26aufirst%3DV.%26aulast%3DJamrozik%26aufirst%3DK.%26aulast%3DOhkubo%26aufirst%3DT.%26aulast%3DWoodward%26aufirst%3DM.%26atitle%3DHypertension%253A%2520its%2520prevalence%2520and%2520population-attributable%2520fraction%2520for%2520mortality%2520from%2520cardiovascular%2520disease%2520in%2520the%2520Asia-Pacific%2520region%26jtitle%3DJ.%2520Hypertens.%26date%3D2007%26volume%3D25%26spage%3D73%26epage%3D79" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit1b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Burt, V. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Whelton, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roccella, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cutler, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Higgins, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Horan, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Labarthe, D.</span><span> </span><span class="NLM_article-title">Prevalence of hypertension in the US adult population. Results from the Third National Health and Nutrition Examination Survey, 1988−1991</span> <span class="citation_source-journal">Hypertension</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x"> (</span><span class="NLM_issue">3</span><span class="NLM_x">) </span> <span class="NLM_fpage">305</span><span class="NLM_x">–</span> <span class="NLM_lpage">313</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=1995&pages=305-313&issue=3&author=V.+L.+Burtauthor=P.+Wheltonauthor=E.+J.+Roccellaauthor=C.+Brownauthor=J.+A.+Cutlerauthor=M.+Higginsauthor=M.+J.+Horanauthor=D.+Labarthe&title=Prevalence+of+hypertension+in+the+US+adult+population.+Results+from+the+Third+National+Health+and+Nutrition+Examination+Survey%2C+1988%E2%88%921991"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBurt%26aufirst%3DV.%2BL.%26aulast%3DWhelton%26aufirst%3DP.%26aulast%3DRoccella%26aufirst%3DE.%2BJ.%26aulast%3DBrown%26aufirst%3DC.%26aulast%3DCutler%26aufirst%3DJ.%2BA.%26aulast%3DHiggins%26aufirst%3DM.%26aulast%3DHoran%26aufirst%3DM.%2BJ.%26aulast%3DLabarthe%26aufirst%3DD.%26atitle%3DPrevalence%2520of%2520hypertension%2520in%2520the%2520US%2520adult%2520population.%2520Results%2520from%2520the%2520Third%2520National%2520Health%2520and%2520Nutrition%2520Examination%2520Survey%252C%25201988%25E2%2588%25921991%26jtitle%3DHypertension%26date%3D1995%26volume%3D25%26issue%3D3%26spage%3D305%26epage%3D313" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit1c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Hajjar, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Theodore, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kotchen, T. A.</span><span> </span><span class="NLM_article-title">Trends in prevalence, awareness, treatment, and control of hypertension in the United States, 1988−2000</span> <span class="citation_source-journal">JAMA, J. Am. Med. Assoc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">290</span><span class="NLM_x">, </span> <span class="NLM_fpage">199</span><span class="NLM_x">–</span> <span class="NLM_lpage">206</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=290&publication_year=2003&pages=199-206&author=I.+Hajjarauthor=A.+Theodoreauthor=T.+A.+Kotchen&title=Trends+in+prevalence%2C+awareness%2C+treatment%2C+and+control+of+hypertension+in+the+United+States%2C+1988%E2%88%922000"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHajjar%26aufirst%3DI.%26aulast%3DTheodore%26aufirst%3DA.%26aulast%3DKotchen%26aufirst%3DT.%2BA.%26atitle%3DTrends%2520in%2520prevalence%252C%2520awareness%252C%2520treatment%252C%2520and%2520control%2520of%2520hypertension%2520in%2520the%2520United%2520States%252C%25201988%25E2%2588%25922000%26jtitle%3DJAMA%252C%2520J.%2520Am.%2520Med.%2520Assoc.%26date%3D2003%26volume%3D290%26spage%3D199%26epage%3D206" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Williams, B.</span><span> </span><span class="NLM_article-title">Drug treatment of hypertension</span> <span class="citation_source-journal">Br. Med. J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">326</span><span class="NLM_x">, </span> <span class="NLM_fpage">61</span><span class="NLM_x">–</span> <span class="NLM_lpage">62</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2a&amp;dbid=16&amp;doi=10.1021%2Fjm100505n&amp;key=10.1136%2Fbmj.326.7380.61" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2a&amp;dbid=32&amp;doi=10.1021%2Fjm100505n&amp;key=1%3ACAS%3A280%3ADC%252BD3s%252FhsFCktw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=326&publication_year=2003&pages=61-62&author=B.+Williams&title=Drug+treatment+of+hypertension"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2aR"><div class="casContent"><span class="casTitleNuber">2a</span><div class="casTitle"><span class="NLM_cas:atitle">Drug treatment of hypertension</span></div><div class="casAuthors">Williams Bryan</div><div class="citationInfo"><span class="NLM_cas:title">BMJ (Clinical research ed.)</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">326</span>
        (<span class="NLM_cas:issue">7380</span>),
    <span class="NLM_cas:pages">61-2</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTtVwgfGO5ZiWPgL4LrC-0VfW6udTcc2eZq0gYbJ6DTQLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD3s%252FhsFCktw%253D%253D&md5=e48bd5b465ba4fc20d849bdabf332bff</span></div><a href="/servlet/linkout?suffix=cit2a&amp;dbid=16384&amp;doi=10.1136%2Fbmj.326.7380.61&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1136%252Fbmj.326.7380.61%26sid%3Dliteratum%253Aachs%26aulast%3DWilliams%26aufirst%3DB.%26atitle%3DDrug%2520treatment%2520of%2520hypertension%26jtitle%3DBr.%2520Med.%2520J.%26date%3D2003%26volume%3D326%26spage%3D61%26epage%3D62" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit2b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Chobanian, A. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bakris, G. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Black, H. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cushman, W. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Green, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Izzo, J. L.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Materson, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oparil, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wright, J. T.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roccella, E. J.</span><span> </span><span class="NLM_article-title">The seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report</span> <span class="citation_source-journal">JAMA, J. Am. Med. Assoc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">289</span><span class="NLM_x">, </span> <span class="NLM_fpage">2560</span><span class="NLM_x">–</span> <span class="NLM_lpage">2572</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=289&publication_year=2003&pages=2560-2572&author=A.+V.+Chobanianauthor=G.+L.+Bakrisauthor=H.+R.+Blackauthor=W.+C.+Cushmanauthor=L.+A.+Greenauthor=J.+L.+Izzoauthor=D.+W.+Jonesauthor=B.+J.+Matersonauthor=S.+Oparilauthor=J.+T.+Wrightauthor=E.+J.+Roccella&title=The+seventh+report+of+the+Joint+National+Committee+on+Prevention%2C+Detection%2C+Evaluation%2C+and+Treatment+of+High+Blood+Pressure%3A+the+JNC+7+report"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DChobanian%26aufirst%3DA.%2BV.%26aulast%3DBakris%26aufirst%3DG.%2BL.%26aulast%3DBlack%26aufirst%3DH.%2BR.%26aulast%3DCushman%26aufirst%3DW.%2BC.%26aulast%3DGreen%26aufirst%3DL.%2BA.%26aulast%3DIzzo%26aufirst%3DJ.%2BL.%26aulast%3DJones%26aufirst%3DD.%2BW.%26aulast%3DMaterson%26aufirst%3DB.%2BJ.%26aulast%3DOparil%26aufirst%3DS.%26aulast%3DWright%26aufirst%3DJ.%2BT.%26aulast%3DRoccella%26aufirst%3DE.%2BJ.%26atitle%3DThe%2520seventh%2520report%2520of%2520the%2520Joint%2520National%2520Committee%2520on%2520Prevention%252C%2520Detection%252C%2520Evaluation%252C%2520and%2520Treatment%2520of%2520High%2520Blood%2520Pressure%253A%2520the%2520JNC%25207%2520report%26jtitle%3DJAMA%252C%2520J.%2520Am.%2520Med.%2520Assoc.%26date%3D2003%26volume%3D289%26spage%3D2560%26epage%3D2572" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group">Young, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Funder, J. W.</span><span> </span><span class="NLM_article-title">Aldosterone and the Heart</span> <span class="citation_source-journal">Trends Endocrinol. Metab.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">224</span><span class="NLM_x">–</span> <span class="NLM_lpage">226</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Fjm100505n&amp;key=10.1016%2FS1043-2760%2800%2900270-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Fjm100505n&amp;key=10878752" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Fjm100505n&amp;key=1%3ACAS%3A528%3ADC%252BD3cXks12rtbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2000&pages=224-226&author=M.+Youngauthor=J.+W.+Funder&title=Aldosterone+and+the+Heart"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Aldosterone and the Heart</span></div><div class="casAuthors">Young, M.; Funder, J. W.</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Endocrinology and Metabolism</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">224-226</span>CODEN:
                <span class="NLM_cas:coden">TENME4</span>;
        ISSN:<span class="NLM_cas:issn">1043-2760</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">A review with 35 refs.  Classically, aldosterone is a steroid hormone secreted from the adrenal cortex, which acts on kidney, colon and sweat/salivary glands to promote unidirectional sodium transport.  Currently, there is excellent exptl. evidence for aldosterone acting directly on the central nervous system to raise blood pressure, and on the heart to cause cardiac hypertrophy and fibrosis.  In addn., there is emerging evidence for aldosterone synthesis in the heart, and for as yet unexplained benefits of aldosterone antagonism in the treatment of cardiac failure.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGogjgONZBhWb7Vg90H21EOLACvtfcHk0lhPLNOeZitMmQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXks12rtbg%253D&md5=cb40142aa246973a217ff37c7351c07f</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1016%2FS1043-2760%2800%2900270-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1043-2760%252800%252900270-8%26sid%3Dliteratum%253Aachs%26aulast%3DYoung%26aufirst%3DM.%26aulast%3DFunder%26aufirst%3DJ.%2BW.%26atitle%3DAldosterone%2520and%2520the%2520Heart%26jtitle%3DTrends%2520Endocrinol.%2520Metab.%26date%3D2000%26volume%3D11%26spage%3D224%26epage%3D226" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Voets, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Antes, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scherer, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Müller-Vieira, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Biemel, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barassin, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marchais-Oberwinkler, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hartmann, R. W.</span><span> </span><span class="NLM_article-title">Heteroaryl-substituted naphthalenes and structurally modified derivatives: selective inhibitors of CYR11B2 for the treatment of congestive heart failure and myocardial fibrosis</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">6632</span><span class="NLM_x">–</span> <span class="NLM_lpage">6642</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm0503704" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=6632-6642&author=M.+Voetsauthor=I.+Antesauthor=C.+Schererauthor=U.+M%C3%BCller-Vieiraauthor=K.+Biemelauthor=C.+Barassinauthor=S.+Marchais-Oberwinklerauthor=R.+W.+Hartmann&title=Heteroaryl-substituted+naphthalenes+and+structurally+modified+derivatives%3A+selective+inhibitors+of+CYR11B2+for+the+treatment+of+congestive+heart+failure+and+myocardial+fibrosis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4a&amp;dbid=16384&amp;doi=10.1021%2Fjm0503704&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0503704%26sid%3Dliteratum%253Aachs%26aulast%3DVoets%26aufirst%3DM.%26aulast%3DAntes%26aufirst%3DI.%26aulast%3DScherer%26aufirst%3DC.%26aulast%3DM%25C3%25BCller-Vieira%26aufirst%3DU.%26aulast%3DBiemel%26aufirst%3DK.%26aulast%3DBarassin%26aufirst%3DC.%26aulast%3DMarchais-Oberwinkler%26aufirst%3DS.%26aulast%3DHartmann%26aufirst%3DR.%2BW.%26atitle%3DHeteroaryl-substituted%2520naphthalenes%2520and%2520structurally%2520modified%2520derivatives%253A%2520selective%2520inhibitors%2520of%2520CYR11B2%2520for%2520the%2520treatment%2520of%2520congestive%2520heart%2520failure%2520and%2520myocardial%2520fibrosis%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2005%26volume%3D48%26spage%3D6632%26epage%3D6642" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit4b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Voets, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Antes, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scherer, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Müller-Vieira, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Biemel, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marchais-Oberwinkler, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hartmann, R. W.</span><span> </span><span class="NLM_article-title">Synthesis and evaluation of heteroaryl-substituted dihydronaphthalenes and indenes: potent and selective inhibitors of aldosterone synthase (CYP11B2) for the treatment of congestive heart failure and myocardial fibrosis</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">2222</span><span class="NLM_x">–</span> <span class="NLM_lpage">2231</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm060055x" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref4/cit4b&amp;dbid=32&amp;doi=10.1021%2Fjm100505n&amp;key=1%3ACAS%3A528%3ADC%252BD28XitVOisb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=2222-2231&author=M.+Voetsauthor=I.+Antesauthor=C.+Schererauthor=U.+M%C3%BCller-Vieiraauthor=K.+Biemelauthor=S.+Marchais-Oberwinklerauthor=R.+W.+Hartmann&title=Synthesis+and+evaluation+of+heteroaryl-substituted+dihydronaphthalenes+and+indenes%3A+potent+and+selective+inhibitors+of+aldosterone+synthase+%28CYP11B2%29+for+the+treatment+of+congestive+heart+failure+and+myocardial+fibrosis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4bR"><div class="casContent"><span class="casTitleNuber">4b</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and Evaluation of Heteroaryl-Substituted Dihydronaphthalenes and Indenes: Potent and Selective Inhibitors of Aldosterone Synthase (CYP11B2) for the Treatment of Congestive Heart Failure and Myocardial Fibrosis</span></div><div class="casAuthors">Voets, Marieke; Antes, Iris; Scherer, Christiane; Mueller-Vieira, Ursula; Biemel, Klaus; Marchais-Oberwinkler, Sandrine; Hartmann, Rolf W.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">2222-2231</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">In this study, the synthesis and biol. evaluation of heteroaryl-substituted dihydronaphthalenes and indenes is described.  The compds. were tested for activity by use of human CYP11B2 expressed in fission yeast and V79 MZh cells and for selectivity by use of human CYP11B1, CYP17, and CYP19.  The most active inhibitor was 2-(3-pyridinyl)-6-methoxy-3,4-dihydronaphthalene (I) (IC50 = 2 nM), showing a Ki value of 1.3 nM and a competitive type of inhibition.  2-(3-Pyridinyl)-5-methoxy-1H-indene was found to be the most selective CYP11B2 inhibitor (IC50 = 4 nM; CYP11B1 IC50 = 5684 nM), which also showed only marginal inhibition of human CYP3A4 and CYP2D6.  Docking and mol. dynamics studies using a homol.-modeled CYP11B2 structure were performed to understand some structure-activity relationships.  Caco-2 cell expts. revealed highly cell-permeable compds., and metabolic studies with I using rat liver microsomes showed sufficient stability.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpQStS_NR31QrVg90H21EOLACvtfcHk0li94uDKttZelA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XitVOisb4%253D&md5=53d9d6484f3c559128a136f398d7cbd4</span></div><a href="/servlet/linkout?suffix=cit4b&amp;dbid=16384&amp;doi=10.1021%2Fjm060055x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm060055x%26sid%3Dliteratum%253Aachs%26aulast%3DVoets%26aufirst%3DM.%26aulast%3DAntes%26aufirst%3DI.%26aulast%3DScherer%26aufirst%3DC.%26aulast%3DM%25C3%25BCller-Vieira%26aufirst%3DU.%26aulast%3DBiemel%26aufirst%3DK.%26aulast%3DMarchais-Oberwinkler%26aufirst%3DS.%26aulast%3DHartmann%26aufirst%3DR.%2BW.%26atitle%3DSynthesis%2520and%2520evaluation%2520of%2520heteroaryl-substituted%2520dihydronaphthalenes%2520and%2520indenes%253A%2520potent%2520and%2520selective%2520inhibitors%2520of%2520aldosterone%2520synthase%2520%2528CYP11B2%2529%2520for%2520the%2520treatment%2520of%2520congestive%2520heart%2520failure%2520and%2520myocardial%2520fibrosis%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D2222%26epage%3D2231" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit4c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Heim, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lucas, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grombein, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ries, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schewe, K. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Negri, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Müller-Vieira, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Birk, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hartmann, R. W.</span><span> </span><span class="NLM_article-title">Overcoming undesirable CYP1A2 inhibition of pyridylnaphthalene-type aldosterone synthase inhibitors: influence of heteroaryl derivatization on potency and selectivity</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">5064</span><span class="NLM_x">–</span> <span class="NLM_lpage">5074</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm800377h" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=5064-5074&author=R.+Heimauthor=S.+Lucasauthor=C.+M.+Grombeinauthor=C.+Riesauthor=K.+E.+Scheweauthor=M.+Negriauthor=U.+M%C3%BCller-Vieiraauthor=B.+Birkauthor=R.+W.+Hartmann&title=Overcoming+undesirable+CYP1A2+inhibition+of+pyridylnaphthalene-type+aldosterone+synthase+inhibitors%3A+influence+of+heteroaryl+derivatization+on+potency+and+selectivity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4c&amp;dbid=16384&amp;doi=10.1021%2Fjm800377h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm800377h%26sid%3Dliteratum%253Aachs%26aulast%3DHeim%26aufirst%3DR.%26aulast%3DLucas%26aufirst%3DS.%26aulast%3DGrombein%26aufirst%3DC.%2BM.%26aulast%3DRies%26aufirst%3DC.%26aulast%3DSchewe%26aufirst%3DK.%2BE.%26aulast%3DNegri%26aufirst%3DM.%26aulast%3DM%25C3%25BCller-Vieira%26aufirst%3DU.%26aulast%3DBirk%26aufirst%3DB.%26aulast%3DHartmann%26aufirst%3DR.%2BW.%26atitle%3DOvercoming%2520undesirable%2520CYP1A2%2520inhibition%2520of%2520pyridylnaphthalene-type%2520aldosterone%2520synthase%2520inhibitors%253A%2520influence%2520of%2520heteroaryl%2520derivatization%2520on%2520potency%2520and%2520selectivity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D5064%26epage%3D5074" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit4d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Lucas, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heim, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Negri, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Antes, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ries, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schewe, K. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bisi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gobbi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hartmann, R. W.</span><span> </span><span class="NLM_article-title">Novel aldosterone synthase inhibitors with extended carbocyclic skeleton by a combined ligand-based and structure-based drug design approach</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">6138</span><span class="NLM_x">–</span> <span class="NLM_lpage">6149</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm800683c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=6138-6149&author=S.+Lucasauthor=R.+Heimauthor=M.+Negriauthor=I.+Antesauthor=C.+Riesauthor=K.+E.+Scheweauthor=A.+Bisiauthor=S.+Gobbiauthor=R.+W.+Hartmann&title=Novel+aldosterone+synthase+inhibitors+with+extended+carbocyclic+skeleton+by+a+combined+ligand-based+and+structure-based+drug+design+approach"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4d&amp;dbid=16384&amp;doi=10.1021%2Fjm800683c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm800683c%26sid%3Dliteratum%253Aachs%26aulast%3DLucas%26aufirst%3DS.%26aulast%3DHeim%26aufirst%3DR.%26aulast%3DNegri%26aufirst%3DM.%26aulast%3DAntes%26aufirst%3DI.%26aulast%3DRies%26aufirst%3DC.%26aulast%3DSchewe%26aufirst%3DK.%2BE.%26aulast%3DBisi%26aufirst%3DA.%26aulast%3DGobbi%26aufirst%3DS.%26aulast%3DHartmann%26aufirst%3DR.%2BW.%26atitle%3DNovel%2520aldosterone%2520synthase%2520inhibitors%2520with%2520extended%2520carbocyclic%2520skeleton%2520by%2520a%2520combined%2520ligand-based%2520and%2520structure-based%2520drug%2520design%2520approach%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D6138%26epage%3D6149" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit4e"><span><span class="NLM_label">(e) </span><span class="NLM_contrib-group">Lucas, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heim, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ries, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schewe, K. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Birk, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hartmann, R. W.</span><span> </span><span class="NLM_article-title">In vivo active aldosterone synthase inhibitors with improved selectivity: lead optimization providing a series of pyridine substituted 3,4-dihydro-1<i>H</i>-quinolin-2-one derivatives</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">8077</span><span class="NLM_x">–</span> <span class="NLM_lpage">8087</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm800888q" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=8077-8087&author=S.+Lucasauthor=R.+Heimauthor=C.+Riesauthor=K.+E.+Scheweauthor=B.+Birkauthor=R.+W.+Hartmann&title=In+vivo+active+aldosterone+synthase+inhibitors+with+improved+selectivity%3A+lead+optimization+providing+a+series+of+pyridine+substituted+3%2C4-dihydro-1H-quinolin-2-one+derivatives"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4e&amp;dbid=16384&amp;doi=10.1021%2Fjm800888q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm800888q%26sid%3Dliteratum%253Aachs%26aulast%3DLucas%26aufirst%3DS.%26aulast%3DHeim%26aufirst%3DR.%26aulast%3DRies%26aufirst%3DC.%26aulast%3DSchewe%26aufirst%3DK.%2BE.%26aulast%3DBirk%26aufirst%3DB.%26aulast%3DHartmann%26aufirst%3DR.%2BW.%26atitle%3DIn%2520vivo%2520active%2520aldosterone%2520synthase%2520inhibitors%2520with%2520improved%2520selectivity%253A%2520lead%2520optimization%2520providing%2520a%2520series%2520of%2520pyridine%2520substituted%25203%252C4-dihydro-1H-quinolin-2-one%2520derivatives%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D8077%26epage%3D8087" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit4f"><span><span class="NLM_label">(f) </span><span class="NLM_contrib-group">Ries, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lucas, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heim, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Birk, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hartmann, R. W.</span><span> </span><span class="NLM_article-title">Selective aldosterone synthase inhibitors reduce aldosterone formation <i>in vitro</i> and <i>in vivo</i></span> <span class="citation_source-journal">J. Steroid Biochem. Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">116</span><span class="NLM_x">, </span> <span class="NLM_fpage">121</span><span class="NLM_x">–</span> <span class="NLM_lpage">126</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4f&amp;dbid=16&amp;doi=10.1021%2Fjm100505n&amp;key=10.1016%2Fj.jsbmb.2009.04.013" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4f&amp;dbid=8&amp;doi=10.1021%2Fjm100505n&amp;key=19427380" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4f&amp;dbid=32&amp;doi=10.1021%2Fjm100505n&amp;key=1%3ACAS%3A528%3ADC%252BD1MXptVGmt70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=116&publication_year=2009&pages=121-126&author=C.+Riesauthor=S.+Lucasauthor=R.+Heimauthor=B.+Birkauthor=R.+W.+Hartmann&title=Selective+aldosterone+synthase+inhibitors+reduce+aldosterone+formation+in+vitro+and+in+vivo"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4fR"><div class="casContent"><span class="casTitleNuber">4f</span><div class="casTitle"><span class="NLM_cas:atitle">Selective aldosterone synthase inhibitors reduce aldosterone formation in vitro and in vivo</span></div><div class="casAuthors">Ries, Christina; Lucas, Simon; Heim, Ralf; Birk, Barbara; Hartmann, Rolf W.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Steroid Biochemistry and Molecular Biology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">116</span>
        (<span class="NLM_cas:issue">3-5</span>),
    <span class="NLM_cas:pages">121-126</span>CODEN:
                <span class="NLM_cas:coden">JSBBEZ</span>;
        ISSN:<span class="NLM_cas:issn">0960-0760</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Aldosterone plays a crucial role in salt and water homeostasis but in case of pathol. increased plasma aldosterone levels it is also involved in the development and the progression of severe cardiovascular diseases like heart failure and myocardial fibrosis.  For the treatment of these diseases we propose inhibition of the aldosterone forming enzyme CYP11B2 as a new pharmacol. strategy.  We recently developed in vitro highly potent and selective inhibitors of human CYP11B2, but the evidence of their in vivo activity is still missing.  For this purpose, rat aldosterone synthase gene was cloned and expressed in V79MZ cells to establish a new screening assay for the identification of "rat-active" substances.  Compds. from the class of heteroaryl substituted 3,4-dihydro-1H-quinolin-2-ones showed a moderate inhibitory effect (65% at 2 μM) on rat CYP11B2 in vitro.  Furthermore, it diminished the conversion of deoxycorticosterone to aldosterone in rat adrenals and significantly reduced plasma aldosterone levels in vivo.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp4yOGn0kT937Vg90H21EOLACvtfcHk0lhmYNC0Y8sRAQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXptVGmt70%253D&md5=a03f287e26dc3bfff893dd9f3e5d0541</span></div><a href="/servlet/linkout?suffix=cit4f&amp;dbid=16384&amp;doi=10.1016%2Fj.jsbmb.2009.04.013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jsbmb.2009.04.013%26sid%3Dliteratum%253Aachs%26aulast%3DRies%26aufirst%3DC.%26aulast%3DLucas%26aufirst%3DS.%26aulast%3DHeim%26aufirst%3DR.%26aulast%3DBirk%26aufirst%3DB.%26aulast%3DHartmann%26aufirst%3DR.%2BW.%26atitle%3DSelective%2520aldosterone%2520synthase%2520inhibitors%2520reduce%2520aldosterone%2520formation%2520in%2520vitro%2520and%2520in%2520vivo%26jtitle%3DJ.%2520Steroid%2520Biochem.%2520Mol.%2520Biol.%26date%3D2009%26volume%3D116%26spage%3D121%26epage%3D126" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Weinberger, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roniker, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krause, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weiss, R. J.</span><span> </span><span class="NLM_article-title">Eplerenone, a selective aldosterone blocker, in mild-to-moderate hypertension</span> <span class="citation_source-journal">Am. J. Hypertens.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">709</span><span class="NLM_x">–</span> <span class="NLM_lpage">716</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5a&amp;dbid=16&amp;doi=10.1021%2Fjm100505n&amp;key=10.1016%2FS0895-7061%2802%2902957-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5a&amp;dbid=8&amp;doi=10.1021%2Fjm100505n&amp;key=12160194" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5a&amp;dbid=32&amp;doi=10.1021%2Fjm100505n&amp;key=1%3ACAS%3A528%3ADC%252BD38Xms1aisLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2002&pages=709-716&author=M.+H.+Weinbergerauthor=B.+Ronikerauthor=S.+L.+Krauseauthor=R.+J.+Weiss&title=Eplerenone%2C+a+selective+aldosterone+blocker%2C+in+mild-to-moderate+hypertension"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5aR"><div class="casContent"><span class="casTitleNuber">5a</span><div class="casTitle"><span class="NLM_cas:atitle">Eplerenone, a selective aldosterone blocker, in mild-to-moderate hypertension</span></div><div class="casAuthors">Weinberger, Myron H.; Roniker, Barbara; Krause, Scott L.; Weiss, Robert J.</div><div class="citationInfo"><span class="NLM_cas:title">American Journal of Hypertension</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">709-716</span>CODEN:
                <span class="NLM_cas:coden">AJHYE6</span>;
        ISSN:<span class="NLM_cas:issn">0895-7061</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Inc.</span>)
        </div><div class="casAbstract">Eplerenone, a selective aldosterone blocker (SAB) that is highly specific for the aldosterone receptor, has the potential to be efficacious in the treatment of hypertension.  This 8-wk, multicenter, double-blind, placebo-controlled trial assessed the efficacy, safety, and tolerability of eplerenone in eligible patients randomized to eplerenone 50, 100, or 400 mg once daily; eplerenone 25, 50, or 200 mg twice daily; spironolactone 50 mg twice daily; or placebo.  The primary efficacy variable was the adjusted mean change in baseline to final visit for seated diastolic blood pressure (DBP).  Of 417 randomized patients, 409 were evaluated for efficacy.  The adjusted mean change from baseline to final visit in seated and standing systolic blood pressure (SBP) and DBP was significantly greater (P <.05) in all eplerenone groups than in the placebo group.  The adjusted mean change in 24-h ambulatory blood pressure monitoring (ABPM) measurements of SBP and DBP also documented a 24-h duration significantly greater (P <.05) than placebo in eplerenone-treated patients.  For all measurements, the antihypertensive effect of eplerenone increased in a dose-response fashion.  Eplerenone (100 mg) reduced BP by 75% compared with spironolactone (100 mg) and had an adverse events incidence rate similar to placebo.  No antiandrogenic or progestational effects or clin. relevant safety issues were obsd. in eplerenone-treated patients.  However, one spironolactone-treated patient reported menstrual irregularities.  Eplerenone doses of 50 to 400 mg once daily are well tolerated and effective in reducing BP in patients with mild-to-moderate hypertension during a 24-h period.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpP2CB2JlWpG7Vg90H21EOLACvtfcHk0lhmYNC0Y8sRAQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38Xms1aisLw%253D&md5=cee8929b94677bfd82aea7994664833a</span></div><a href="/servlet/linkout?suffix=cit5a&amp;dbid=16384&amp;doi=10.1016%2FS0895-7061%2802%2902957-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0895-7061%252802%252902957-6%26sid%3Dliteratum%253Aachs%26aulast%3DWeinberger%26aufirst%3DM.%2BH.%26aulast%3DRoniker%26aufirst%3DB.%26aulast%3DKrause%26aufirst%3DS.%2BL.%26aulast%3DWeiss%26aufirst%3DR.%2BJ.%26atitle%3DEplerenone%252C%2520a%2520selective%2520aldosterone%2520blocker%252C%2520in%2520mild-to-moderate%2520hypertension%26jtitle%3DAm.%2520J.%2520Hypertens.%26date%3D2002%26volume%3D15%26spage%3D709%26epage%3D716" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit5b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Pitt, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Remme, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zannad, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neaton, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martinez, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roniker, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bittman, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hurley, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kleiman, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gatlin, M.</span><span> </span><span class="NLM_article-title">Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction</span> <span class="citation_source-journal">N. Engl. J. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">348</span><span class="NLM_x">, </span> <span class="NLM_fpage">1309</span><span class="NLM_x">–</span> <span class="NLM_lpage">1321</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5b&amp;dbid=16&amp;doi=10.1021%2Fjm100505n&amp;key=10.1056%2FNEJMoa030207" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5b&amp;dbid=8&amp;doi=10.1021%2Fjm100505n&amp;key=12668699" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5b&amp;dbid=32&amp;doi=10.1021%2Fjm100505n&amp;key=1%3ACAS%3A528%3ADC%252BD3sXis1ehurY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=348&publication_year=2003&pages=1309-1321&author=B.+Pittauthor=W.+Remmeauthor=F.+Zannadauthor=J.+Neatonauthor=F.+Martinezauthor=B.+Ronikerauthor=R.+Bittmanauthor=S.+Hurleyauthor=J.+Kleimanauthor=M.+Gatlin&title=Eplerenone%2C+a+selective+aldosterone+blocker%2C+in+patients+with+left+ventricular+dysfunction+after+myocardial+infarction"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5bR"><div class="casContent"><span class="casTitleNuber">5b</span><div class="casTitle"><span class="NLM_cas:atitle">Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction</span></div><div class="casAuthors">Pitt, Bertram; Remme, Willem; Zannad, Faiez; Neaton, James; Martinez, Felipe; Roniker, Barbara; Bittman, Richard; Hurley, Steve; Kleiman, Jay; Gatlin, Marjorie; Ambrosioni, E.; Anderson, J. L.; Apetrei, E.; Aschermann, M.; Banas, J.; Cardoso, S.; Caspi, A.; Chung, N.; Corbalan, R.; Dargie, H. J.; Bietz, R.; Erhardt, L.; Garcia-Castillo, A.; Gheorghiade, M.; Hernandez, E.; Hess, O.; Jamerson, K.; Kjekshus, J.; Klug, E.; Krum, H.; Lee, Y.-T.; Lopez, N.; Lopez-Sendon, J.-L.; Martinez, F.; Murin, J.; Neaton, J.; Nicolau, J.-C.; Ostor, E.; Parkhomenko, A.; Pitt, B.; Ross, H.; Stepinska, J.; Torp-Pedersen, C.; Van Mieghem, W.; van Veldhuisen, D.-J.; White, H.; Wilvox, R. G.; Willenbrock, R.; Yotov, Y.-T.; Zannad, F.; Boissel, J.-P.; Furberg, C.; Julian, D.; Kulbertus, H.; Pocock, S.; Wittes, J.; Battler, A.; Blumenfeld, J.; Brilla, C.; Duprez, D.; Fowler, M.; Gavazzi, A.; Hildebrandt, P.; Komajda, M.; Korewicki, J.; Kosturakis, D.; Marin-Neto, J. A.; Miller, A.; Munoz Aguilera, R.; Oliveri, R.; Remme, W.; White, M.; Widimsky, P.; Bakris, G.; Castaigne, A.; Deedwania, P.; Duprez, D.; Ketelslegers, J. M.; Liu, P.; Mancia, G.; Nicklas, J.; Rouleau, J.-L.; Ruilope, L.; Sasayama, S.; Schiffrin, E.; Spertus, J.; Struthers, A.; Vaughan, D.; Weber, M.; Williams, G.; Abinader, E.; Adams, J.; Adams, P. C.; Adamus, J.; Ahlstrom, P.; Akesson, H. S.; Akhmedzhanov, N.; Alcasena Juango, S.; Ali Khan, S.; Alonso Garcia, A.; Amat, G.; Amerena, J.; Arnosova, K. M.; Andreoli, L.; Angelo-Nielsen, K.; Antonio de Velasco, J.; Apetrei, E.; Aroutiounov, G.; Aschermann, M.; Asklund, M.; Assmann, I.; Aumont, M.-C.; Avtandilov, A.; Azarin, O.; Bada, V.; Bakoumov, P.; Balazovjech, L.; Baldjiev, E.; Baluda, M.; Barrazueta, R.; Barsi, B.; Bashir, Y.; Batin, P. D.; Belenky, D.; Belyi, Y.; Bendermacher, P. E. F.; Berget, K.; Bergmeier, C.; Berning, J.; Berrazueta-Fernandez, J. R.; Block, P.; Boberg, G.; Bocek, P.; Bohlscheid, V.; Bokarev, I.; Bolinska, H.; Boman, K.; Bondarev, S.; Bonzel, T.; Boreux, J.-L.; Borggrefe, M.; Borisov, M.; Boxho, G.; Boyarkin, M.; Brachmann, J.; Brack, M.; Branea, I.; Breivik, K.; Brigden, G. S.; Bronzwaer, P. N. A.; Bruce, D.; Bruckner, I.; Brunvand, H.; Bryukhovetski, A.; Buser, P.; Campbell, T.; Campeanu, A.; Capucci, A.; Carasca, E.; Cardoso, J.; Carrageta, M.; Caspi, A.; Cassim, S.; Caturla, J.; Ceia, F.; Cernosek, B.; Channer, K.; Chati, Z.; Christensen, P. D.; Chung, N. S.; Cinteza, M.; Cleland, J. G. F.; Cocchieri, M.; Commerford, P.; Conti, U.; Corsini, G.; Cortina Liosa, A.; Coupez, J.-M.; Cribier, A.; Csillag, J.; Cyran, J.; Dahlstrom, U.; Dalby, A.; Dalin, L. J.; Dalkowski, M.; Dargie, H. J.; Darius, H.; Datcu, D. M.; David, D.; De Myttenaere, M.; De Teresa, E.; De Velasco, J.; de Vries, A. G.; den Hartog, F. R.; Desjoyaux, E.; Dezerbi, A.; Dhawan, J.; Biaz Molina, B.; Dickstein, K.; Dorobantu, M.; Doschitsin, V.; Doubell, A.; Dovgalevsky, P.; Dragulescu, S. I.; Drapkina, O.; Dubourg, O.; Dunselman, P. H. J. M.; Dyadyk, O. I.; Dykun, Y. V.; Dzyak, G. V.; Egorova, L. P.; Egstrup, K.; Eha, J.; Ehrenbergerova, M.; El Allaf, D.; Elenkova, A.; Ellis, C. J.; Engbers, J. G.; Fainyk, A. F.; Falck, G.; Fanelli, R.; Farre-Mun, J.; Favier, J.; Ferrari, G.; Ferreira, I.; Rischer, H.; Fotyanov, S.; Freericks, M. P.; Froeland, G.; Galve, E.; Garcia, M. M.; Garcia, A. A.; Garnier, L. F.; Gazaryan, G.; Georgescu, C.; Geraedts, J.; Glezer, M. G.; Goloborodko, B. I.; Goloshchekin, B.; Gonsorcik, J.; Gotchev, D.; Gotcheva, N.; Gottwik, M. G.; Grande, P.; Gratsiansky, N.; Grishina, E. I.; Groch, L.; Gruzdev, A.; Guenova, D.; Gundersen, T.; Hagerman, I.; Hambrecht, R.; Hammermann, H.; Hansen, O.; Hansteen, V.; Hart, H.; Hauf, G. F.; Hecker, U.; Hegyi, I.; Herlitz, J.; Hertzberger, D. P.; Herweijer, A. H.; Heyndrickx, G. R.; Hittinger, L.; Hoang, V.; Hobbach, H.-P.; Hofman-Bang, C.; Holwerda, N. J.; Hong, K. P.; Horacek, T.; Hormann, J.; Horowitz, J. D.; Hradec, J.; Hurtig, U.; Ikram, H.; Ioan, A.; Jaarsma, W.; Jadraque, L. M.; Jakobsen, T. J.; Janicki, K. J.; Jankelow, D.; Janosi, A.; Jansky, P.; Janssens, L.; Janzen, I.; Jensen, P.; Jirmar, R.; Jobic, Y.; Jones, A.; Jonsson, J.; Kahles, H.; Kaliska, G.; Kamensky, G.; Kappenberger, L.; Karlsson, J. E.; Karpati, P.; Karpenko, O. I.; Karpov, Y.; Kawecka-Jaszcz, J.; Keeling, P. J.; Keren, G.; Khalife, K.; Khrakovskaya, M.; Khrustalev, O. A.; Klarlund, K. K.; Kleber, E.-X.; Klug, E.; Koenig, W.; Komarek, J.; Kononenko, L. G.; Konz, K.; Komacewicz-Jach, Z.; Kostenko, V.; Kotous, J.; Kovalsky, I.; Kozak, P.; Kreider-Stempfle, H. U.; Kromer, E. P.; Krum, H.; Krzeminska-Pakula, M.; Kuc, K.; Kucera, P.; Kurowski, M.; Lach, L.; Lai, C.; Lane, G.; Lang, E.; Lankes, W.; Lankisch, P.-G.; Laraudogoitia, E.; Larsen, J.; Larsson, L.-E.; Laruelle, C.; Lazar, A.; Lee, Y.-T.; Legkonogov, A. V.; Leitch, J.; Lengfelder, W.; Lescot, C. D.; Lewis, B. S.; Lewis, P.; Libov, I. A.; Liel-Cohen, N.; Lim, H. K.; Lin, C.-S.; Linssen, G. C. M.; Liu, C.-P.; Lok, D. J. A.; Lopatin, Y. M.; Lopez De Sa, E.; Lotan, C.; Lousada, N.; Lucas, C.; Lucatti, A.; Lusov, V.; Mabin, T. A.; Macleod, D. C.; Maeurer, W.; Magnusson, J.-O.; Maisch, B.; Malinski, A.; Maltchougine, M.; Manga, P.; Mantov, S.; Marchi, S.; Marcinowska-Suchowierska, E.; Marenne, F.; Maresca, F. S.; Markov, V.; Marmor, A. T.; Martines, C.; Martinez, A.; Martin-Jadraque, L.; Martins, L. F. R.; Martos Ferres, R.; Mary, D. A. S. G.; Masini, F.; Matta, F.; Maurer, W.; Mazzini, A. C.; McDonald, K. M. A.; Meeder, J. G.; Melandri, F.; Melin, J.; Menezes, C.; Michels, H. R.; Missault, L.; Mitrovic, V.; Mntla, P.; Mobilij, A.; Mogilevsky, A.; Moiseev, V.; Mokan, M.; Moeller, B.; Moreira, I.; Mouhoub, D.; Moura, B.; Muders, E.; Mudra, H.; Munz, J.; Murin, J.; Musial, W. J.; Myburgh, D. P.; Naqvi, N.; Naumann, G.; Nazimov, S. V.; Nadelec, G.; Nedogoda, S. V.; Nielsen, I.; Nielsen, T.; Nierop, P. R.; Nilsson, G.; Notaristefano, A.; Novitsky, I. N.; Nykl, L.; Ofner, P.; Olariu, C.; Olbrich, H. G.; Oldroyd, K. G.; Olinic, N.; Oliveira, J.; Omland, T.; Orus, J.; Owensby, D.; Page, A.; Park, K. S.; Parkhomenko, O. M.; Pasotti, C.; Pasowicz, M.; Pecce, P.; Pell, A. C. H.; Penkov, N. I.; Perez de Juan, M.; Perez, H.; Petersen, M.; Petrov, A. A.; Peuhkurinen, K.; Philonenko, X.; Pieper, M.; Pieske, B.; Pluta, W.; Podzemska, B.; Popeye, R.; Prost, C.; Purcaro, A.; Put, P.; Radchenko, V.; Radoi, M.; Rae, A. P.; Raev, D.; Ramik, C.; Rasmussen, S. L.; Reisin, L.; Renker, B.; Ribeiro, V. G.; Richardt, G.; Rjecansky, I.; Risenfors, M.; Rivis, I. A.; Robson, R. H.; Rocher, R.; Rodriquez Padial, L.; Rose, E. L.; Rosen, S. D.; Rosenfeld, T.; Rowlands, D. B.; Rozkovec, A.; Rudas, L.; Rudenko, L. V.; Ruiz-Rejon, F.; Rutsch, W.; Rybar, R.; Rybka, J.; Saetre, H. A.; Sarosi, I.; Savalle, L. H.; Schmidt, A.; Schuren, K. P.; Schwartz, Y.; Schwinger, R.; Schwob, J. P.; Scott, D.; Sechtem, U.; Sela, O.; Semrad, B.; Senni, M.; Shilkina, N. P.; Shpektor, A.; Silas, J.; Sindone, A.; Sinescu, C. J.; Sipila, R.; Sirek, J.; Skagen, K.; Shura, M.; Slanina, M.; Slowinski, S.; Smid, J.; Smielak-Korombel, W.; Solodky, A.; Spacek, R.; Squire, I.; Steingo, L.; Stepinska, J.; Stogowski, A.; Storzhakov, G.; Striouk, R.; Strunge, P.; Suter, T.; Svitil, P.; Swedberg, K.; Swidzinski, M.; Syvolap, V. D.; Sztajzel, J.; Tahk, S. J.; Tans, A. C.; Tans, J. G. M.; Targonski, R.; Tarjan, J.; Tartagni, F.; Tchartchoglian, R.; Tebloev, K.; Teesalu, R.; Ten Kate, J. B. L.; Terrosu, P.; Thompson, P. L.; Thybo, N. K.; Thygesen, K.; Tilon, P. A.; Timar, S.; Titkov, Y.; Titlbach, O. J.; Torp-Pedersen, C.; Torvik, D. T.; Touboul, P.; Trelawny, J. M.; Trillo Nouche, R.; Trochina, E.; Trojnar, R.; Tzekova, M. L.; Tzivoni, D.; Vahula, V.; Valagussa, F.; Valdes, M.; Van Der Heijden, R.; Van Der Sloot, J. A. P.; Van Hal, J. M. C.; Van Kempen, L. H. J.; Van Mieghem, W.; Van Rugge, F. P.; Van Veldhuisen, D. J.; Van Vlies, B.; Van Wijk, L. M.; Vasyuk, Y.; Vatutin, M.; Vered, Z.; Vergoni, W.; Vertkine, A.; Vigholt, E.; Vishnevskiy, A.; Voegelin, H.-P.; Voipio-Pulkki, L. M.; Von Mengden, H.-J.; Waites, J.; Watson, R. D. S.; Weiss, A. T.; Werner, H. A.; Wesdorp, J. C. L.; White, H.; Wiggers, P.; Wilcox, R. G.; Wilkinson, P.; Willems, A. R.; Willenbrock, R.; Wirth, M.; Wojciechowski, D.; Worth, H.; Wray, R.; Wu, C.-J.; Yakusevich, V. V.; Yang, S.-P.; Yarohno, N.; Zadionchenko, V. S.; Zaleska, T.; Zalewski, M.; Zannad, F.; Zateyshchikov, D.; Zeltin-Abramov, E.; Zeymer, U.; Zimmermann, R.; Albuquerque, D. C.; Alcaino, M.; Allall, O. A.; Beer, N.; Bortman, G.; Botero, R.; Cardoso, J. S.; Carrageta, M.; Carrillo, E.; Carvalho, A. C.; Castano, R.; Ceia, F.; Cesar, L. A. M.; Chevez, E.; Coelho, O. R.; Colombo, H. R.; Corbalan, R.; Doval, H.; Dutra, O.; Franken, R. A.; Gallardo, L.; Garcia, A.; Garcia, J.; Gomez, E. A.; Gomez, E.; Gonzalez, J.; Gonzalez, R. A.; Greque, G. V.; Guzman, L.; Haiek, J. C.; Hernandez, E.; Hominal, M. A.; Isea, J.; Lanas, F.; Leiva, J. L.; Lemus, J.; Llancaqueo, A.; Lopez, N.; Lousada, N.; Maia, L. N.; Maranhao, M. F.; Martinez, J. A.; Martinez, F. A.; Martins, F. A.; Martins, L.; Matadamas, N.; Matiz, H.; Mendoza, I.; Menezes, C.; Moises, O.; Moreira, J. I.; Moura, J. C.; Nicolau, J. C.; Nobrega, J.; Null, D.; Oliveira, M. S.; Palacios, A. O.; Pazin Filho, A.; Perrone, S. V.; Peigas, L. S.; Prieto, J. C.; Junior, A. R.; Rassi, S.; Ribeiro, V. G.; Rico, J. N.; Rivera, J. M.; Robledo, G.; Rodriguez, H.; Rosenthal, J.; Rossi, P. R. F.; Saraiva, J. F.; Soifer, S.; Sosa Liprandi, A.; Torres, H. G.; Uruchurtu, E.; Velasco, R. G.; Velasquez, J. G.; Vita, N.; Waich, S.; Zelaya, F. R.; Abariotis, N.; Abdollah, H.; Abraham, W.; Alaie, D.; Allison, W.; Ameen, A.; Amidi, M.; Anand, I.; Anderson, J. L.; Andreae, G. E.; Aquino, V.; Ballard, W.; Banas, J. S.; Baron, S. B.; Bata, I.; Berk, M. R.; Bhesania, T.; Binkley, P.; Booth, D. C.; Borts, D.; Brookfield, L. A.; Brown, C. S.; Browne, K. F.; Butman, S. M.; Capodilupo, R. C.; Caralis, D. G.; Carr, K. W.; Castan, R.; Chadow, H.; Chalavarya, G. K.; Chua, G. L.; Cinderella, J. A.; Clavette, P.; Clemson, B. S.; Cohen, T. J.; Colfer, H. T.; Corder, C. N.; Courtade, D. J.; Courtney, D. L.; Coutu, B.; Cucher, F. H.; Czarnecki, W.; Danisa, K.; D'Astous, M.; Dauber, I.; Davies, R.; Deedwania, P. C.; Delehanty, J. M.; Denny, D. M.; Denys, B. G.; DeYoung, P. J. P.; Dion, D.; Donohue, T. J.; El Shahawy, M.; Elkayam, U.; Escabi, J.; Essandoh, L. K.; Felicetta, J. V.; Fintel, D.; Fontaine, J. M.; Foster, R. E.; Frank, T. A.; Gin, K.; Goldberg, M. C.; Goldman, S.; Gossard, D.; Gosselin, G.; Gradman, A. H.; Grandmont, D.; Hack, T.; Hagar, J.; Haikal, M.; Hall, S. A.; Halpern, S.; Hanley, H. G.; Hanovich, G. D.; Hargrove, J. L.; Harlamert, E. A.; Hastings, T. E.; Hathaway, W. R.; Haught, W. H.; Hilliard, G. K.; Hodsden, J.; Hui, W.; Hurley, W.; Ibrahim, H. M.; Jafri, S.; Jain, A.; Jennison, S.; Jesse, R. L.; Joseph, J.; Kalman, J.; Karisberg, R. P.; Khant, R.; Koren, M.; Kosinski, E. J.; Kosolcharoen, P.; Kostuk, W. J.; Kouz, S. M.; Lai, C.; Langholz, D. E.; LeJemtel, T. H.; Leader, R.; Leblanc, M.-H.; Lee, H.; Lepage, S.; Lopez, M.; Lu, D. Y.; Lubelsky, B. J.; Luckasen, G. J.; Ma, P.-T.-S.; MacCallum, C. G.; Madu, E. C.; Maisel, A. S.; Mallis, G. I.; Mann, J. T.; Marr, D. R.; McGrew, F. A., III; McKay, R. J.; Mclellan, B.; Meisner, J.; Meyer, T.; Mikati, I.; Miller, L. A.; Miller, L. W.; Moe, G. W.; Mohiuddin, S. M.; Moir, G. D.; Morgan, A. W.; Morris, A.; Murphy, B. J.; Nallasivan, M.; Narula, J.; Nicklas, J. M.; Niederman, A. L.; Nitkin, R.; O'Keefe, J. H.; Oken, K. R.; O'Neill, P. G.; Orchard, R. C.; O'Riordan, W. D.; Paraboschi, C. F.; Patel, R. I.; Pennock, G.; Pesant, Y.; Phaneuf, D.; Phillips, D. F.; Plehn, J.; Promisloff, S.; Rajakumar, A. J.; Ramadurai, R.; Rashkow, A.; Rauh, R. A.; Rebane, T. M.; Riba, A. L.; Richard, C.; Riddle, J. C.; Ringuette, G.; Rivera, E.; Rockson, S.; Rogers, E.; Ross, H.; Roux, R.; Rupka, D.; Saenz, A.; Sampson, J.; Schulman, S. P.; Schuyler, G.; Sequeira, R. F.; Shah, A. R.; Shah, P. K.; Shakar, S. F.; Shalev, Y.; Sheikh, K. H.; Shettigar, U. R.; Siegel, R. M.; Sigal, S. L.; Singh, V. N.; Sotolongo, C. M.; Soucier, R. J.; Stagaman, D. J.; Stephan, W. J.; Stine, M.; Stoever, W. W.; Talano, J. V.; Tan, J. L.; Tanser, P. H.; Taussig, A. S.; Thadani, U.; Timmis, S. B. H.; Timothee, J. R.; Tragoon, S.; Tremblay, B.; Upadhya, K. J.; Vijay, N. K.; Wagoner, L. E.; Walker, J. L.; Wickemeyer, W. J.; Williams, G. A.; Williams, M. B.; Williams, R. E.; Wiseman, A. H.; Wool, K. J.; Yasin, M.; Zabalgoitia, M.; Zarich, S.; Zimmermann, R.; Zucker, R. P.</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">348</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">1309-1321</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">Background: Aldosterone blockade reduces mortality and morbidity among patients with severe heart failure.  We conducted a double-blind, placebo-controlled study evaluating the effect of eplerenone, a selective aldosterone blocker, on morbidity and mortality among patients with acute myocardial infarction complicated by left ventricular dysfunction and heart failure.  Methods: Patients were randomly assigned to eplerenone (25 mg per day initially, titrated to a max. of 50 mg per day; 3313 patients) or placebo (3319 patients) in addn. to optimal medical therapy.  The study continued until 1012 deaths occurred.  The primary end points were death from any cause and death from cardiovascular causes or hospitalization for heart failure, acute myocardial infarction, stroke, or ventricular arrhythmia.  Results: During a mean follow-up of 16 mo, there were 478 deaths in the eplerenone group and 554 deaths in the placebo group (relative risk, 0.85; 95 percent confidence interval, 0.75 to 0.96; P=0.008).  Of these deaths, 407 in the eplerenone group and 483 in the placebo group were attributed to cardiovascular causes (relative risk, 0.83; 95 percent confidence interval, 0.72 to 0.94; P= 0.005).  The rate of the other primary end point, death from cardiovascular causes or hospitalization for cardiovascular events, was reduced by eplerenone (relative risk, 0.87; 95 percent confidence interval, 0.79 to 0.95; P=0.002), as was the secondary end point of death from any cause or any hospitalization (relative risk, 0.92; 95 percent confidence interval, 0.86 to 0.98; P=0.02).  There was also a redn. in the rate of sudden death from cardiac causes (relative risk, 0.79; 95 percent confidence interval, 0.64 to 0.97; P=0.03).  The rate of serious hyperkalemia was 5.5 percent in the eplerenone group and 3.9 percent in the placebo group (P=0.002), whereas the rate of hypokalemia was 8.4 percent in the eplerenone group and 13.1 percent in the placebo group (P<0.001).  Conclusions: The addn. of eplerenone to optimal medical therapy reduces morbidity and mortality among patients with acute myocardial infarction complicated by left ventricular dysfunction and heart failure.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoTXvg9fCdjlrVg90H21EOLACvtfcHk0lhmYNC0Y8sRAQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXis1ehurY%253D&md5=cee432bc75bcca5f33098fe3bc8575df</span></div><a href="/servlet/linkout?suffix=cit5b&amp;dbid=16384&amp;doi=10.1056%2FNEJMoa030207&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMoa030207%26sid%3Dliteratum%253Aachs%26aulast%3DPitt%26aufirst%3DB.%26aulast%3DRemme%26aufirst%3DW.%26aulast%3DZannad%26aufirst%3DF.%26aulast%3DNeaton%26aufirst%3DJ.%26aulast%3DMartinez%26aufirst%3DF.%26aulast%3DRoniker%26aufirst%3DB.%26aulast%3DBittman%26aufirst%3DR.%26aulast%3DHurley%26aufirst%3DS.%26aulast%3DKleiman%26aufirst%3DJ.%26aulast%3DGatlin%26aufirst%3DM.%26atitle%3DEplerenone%252C%2520a%2520selective%2520aldosterone%2520blocker%252C%2520in%2520patients%2520with%2520left%2520ventricular%2520dysfunction%2520after%2520myocardial%2520infarction%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2003%26volume%3D348%26spage%3D1309%26epage%3D1321" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit5c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Hu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McMahon, E. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lala, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rudolph, A. E.</span><span> </span><span class="NLM_article-title">Molecular mechanisms of mineralocorticoid receptor antagonism by eplerenone</span> <span class="citation_source-journal">Mini-Rev. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">709</span><span class="NLM_x">–</span> <span class="NLM_lpage">718</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2005&pages=709-718&author=X.+Huauthor=S.+Liauthor=E.+G.+McMahonauthor=D.+S.+Lalaauthor=A.+E.+Rudolph&title=Molecular+mechanisms+of+mineralocorticoid+receptor+antagonism+by+eplerenone"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHu%26aufirst%3DX.%26aulast%3DLi%26aufirst%3DS.%26aulast%3DMcMahon%26aufirst%3DE.%2BG.%26aulast%3DLala%26aufirst%3DD.%2BS.%26aulast%3DRudolph%26aufirst%3DA.%2BE.%26atitle%3DMolecular%2520mechanisms%2520of%2520mineralocorticoid%2520receptor%2520antagonism%2520by%2520eplerenone%26jtitle%3DMini-Rev.%2520Med.%2520Chem.%26date%3D2005%26volume%3D5%26spage%3D709%26epage%3D718" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Mehdi, U. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adams-Huet, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raskin, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vega, G. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toto, R. D.</span><span> </span><span class="NLM_article-title">Addition of angiotensin receptor blockade or mineralocorticoid antagonism to maximal angiotensin-converting enzyme inhibition in diabetic nephropathy</span> <span class="citation_source-journal">J. Am. Soc. Nephrol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">2641</span><span class="NLM_x">–</span> <span class="NLM_lpage">2650</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6a&amp;dbid=16&amp;doi=10.1021%2Fjm100505n&amp;key=10.1681%2FASN.2009070737" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6a&amp;dbid=8&amp;doi=10.1021%2Fjm100505n&amp;key=19926893" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6a&amp;dbid=32&amp;doi=10.1021%2Fjm100505n&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhs1Witb3P" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2009&pages=2641-2650&author=U.+F.+Mehdiauthor=B.+Adams-Huetauthor=P.+Raskinauthor=G.+L.+Vegaauthor=R.+D.+Toto&title=Addition+of+angiotensin+receptor+blockade+or+mineralocorticoid+antagonism+to+maximal+angiotensin-converting+enzyme+inhibition+in+diabetic+nephropathy"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6aR"><div class="casContent"><span class="casTitleNuber">6a</span><div class="casTitle"><span class="NLM_cas:atitle">Addition of angiotensin receptor blockade or mineralocorticoid antagonism to maximal angiotensin-converting enzyme inhibition in diabetic nephropathy</span></div><div class="casAuthors">Mehdi, Uzma F.; Adams-Huet, Beverley; Raskin, Philip; Vega, Gloria L.; Toto, Robert D.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Society of Nephrology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">2641-2650</span>CODEN:
                <span class="NLM_cas:coden">JASNEU</span>;
        ISSN:<span class="NLM_cas:issn">1046-6673</span>.
    
            (<span class="NLM_cas:orgname">American Society of Nephrology</span>)
        </div><div class="casAbstract">Aldosterone promotes glomerular and tubular sclerosis independent of angiotensin II in animal models of diabetic nephropathy.  Most human studies testing the renoprotective benefit of adding an angiotensin receptor blocker or a mineralocorticoid receptor antagonist to a regimen based on inhibition of angiotensin-converting enzyme (ACE) used relatively low doses of ACE inhibitors.  Furthermore, these studies did not det. whether antiproteinuric effects were independent of BP lowering.  We conducted a double-blind, placebo-controlled trial in 81 patients with diabetes, hypertension, and albuminuria (urine albumin-to-creatinine ratio ≥300 mg/g) who all received lisinopril (80 mg once daily).  We randomly assigned the patients to placebo, losartan (100 mg daily), or spironolactone (25 mg daily) for 48 wk.  We obtained blood and urine albumin, urea, creatinine, electrolytes, A1c, and ambulatory BP at baseline, 24, and 48 wk.  Compared with placebo, the urine albumin-to-creatinine ratio decreased by 34.0% (95% CI, -51.0%, -11.2%, P = 0.007) in the group assigned to spironolactone and by 16.8% (95% CI, -37.3%, +10.5%, P = 0.20) in the group assigned to losartan.  Clinic and ambulatory BP, creatinine clearance, sodium and protein intake, and glycemic control did not differ between groups.  Serum potassium level was significantly higher with the addn. of either spironolactone or losartan.  In conclusion, the addn. of spironolactone, but not losartan, to a regimen including maximal ACE inhibition affords greater renoprotection in diabetic nephropathy despite a similar effect on BP.  These results support the need to conduct a long-term, large-scale, renal failure outcomes trial.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpBfOkzs-qpvrVg90H21EOLACvtfcHk0lg79TAPSVP8Rg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhs1Witb3P&md5=311c4cb35c7cc5458aefd79b1398362f</span></div><a href="/servlet/linkout?suffix=cit6a&amp;dbid=16384&amp;doi=10.1681%2FASN.2009070737&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1681%252FASN.2009070737%26sid%3Dliteratum%253Aachs%26aulast%3DMehdi%26aufirst%3DU.%2BF.%26aulast%3DAdams-Huet%26aufirst%3DB.%26aulast%3DRaskin%26aufirst%3DP.%26aulast%3DVega%26aufirst%3DG.%2BL.%26aulast%3DToto%26aufirst%3DR.%2BD.%26atitle%3DAddition%2520of%2520angiotensin%2520receptor%2520blockade%2520or%2520mineralocorticoid%2520antagonism%2520to%2520maximal%2520angiotensin-converting%2520enzyme%2520inhibition%2520in%2520diabetic%2520nephropathy%26jtitle%3DJ.%2520Am.%2520Soc.%2520Nephrol.%26date%3D2009%26volume%3D20%26spage%3D2641%26epage%3D2650" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit6b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Williams, G. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burgess, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kolloch, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ruilope, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Niegowska, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kipnes, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roniker, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patrick, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krause, S. L.</span><span> </span><span class="NLM_article-title">Efficacy of eplerenone versus enalapril as monotherapy in systemic hypertension</span> <span class="citation_source-journal">Clin. Exp. Pharmacol. Physiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">33</span><span class="NLM_x">, </span> <span class="NLM_fpage">990</span><span class="NLM_x">–</span> <span class="NLM_lpage">996</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6b&amp;dbid=16&amp;doi=10.1021%2Fjm100505n&amp;key=10.1111%2Fj.1440-1681.2006.04354.x" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2006&pages=990-996&author=G.+H.+Williamsauthor=E.+Burgessauthor=R.+E.+Kollochauthor=L.+M.+Ruilopeauthor=J.+Niegowskaauthor=M.+S.+Kipnesauthor=B.+Ronikerauthor=J.+L.+Patrickauthor=S.+L.+Krause&title=Efficacy+of+eplerenone+versus+enalapril+as+monotherapy+in+systemic+hypertension"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6b&amp;dbid=16384&amp;doi=10.1111%2Fj.1440-1681.2006.04354.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1440-1681.2006.04354.x%26sid%3Dliteratum%253Aachs%26aulast%3DWilliams%26aufirst%3DG.%2BH.%26aulast%3DBurgess%26aufirst%3DE.%26aulast%3DKolloch%26aufirst%3DR.%2BE.%26aulast%3DRuilope%26aufirst%3DL.%2BM.%26aulast%3DNiegowska%26aufirst%3DJ.%26aulast%3DKipnes%26aufirst%3DM.%2BS.%26aulast%3DRoniker%26aufirst%3DB.%26aulast%3DPatrick%26aufirst%3DJ.%2BL.%26aulast%3DKrause%26aufirst%3DS.%2BL.%26atitle%3DEfficacy%2520of%2520eplerenone%2520versus%2520enalapril%2520as%2520monotherapy%2520in%2520systemic%2520hypertension%26jtitle%3DClin.%2520Exp.%2520Pharmacol.%2520Physiol.%26date%3D2006%26volume%3D33%26spage%3D990%26epage%3D996" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group">De Gasparo, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Whitebread, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Preiswerk, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jeunemaitre, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Corvol, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Menard, J.</span><span> </span><span class="NLM_article-title">Antialdosterones: incidence and prevention of sexual side effects</span> <span class="citation_source-journal">J. Steroid Biochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1989</span><span class="NLM_x">, </span> <span class="NLM_volume">32</span><span class="NLM_x"> (</span><span class="NLM_issue">1B</span><span class="NLM_x">) </span> <span class="NLM_fpage">223</span><span class="NLM_x">–</span> <span class="NLM_lpage">227</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Fjm100505n&amp;key=10.1016%2F0022-4731%2889%2990169-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Fjm100505n&amp;key=2913412" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Fjm100505n&amp;key=1%3ACAS%3A528%3ADyaL1MXht1yktbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=1989&pages=223-227&issue=1B&author=M.+De+Gasparoauthor=S.+E.+Whitebreadauthor=G.+Preiswerkauthor=X.+Jeunemaitreauthor=P.+Corvolauthor=J.+Menard&title=Antialdosterones%3A+incidence+and+prevention+of+sexual+side+effects"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Antialdosterones:  incidence and prevention of sexual side effects</span></div><div class="casAuthors">De Gasparo, M.; Whitebread, S. E.; Preiswerk, G.; Jeunemaitre, X.; Corvol, P.; Menard, J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Steroid Biochemistry</span>
        (<span class="NLM_cas:date">1989</span>),
    <span class="NLM_cas:volume">32</span>
        (<span class="NLM_cas:issue">1B</span>),
    <span class="NLM_cas:pages">223-7</span>CODEN:
                <span class="NLM_cas:coden">JSTBBK</span>;
        ISSN:<span class="NLM_cas:issn">0022-4731</span>.
    </div><div class="casAbstract">The use of spironolactone in the treatment of hypertension has been limited by the occurrence of sexual effects, mainly menstrual disturbances in women and gynecomastia in men.  To minimize this limitation on the use of an effective K-sparing antihypertensive agent, 2 strategies were proposed: a decrease in the daily dose of spironolactone and improvement in the receptor-binding specificity of spironolactone.  In 182 patients with essential hypertension treated with spironolactone alone for a mean follow-up period of 23 mo, daily doses of 75-100 mg were as effective on blood pressure as doses of 150-300 mg.  In contrast, the development of gynaecomastia (91 cases among 699 men) was dose-related in 6.9% (50 mg/day) to 52.2% (≥150 mg/day) of the cases.  Two 9α,11α-epoxy derivs. were characterized in vitro in rats and in rabbits.  They exhibited a 3-10-fold decrease of the antiandrogenic and progestagenic effect, compared with spironolactone.  In humans, 1 of these derivs., epoxymexrenone (I) counteracted the fall in urinary Na/K ratio induced by 9α-fluorohydrocortisone at a 25 mg dose.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrFvlSJXHUb_rVg90H21EOLACvtfcHk0lg79TAPSVP8Rg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL1MXht1yktbk%253D&md5=9800827e17521944a6566df8972960cd</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1016%2F0022-4731%2889%2990169-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0022-4731%252889%252990169-6%26sid%3Dliteratum%253Aachs%26aulast%3DDe%2BGasparo%26aufirst%3DM.%26aulast%3DWhitebread%26aufirst%3DS.%2BE.%26aulast%3DPreiswerk%26aufirst%3DG.%26aulast%3DJeunemaitre%26aufirst%3DX.%26aulast%3DCorvol%26aufirst%3DP.%26aulast%3DMenard%26aufirst%3DJ.%26atitle%3DAntialdosterones%253A%2520incidence%2520and%2520prevention%2520of%2520sexual%2520side%2520effects%26jtitle%3DJ.%2520Steroid%2520Biochem.%26date%3D1989%26volume%3D32%26issue%3D1B%26spage%3D223%26epage%3D227" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="note"><p class="first last">For a recent review, see the following: </p></div><div class="NLM_citation" id="rightTab-cit8a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Meyers, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hu, X.</span><span> </span><span class="NLM_article-title">Non-steroidal mineralocorticoid receptor antagonists</span> <span class="citation_source-journal">Expert Opin. Ther. Pat.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">17</span><span class="NLM_x">–</span> <span class="NLM_lpage">23</span><div class="note"><p class="first last"> and references therein</p></div></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8a&amp;dbid=16&amp;doi=10.1021%2Fjm100505n&amp;key=10.1517%2F13543776.17.1.17" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8a&amp;dbid=32&amp;doi=10.1021%2Fjm100505n&amp;key=1%3ACAS%3A528%3ADC%252BD2sXitFSqtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2007&pages=17-23&author=M.+J.+Meyersauthor=X.+Hu&title=Non-steroidal+mineralocorticoid+receptor+antagonists"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8aR"><div class="casContent"><span class="casTitleNuber">8a</span><div class="casTitle"><span class="NLM_cas:atitle">Non-steroidal mineralocorticoid receptor antagonists</span></div><div class="casAuthors">Meyers, Marvin J.; Hu, Xiao</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Therapeutic Patents</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">17-23</span>CODEN:
                <span class="NLM_cas:coden">EOTPEG</span>;
        ISSN:<span class="NLM_cas:issn">1354-3776</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  The mineralocorticoid hormone aldosterone is essential in regulating the body's salt and water balance.  However, abnormal activation of the mineralocorticoid receptor (MR) by elevated levels of aldosterone and salt imbalance cause hypertension and other effects detrimental to the cardiovascular system.  Thus, MR antagonists are expected to be beneficial to patients with high blood pressure and other cardiovascular diseases, such as heart failure.  Until recently, only steroidal MR antagonists have been developed for therapeutic use.  However, due to complexity in chem. synthesis, limited scope for selectivity vs. other steroid hormone receptors, and undesirable phys. and chem. properties, appropriate steroidal compds. have been difficult to identify and develop.  Despite > 40 years of research, only two major steroidal MR antagonists, spironolactone and eplerenone, have been brought to the market for the treatment of hypertension and heart failure.  Novel classes of non-steroidal MR antagonists have just begun to emerge over the past few years.  This review summarizes the existing information available on non-steroidal MR antagonists from patent applications and the scientific literature published since 2003.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrLrmKDsJ1HeLVg90H21EOLACvtfcHk0lg79TAPSVP8Rg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXitFSqtA%253D%253D&md5=f32f0c05796b3681f3236ad133e0cf24</span></div><a href="/servlet/linkout?suffix=cit8a&amp;dbid=16384&amp;doi=10.1517%2F13543776.17.1.17&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F13543776.17.1.17%26sid%3Dliteratum%253Aachs%26aulast%3DMeyers%26aufirst%3DM.%2BJ.%26aulast%3DHu%26aufirst%3DX.%26atitle%3DNon-steroidal%2520mineralocorticoid%2520receptor%2520antagonists%26jtitle%3DExpert%2520Opin.%2520Ther.%2520Pat.%26date%3D2007%26volume%3D17%26spage%3D17%26epage%3D23" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit8b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Bell, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gernert, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grese, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Belvo, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borromeo, P. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kelley, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kennedy, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kolis, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lander, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Richey, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sharp, V. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stephenson, G. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zimmerman, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steinberg, M. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jadhav, P. K.</span><span> </span><span class="NLM_article-title">(<i>S</i>)-<i>N</i>-{3-[1-Cyclopropyl-1-(2,4-difluoro-phenyl)-ethyl]-1<i>H</i>-indol-7-yl}-methanesulfonamide: a potent, nonsteroidal, functional antagonist of the mineralocorticoid receptor</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">6443</span><span class="NLM_x">–</span> <span class="NLM_lpage">6445</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm701186z" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2007&pages=6443-6445&author=M.+G.+Bellauthor=D.+L.+Gernertauthor=T.+A.+Greseauthor=M.+D.+Belvoauthor=P.+S.+Borromeoauthor=S.+A.+Kelleyauthor=J.+H.+Kennedyauthor=S.+P.+Kolisauthor=P.+A.+Landerauthor=R.+Richeyauthor=V.+S.+Sharpauthor=G.+A.+Stephensonauthor=J.+D.+Williamsauthor=H.+Yuauthor=K.+M.+Zimmermanauthor=M.+I.+Steinbergauthor=P.+K.+Jadhav&title=%28S%29-N-%7B3-%5B1-Cyclopropyl-1-%282%2C4-difluoro-phenyl%29-ethyl%5D-1H-indol-7-yl%7D-methanesulfonamide%3A+a+potent%2C+nonsteroidal%2C+functional+antagonist+of+the+mineralocorticoid+receptor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8b&amp;dbid=16384&amp;doi=10.1021%2Fjm701186z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm701186z%26sid%3Dliteratum%253Aachs%26aulast%3DBell%26aufirst%3DM.%2BG.%26aulast%3DGernert%26aufirst%3DD.%2BL.%26aulast%3DGrese%26aufirst%3DT.%2BA.%26aulast%3DBelvo%26aufirst%3DM.%2BD.%26aulast%3DBorromeo%26aufirst%3DP.%2BS.%26aulast%3DKelley%26aufirst%3DS.%2BA.%26aulast%3DKennedy%26aufirst%3DJ.%2BH.%26aulast%3DKolis%26aufirst%3DS.%2BP.%26aulast%3DLander%26aufirst%3DP.%2BA.%26aulast%3DRichey%26aufirst%3DR.%26aulast%3DSharp%26aufirst%3DV.%2BS.%26aulast%3DStephenson%26aufirst%3DG.%2BA.%26aulast%3DWilliams%26aufirst%3DJ.%2BD.%26aulast%3DYu%26aufirst%3DH.%26aulast%3DZimmerman%26aufirst%3DK.%2BM.%26aulast%3DSteinberg%26aufirst%3DM.%2BI.%26aulast%3DJadhav%26aufirst%3DP.%2BK.%26atitle%3D%2528S%2529-N-%257B3-%255B1-Cyclopropyl-1-%25282%252C4-difluoro-phenyl%2529-ethyl%255D-1H-indol-7-yl%257D-methanesulfonamide%253A%2520a%2520potent%252C%2520nonsteroidal%252C%2520functional%2520antagonist%2520of%2520the%2520mineralocorticoid%2520receptor%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2007%26volume%3D50%26spage%3D6443%26epage%3D6445" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Dietz, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Du, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bolten, C. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Payne, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xia, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blinn, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Funder, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hu, X.</span><span> </span><span class="NLM_article-title">A number of marketed dihydropyridine calcium channel blockers have mineralocorticoid receptor antagonist activity</span> <span class="citation_source-journal">Hypertension</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">42</span><span class="NLM_x">–</span> <span class="NLM_lpage">748</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=42-748&author=J.+D.+Dietzauthor=S.+Duauthor=C.+W.+Boltenauthor=M.+A.+Payneauthor=C.+Xiaauthor=J.+R.+Blinnauthor=J.+W.+Funderauthor=X.+Hu&title=A+number+of+marketed+dihydropyridine+calcium+channel+blockers+have+mineralocorticoid+receptor+antagonist+activity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDietz%26aufirst%3DJ.%2BD.%26aulast%3DDu%26aufirst%3DS.%26aulast%3DBolten%26aufirst%3DC.%2BW.%26aulast%3DPayne%26aufirst%3DM.%2BA.%26aulast%3DXia%26aufirst%3DC.%26aulast%3DBlinn%26aufirst%3DJ.%2BR.%26aulast%3DFunder%26aufirst%3DJ.%2BW.%26aulast%3DHu%26aufirst%3DX.%26atitle%3DA%2520number%2520of%2520marketed%2520dihydropyridine%2520calcium%2520channel%2520blockers%2520have%2520mineralocorticoid%2520receptor%2520antagonist%2520activity%26jtitle%3DHypertension%26date%3D2008%26volume%3D51%26spage%3D42%26epage%3D748" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit9b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Fukumoto, S.; Ohra, T.; Sakamoto, J.</span><span> </span><span class="NLM_article-title">Aldosterone Receptor Antagonists</span>. WO2005/097118, October 20,<span class="NLM_x"> </span><span class="NLM_year">2005</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2005&author=S.+Fukumoto&author=T.+Ohra&author=J.+Sakamoto&title=Aldosterone+Receptor+Antagonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DFukumoto%26aufirst%3DS.%26atitle%3DAldosterone%2520Receptor%2520Antagonists%26date%3D2005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit9c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Bärfacker, L.; Kolkhof, P.; Schlemmer, K.-H.; Grosser, R.; Nitsche, A.; Klein, M.; Münter, K.; Albrecht-Küpper, B.; Hartmann, E.</span><span> </span><span class="NLM_article-title">Substituted 4-Aryl-1,4-dihydro-1,6-naphthyridinamides and Use Thereof</span>. WO2008/104306, September 4,<span class="NLM_x"> </span><span class="NLM_year">2008</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2008&author=L.+B%C3%A4rfacker&author=P.+Kolkhof&author=K.-H.+Schlemmer&author=R.+Grosser&author=A.+Nitsche&author=M.+Klein&author=K.+M%C3%BCnter&author=B.+Albrecht-K%C3%BCpper&author=E.+Hartmann&title=Substituted+4-Aryl-1%2C4-dihydro-1%2C6-naphthyridinamides+and+Use+Thereof"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DB%25C3%25A4rfacker%26aufirst%3DL.%26atitle%3DSubstituted%25204-Aryl-1%252C4-dihydro-1%252C6-naphthyridinamides%2520and%2520Use%2520Thereof%26date%3D2008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit9d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Arhancet, G. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woodard, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dietz, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garland, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wagner, G. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iyanar, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Collins, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blinn, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Numann, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, H.-C.</span><span> </span><span class="NLM_article-title">Stereochemical Requirements for the Mineralocorticoid Receptor Antagonist Activity of Dihydropyridines</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">4300</span><span class="NLM_x">–</span> <span class="NLM_lpage">4304</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm1002827" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=4300-4304&author=G.+B.+Arhancetauthor=S.+S.+Woodardauthor=J.+D.+Dietzauthor=D.+J.+Garlandauthor=G.+M.+Wagnerauthor=K.+Iyanarauthor=J.+T.+Collinsauthor=J.+R.+Blinnauthor=R.+E.+Numannauthor=X.+Huauthor=H.-C.+Huang&title=Stereochemical+Requirements+for+the+Mineralocorticoid+Receptor+Antagonist+Activity+of+Dihydropyridines"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9d&amp;dbid=16384&amp;doi=10.1021%2Fjm1002827&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm1002827%26sid%3Dliteratum%253Aachs%26aulast%3DArhancet%26aufirst%3DG.%2BB.%26aulast%3DWoodard%26aufirst%3DS.%2BS.%26aulast%3DDietz%26aufirst%3DJ.%2BD.%26aulast%3DGarland%26aufirst%3DD.%2BJ.%26aulast%3DWagner%26aufirst%3DG.%2BM.%26aulast%3DIyanar%26aufirst%3DK.%26aulast%3DCollins%26aufirst%3DJ.%2BT.%26aulast%3DBlinn%26aufirst%3DJ.%2BR.%26aulast%3DNumann%26aufirst%3DR.%2BE.%26aulast%3DHu%26aufirst%3DX.%26aulast%3DHuang%26aufirst%3DH.-C.%26atitle%3DStereochemical%2520Requirements%2520for%2520the%2520Mineralocorticoid%2520Receptor%2520Antagonist%2520Activity%2520of%2520Dihydropyridines%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D4300%26epage%3D4304" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit9e"><span><span class="NLM_label">(e) </span><span class="NLM_contrib-group">Arhancet, G. B.; Woodard, S. S.; Iyanar, K.; Case, B. L.; Woerndle, R.; Dietz, J. D.; Garland, D. J.; Collins, J. T.; Payne, M. A.; Blinn, J. R.; Pomposiello, S. I.; Hu, X.; Heron, M. I.; Huang, H.-C.; Lee, L. F.</span><span> </span><span class="NLM_article-title">Discovery of Novel Cyanodihydropyridines as Potent Mineralocorticoid Receptor Antagonists</span>.  <span class="citation_source-journal">J. Med. Chem.</span> DOI: <span class="refDoi"> DOI: 10.1021/jm100506y</span> .</span><div class="citationLinks">[<a href="/doi/10.1021/jm100506y" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Arhancet%2C+G.+B.%3B+Woodard%2C+S.+S.%3B+Iyanar%2C+K.%3B+Case%2C+B.+L.%3B+Woerndle%2C+R.%3B+Dietz%2C+J.+D.%3B+Garland%2C+D.+J.%3B+Collins%2C+J.+T.%3B+Payne%2C+M.+A.%3B+Blinn%2C+J.+R.%3B+Pomposiello%2C+S.+I.%3B+Hu%2C+X.%3B+Heron%2C+M.+I.%3B+Huang%2C+H.-C.%3B+Lee%2C+L.+F.+Discovery+of+Novel+Cyanodihydropyridines+as+Potent+Mineralocorticoid+Receptor+Antagonists.+J.+Med.+Chem.+DOI%3A+10.1021%2Fjm100506y."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9e&amp;dbid=16384&amp;doi=10.1021%2Fjm100506y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm100506y%26sid%3Dliteratum%253Aachs%26aulast%3DArhancet%26aufirst%3DG.%2BB.%26atitle%3DDiscovery%2520of%2520Novel%2520Cyanodihydropyridines%2520as%2520Potent%2520Mineralocorticoid%2520Receptor%2520Antagonists%26jtitle%3DJ.%2520Med.%2520Chem.%26doi%3D10.1021%2Fjm100506y" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="note"><p class="first last">For examples, see the following: </p></div><div class="NLM_citation" id="rightTab-cit10a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Zhang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Allan, G. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sbriscia, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Linton, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lundeen, S. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sui, Z.</span><span> </span><span class="NLM_article-title">Design, synthesis, and in vivo SAR of a novel series of pyrazolines as potent selective androgen receptor modulators</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">3857</span><span class="NLM_x">–</span> <span class="NLM_lpage">3869</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm0613976" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2007&pages=3857-3869&author=X.+Zhangauthor=X.+Liauthor=G.+F.+Allanauthor=T.+Sbrisciaauthor=O.+Lintonauthor=S.+G.+Lundeenauthor=Z.+Sui&title=Design%2C+synthesis%2C+and+in+vivo+SAR+of+a+novel+series+of+pyrazolines+as+potent+selective+androgen+receptor+modulators"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10a&amp;dbid=16384&amp;doi=10.1021%2Fjm0613976&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0613976%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DLi%26aufirst%3DX.%26aulast%3DAllan%26aufirst%3DG.%2BF.%26aulast%3DSbriscia%26aufirst%3DT.%26aulast%3DLinton%26aufirst%3DO.%26aulast%3DLundeen%26aufirst%3DS.%2BG.%26aulast%3DSui%26aufirst%3DZ.%26atitle%3DDesign%252C%2520synthesis%252C%2520and%2520in%2520vivo%2520SAR%2520of%2520a%2520novel%2520series%2520of%2520pyrazolines%2520as%2520potent%2520selective%2520androgen%2520receptor%2520modulators%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2007%26volume%3D50%26spage%3D3857%26epage%3D3869" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit10b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Zhang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Allan, G. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sbriscia, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Linton, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lundeen, S. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sui, Z.</span><span> </span><span class="NLM_article-title">Serendipitous discovery of novel imidazolopyrazole scaffold as selective androgen receptor modulators</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">439</span><span class="NLM_x">–</span> <span class="NLM_lpage">443</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2007&pages=439-443&author=X.+Zhangauthor=X.+Liauthor=G.+F.+Allanauthor=T.+Sbrisciaauthor=O.+Lintonauthor=S.+G.+Lundeenauthor=Z.+Sui&title=Serendipitous+discovery+of+novel+imidazolopyrazole+scaffold+as+selective+androgen+receptor+modulators"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DLi%26aufirst%3DX.%26aulast%3DAllan%26aufirst%3DG.%2BF.%26aulast%3DSbriscia%26aufirst%3DT.%26aulast%3DLinton%26aufirst%3DO.%26aulast%3DLundeen%26aufirst%3DS.%2BG.%26aulast%3DSui%26aufirst%3DZ.%26atitle%3DSerendipitous%2520discovery%2520of%2520novel%2520imidazolopyrazole%2520scaffold%2520as%2520selective%2520androgen%2520receptor%2520modulators%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2007%26volume%3D17%26spage%3D439%26epage%3D443" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit10c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Jones, D. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stewart, E. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Noe, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kallander, L. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Madauss, K. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thompson, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gray, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoekstra, W. J.</span><span> </span><span class="NLM_article-title">Discovery of non-steroidal mifepristone mimetics: pyrazoline-based PR antagonists</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">3203</span><span class="NLM_x">–</span> <span class="NLM_lpage">3206</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2005&pages=3203-3206&author=D.+G.+Jonesauthor=X.+Liangauthor=E.+L.+Stewartauthor=R.+A.+Noeauthor=L.+S.+Kallanderauthor=K.+P.+Madaussauthor=S.+P.+Williamsauthor=S.+K.+Thompsonauthor=D.+W.+Grayauthor=W.+J.+Hoekstra&title=Discovery+of+non-steroidal+mifepristone+mimetics%3A+pyrazoline-based+PR+antagonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DJones%26aufirst%3DD.%2BG.%26aulast%3DLiang%26aufirst%3DX.%26aulast%3DStewart%26aufirst%3DE.%2BL.%26aulast%3DNoe%26aufirst%3DR.%2BA.%26aulast%3DKallander%26aufirst%3DL.%2BS.%26aulast%3DMadauss%26aufirst%3DK.%2BP.%26aulast%3DWilliams%26aufirst%3DS.%2BP.%26aulast%3DThompson%26aufirst%3DS.%2BK.%26aulast%3DGray%26aufirst%3DD.%2BW.%26aulast%3DHoekstra%26aufirst%3DW.%2BJ.%26atitle%3DDiscovery%2520of%2520non-steroidal%2520mifepristone%2520mimetics%253A%2520pyrazoline-based%2520PR%2520antagonists%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2005%26volume%3D15%26spage%3D3203%26epage%3D3206" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit10d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Combs, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reese, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cornelius, L. A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gunnet, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cryan, E. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Granger, K. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jordan, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Demarest, K. T.</span><span> </span><span class="NLM_article-title">Nonsteroidal progesterone receptor ligands. 2. High-affinity ligands with selectivity for bone cell progesterone receptors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">38</span><span class="NLM_x">, </span> <span class="NLM_fpage">4880</span><span class="NLM_x">–</span> <span class="NLM_lpage">4884</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm00025a004" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=1995&pages=4880-4884&author=D.+W.+Combsauthor=K.+Reeseauthor=L.+A.+M.+Corneliusauthor=J.+W.+Gunnetauthor=E.+V.+Cryanauthor=K.+S.+Grangerauthor=J.+J.+Jordanauthor=K.+T.+Demarest&title=Nonsteroidal+progesterone+receptor+ligands.+2.+High-affinity+ligands+with+selectivity+for+bone+cell+progesterone+receptors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10d&amp;dbid=16384&amp;doi=10.1021%2Fjm00025a004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00025a004%26sid%3Dliteratum%253Aachs%26aulast%3DCombs%26aufirst%3DD.%2BW.%26aulast%3DReese%26aufirst%3DK.%26aulast%3DCornelius%26aufirst%3DL.%2BA.%2BM.%26aulast%3DGunnet%26aufirst%3DJ.%2BW.%26aulast%3DCryan%26aufirst%3DE.%2BV.%26aulast%3DGranger%26aufirst%3DK.%2BS.%26aulast%3DJordan%26aufirst%3DJ.%2BJ.%26aulast%3DDemarest%26aufirst%3DK.%2BT.%26atitle%3DNonsteroidal%2520progesterone%2520receptor%2520ligands.%25202.%2520High-affinity%2520ligands%2520with%2520selectivity%2520for%2520bone%2520cell%2520progesterone%2520receptors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1995%26volume%3D38%26spage%3D4880%26epage%3D4884" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit10e"><span><span class="NLM_label">(e) </span><span class="NLM_contrib-group">Stauffer, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, Y. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aron, Z. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coletta, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Katzenellenbogen, B. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Katzenellenbogen, J. A.</span><span> </span><span class="NLM_article-title">Triarylpyrazoles with basic side chains: development of pyrazole-based estrogen receptor antagonists</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">151</span><span class="NLM_x">–</span> <span class="NLM_lpage">161</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2001&pages=151-161&author=S.+R.+Staufferauthor=Y.+R.+Huangauthor=Z.+A.+Aronauthor=C.+J.+Colettaauthor=J.+Sunauthor=B.+S.+Katzenellenbogenauthor=J.+A.+Katzenellenbogen&title=Triarylpyrazoles+with+basic+side+chains%3A+development+of+pyrazole-based+estrogen+receptor+antagonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10e&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DStauffer%26aufirst%3DS.%2BR.%26aulast%3DHuang%26aufirst%3DY.%2BR.%26aulast%3DAron%26aufirst%3DZ.%2BA.%26aulast%3DColetta%26aufirst%3DC.%2BJ.%26aulast%3DSun%26aufirst%3DJ.%26aulast%3DKatzenellenbogen%26aufirst%3DB.%2BS.%26aulast%3DKatzenellenbogen%26aufirst%3DJ.%2BA.%26atitle%3DTriarylpyrazoles%2520with%2520basic%2520side%2520chains%253A%2520development%2520of%2520pyrazole-based%2520estrogen%2520receptor%2520antagonists%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2001%26volume%3D9%26spage%3D151%26epage%3D161" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Dahl, L. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heine, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tassinari, L.</span><span> </span><span class="NLM_article-title">Effects of chronic excess salt ingestion. Evidence that genetic factors play an important role in susceptibility to experimental hypertension</span> <span class="citation_source-journal">J. Exp. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1962</span><span class="NLM_x">, </span> <span class="NLM_volume">115</span><span class="NLM_x">, </span> <span class="NLM_fpage">1173</span><span class="NLM_x">–</span> <span class="NLM_lpage">1190</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=115&publication_year=1962&pages=1173-1190&author=L.+K.+Dahlauthor=M.+Heineauthor=L.+Tassinari&title=Effects+of+chronic+excess+salt+ingestion.+Evidence+that+genetic+factors+play+an+important+role+in+susceptibility+to+experimental+hypertension"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDahl%26aufirst%3DL.%2BK.%26aulast%3DHeine%26aufirst%3DM.%26aulast%3DTassinari%26aufirst%3DL.%26atitle%3DEffects%2520of%2520chronic%2520excess%2520salt%2520ingestion.%2520Evidence%2520that%2520genetic%2520factors%2520play%2520an%2520important%2520role%2520in%2520susceptibility%2520to%2520experimental%2520hypertension%26jtitle%3DJ.%2520Exp.%2520Med.%26date%3D1962%26volume%3D115%26spage%3D1173%26epage%3D1190" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit11b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Meyers, M. J.; Arhancet, G. B.; Chen, X.; Hockerman, S. L.; Long, S. A.; Mahoney, M. W.; Reitz, D. B.; Rico, J. G.</span><span> </span><span class="NLM_article-title">Pyrazoline Compounds as Mineralocorticoid Receptor Antagonists</span>. WO 2008/053300, May 8,<span class="NLM_x"> </span><span class="NLM_year">2008</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2008&author=M.+J.+Meyers&author=G.+B.+Arhancet&author=X.+Chen&author=S.+L.+Hockerman&author=S.+A.+Long&author=M.+W.+Mahoney&author=D.+B.+Reitz&author=J.+G.+Rico&title=Pyrazoline+Compounds+as+Mineralocorticoid+Receptor+Antagonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DMeyers%26aufirst%3DM.%2BJ.%26atitle%3DPyrazoline%2520Compounds%2520as%2520Mineralocorticoid%2520Receptor%2520Antagonists%26date%3D2008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group">Hultman, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krasnoperova, N. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Du, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xia, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dietz, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lala, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Welsch, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hu, X.</span><span> </span><span class="NLM_article-title">The ligand-dependent interaction of mineralocorticoid receptor with coactivator and corepressor peptides suggests multiple activation mechanisms</span> <span class="citation_source-journal">Mol. Endocrinol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">1460</span><span class="NLM_x">–</span> <span class="NLM_lpage">1473</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Fjm100505n&amp;key=10.1210%2Fme.2004-0537" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Fjm100505n&amp;key=15761029" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Fjm100505n&amp;key=1%3ACAS%3A528%3ADC%252BD2MXkslyqtrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2005&pages=1460-1473&author=M.+L.+Hultmanauthor=N.+V.+Krasnoperovaauthor=S.+Liauthor=S.+Duauthor=C.+Xiaauthor=J.+D.+Dietzauthor=D.+S.+Lalaauthor=D.+J.+Welschauthor=X.+Hu&title=The+ligand-dependent+interaction+of+mineralocorticoid+receptor+with+coactivator+and+corepressor+peptides+suggests+multiple+activation+mechanisms"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">The ligand-dependent interaction of mineralocorticoid receptor with coactivator and corepressor peptides suggests multiple activation mechanisms</span></div><div class="casAuthors">Hultman, Monica L.; Krasnoperova, Nataliia V.; Li, Suzhen; Du, Sarah; Xia, Chunsheng; Dietz, Jessica D.; Lala, Deepak S.; Welsch, Dean J.; Hu, Xiao</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Endocrinology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1460-1473</span>CODEN:
                <span class="NLM_cas:coden">MOENEN</span>;
        ISSN:<span class="NLM_cas:issn">0888-8809</span>.
    
            (<span class="NLM_cas:orgname">Endocrine Society</span>)
        </div><div class="casAbstract">We investigated the coregulator (coactivator and corepressor) interactions with the mineralocorticoid receptor (MR) that lead to activation and inhibition of the receptor in the presence of agonist and/or antagonist.  Our results indicate that MR ligand binding domain (LBD) interacts strongly with only a few specific coactivator peptides in the presence of the agonist aldosterone and that these interactions are blocked by the antagonist eplerenone.  We also discovered that cortisol, the preferred physiol. ligand for the glucocorticoid receptor in humans, is a partial MR agonist/antagonist, providing a possible mol. explanation of the tissue-selective effects of glucocorticoids on MR.  However, when we examd. the coactivator and corepressor peptide interactions in the presence of cortisol, we found that MR bound with cortisol or aldosterone interacted with the same set of peptides.  Thus, the partial agonism shown by cortisol is unlikely to be the result of differential interaction with known coactivators and corepressors.  On the other hand, we have identified coactivator binding groove mutations that are crit. for cortisol activation but not for aldosterone activation, suggesting that the two steroids induce different MR LBD conformations.  In addn., we also show that cortisol becomes full agonist when S810L mutation is introduced in the LBD of MR.  Interestingly, MR antagonists, such as eplerenone and progesterone, become partial agonist/antagonist of S810L but are still able to recruit LXXLL peptides to the mutant receptor.  Together, these findings suggest a model to explain the MR activation by various ligands.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqDY358OY2yLbVg90H21EOLACvtfcHk0lgnoq5K_npd5A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXkslyqtrs%253D&md5=f29e9129e4dc69f90c71a4c41335aa5e</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1210%2Fme.2004-0537&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1210%252Fme.2004-0537%26sid%3Dliteratum%253Aachs%26aulast%3DHultman%26aufirst%3DM.%2BL.%26aulast%3DKrasnoperova%26aufirst%3DN.%2BV.%26aulast%3DLi%26aufirst%3DS.%26aulast%3DDu%26aufirst%3DS.%26aulast%3DXia%26aufirst%3DC.%26aulast%3DDietz%26aufirst%3DJ.%2BD.%26aulast%3DLala%26aufirst%3DD.%2BS.%26aulast%3DWelsch%26aufirst%3DD.%2BJ.%26aulast%3DHu%26aufirst%3DX.%26atitle%3DThe%2520ligand-dependent%2520interaction%2520of%2520mineralocorticoid%2520receptor%2520with%2520coactivator%2520and%2520corepressor%2520peptides%2520suggests%2520multiple%2520activation%2520mechanisms%26jtitle%3DMol.%2520Endocrinol.%26date%3D2005%26volume%3D19%26spage%3D1460%26epage%3D1473" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group">Powers, D. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Casebier, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fokas, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ryan, W. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Troth, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coffen, D. L.</span><span> </span><span class="NLM_article-title">Automated parallel synthesis of chalcone-based screening libraries</span> <span class="citation_source-journal">Tetrahedron</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">4085</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=1998&pages=4085&author=D.+G.+Powersauthor=D.+S.+Casebierauthor=D.+Fokasauthor=W.+J.+Ryanauthor=J.+R.+Trothauthor=D.+L.+Coffen&title=Automated+parallel+synthesis+of+chalcone-based+screening+libraries"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPowers%26aufirst%3DD.%2BG.%26aulast%3DCasebier%26aufirst%3DD.%2BS.%26aulast%3DFokas%26aufirst%3DD.%26aulast%3DRyan%26aufirst%3DW.%2BJ.%26aulast%3DTroth%26aufirst%3DJ.%2BR.%26aulast%3DCoffen%26aufirst%3DD.%2BL.%26atitle%3DAutomated%2520parallel%2520synthesis%2520of%2520chalcone-based%2520screening%2520libraries%26jtitle%3DTetrahedron%26date%3D1998%26volume%3D54%26spage%3D4085" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Bach, K. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">El-Seedi, H. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jensen, H. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nielsen, H. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomsen, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Torssell, K. B. G.</span><span> </span><span class="NLM_article-title">1,3-Dipolar cycloadditions of ethoxycarbonyl-nitrile benzylimine, EtOOC≡CN<sup>+</sup>−N<sup>−</sup>CH<sub>2</sub>C<sub>6</sub>H<sub>5</sub>, and synthesis of β-amino acids. Synthesis and reactions of ethyl 2-chloro-2-ethoxyacetate and 2-chloro-2-ethoxyacetyl chloride</span> <span class="citation_source-journal">Tetrahedron</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">7543</span><span class="NLM_x">–</span> <span class="NLM_lpage">7556</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=1994&pages=7543-7556&author=K.+K.+Bachauthor=H.+R.+El-Seediauthor=H.+M.+Jensenauthor=H.+B.+Nielsenauthor=I.+Thomsenauthor=K.+B.+G.+Torssell&title=1%2C3-Dipolar+cycloadditions+of+ethoxycarbonyl-nitrile+benzylimine%2C+EtOOC%E2%89%A1CN%2B%E2%88%92N%E2%88%92CH2C6H5%2C+and+synthesis+of+%CE%B2-amino+acids.+Synthesis+and+reactions+of+ethyl+2-chloro-2-ethoxyacetate+and+2-chloro-2-ethoxyacetyl+chloride"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBach%26aufirst%3DK.%2BK.%26aulast%3DEl-Seedi%26aufirst%3DH.%2BR.%26aulast%3DJensen%26aufirst%3DH.%2BM.%26aulast%3DNielsen%26aufirst%3DH.%2BB.%26aulast%3DThomsen%26aufirst%3DI.%26aulast%3DTorssell%26aufirst%3DK.%2BB.%2BG.%26atitle%3D1%252C3-Dipolar%2520cycloadditions%2520of%2520ethoxycarbonyl-nitrile%2520benzylimine%252C%2520EtOOC%25E2%2589%25A1CN%252B%25E2%2588%2592N%25E2%2588%2592CH2C6H5%252C%2520and%2520synthesis%2520of%2520%25CE%25B2-amino%2520acids.%2520Synthesis%2520and%2520reactions%2520of%2520ethyl%25202-chloro-2-ethoxyacetate%2520and%25202-chloro-2-ethoxyacetyl%2520chloride%26jtitle%3DTetrahedron%26date%3D1994%26volume%3D50%26spage%3D7543%26epage%3D7556" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit14b"><span><span class="NLM_label">(b) </span><div class="note"><p class="first last">For a general review of nitrilimine cycloadditions, see the following:</p></div> <span class="citation_source-book">1,3-Dipolar Cycloaddition Chemistry</span>; <span class="NLM_contrib-group">Padwa, A.</span>, Ed.; <span class="NLM_publisher-name">Wiley</span>: <span class="NLM_publisher-loc">New York</span>,<span class="NLM_x"> </span><span class="NLM_year">1984</span><span class="NLM_x">; </span>Chapter 7.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1984&author=A.+Padwa&title=1%2C3-Dipolar+Cycloaddition+Chemistry"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26btitle%3D1%252C3-Dipolar%2520Cycloaddition%2520Chemistry%26aulast%3DPadwa%26aufirst%3DA.%26pub%3DWiley%26date%3D1984" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit14c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Manyem, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sibi, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lushington, G. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neuenswander, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schoenen, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aubé, J.</span><span> </span><span class="NLM_article-title">Solution-phase parallel synthesis of a library of Δ<sup>2</sup>-pyrazolines</span> <span class="citation_source-journal">J. Comb. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">20</span><span class="NLM_x">–</span> <span class="NLM_lpage">28</span></span><div class="citationLinks">[<a href="/doi/10.1021/cc0601175" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref14/cit14c&amp;dbid=32&amp;doi=10.1021%2Fjm100505n&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtFOmtLrO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2007&pages=20-28&author=S.+Manyemauthor=M.+P.+Sibiauthor=G.+H.+Lushingtonauthor=B.+Neuenswanderauthor=F.+Schoenenauthor=J.+Aub%C3%A9&title=Solution-phase+parallel+synthesis+of+a+library+of+%CE%942-pyrazolines"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14cR"><div class="casContent"><span class="casTitleNuber">14c</span><div class="casTitle"><span class="NLM_cas:atitle">Solution-Phase Parallel Synthesis of a Library of Δ2-Pyrazolines</span></div><div class="casAuthors">Manyem, Shankar; Sibi, Mukund P.; Lushington, Gerald H.; Neuenswander, Benjamin; Schoenen, Frank; Aube, Jeffrey</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Combinatorial Chemistry</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">20-28</span>CODEN:
                <span class="NLM_cas:coden">JCCHFF</span>;
        ISSN:<span class="NLM_cas:issn">1520-4766</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A parallel synthesis of a library (80 members) of 2-pyrazolines in soln. phase is described.  The 2-pyrazoline core was accessed through the [3 + 2] cycloaddn. of nitrilimines R1CX:NNHR2 (R1 = Ph, 3-MeC6H4, 3-ClC6H4, 4-FC6H4; R2 = Ph, X = Cl; R2 = 4-BrC6H4, X = Br) with enoyl oxazolidinones I (R3 = Me, Et, Ph, 4-ClC6H4, 4-FC6H4, 4-O2NC6H4, 2-MeOC6H4).  The cycloaddn. provided two regioisomers, the major product being the C regioisomer II.  The oxazolidinone moiety was further reduced to the primary alc., producing another library of 5-hydroxymethyl-2-pyrazolines.  The Lipinski profiles and calcd. ADME properties of the compds. are also reported.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrQth4QgyJqCrVg90H21EOLACvtfcHk0lgnoq5K_npd5A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtFOmtLrO&md5=fb752e9bc6f11dc7b2b97c3f488e5494</span></div><a href="/servlet/linkout?suffix=cit14c&amp;dbid=16384&amp;doi=10.1021%2Fcc0601175&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcc0601175%26sid%3Dliteratum%253Aachs%26aulast%3DManyem%26aufirst%3DS.%26aulast%3DSibi%26aufirst%3DM.%2BP.%26aulast%3DLushington%26aufirst%3DG.%2BH.%26aulast%3DNeuenswander%26aufirst%3DB.%26aulast%3DSchoenen%26aufirst%3DF.%26aulast%3DAub%25C3%25A9%26aufirst%3DJ.%26atitle%3DSolution-phase%2520parallel%2520synthesis%2520of%2520a%2520library%2520of%2520%25CE%25942-pyrazolines%26jtitle%3DJ.%2520Comb.%2520Chem.%26date%3D2007%26volume%3D9%26spage%3D20%26epage%3D28" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group">Foti, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grassi, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Risitano, F.</span><span> </span><span class="NLM_article-title">First synthesis of a bromonitrilimine. Direct formation of 3-bromopyrazole derivatives</span> <span class="citation_source-journal">Tetrahedron Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">40</span><span class="NLM_x">, </span> <span class="NLM_fpage">2605</span><span class="NLM_x">–</span> <span class="NLM_lpage">2606</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=1999&pages=2605-2606&author=F.+Fotiauthor=G.+Grassiauthor=F.+Risitano&title=First+synthesis+of+a+bromonitrilimine.+Direct+formation+of+3-bromopyrazole+derivatives"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFoti%26aufirst%3DF.%26aulast%3DGrassi%26aufirst%3DG.%26aulast%3DRisitano%26aufirst%3DF.%26atitle%3DFirst%2520synthesis%2520of%2520a%2520bromonitrilimine.%2520Direct%2520formation%2520of%25203-bromopyrazole%2520derivatives%26jtitle%3DTetrahedron%2520Lett.%26date%3D1999%26volume%3D40%26spage%3D2605%26epage%3D2606" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group">Freudenberger, J. H.; Lahm, G. P.; Selby, T. P.; Stevenson, T. M.</span><span> </span><span class="NLM_article-title">Substituted Dihydro 3-Halo-1<i>H</i>-pyrazole-5-carboxylates Their Preparation and Use</span>. WO 03/016283, February 27,<span class="NLM_x"> </span><span class="NLM_year">2003</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2003&author=J.+H.+Freudenberger&author=G.+P.+Lahm&author=T.+P.+Selby&author=T.+M.+Stevenson&title=Substituted+Dihydro+3-Halo-1H-pyrazole-5-carboxylates+Their+Preparation+and+Use"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DFreudenberger%26aufirst%3DJ.%2BH.%26atitle%3DSubstituted%2520Dihydro%25203-Halo-1H-pyrazole-5-carboxylates%2520Their%2520Preparation%2520and%2520Use%26date%3D2003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Jamieson, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moir, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rankovic, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wishart, G.</span><span> </span><span class="NLM_article-title">Medicinal chemistry of hERG optimizations: highlights and hang-ups</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">5029</span><span class="NLM_x">–</span> <span class="NLM_lpage">5046</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2006&pages=5029-5046&author=C.+Jamiesonauthor=E.+M.+Moirauthor=Z.+Rankovicauthor=G.+Wishart&title=Medicinal+chemistry+of+hERG+optimizations%3A+highlights+and+hang-ups"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DJamieson%26aufirst%3DC.%26aulast%3DMoir%26aufirst%3DE.%2BM.%26aulast%3DRankovic%26aufirst%3DZ.%26aulast%3DWishart%26aufirst%3DG.%26atitle%3DMedicinal%2520chemistry%2520of%2520hERG%2520optimizations%253A%2520highlights%2520and%2520hang-ups%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D17%26spage%3D5029%26epage%3D5046" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit17b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Jalaie, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holsworth, D. D.</span><span> </span><span class="NLM_article-title">QT interval prolongation: and the beat goes on</span> <span class="citation_source-journal">Mini-Rev. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">1083</span><span class="NLM_x">–</span> <span class="NLM_lpage">1091</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2005&pages=1083-1091&author=M.+Jalaieauthor=D.+D.+Holsworth&title=QT+interval+prolongation%3A+and+the+beat+goes+on"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DJalaie%26aufirst%3DM.%26aulast%3DHolsworth%26aufirst%3DD.%2BD.%26atitle%3DQT%2520interval%2520prolongation%253A%2520and%2520the%2520beat%2520goes%2520on%26jtitle%3DMini-Rev.%2520Med.%2520Chem.%26date%3D2005%26volume%3D5%26spage%3D1083%26epage%3D1091" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit17c"><span><span class="NLM_label">(c) </span><div class="note"><p class="first last">The dofetilide assay was performed as previously reported: </p></div><span class="NLM_contrib-group">Singleton, D. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boyd, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steidl-Nichols, J. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deacon, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Groot, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Price, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nettleton, D. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wallace, N. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Troutman, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boyd, J. G.</span><span> </span><span class="NLM_article-title">Fluorescently labeled analogues of dofetilide as high-affinity fluorescence polarization ligands for the human ether-a-go-go-related gene (hERG) channel</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">2931</span><span class="NLM_x">–</span> <span class="NLM_lpage">2941</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm0700565" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2007&pages=2931-2941&author=D.+H.+Singletonauthor=H.+Boydauthor=J.+V.+Steidl-Nicholsauthor=M.+Deaconauthor=M.+J.+de+Grootauthor=D.+Priceauthor=D.+O.+Nettletonauthor=N.+K.+Wallaceauthor=M.+D.+Troutmanauthor=C.+Williamsauthor=J.+G.+Boyd&title=Fluorescently+labeled+analogues+of+dofetilide+as+high-affinity+fluorescence+polarization+ligands+for+the+human+ether-a-go-go-related+gene+%28hERG%29+channel"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17c&amp;dbid=16384&amp;doi=10.1021%2Fjm0700565&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0700565%26sid%3Dliteratum%253Aachs%26aulast%3DSingleton%26aufirst%3DD.%2BH.%26aulast%3DBoyd%26aufirst%3DH.%26aulast%3DSteidl-Nichols%26aufirst%3DJ.%2BV.%26aulast%3DDeacon%26aufirst%3DM.%26aulast%3Dde%2BGroot%26aufirst%3DM.%2BJ.%26aulast%3DPrice%26aufirst%3DD.%26aulast%3DNettleton%26aufirst%3DD.%2BO.%26aulast%3DWallace%26aufirst%3DN.%2BK.%26aulast%3DTroutman%26aufirst%3DM.%2BD.%26aulast%3DWilliams%26aufirst%3DC.%26aulast%3DBoyd%26aufirst%3DJ.%2BG.%26atitle%3DFluorescently%2520labeled%2520analogues%2520of%2520dofetilide%2520as%2520high-affinity%2520fluorescence%2520polarization%2520ligands%2520for%2520the%2520human%2520ether-a-go-go-related%2520gene%2520%2528hERG%2529%2520channel%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2007%26volume%3D50%26spage%3D2931%26epage%3D2941" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit17d"><span><span class="NLM_label">(d) </span><div class="note"><p class="first last">The hERG patch-clamp assay was performed as previously reported: </p></div><span class="NLM_contrib-group">Volberg, W. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koci, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Su, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zho, J.</span><span> </span><span class="NLM_article-title">Blockade of human cardiac potassium channel human ether-a-go-go-related gene (HERG) by macrolide antibiotics</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">302</span><span class="NLM_x">, </span> <span class="NLM_fpage">320</span><span class="NLM_x">–</span> <span class="NLM_lpage">327</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17d&amp;dbid=16&amp;doi=10.1021%2Fjm100505n&amp;key=10.1124%2Fjpet.302.1.320" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17d&amp;dbid=8&amp;doi=10.1021%2Fjm100505n&amp;key=12065733" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17d&amp;dbid=32&amp;doi=10.1021%2Fjm100505n&amp;key=1%3ACAS%3A528%3ADC%252BD38Xlt1SnsL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=302&publication_year=2002&pages=320-327&author=W.+A.+Volbergauthor=B.+J.+Kociauthor=W.+Suauthor=J.+Linauthor=J.+Zho&title=Blockade+of+human+cardiac+potassium+channel+human+ether-a-go-go-related+gene+%28HERG%29+by+macrolide+antibiotics"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17dR"><div class="casContent"><span class="casTitleNuber">17d</span><div class="casTitle"><span class="NLM_cas:atitle">Blockade of human cardiac potassium channel human ether-a-go-go-related gene (HERG) by macrolide antibiotics</span></div><div class="casAuthors">Volberg, Walter A.; Koci, Bryan J.; Su, Weiguo; Lin, Jing; Zhou, Jun</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">302</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">320-327</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Several macrolides have been reported to cause QT prolongation and ventricular arrhythmias such as torsades de pointes.  To clarify the underlying ionic mechanisms, we examd. the effects of six macrolides on the human ether-a-go-go-related gene (HERG)-encoded potassium current stably expressed in human embryonic kidney-293 cells.  All six drugs showed a concn.-dependent inhibition of the current with the following IC50 values: clarithromycin, 32.9 μM; roxithromycin, 36.5 μM; erythromycin, 72.2 μM; josamycin, 102.4 μM; erythromycylamine, 273.9 μM; and oleandomycin, 339.6 μM.  A metabolite of erythromycin, des-Me erythromycin, was also found to inhibit HERG current with an IC50 of 147.1 μM.  These findings imply that the blockade of HERG may be a common feature of macrolides and may contribute to the QT prolongation obsd. clin. with some of these compds.  Mechanistic studies showed that inhibition of HERG current by clarithromycin did not require activation of the channel and was both voltage- and time-dependent.  The blocking time course could be described by a first-order reaction between the drug and the channel.  Both binding and unbinding processes appeared to speed up as the membrane was more depolarized, indicating that the drug-channel interaction may be affected by electrostatic responses.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqaR7kRksuR47Vg90H21EOLACvtfcHk0lh8Z5CagsqnbA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38Xlt1SnsL4%253D&md5=313db7019efd02abcf6f40db06a433b0</span></div><a href="/servlet/linkout?suffix=cit17d&amp;dbid=16384&amp;doi=10.1124%2Fjpet.302.1.320&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.302.1.320%26sid%3Dliteratum%253Aachs%26aulast%3DVolberg%26aufirst%3DW.%2BA.%26aulast%3DKoci%26aufirst%3DB.%2BJ.%26aulast%3DSu%26aufirst%3DW.%26aulast%3DLin%26aufirst%3DJ.%26aulast%3DZho%26aufirst%3DJ.%26atitle%3DBlockade%2520of%2520human%2520cardiac%2520potassium%2520channel%2520human%2520ether-a-go-go-related%2520gene%2520%2528HERG%2529%2520by%2520macrolide%2520antibiotics%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2002%26volume%3D302%26spage%3D320%26epage%3D327" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group">Li, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suino, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Daugherty, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, H. E.</span><span> </span><span class="NLM_article-title">Structural and biochemical mechanisms for the specificity of hormone binding and coactivator assembly by mineralocorticoid receptor</span> <span class="citation_source-journal">Mol. Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">367</span><span class="NLM_x">–</span> <span class="NLM_lpage">380</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2005&pages=367-380&author=Y.+Liauthor=K.+Suinoauthor=J.+Daughertyauthor=H.+E.+Xu&title=Structural+and+biochemical+mechanisms+for+the+specificity+of+hormone+binding+and+coactivator+assembly+by+mineralocorticoid+receptor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DY.%26aulast%3DSuino%26aufirst%3DK.%26aulast%3DDaugherty%26aufirst%3DJ.%26aulast%3DXu%26aufirst%3DH.%2BE.%26atitle%3DStructural%2520and%2520biochemical%2520mechanisms%2520for%2520the%2520specificity%2520of%2520hormone%2520binding%2520and%2520coactivator%2520assembly%2520by%2520mineralocorticoid%2520receptor%26jtitle%3DMol.%2520Cell%26date%3D2005%26volume%3D19%26spage%3D367%26epage%3D380" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Sun, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robl, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, T. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuhns, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lupisella, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beehler, B. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Golla, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sleph, P. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seethala, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fura, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krystek, S. R.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">An, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malley, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sack, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salvati, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grover, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ostrowski, J. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamann, L. G.</span><span> </span><span class="NLM_article-title">Discovery of potent, orally-active, and muscle-selective androgen receptor modulators based on an <i>N</i>-aryl-hydroxybicyclohydantoin scaffold</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">7596</span><span class="NLM_x">–</span> <span class="NLM_lpage">7599</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm061101w" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=7596-7599&author=C.+Sunauthor=J.+A.+Roblauthor=T.+C.+Wangauthor=Y.+Huangauthor=J.+E.+Kuhnsauthor=J.+A.+Lupisellaauthor=B.+C.+Beehlerauthor=R.+Gollaauthor=P.+G.+Slephauthor=R.+Seethalaauthor=A.+Furaauthor=S.+R.+Krystekauthor=Y.+Anauthor=M.+F.+Malleyauthor=J.+S.+Sackauthor=M.+E.+Salvatiauthor=G.+J.+Groverauthor=J.+O.+Ostrowskiauthor=L.+G.+Hamann&title=Discovery+of+potent%2C+orally-active%2C+and+muscle-selective+androgen+receptor+modulators+based+on+an+N-aryl-hydroxybicyclohydantoin+scaffold"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19a&amp;dbid=16384&amp;doi=10.1021%2Fjm061101w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm061101w%26sid%3Dliteratum%253Aachs%26aulast%3DSun%26aufirst%3DC.%26aulast%3DRobl%26aufirst%3DJ.%2BA.%26aulast%3DWang%26aufirst%3DT.%2BC.%26aulast%3DHuang%26aufirst%3DY.%26aulast%3DKuhns%26aufirst%3DJ.%2BE.%26aulast%3DLupisella%26aufirst%3DJ.%2BA.%26aulast%3DBeehler%26aufirst%3DB.%2BC.%26aulast%3DGolla%26aufirst%3DR.%26aulast%3DSleph%26aufirst%3DP.%2BG.%26aulast%3DSeethala%26aufirst%3DR.%26aulast%3DFura%26aufirst%3DA.%26aulast%3DKrystek%26aufirst%3DS.%2BR.%26aulast%3DAn%26aufirst%3DY.%26aulast%3DMalley%26aufirst%3DM.%2BF.%26aulast%3DSack%26aufirst%3DJ.%2BS.%26aulast%3DSalvati%26aufirst%3DM.%2BE.%26aulast%3DGrover%26aufirst%3DG.%2BJ.%26aulast%3DOstrowski%26aufirst%3DJ.%2BO.%26aulast%3DHamann%26aufirst%3DL.%2BG.%26atitle%3DDiscovery%2520of%2520potent%252C%2520orally-active%252C%2520and%2520muscle-selective%2520androgen%2520receptor%2520modulators%2520based%2520on%2520an%2520N-aryl-hydroxybicyclohydantoin%2520scaffold%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D7596%26epage%3D7599" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit19b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Nirschl, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zou, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krystek, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sutton, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simpkins, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lupisella, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuhns, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seethala, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Golla, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sleph, P. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beehler, B. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grover, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Egan, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fura, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vyas, V. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Y. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sack, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kish, K. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">An, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bryson, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gougoutas, J. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DiMarco, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zahler, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ostrowski, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamann, L. G.</span><span> </span><span class="NLM_article-title"><i>N</i>-Aryl-oxazolidin-2-imine muscle selective androgen receptor modulators enhance potency through pharmacophore reorientation</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">2794</span><span class="NLM_x">–</span> <span class="NLM_lpage">2798</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm801583j" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=2794-2798&author=A.+A.+Nirschlauthor=Y.+Zouauthor=S.+R.+Krystekauthor=J.+C.+Suttonauthor=L.+M.+Simpkinsauthor=J.+A.+Lupisellaauthor=J.+E.+Kuhnsauthor=R.+Seethalaauthor=R.+Gollaauthor=P.+G.+Slephauthor=B.+C.+Beehlerauthor=G.+J.+Groverauthor=D.+Eganauthor=A.+Furaauthor=V.+P.+Vyasauthor=Y.+X.+Liauthor=J.+S.+Sackauthor=K.+F.+Kishauthor=Y.+Anauthor=J.+A.+Brysonauthor=J.+Z.+Gougoutasauthor=J.+DiMarcoauthor=R.+Zahlerauthor=J.+Ostrowskiauthor=L.+G.+Hamann&title=N-Aryl-oxazolidin-2-imine+muscle+selective+androgen+receptor+modulators+enhance+potency+through+pharmacophore+reorientation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19b&amp;dbid=16384&amp;doi=10.1021%2Fjm801583j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm801583j%26sid%3Dliteratum%253Aachs%26aulast%3DNirschl%26aufirst%3DA.%2BA.%26aulast%3DZou%26aufirst%3DY.%26aulast%3DKrystek%26aufirst%3DS.%2BR.%26aulast%3DSutton%26aufirst%3DJ.%2BC.%26aulast%3DSimpkins%26aufirst%3DL.%2BM.%26aulast%3DLupisella%26aufirst%3DJ.%2BA.%26aulast%3DKuhns%26aufirst%3DJ.%2BE.%26aulast%3DSeethala%26aufirst%3DR.%26aulast%3DGolla%26aufirst%3DR.%26aulast%3DSleph%26aufirst%3DP.%2BG.%26aulast%3DBeehler%26aufirst%3DB.%2BC.%26aulast%3DGrover%26aufirst%3DG.%2BJ.%26aulast%3DEgan%26aufirst%3DD.%26aulast%3DFura%26aufirst%3DA.%26aulast%3DVyas%26aufirst%3DV.%2BP.%26aulast%3DLi%26aufirst%3DY.%2BX.%26aulast%3DSack%26aufirst%3DJ.%2BS.%26aulast%3DKish%26aufirst%3DK.%2BF.%26aulast%3DAn%26aufirst%3DY.%26aulast%3DBryson%26aufirst%3DJ.%2BA.%26aulast%3DGougoutas%26aufirst%3DJ.%2BZ.%26aulast%3DDiMarco%26aufirst%3DJ.%26aulast%3DZahler%26aufirst%3DR.%26aulast%3DOstrowski%26aufirst%3DJ.%26aulast%3DHamann%26aufirst%3DL.%2BG.%26atitle%3DN-Aryl-oxazolidin-2-imine%2520muscle%2520selective%2520androgen%2520receptor%2520modulators%2520enhance%2520potency%2520through%2520pharmacophore%2520reorientation%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D2794%26epage%3D2798" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit19c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Bohl, C. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mohler, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hwang, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mustafa, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, D. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bell, C. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dalton, J. T.</span><span> </span><span class="NLM_article-title">Effect of B-ring substitution pattern on binding mode of propionamide selective androgen receptor modulators</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">5567</span><span class="NLM_x">–</span> <span class="NLM_lpage">5570</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2008&pages=5567-5570&author=C.+E.+Bohlauthor=Z.+Wuauthor=J.+Chenauthor=M.+L.+Mohlerauthor=J.+Yangauthor=D.+J.+Hwangauthor=S.+Mustafaauthor=D.+D.+Millerauthor=C.+E.+Bellauthor=J.+T.+Dalton&title=Effect+of+B-ring+substitution+pattern+on+binding+mode+of+propionamide+selective+androgen+receptor+modulators"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBohl%26aufirst%3DC.%2BE.%26aulast%3DWu%26aufirst%3DZ.%26aulast%3DChen%26aufirst%3DJ.%26aulast%3DMohler%26aufirst%3DM.%2BL.%26aulast%3DYang%26aufirst%3DJ.%26aulast%3DHwang%26aufirst%3DD.%2BJ.%26aulast%3DMustafa%26aufirst%3DS.%26aulast%3DMiller%26aufirst%3DD.%2BD.%26aulast%3DBell%26aufirst%3DC.%2BE.%26aulast%3DDalton%26aufirst%3DJ.%2BT.%26atitle%3DEffect%2520of%2520B-ring%2520substitution%2520pattern%2520on%2520binding%2520mode%2520of%2520propionamide%2520selective%2520androgen%2520receptor%2520modulators%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2008%26volume%3D18%26spage%3D5567%26epage%3D5570" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit19d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Ostrowski, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuhns, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lupisella, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Manfredi, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beehler, B. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krystek, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bi, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seethala, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Golla, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sleph, P. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fura, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">An, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kish, K. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sack, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mookhtiar, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grover, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamann, L. G.</span><span> </span><span class="NLM_article-title">Pharmacological and X-ray structural characterization of a novel selective androgen receptor modulator: potent hyperanabolic stimulation of skeletal muscle with hypostimulation of prostate in rats</span> <span class="citation_source-journal">Endocrinolgy</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">148</span><span class="NLM_x">, </span> <span class="NLM_fpage">4</span><span class="NLM_x">–</span> <span class="NLM_lpage">12</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19d&amp;dbid=16&amp;doi=10.1021%2Fjm100505n&amp;key=10.1210%2Fen.2006-0843" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19d&amp;dbid=8&amp;doi=10.1021%2Fjm100505n&amp;key=17008401" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19d&amp;dbid=32&amp;doi=10.1021%2Fjm100505n&amp;key=1%3ACAS%3A528%3ADC%252BD2sXjsV2kug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=148&publication_year=2007&pages=4-12&author=J.+Ostrowskiauthor=J.+E.+Kuhnsauthor=J.+A.+Lupisellaauthor=M.+C.+Manfrediauthor=B.+C.+Beehlerauthor=S.+R.+Krystekauthor=Y.+Biauthor=C.+Sunauthor=R.+Seethalaauthor=R.+Gollaauthor=P.+G.+Slephauthor=A.+Furaauthor=Y.+Anauthor=K.+F.+Kishauthor=J.+S.+Sackauthor=K.+A.+Mookhtiarauthor=G.+J.+Groverauthor=L.+G.+Hamann&title=Pharmacological+and+X-ray+structural+characterization+of+a+novel+selective+androgen+receptor+modulator%3A+potent+hyperanabolic+stimulation+of+skeletal+muscle+with+hypostimulation+of+prostate+in+rats"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19dR"><div class="casContent"><span class="casTitleNuber">19d</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacological and X-ray structural characterization of a novel selective androgen receptor modulator: potent hyperanabolic stimulation of skeletal muscle with hypostimulation of prostate in rats</span></div><div class="casAuthors">Ostrowski, Jacek; Kuhns, Joyce E.; Lupisella, John A.; Manfredi, Mark C.; Beehler, Blake C.; Krystek, Stanley R., Jr.; Bi, Yingzhi; Sun, Chongqing; Seethala, Ramakrishna; Golla, Rajasree; Sleph, Paul G.; Fura, Aberra; An, Yongmi; Kish, Kevin F.; Sack, John S.; Mookhtiar, Kasim A.; Grover, Gary J.; Hamann, Lawrence G.</div><div class="citationInfo"><span class="NLM_cas:title">Endocrinology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">148</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">4-12</span>CODEN:
                <span class="NLM_cas:coden">ENDOAO</span>;
        ISSN:<span class="NLM_cas:issn">0013-7227</span>.
    
            (<span class="NLM_cas:orgname">Endocrine Society</span>)
        </div><div class="casAbstract">A novel, highly potent, orally active, nonsteroidal tissue selective androgen receptor (AR) modulator (BMS-564929) has been identified, and this compd. has been advanced to clin. trials for the treatment of age-related functional decline.  BMS-564929 is a subnanomolar AR agonist in vitro, is highly selective for the AR vs. other steroid hormone receptors, and exhibits no significant interactions with SHBG or aromatase.  Dose response studies in castrated male rats show that BMS-564929 is substantially more potent than testosterone (T) in stimulating the growth of the levator ani muscle, and unlike T, highly selective for muscle vs. prostate.  Key differences in the binding interactions of BMS-564929 with the AR relative to the native hormones were revealed through x-ray crystallog., including several unique contacts located in specific helixes of the ligand binding domain important for coregulatory protein recruitment.  Results from addnl. pharmacol. studies effectively exclude alternative mechanistic contributions to the obsd. tissue selectivity of this unique, orally active androgen.  Because concerns regarding the potential hyperstimulatory effects on prostate and an inconvenient route of administration are major drawbacks that limit the clin. use of T, the potent oral activity and tissue selectivity exhibited by BMS-564929 are expected to yield a clin. profile that provides the demonstrated beneficial effects of T in muscle and other tissues with a more favorable safety window.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoPlMZ4uH6ck7Vg90H21EOLACvtfcHk0liaTSNo1frb9A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXjsV2kug%253D%253D&md5=ae52cf587505a3f2e4debf60f9a885d9</span></div><a href="/servlet/linkout?suffix=cit19d&amp;dbid=16384&amp;doi=10.1210%2Fen.2006-0843&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1210%252Fen.2006-0843%26sid%3Dliteratum%253Aachs%26aulast%3DOstrowski%26aufirst%3DJ.%26aulast%3DKuhns%26aufirst%3DJ.%2BE.%26aulast%3DLupisella%26aufirst%3DJ.%2BA.%26aulast%3DManfredi%26aufirst%3DM.%2BC.%26aulast%3DBeehler%26aufirst%3DB.%2BC.%26aulast%3DKrystek%26aufirst%3DS.%2BR.%26aulast%3DBi%26aufirst%3DY.%26aulast%3DSun%26aufirst%3DC.%26aulast%3DSeethala%26aufirst%3DR.%26aulast%3DGolla%26aufirst%3DR.%26aulast%3DSleph%26aufirst%3DP.%2BG.%26aulast%3DFura%26aufirst%3DA.%26aulast%3DAn%26aufirst%3DY.%26aulast%3DKish%26aufirst%3DK.%2BF.%26aulast%3DSack%26aufirst%3DJ.%2BS.%26aulast%3DMookhtiar%26aufirst%3DK.%2BA.%26aulast%3DGrover%26aufirst%3DG.%2BJ.%26aulast%3DHamann%26aufirst%3DL.%2BG.%26atitle%3DPharmacological%2520and%2520X-ray%2520structural%2520characterization%2520of%2520a%2520novel%2520selective%2520androgen%2520receptor%2520modulator%253A%2520potent%2520hyperanabolic%2520stimulation%2520of%2520skeletal%2520muscle%2520with%2520hypostimulation%2520of%2520prostate%2520in%2520rats%26jtitle%3DEndocrinolgy%26date%3D2007%26volume%3D148%26spage%3D4%26epage%3D12" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit19e"><span><span class="NLM_label">(e) </span><span class="NLM_contrib-group">Bohl, C. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gao, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, D. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bell, C. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dalton, J. T.</span><span> </span><span class="NLM_article-title">Structural basis for antagonism and resistance of bicalutamide in prostate cancer</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">102</span><span class="NLM_x">, </span> <span class="NLM_fpage">6201</span><span class="NLM_x">–</span> <span class="NLM_lpage">6206</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19e&amp;dbid=16&amp;doi=10.1021%2Fjm100505n&amp;key=10.1073%2Fpnas.0500381102" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19e&amp;dbid=8&amp;doi=10.1021%2Fjm100505n&amp;key=15833816" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19e&amp;dbid=32&amp;doi=10.1021%2Fjm100505n&amp;key=1%3ACAS%3A528%3ADC%252BD2MXkt1ClsLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=102&publication_year=2005&pages=6201-6206&author=C.+E.+Bohlauthor=W.+Gaoauthor=D.+D.+Millerauthor=C.+E.+Bellauthor=J.+T.+Dalton&title=Structural+basis+for+antagonism+and+resistance+of+bicalutamide+in+prostate+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19eR"><div class="casContent"><span class="casTitleNuber">19e</span><div class="casTitle"><span class="NLM_cas:atitle">Structural basis for antagonism and resistance of bicalutamide in prostate cancer</span></div><div class="casAuthors">Bohl, Casey E.; Gao, Wenqing; Miller, Duane D.; Bell, Charles E.; Dalton, James T.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">102</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">6201-6206</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Carcinoma of the prostate is the most commonly diagnosed cancer in men.  The current pharmacol. treatment of choice for progressive androgen-dependent prostate cancer is the nonsteroidal antiandrogen, bicalutamide, either as monotherapy or with adjuvant castration or LH-releasing hormone superagonists to block the synthesis of endogenous testosterone.  To date, no nonsteroidal or antagonist-bound androgen receptor (AR) structure is available.  The authors solved the x-ray crystal structure of the mutant W741L AR ligand-binding domain bound to R-bicalutamide at 1.8-Å resoln.  This mutation confers agonist activity to bicalutamide and is likely involved in bicalutamide withdrawal syndrome.  The three-dimensional structure demonstrates that the B ring of R-bicalutamide in the W741L mutant is accommodated at the location of the indole ring of Trp-741 in the WT AR bound to dihydrotestosterone.  Knowledge of the binding mechanism for R-bicalutamide will provide mol. rationale for the development of new antiandrogens and selective AR modulators.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrCQ1V6LCoc07Vg90H21EOLACvtfcHk0liaTSNo1frb9A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXkt1ClsLs%253D&md5=0ca230450eba66abd4136bfb95928ce0</span></div><a href="/servlet/linkout?suffix=cit19e&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0500381102&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0500381102%26sid%3Dliteratum%253Aachs%26aulast%3DBohl%26aufirst%3DC.%2BE.%26aulast%3DGao%26aufirst%3DW.%26aulast%3DMiller%26aufirst%3DD.%2BD.%26aulast%3DBell%26aufirst%3DC.%2BE.%26aulast%3DDalton%26aufirst%3DJ.%2BT.%26atitle%3DStructural%2520basis%2520for%2520antagonism%2520and%2520resistance%2520of%2520bicalutamide%2520in%2520prostate%2520cancer%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2005%26volume%3D102%26spage%3D6201%26epage%3D6206" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit19f"><span><span class="NLM_label">(f) </span><span class="NLM_contrib-group">Zhang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olland, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cohen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berrodin, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chippari, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Appavu, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilhem, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chopra, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fensome, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wrobel, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Unwalla, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lyttle, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Winneker, R. C.</span><span> </span><span class="NLM_article-title">Molecular and pharmacological properties of a potent and selective novel nonsteroidal progesterone receptor agonist tanaproget</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">280</span><span class="NLM_x">, </span> <span class="NLM_fpage">28468</span><span class="NLM_x">–</span> <span class="NLM_lpage">28475</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=280&publication_year=2005&pages=28468-28475&author=Z.+Zhangauthor=A.+M.+Ollandauthor=Y.+Zhuauthor=J.+Cohenauthor=T.+Berrodinauthor=S.+Chippariauthor=C.+Appavuauthor=S.+Liauthor=J.+Wilhemauthor=R.+Chopraauthor=A.+Fensomeauthor=P.+Zhangauthor=J.+Wrobelauthor=R.+J.+Unwallaauthor=C.+R.+Lyttleauthor=R.+C.+Winneker&title=Molecular+and+pharmacological+properties+of+a+potent+and+selective+novel+nonsteroidal+progesterone+receptor+agonist+tanaproget"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19f&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DZ.%26aulast%3DOlland%26aufirst%3DA.%2BM.%26aulast%3DZhu%26aufirst%3DY.%26aulast%3DCohen%26aufirst%3DJ.%26aulast%3DBerrodin%26aufirst%3DT.%26aulast%3DChippari%26aufirst%3DS.%26aulast%3DAppavu%26aufirst%3DC.%26aulast%3DLi%26aufirst%3DS.%26aulast%3DWilhem%26aufirst%3DJ.%26aulast%3DChopra%26aufirst%3DR.%26aulast%3DFensome%26aufirst%3DA.%26aulast%3DZhang%26aufirst%3DP.%26aulast%3DWrobel%26aufirst%3DJ.%26aulast%3DUnwalla%26aufirst%3DR.%2BJ.%26aulast%3DLyttle%26aufirst%3DC.%2BR.%26aulast%3DWinneker%26aufirst%3DR.%2BC.%26atitle%3DMolecular%2520and%2520pharmacological%2520properties%2520of%2520a%2520potent%2520and%2520selective%2520novel%2520nonsteroidal%2520progesterone%2520receptor%2520agonist%2520tanaproget%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2005%26volume%3D280%26spage%3D28468%26epage%3D28475" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group">Bledsoe, R. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Madauss, K. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holt, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Apolito, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lambert, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pearce, K. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stanley, T. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stewart, E. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trump, R. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Willson, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams., S. P.</span><span> </span><span class="NLM_article-title">A ligand-mediated hydrogen bond network required for the activation of the mineralocorticoid receptor</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">280</span><span class="NLM_x">, </span> <span class="NLM_fpage">31283</span><span class="NLM_x">–</span> <span class="NLM_lpage">31293</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Fjm100505n&amp;key=10.1074%2Fjbc.M504098200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Fjm100505n&amp;key=15967794" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Fjm100505n&amp;key=1%3ACAS%3A528%3ADC%252BD2MXpsVCmu7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=280&publication_year=2005&pages=31283-31293&author=R.+K.+Bledsoeauthor=K.+P.+Madaussauthor=J.+A.+Holtauthor=C.+J.+Apolitoauthor=M.+H.+Lambertauthor=K.+H.+Pearceauthor=T.+B.+Stanleyauthor=E.+L.+Stewartauthor=R.+P.+Trumpauthor=T.+M.+Willsonauthor=S.+P.+Williams.&title=A+ligand-mediated+hydrogen+bond+network+required+for+the+activation+of+the+mineralocorticoid+receptor"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">A Ligand-mediated Hydrogen Bond Network Required for the Activation of the Mineralocorticoid Receptor</span></div><div class="casAuthors">Bledsoe, Randy K.; Madauss, Kevin P.; Holt, Jason A.; Apolito, Christopher J.; Lambert, Millard H.; Pearce, Kenneth H.; Stanley, Thomas B.; Stewart, Eugene L.; Trump, Ryan P.; Willson, Timothy M.; Williams, Shawn P.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">280</span>
        (<span class="NLM_cas:issue">35</span>),
    <span class="NLM_cas:pages">31283-31293</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Ligand binding is the first step in hormone regulation of mineralocorticoid receptor (MR) activity.  Here, the authors report multiple crystal structures of MR (NR3C2) bound to both agonist and antagonists.  These structures combined with mutagenesis studies reveal that maximal receptor activation involves an intricate ligand-mediated hydrogen bond network with Asn770 which serves dual roles: stabilization of the loop preceding the C-terminal activation function-2 helix and direct contact with the hormone ligand.  In addn., most activating ligands hydrogen bond to Thr945 on helix 10.  Structural characterization of the naturally occurring S810L mutant explains how stabilization of a helix 3/helix 5 interaction can circumvent the requirement for this hydrogen bond network.  Taken together, these results explain the potency of MR activation by aldosterone, the weak activation induced by progesterone and the antihypertensive agent spironolactone, and the binding selectivity of cortisol over cortisone.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqE7HiXGk8tJLVg90H21EOLACvtfcHk0liaTSNo1frb9A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXpsVCmu7g%253D&md5=36afe797ab0337f5309aec7652f45012</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M504098200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M504098200%26sid%3Dliteratum%253Aachs%26aulast%3DBledsoe%26aufirst%3DR.%2BK.%26aulast%3DMadauss%26aufirst%3DK.%2BP.%26aulast%3DHolt%26aufirst%3DJ.%2BA.%26aulast%3DApolito%26aufirst%3DC.%2BJ.%26aulast%3DLambert%26aufirst%3DM.%2BH.%26aulast%3DPearce%26aufirst%3DK.%2BH.%26aulast%3DStanley%26aufirst%3DT.%2BB.%26aulast%3DStewart%26aufirst%3DE.%2BL.%26aulast%3DTrump%26aufirst%3DR.%2BP.%26aulast%3DWillson%26aufirst%3DT.%2BM.%26aulast%3DWilliams.%26aufirst%3DS.%2BP.%26atitle%3DA%2520ligand-mediated%2520hydrogen%2520bond%2520network%2520required%2520for%2520the%2520activation%2520of%2520the%2520mineralocorticoid%2520receptor%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2005%26volume%3D280%26spage%3D31283%26epage%3D31293" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group">Collins, P. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gasiecki, A. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perkins, W. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gullikson, G. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, P. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bauer, R. F.</span><span> </span><span class="NLM_article-title">18-Cycloalkyl analogues of enisoprost</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1989</span><span class="NLM_x">, </span> <span class="NLM_volume">32</span><span class="NLM_x">, </span> <span class="NLM_fpage">1001</span><span class="NLM_x">–</span> <span class="NLM_lpage">1006</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm00125a013" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=1989&pages=1001-1006&author=P.+W.+Collinsauthor=A.+F.+Gasieckiauthor=W.+E.+Perkinsauthor=G.+W.+Gulliksonauthor=P.+H.+Jonesauthor=R.+F.+Bauer&title=18-Cycloalkyl+analogues+of+enisoprost"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1021%2Fjm00125a013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00125a013%26sid%3Dliteratum%253Aachs%26aulast%3DCollins%26aufirst%3DP.%2BW.%26aulast%3DGasiecki%26aufirst%3DA.%2BF.%26aulast%3DPerkins%26aufirst%3DW.%2BE.%26aulast%3DGullikson%26aufirst%3DG.%2BW.%26aulast%3DJones%26aufirst%3DP.%2BH.%26aulast%3DBauer%26aufirst%3DR.%2BF.%26atitle%3D18-Cycloalkyl%2520analogues%2520of%2520enisoprost%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1989%26volume%3D32%26spage%3D1001%26epage%3D1006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group">Koch, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Biggers, M. S.</span><span> </span><span class="NLM_article-title">General preparation of 7-substituted 4-chromanones: synthesis of a potent aldose reductase inhibitor</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">59</span><span class="NLM_x">, </span> <span class="NLM_fpage">1216</span><span class="NLM_x">–</span> <span class="NLM_lpage">1218</span></span><div class="citationLinks">[<a href="/doi/10.1021/jo00084a050" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=1994&pages=1216-1218&author=K.+Kochauthor=M.+S.+Biggers&title=General+preparation+of+7-substituted+4-chromanones%3A+synthesis+of+a+potent+aldose+reductase+inhibitor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1021%2Fjo00084a050&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo00084a050%26sid%3Dliteratum%253Aachs%26aulast%3DKoch%26aufirst%3DK.%26aulast%3DBiggers%26aufirst%3DM.%2BS.%26atitle%3DGeneral%2520preparation%2520of%25207-substituted%25204-chromanones%253A%2520synthesis%2520of%2520a%2520potent%2520aldose%2520reductase%2520inhibitor%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D1994%26volume%3D59%26spage%3D1216%26epage%3D1218" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group">Rodríguez-Iturbe, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferrebuz, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vanegas, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quiroz, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Espinoza, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pons, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vaziri, N. D.</span><span> </span><span class="NLM_article-title">Early treatment with cGMP phosphodiesterase inhibitor ameliorates progression of renal damage</span> <span class="citation_source-journal">Kidney Int.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">68</span><span class="NLM_x">, </span> <span class="NLM_fpage">2131</span><span class="NLM_x">–</span> <span class="NLM_lpage">2142</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Fjm100505n&amp;key=1%3ACAS%3A528%3ADC%252BD2MXht1SgtbbO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=68&publication_year=2005&pages=2131-2142&author=B.+Rodr%C3%ADguez-Iturbeauthor=A.+Ferrebuzauthor=V.+Vanegasauthor=Y.+Quirozauthor=F.+Espinozaauthor=H.+Ponsauthor=N.+D.+Vaziri&title=Early+treatment+with+cGMP+phosphodiesterase+inhibitor+ameliorates+progression+of+renal+damage"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Early treatment with cGMP phosphodiesterase inhibitor ameliorates progression of renal damage</span></div><div class="casAuthors">Rodriguez-Iturbe, Bernardo; Ferrebuz, Atilio; Vanegas, Valentina; Quiroz, Yasmir; Espinoza, Fabiana; Pons, Hector; Vaziri, Nosratola D.</div><div class="citationInfo"><span class="NLM_cas:title">Kidney International</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">68</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">2131-2142</span>CODEN:
                <span class="NLM_cas:coden">KDYIA5</span>;
        ISSN:<span class="NLM_cas:issn">0085-2538</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing, Inc.</span>)
        </div><div class="casAbstract">Chronic renal disease is assocd. with oxidative stress and reduced nitric oxide availability which, in turn, promotes hypertension and further progression of renal damage.  Most actions of nitric oxide are mediated by cyclic 3',5' guanosine monophosphate (cGMP) which is rapidly degraded by phosphodiesterases (PDE).  Therefore, we investigated if inhibition of PDE-5 would retard the progression of chronic renal failure.  We studied rats with 5/6 nephrectomy treated with sildenafil (2.5 mg/kg-1/day-1) in two exptl. protocols.  In the first protocol, we started sildenafil therapy immediately after renal ablation and continued treatment for 8 wk.  Control groups consisted of rats with renal ablation treated with drug-free vehicle and sham-operated rats with and without sildenafil treatment.  In these studies, sildenafil treatment prevented hypertension and deterioration of renal function, reduced histol. damage, inflammation and apoptosis, delayed the onset of proteinuria, and preserved renal capillary integrity.  In the second protocol we compared sildenafil with losartan (7.5 mg/kg-1/day-1) and the combination of both drugs in established renal disease, starting these drugs 4 wk after 5/6 nephrectomy.  Delayed sildenafil treatment failed to improve proteinuria and glomerulosclerosis but ameliorated hypertension and azotemia.  These observations suggest that currently available PDE-5 inhibitors have potential clin. value in the treatment of chronic renal disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpitMKMSUBemLVg90H21EOLACvtfcHk0lhUHSmHVHOwyw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXht1SgtbbO&md5=26fe2c91f38e675cdc2ec2081319491a</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRodr%25C3%25ADguez-Iturbe%26aufirst%3DB.%26aulast%3DFerrebuz%26aufirst%3DA.%26aulast%3DVanegas%26aufirst%3DV.%26aulast%3DQuiroz%26aufirst%3DY.%26aulast%3DEspinoza%26aufirst%3DF.%26aulast%3DPons%26aufirst%3DH.%26aulast%3DVaziri%26aufirst%3DN.%2BD.%26atitle%3DEarly%2520treatment%2520with%2520cGMP%2520phosphodiesterase%2520inhibitor%2520ameliorates%2520progression%2520of%2520renal%2520damage%26jtitle%3DKidney%2520Int.%26date%3D2005%26volume%3D68%26spage%3D2131%26epage%3D2142" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group">Sherman, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Day, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobson, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Friesner, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Farid, R.</span><span> </span><span class="NLM_article-title">Novel procedure for modeling ligand/receptor induced fit effects</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">534</span><span class="NLM_x">–</span> <span class="NLM_lpage">553</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm050540c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Fjm100505n&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtlCgsr7I" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=534-553&author=W.+Shermanauthor=T.+Dayauthor=M.+P.+Jacobsonauthor=R.+A.+Friesnerauthor=R.+Farid&title=Novel+procedure+for+modeling+ligand%2Freceptor+induced+fit+effects"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Novel Procedure for Modeling Ligand/Receptor Induced Fit Effects</span></div><div class="casAuthors">Sherman, Woody; Day, Tyler; Jacobson, Matthew P.; Friesner, Richard A.; Farid, Ramy</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">534-553</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">We present a novel protein-ligand docking method that accurately accounts for both ligand and receptor flexibility by iteratively combining rigid receptor docking (Glide) with protein structure prediction (Prime) techniques.  While traditional rigid-receptor docking methods are useful when the receptor structure does not change substantially upon ligand binding, success is limited when the protein must be "induced" into the correct binding conformation for a given ligand.  We provide an in-depth description of our novel methodol. and present results for 21 pharmaceutically relevant examples.  Traditional rigid-receptor docking for these 21 cases yields an av. RMSD of 5.5 Å.  The av. ligand RMSD for docking to a flexible receptor for the 21 pairs is 1.4 Å; the RMSD is ≤1.8 Å for 18 of the cases.  For the three cases with RMSDs greater than 1.8 Å, the core of the ligand is properly docked and all key protein/ligand interactions are captured.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqm3E6ctnPGSrVg90H21EOLACvtfcHk0lhUHSmHVHOwyw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtlCgsr7I&md5=388811ead5cee1fd460951263de486cb</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1021%2Fjm050540c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm050540c%26sid%3Dliteratum%253Aachs%26aulast%3DSherman%26aufirst%3DW.%26aulast%3DDay%26aufirst%3DT.%26aulast%3DJacobson%26aufirst%3DM.%2BP.%26aulast%3DFriesner%26aufirst%3DR.%2BA.%26aulast%3DFarid%26aufirst%3DR.%26atitle%3DNovel%2520procedure%2520for%2520modeling%2520ligand%252Freceptor%2520induced%2520fit%2520effects%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D534%26epage%3D553" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><div class="accessionCode mb-5"><div class="toolbar-section accession-codes"><ul><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2A3I" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2A3I','PDB','2A3I'); return false;">PDB: 2A3I</a></li></ul></div></div><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i143"><a href="/doi/suppl/10.1021/jm100505n">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_65474"></div></div></div></div></div><hr /></hr><p class="last">X-ray crystallographic data for compounds <b><i>R</i>-17</b> and <b>3<i>R</i>,3a<i>R</i>-27c</b> and combustion analysis data. This material is available free of charge via the Internet at <a class="extLink" href="http://pubs.acs.org">http://pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm100505n/suppl_file/jm100505n_si_001.pdf">jm100505n_si_001.pdf (83.66 kb)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Fjm100505n&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Barticle%3Aarticle%3A10.1021%2Fjm100505n%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2010.53.issue-16%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/jm100505n" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                3MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"6799de4cef0e32c1","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
